1	The	DT	O	the	det	3	SENT_1	[p1l474t188r583b249],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l644t175r955b251],
3	ENGLAND	NNP	LOCATION	ENGLAND	_	0	SENT_1	[p1l1008t174r1680b251],

1	JOURNAL	NN	O	journal	_	0	SENT_2	[p1l312t299r949b402],
2	of	IN	O	of	_	0	SENT_2	[p1l1014t313r1084b392],
3	MEDICINE	NNP	O	MEDICINE	prep_of	1	SENT_2	[p1l1125t299r1840b376],

1	ESTABLISHED	VBN	O	establish	_	0	SENT_3	[p1l318t481r520b499],
2	IN	IN	O	in	_	0	SENT_3	[p1l532t481r567b499],
3	1812	CD	DATE	1812	prep_in	1	SENT_3	[p1l580t481r647b499],

1	NOVEMBER	NNP	DATE	NOVEMBER	_	0	SENT_4	[p1l917t475r1151b499],
2	3	CD	DATE	3	num	1	SENT_4	[p1l1164t475r1196b506],
3	,	,	DATE	,	_	0	SENT_4	[p1l1164t475r1196b506],
4	2011	CD	DATE	2011	appos	1	SENT_4	[p1l1214t474r1307b499],

1	VOL	NNP	O	VOL	_	0	SENT_5	[p1l1577t481r1641b499],
2	.	.	O	.	_	0	SENT_5	[p1l1577t481r1641b499],

1	365	CD	NUMBER	365	_	0	SENT_6	[p1l1654t480r1703b500],
2	NO.	NNP	O	NO.	dep	1	SENT_6	[p1l1742t481r1795b499],
3	18	CD	NUMBER	18	num	2	SENT_6	[p1l1809t481r1840b499],

1	A	DT	O	a	det	3	SENT_7	[p1l599t597r645b646],
2	CFTR	NNP	O	CFTR	nn	3	SENT_7	[p1l672t596r848b650],
3	Potentiator	NNP	O	Potentiator	_	0	SENT_7	[p1l869t593r1205b647],
4	in	IN	O	in	_	0	SENT_7	[p1l1232t593r1289b646],
5	Patients	NNS	O	patient	prep_in	3	SENT_7	[p1l1317t593r1554b646],
6	with	IN	O	with	_	0	SENT_7	[p1l379t675r513b730],
7	Cystic	JJ	MISC	cystic	amod	8	SENT_7	[p1l542t676r721b745],
8	Fibrosis	NN	MISC	fibrosis	prep_with	3	SENT_7	[p1l749t675r989b730],
9	and	CC	O	and	_	0	SENT_7	[p1l1019t675r1129b730],
10	the	DT	O	the	det	12	SENT_7	[p1l1159t675r1250b730],
11	GSSID	NNP	MISC	GSSID	nn	12	SENT_7	[p1l1280t679r1472b729],
12	Mutation	NN	MISC	mutation	prep_with	3	SENT_7	[p1l1499t675r1776b730],

1	Bonnie	NNP	PERSON	Bonnie	nn	3	SENT_8	[p1l179t784r293b812],
2	W.	NNP	PERSON	W.	nn	3	SENT_8	[p1l304t784r345b812],
3	Ramsey	NNP	PERSON	Ramsey	_	0	SENT_8	[p1l361t784r494b822],
4	,	,	O	,	_	0	SENT_8	[p1l361t784r494b822],
5	M.D.	NNP	O	M.D.	appos	3	SENT_8	[p1l511t784r681b821],
6	,	,	O	,	_	0	SENT_8	[p1l511t784r681b821],
7	jane	NNP	PERSON	jane	nn	14	SENT_8	[p1l511t784r681b821],
8	Davies	NNP	PERSON	Davies	nn	14	SENT_8	[p1l696t784r812b818],
9	,	,	O	,	_	0	SENT_8	[p1l696t784r812b818],
10	M.D.	NNP	O	M.D.	appos	14	SENT_8	[p1l829t784r916b818],
11	,	,	O	,	_	0	SENT_8	[p1l829t784r916b818],
12	M.B.	NNP	LOCATION	M.B.	appos	14	SENT_8	[p1l932t784r1015b818],
13	,	,	O	,	_	0	SENT_8	[p1l932t784r1015b818],
14	Ch	NNP	O	Ch	appos	5	SENT_8	[p1l1029t781r1126b818],
15	.	.	O	.	_	0	SENT_8	[p1l1029t781r1126b818],

1	B.	NNP	O	B.	_	0	SENT_9	[p1l1029t781r1126b818],
2	,	,	O	,	_	0	SENT_9	[p1l1029t781r1126b818],
3	N.	NNP	PERSON	N.	nn	5	SENT_9	[p1l1142t784r1176b812],
4	Gerard	NNP	PERSON	Gerard	nn	5	SENT_9	[p1l1190t781r1302b812],
5	McElvaney	NNP	PERSON	McElvaney	dep	1	SENT_9	[p1l1319t781r1501b822],
6	,	,	O	,	_	0	SENT_9	[p1l1319t781r1501b822],
7	M.D.	NNP	O	M.D.	appos	5	SENT_9	[p1l1517t784r1604b818],
8	,	,	O	,	_	0	SENT_9	[p1l1517t784r1604b818],
9	Elizabeth	NNP	PERSON	Elizabeth	nn	10	SENT_9	[p1l1621t781r1768b812],
10	Tullis	NNP	PERSON	Tullis	appos	5	SENT_9	[p1l1780t781r1875b818],
11	,	,	O	,	_	0	SENT_9	[p1l1780t781r1875b818],
12	M.D.	NNP	O	M.D.	appos	5	SENT_9	[p1l1891t784r1978b818],
13	,	,	O	,	_	0	SENT_9	[p1l1891t784r1978b818],

1	Scott	NNP	PERSON	Scott	nn	3	SENT_10	[p1l229t833r313b861],
2	C.	NNP	PERSON	C.	nn	3	SENT_10	[p1l325t833r356b861],
3	Bell	NNP	PERSON	Bell	_	0	SENT_10	[p1l373t830r439b867],
4	,	,	O	,	_	0	SENT_10	[p1l373t830r439b867],
5	M.B.	NNP	LOCATION	M.B.	nn	12	SENT_10	[p1l455t833r538b867],
6	,	,	O	,	_	0	SENT_10	[p1l455t833r538b867],
7	B.S.	NNP	LOCATION	B.S.	appos	12	SENT_10	[p1l555t833r624b867],
8	,	,	O	,	_	0	SENT_10	[p1l555t833r624b867],
9	M.D.	NNP	O	M.D.	appos	12	SENT_10	[p1l641t833r728b867],
10	,	,	O	,	_	0	SENT_10	[p1l641t833r728b867],
11	Pavel	NNP	PERSON	Pavel	appos	12	SENT_10	[p1l744t830r825b862],
12	Dfevinek	NNP	PERSON	Dfevinek	dep	3	SENT_10	[p1l842t830r997b867],
13	,	,	O	,	_	0	SENT_10	[p1l842t830r997b867],
14	M.D.	NNP	O	M.D.	appos	12	SENT_10	[p1l1014t833r1101b867],
15	,	,	O	,	_	0	SENT_10	[p1l1014t833r1101b867],
16	Matthias	NNP	PERSON	Matthias	nn	17	SENT_10	[p1l1117t830r1261b861],
17	Griese	NNP	PERSON	Griese	appos	12	SENT_10	[p1l1274t833r1389b867],
18	,	,	O	,	_	0	SENT_10	[p1l1274t833r1389b867],
19	M.D.	NNP	O	M.D.	appos	12	SENT_10	[p1l1405t833r1492b867],
20	,	,	O	,	_	0	SENT_10	[p1l1405t833r1492b867],
21	Edward	NNP	PERSON	Edward	nn	23	SENT_10	[p1l1509t830r1627b862],
22	F.	NNP	PERSON	F.	nn	23	SENT_10	[p1l1644t833r1665b861],
23	McKone	NNP	PERSON	McKone	appos	12	SENT_10	[p1l1681t833r1824b867],
24	,	,	O	,	_	0	SENT_10	[p1l1681t833r1824b867],
25	M.D.	NNP	O	M.D.	appos	12	SENT_10	[p1l1840t833r1927b867],
26	,	,	O	,	_	0	SENT_10	[p1l1840t833r1927b867],

1	Claire	NNP	PERSON	Claire	nn	3	SENT_11	[p1l142t880r234b911],
2	E.	NNP	PERSON	E.	nn	3	SENT_11	[p1l249t883r274b911],
3	Wainwright	NNP	PERSON	Wainwright	_	0	SENT_11	[p1l286t880r486b921],
4	,	,	O	,	_	0	SENT_11	[p1l286t880r486b921],
5	M.D.	NNP	O	M.D.	nn	13	SENT_11	[p1l502t883r589b917],
6	,	,	O	,	_	0	SENT_11	[p1l502t883r589b917],
7	M.B.	NNP	LOCATION	M.B.	appos	13	SENT_11	[p1l606t883r689b917],
8	,	,	O	,	_	0	SENT_11	[p1l606t883r689b917],
9	B.S.	NNP	O	B.S.	appos	13	SENT_11	[p1l705t883r775b917],
10	,	,	O	,	_	0	SENT_11	[p1l705t883r775b917],
11	Michael	NNP	PERSON	Michael	appos	13	SENT_11	[p1l791t880r918b911],
12	W.	NNP	PERSON	W.	nn	13	SENT_11	[p1l931t883r971b911],
13	Konstan	NNP	PERSON	Konstan	appos	3	SENT_11	[p1l988t883r1130b917],
14	,	,	O	,	_	0	SENT_11	[p1l988t883r1130b917],
15	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l1146t883r1233b917],
16	,	,	O	,	_	0	SENT_11	[p1l1146t883r1233b917],
17	Richard	NNP	PERSON	Richard	nn	18	SENT_11	[p1l1250t880r1371b911],
18	Moss	NNP	PERSON	Moss	appos	3	SENT_11	[p1l1387t883r1484b917],
19	,	,	O	,	_	0	SENT_11	[p1l1387t883r1484b917],
20	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l1500t883r1587b917],
21	,	,	O	,	_	0	SENT_11	[p1l1500t883r1587b917],
22	Felix	NNP	PERSON	Felix	nn	23	SENT_11	[p1l1604t880r1675b911],
23	Ratjen	NNP	PERSON	Ratjen	appos	3	SENT_11	[p1l1689t883r1799b921],
24	,	,	O	,	_	0	SENT_11	[p1l1689t883r1799b921],
25	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l1815t883r1902b917],
26	,	,	O	,	_	0	SENT_11	[p1l1815t883r1902b917],
27	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_11	[p1l1918t880r2014b917],
28	,	,	O	,	_	0	SENT_11	[p1l1918t880r2014b917],
29	Isabelle	NNP	PERSON	Isabelle	nn	30	SENT_11	[p1l105t929r225b960],
30	Sermet-Gaudelus	NNP	PERSON	Sermet-Gaudelus	appos	3	SENT_11	[p1l237t929r533b966],
31	,	,	O	,	_	0	SENT_11	[p1l237t929r533b966],
32	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l549t932r635b966],
33	,	,	O	,	_	0	SENT_11	[p1l549t932r635b966],
34	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_11	[p1l650t929r744b966],
35	,	,	O	,	_	0	SENT_11	[p1l650t929r744b966],
36	Steven	NNP	PERSON	Steven	nn	38	SENT_11	[p1l758t932r864b960],
37	M.	NNP	PERSON	M.	nn	38	SENT_11	[p1l880t932r918b960],
38	Rowe	NNP	PERSON	Rowe	appos	3	SENT_11	[p1l934t932r1028b966],
39	,	,	O	,	_	0	SENT_11	[p1l934t932r1028b966],
40	M.D.	NNP	O	M.D.	appos	3	SENT_11	[p1l1044t932r1129b966],
41	,	,	O	,	_	0	SENT_11	[p1l1044t932r1129b966],
42	M.S.P.H.	NNP	ORGANIZATION	M.S.P.H.	appos	3	SENT_11	[p1l1145t932r1295b966],
43	,	,	O	,	_	0	SENT_11	[p1l1145t932r1295b966],
44	Qunming	NNP	PERSON	Qunming	nn	45	SENT_11	[p1l1308t932r1466b970],
45	Dong	NNP	PERSON	Dong	appos	3	SENT_11	[p1l1479t932r1575b970],
46	,	,	O	,	_	0	SENT_11	[p1l1479t932r1575b970],
47	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_11	[p1l1591t929r1685b966],
48	,	,	O	,	_	0	SENT_11	[p1l1591t929r1685b966],
49	Sally	NNP	PERSON	Sally	nn	52	SENT_11	[p1l1699t929r1771b970],
50	Rodriguez	NNP	PERSON	Rodriguez	nn	52	SENT_11	[p1l1784t929r1957b970],
51	,	,	O	,	_	0	SENT_11	[p1l1784t929r1957b970],
52	M.S.	NNP	LOCATION	M.S.	appos	3	SENT_11	[p1l1973t932r2053b966],
53	,	,	O	,	_	0	SENT_11	[p1l1973t932r2053b966],

1	Karl	NNP	PERSON	Karl	nn	2	SENT_12	[p1l226t979r285b1010],
2	Yen	NNP	PERSON	Yen	_	0	SENT_12	[p1l298t981r366b1016],
3	,	,	O	,	_	0	SENT_12	[p1l298t981r366b1016],
4	M.D.	NNP	O	M.D.	appos	2	SENT_12	[p1l383t981r470b1016],
5	,	,	O	,	_	0	SENT_12	[p1l383t981r470b1016],
6	Claudia	NNP	PERSON	Claudia	nn	7	SENT_12	[p1l484t979r607b1010],
7	Ordonez	NNP	PERSON	Ordonez	conj_and	4	SENT_12	[p1l620t979r775b1016],
8	,	,	O	,	_	0	SENT_12	[p1l620t979r775b1016],
9	M.D.	NNP	O	M.D.	appos	2	SENT_12	[p1l791t982r878b1016],
10	,	,	O	,	_	0	SENT_12	[p1l791t982r878b1016],
11	and	CC	O	and	_	0	SENT_12	[p1l892t979r983b1019],
12	]	NN	O	]	appos	2	SENT_12	[p1l892t979r983b1019],
13	.	.	O	.	_	0	SENT_12	[p1l892t979r983b1019],

1	Stuart	NNP	PERSON	Stuart	nn	2	SENT_13	[p1l997t981r1097b1010],
2	Elborn	NNP	PERSON	Elborn	_	0	SENT_13	[p1l1111t979r1225b1016],
3	,	,	O	,	_	0	SENT_13	[p1l1111t979r1225b1016],
4	M.D.	NNP	O	M.D.	appos	2	SENT_13	[p1l1241t982r1328b1016],
5	,	,	O	,	_	0	SENT_13	[p1l1241t982r1328b1016],
6	for	IN	O	for	_	0	SENT_13	[p1l1341t978r1387b1010],
7	the	DT	O	the	det	11	SENT_13	[p1l1397t979r1449b1010],
8	VX08	NN	O	vx08	nn	11	SENT_13	[p1l1460t981r1691b1010],
9	—	NN	O	—	nn	11	SENT_13	[p1l1460t981r1691b1010],
10	770	CD	NUMBER	770	num	11	SENT_13	[p1l1460t981r1691b1010],
11	—	NN	O	—	prep_for	2	SENT_13	[p1l1460t981r1691b1010],
12	102	CD	NUMBER	102	num	14	SENT_13	[p1l1460t981r1691b1010],
13	Study	NNP	O	Study	nn	14	SENT_13	[p1l1704t979r1797b1020],
14	Group	NNP	O	Group	dep	11	SENT_13	[p1l1808t981r1933b1020],
15	?	.	O	?	_	0	SENT_13	[p1l1808t981r1933b1020],
16	"	''	O	"	punct	2	SENT_13	[p1l1808t981r1933b1020],

1	ABSTRACT	NN	O	abstract	_	0	SENT_14	[p1l967t1086r1190b1109],

1	BAC	NN	O	bac	nn	7	SENT_15	[p1l94t1185r149b1204],
2	KG	NN	O	kg	nn	7	SENT_15	[p1l154t1185r190b1204],
3	R	NN	O	r	nn	7	SENT_15	[p1l197t1185r211b1204],
4	o	NN	O	o	nn	7	SENT_15	[p1l216t1185r237b1204],
5	u	NN	O	u	nn	7	SENT_15	[p1l242t1185r259b1204],
6	N	NN	O	n	nn	7	SENT_15	[p1l266t1185r283b1204],
7	D	NN	O	d	nsubj	25	SENT_15	[p1l291t1185r309b1204],
8	Increasing	VBG	O	increase	partmod	7	SENT_15	[p1l91t1218r264b1257],
9	the	DT	O	the	det	10	SENT_15	[p1l273t1218r324b1248],
10	activity	NN	O	activity	dobj	8	SENT_15	[p1l334t1218r451b1257],
11	of	IN	O	of	_	0	SENT_15	[p1l460t1218r498b1249],
12	defective	JJ	O	defective	amod	14	SENT_15	[p1l501t1218r644b1249],
13	cystic	JJ	O	cystic	amod	14	SENT_15	[p1l654t1218r744b1257],
14	ﬁbrosis	NN	O	ﬁbrosis	prep_of	10	SENT_15	[p1l754t1218r877b1249],
15	transmembrane	NN	O	transmembrane	nn	21	SENT_15	[p1l888t1218r1149b1249],
16	conductance	NN	O	conductance	nn	21	SENT_15	[p1l1159t1218r1365b1249],
17	regulator	NN	O	regulator	nn	21	SENT_15	[p1l1375t1218r1490b1257, p1l92t1274r139b1298],
18	(	CD	NUMBER	(	num	21	SENT_15	[p1l152t1270r266b1303],
19	CFTR	NNP	ORGANIZATION	CFTR	nn	21	SENT_15	[p1l152t1270r266b1303],
20	)	NN	O	)	nn	21	SENT_15	[p1l152t1270r266b1303],
21	protein	NN	O	protein	dep	14	SENT_15	[p1l280t1268r399b1306],
22	is	VBZ	O	be	cop	25	SENT_15	[p1l411t1268r436b1298],
23	a	DT	O	a	det	25	SENT_15	[p1l449t1278r466b1298],
24	potential	JJ	O	potential	amod	25	SENT_15	[p1l478t1268r625b1306],
25	treatment	NN	O	treatment	_	0	SENT_15	[p1l637t1274r798b1298],
26	for	IN	O	for	_	0	SENT_15	[p1l809t1267r856b1298],
27	cystic	JJ	O	cystic	amod	28	SENT_15	[p1l867t1268r958b1306],
28	fibrosis	NN	O	fibrosis	prep_for	25	SENT_15	[p1l970t1267r1102b1298],
29	.	.	O	.	_	0	SENT_15	[p1l970t1267r1102b1298],

1	M	NN	O	m	nn	3	SENT_16	[p1l95t1332r115b1351],
2	ETH	NN	O	eth	nn	3	SENT_16	[p1l123t1332r178b1351],
3	o	NN	O	o	nsubj	6	SENT_16	[p1l184t1332r205b1351],
4	as	IN	O	as	_	0	SENT_16	[p1l211t1332r247b1351],
5	We	PRP	O	we	prep_as	3	SENT_16	[p1l91t1376r141b1403],
6	conducted	VBD	O	conduct	_	0	SENT_16	[p1l151t1373r316b1403],
7	a	DT	O	a	nsubj	8	SENT_16	[p1l325t1383r342b1403],
8	randomized	VBN	O	randomize	ccomp	6	SENT_16	[p1l352t1373r554b1410],
9	,	,	O	,	_	0	SENT_16	[p1l352t1373r554b1410],
10	double-blind	JJ	O	double-blind	amod	13	SENT_16	[p1l566t1373r777b1410],
11	,	,	O	,	_	0	SENT_16	[p1l566t1373r777b1410],
12	placebo-controlled	JJ	O	placebo-controlled	amod	13	SENT_16	[p1l788t1373r1088b1412],
13	trial	NN	O	trial	dobj	8	SENT_16	[p1l1098t1373r1163b1403],
14	to	TO	O	to	aux	15	SENT_16	[p1l1173t1379r1204b1403],
15	evaluate	VB	O	evaluate	infmod	13	SENT_16	[p1l1214t1373r1343b1404],
16	ivacaftor	NN	O	ivacaftor	nn	19	SENT_16	[p1l1352t1372r1491b1403],
17	(	NN	O	(	nn	19	SENT_16	[p1l94t1425r239b1460],
18	VX-770	NN	O	vx-770	nn	19	SENT_16	[p1l94t1425r239b1460],
19	)	NN	O	)	dobj	15	SENT_16	[p1l94t1425r239b1460],
20	,	,	O	,	_	0	SENT_16	[p1l94t1425r239b1460],
21	a	DT	O	a	det	23	SENT_16	[p1l253t1433r270b1453],
22	CFTR	NNP	O	CFTR	nn	23	SENT_16	[p1l281t1425r378b1455],
23	potentiator	NN	O	potentiator	appos	19	SENT_16	[p1l385t1423r578b1462],
24	,	,	O	,	_	0	SENT_16	[p1l385t1423r578b1462],
25	in	IN	O	in	_	0	SENT_16	[p1l592t1423r624b1453],
26	subjects	NNS	O	subject	prep_in	19	SENT_16	[p1l636t1423r767b1462],
27	12	CD	DURATION	12	num	28	SENT_16	[p1l781t1425r818b1453],
28	years	NNS	NUMBER	year	tmod	26	SENT_16	[p1l829t1433r913b1462],
29	of	IN	O	of	_	0	SENT_16	[p1l926t1422r965b1453],
30	age	NN	O	age	prep_of	26	SENT_16	[p1l969t1433r1024b1462],
31	or	CC	O	or	_	0	SENT_16	[p1l1037t1433r1071b1453],
32	older	JJR	O	older	conj_or	8	SENT_16	[p1l1082t1423r1165b1453],
33	with	IN	O	with	_	0	SENT_16	[p1l1174t1423r1249b1453],
34	cystic	JJ	O	cystic	amod	35	SENT_16	[p1l1262t1423r1353b1462],
35	fibrosis	NN	O	fibrosis	prep_with	32	SENT_16	[p1l1365t1422r1489b1453],
36	and	CC	O	and	_	0	SENT_16	[p1l92t1473r153b1503],
37	at	IN	O	at	quantmod	39	SENT_16	[p1l166t1479r197b1503],
38	least	JJS	O	least	mwe	37	SENT_16	[p1l209t1473r286b1503],
39	one	CD	NUMBER	one	num	41	SENT_16	[p1l299t1483r357b1503],
40	GSSID-CFTR	NN	O	gssid-cftr	nn	41	SENT_16	[p1l372t1475r568b1504],
41	mutation	NN	O	mutation	conj_and	35	SENT_16	[p1l580t1473r741b1503],
42	.	.	O	.	_	0	SENT_16	[p1l580t1473r741b1503],

1	Subjects	NNS	O	subject	nsubjpass	4	SENT_17	[p1l758t1473r893b1512],
2	were	VBD	O	be	auxpass	4	SENT_17	[p1l906t1483r985b1503],
3	randomly	RB	O	randomly	advmod	4	SENT_17	[p1l999t1473r1160b1512],
4	assigned	VBN	O	assign	dep	14	SENT_17	[p1l1172t1473r1317b1512],
5	to	TO	O	to	aux	6	SENT_17	[p1l1332t1479r1363b1503],
6	receive	VB	O	receive	xcomp	4	SENT_17	[p1l1378t1473r1490b1503],
7	150	CD	NUMBER	150	num	8	SENT_17	[p1l93t1525r151b1553],
8	mg	NN	O	mg	dobj	6	SENT_17	[p1l166t1533r220b1562],
9	of	IN	O	of	_	0	SENT_17	[p1l234t1522r273b1553],
10	ivacaftor	NN	O	ivacaftor	prep_of	8	SENT_17	[p1l281t1522r427b1554],
11	every	DT	SET	every	det	13	SENT_17	[p1l441t1533r526b1562],
12	12	CD	SET	12	num	13	SENT_17	[p1l541t1525r579b1553],
13	hours	NNS	NUMBER	hour	tmod	6	SENT_17	[p1l594t1523r689b1554],
14	(	VBP	O	(	_	0	SENT_17	[p1l706t1525r756b1558],
15	84	CD	NUMBER	84	num	16	SENT_17	[p1l706t1525r756b1558],
16	subjects	NNS	O	subject	dobj	14	SENT_17	[p1l772t1523r913b1562],
17	,	,	O	,	_	0	SENT_17	[p1l772t1523r913b1562],
18	of	IN	O	of	_	0	SENT_17	[p1l930t1522r969b1553],
19	whom	WP	O	whom	rel	21	SENT_17	[p1l975t1523r1080b1554],
20	83	CD	NUMBER	83	nsubj	21	SENT_17	[p1l1096t1525r1133b1554],
21	received	VBN	O	receive	rcmod	16	SENT_17	[p1l1149t1523r1283b1554],
22	at	IN	O	at	quantmod	24	SENT_17	[p1l1298t1529r1328b1553],
23	least	JJS	O	least	mwe	22	SENT_17	[p1l1341t1523r1418b1553],
24	one	CD	NUMBER	one	num	26	SENT_17	[p1l1431t1533r1490b1553],
25	dose	NN	O	dose	nn	26	SENT_17	[p1l92t1573r177b1609],
26	)	NN	O	)	dobj	21	SENT_17	[p1l92t1573r177b1609],
27	or	CC	O	or	_	0	SENT_17	[p1l193t1583r227b1604],
28	placebo	NN	O	placebo	conj_or	26	SENT_17	[p1l239t1573r367b1612],
29	(	CD	NUMBER	(	num	30	SENT_17	[p1l382t1575r440b1610],
30	83	CD	NUMBER	83	nsubj	14	SENT_17	[p1l382t1575r440b1610],
31	,	,	O	,	_	0	SENT_17	[p1l382t1575r440b1610],
32	of	IN	O	of	_	0	SENT_17	[p1l456t1573r494b1604],
33	whom	WP	O	whom	rel	35	SENT_17	[p1l499t1573r604b1604],
34	78	CD	NUMBER	78	nsubj	35	SENT_17	[p1l618t1575r655b1604],
35	received	VBN	O	receive	rcmod	30	SENT_17	[p1l669t1573r803b1604],
36	at	IN	O	at	quantmod	38	SENT_17	[p1l816t1579r847b1604],
37	least	JJS	O	least	mwe	36	SENT_17	[p1l858t1573r935b1604],
38	one	CD	NUMBER	one	num	40	SENT_17	[p1l947t1583r1005b1604],
39	dose	NN	O	dose	nn	40	SENT_17	[p1l1019t1573r1104b1609],
40	)	NN	O	)	dobj	35	SENT_17	[p1l1019t1573r1104b1609],
41	for	IN	O	for	_	0	SENT_17	[p1l1119t1573r1167b1604],
42	48	CD	DURATION	48	num	43	SENT_17	[p1l1179t1575r1218b1604],
43	weeks	NNS	NUMBER	week	prep_for	40	SENT_17	[p1l1231t1573r1342b1604],
44	.	.	O	.	_	0	SENT_17	[p1l1231t1573r1342b1604],

1	The	DT	O	the	det	4	SENT_18	[p1l1356t1573r1418b1604],
2	primary	JJ	O	primary	amod	4	SENT_18	[p1l1431t1573r1490b1612, p1l92t1633r179b1663],
3	end	NN	O	end	nn	4	SENT_18	[p1l191t1623r250b1654],
4	point	NN	O	point	nsubj	9	SENT_18	[p1l262t1624r352b1663],
5	was	VBD	O	be	cop	9	SENT_18	[p1l361t1634r424b1654],
6	the	DT	O	the	det	9	SENT_18	[p1l439t1623r490b1654],
7	estimated	VBN	O	estimate	amod	9	SENT_18	[p1l503t1623r667b1654],
8	mean	JJ	O	mean	amod	9	SENT_18	[p1l680t1633r772b1654],
9	change	NN	O	change	_	0	SENT_18	[p1l786t1623r904b1663],
10	from	IN	O	from	_	0	SENT_18	[p1l917t1623r999b1654],
11	baseline	NN	O	baseline	prep_from	9	SENT_18	[p1l1012t1623r1149b1654],
12	through	IN	O	through	_	0	SENT_18	[p1l1162t1623r1297b1663],
13	week	NN	DATE	week	prep_through	11	SENT_18	[p1l1309t1623r1395b1655],
14	24	CD	DATE	24	num	13	SENT_18	[p1l1407t1626r1445b1654],
15	in	IN	O	in	_	0	SENT_18	[p1l1458t1624r1490b1654],
16	the	DT	O	the	det	17	SENT_18	[p1l92t1673r144b1704],
17	percent	NN	O	percent	prep_in	9	SENT_18	[p1l157t1680r282b1713],
18	of	IN	O	of	_	0	SENT_18	[p1l293t1673r332b1704],
19	predicted	VBN	O	predict	prepc_of	17	SENT_18	[p1l338t1673r494b1713],
20	forced	JJ	O	forced	amod	22	SENT_18	[p1l507t1673r612b1704],
21	expiratory	JJ	O	expiratory	amod	22	SENT_18	[p1l625t1674r796b1713],
22	volume	NN	O	volume	nsubj	28	SENT_18	[p1l805t1673r926b1704],
23	in	IN	O	in	_	0	SENT_18	[p1l939t1674r972b1704],
24	1	CD	DURATION	1	prep_in	22	SENT_18	[p1l986t1676r1003b1704],
25	second	JJ	NUMBER	second	amod	28	SENT_18	[p1l1018t1673r1133b1704],
26	(	NN	O	(	nn	28	SENT_18	[p1l1148t1676r1255b1714],
27	FEV1	NN	O	fev1	nn	28	SENT_18	[p1l1148t1676r1255b1714],
28	)	NN	O	)	xcomp	19	SENT_18	[p1l1148t1676r1255b1714],
29	.	.	O	.	_	0	SENT_18	[p1l1148t1676r1255b1714],

1	R	NN	O	r	nn	4	SENT_19	[p1l94t1739r108b1758],
2	ES	NN	O	e	nn	4	SENT_19	[p1l114t1738r146b1758],
3	u	NN	O	u	nn	4	SENT_19	[p1l151t1739r168b1758],
4	LTS	NN	O	lt	nsubj	19	SENT_19	[p1l175t1738r221b1758],
5	The	DT	O	the	det	6	SENT_19	[p1l91t1780r151b1811],
6	change	NN	O	change	dep	4	SENT_19	[p1l162t1780r276b1819],
7	from	IN	O	from	_	0	SENT_19	[p1l286t1780r365b1811],
8	baseline	NN	O	baseline	prep_from	6	SENT_19	[p1l375t1780r506b1811],
9	through	IN	O	through	_	0	SENT_19	[p1l516t1780r646b1819],
10	week	NN	DATE	week	prep_through	6	SENT_19	[p1l654t1780r738b1811],
11	24	CD	DATE	24	num	10	SENT_19	[p1l747t1782r784b1811],
12	in	IN	O	in	_	0	SENT_19	[p1l794t1781r826b1810],
13	the	DT	O	the	det	14	SENT_19	[p1l836t1780r886b1811],
14	percent	NN	O	percent	prep_in	4	SENT_19	[p1l896t1787r1015b1819],
15	of	IN	O	of	_	0	SENT_19	[p1l1024t1780r1062b1811],
16	predicted	VBN	O	predict	amod	17	SENT_19	[p1l1064t1780r1213b1819],
17	FEV1	NN	O	fev1	prep_of	14	SENT_19	[p1l1223t1783r1296b1821],
18	was	VBD	O	be	cop	19	SENT_19	[p1l1306t1790r1367b1811],
19	greater	JJR	O	greater	_	0	SENT_19	[p1l1379t1786r1491b1819],
20	by	IN	O	by	_	0	SENT_19	[p1l92t1830r129b1869],
21	10.6	CD	NUMBER	10.6	num	23	SENT_19	[p1l142t1833r206b1861],
22	percentage	NN	O	percentage	nn	23	SENT_19	[p1l219t1837r395b1870],
23	points	NNS	O	point	prep_by	19	SENT_19	[p1l407t1831r509b1869],
24	in	IN	O	in	_	0	SENT_19	[p1l522t1831r554b1861],
25	the	DT	O	the	det	27	SENT_19	[p1l567t1830r617b1861],
26	ivacaftor	NN	O	ivacaftor	nn	27	SENT_19	[p1l629t1830r770b1861],
27	group	NN	O	group	prep_in	23	SENT_19	[p1l782t1840r877b1870],
28	than	IN	O	than	advmod	23	SENT_19	[p1l891t1830r965b1861],
29	in	IN	O	in	_	0	SENT_19	[p1l977t1831r1009b1861],
30	the	DT	O	the	det	32	SENT_19	[p1l1022t1830r1072b1861],
31	placebo	NN	O	placebo	nn	32	SENT_19	[p1l1085t1830r1208b1869],
32	group	NN	O	group	prep_in	28	SENT_19	[p1l1221t1840r1317b1870],
33	(	CD	NUMBER	(	num	34	SENT_19	[p1l1332t1833r1488b1866],
34	P	NN	O	p	npadvmod	35	SENT_19	[p1l1332t1833r1488b1866],
35	<	JJR	O	<	amod	32	SENT_19	[p1l1332t1833r1488b1866],
36	0.001	CD	NUMBER	0.001	num	37	SENT_19	[p1l1332t1833r1488b1866],
37	)	NN	O	)	dep	23	SENT_19	[p1l1332t1833r1488b1866],
38	.	.	O	.	_	0	SENT_19	[p1l1332t1833r1488b1866],

1	Effects	NNS	O	effect	nsubjpass	6	SENT_20	[p1l91t1880r206b1911],
2	on	IN	O	on	_	0	SENT_20	[p1l220t1890r261b1911],
3	pulmonary	JJ	O	pulmonary	amod	4	SENT_20	[p1l273t1880r460b1919],
4	function	NN	O	function	prep_on	1	SENT_20	[p1l471t1880r614b1911],
5	were	VBD	O	be	auxpass	6	SENT_20	[p1l625t1890r704b1911],
6	noted	VBN	O	note	_	0	SENT_20	[p1l717t1880r811b1911],
7	by	IN	O	by	_	0	SENT_20	[p1l824t1880r862b1919],
8	2	CD	DURATION	2	num	9	SENT_20	[p1l873t1882r891b1910],
9	weeks	NNS	NUMBER	week	agent	6	SENT_20	[p1l903t1880r1014b1917],
10	,	,	O	,	_	0	SENT_20	[p1l903t1880r1014b1917],
11	and	CC	O	and	_	0	SENT_20	[p1l1029t1880r1091b1911],
12	a	DT	O	a	det	15	SENT_20	[p1l1103t1890r1121b1911],
13	significant	JJ	O	significant	amod	15	SENT_20	[p1l1134t1880r1316b1919],
14	treatment	NN	O	treatment	nn	15	SENT_20	[p1l1327t1886r1492b1911],
15	effect	NN	O	effect	nsubjpass	17	SENT_20	[p1l92t1930r186b1961],
16	was	VBD	O	be	auxpass	17	SENT_20	[p1l195t1940r259b1961],
17	maintained	VBN	O	maintain	conj_and	6	SENT_20	[p1l272t1930r465b1961],
18	through	IN	O	through	_	0	SENT_20	[p1l478t1930r613b1970],
19	week	NN	DURATION	week	prep_through	17	SENT_20	[p1l624t1930r711b1961],
20	48	CD	NUMBER	48	num	19	SENT_20	[p1l721t1932r771b1961],
21	.	.	O	.	_	0	SENT_20	[p1l721t1932r771b1961],

1	Subjects	NNS	O	subject	nsubj	8	SENT_21	[p1l786t1930r922b1969],
2	receiving	VBG	O	receive	partmod	1	SENT_21	[p1l935t1931r1087b1970],
3	ivacaftor	NN	O	ivacaftor	dobj	2	SENT_21	[p1l1098t1930r1245b1961],
4	were	VBD	O	be	cop	8	SENT_21	[p1l1254t1940r1333b1961],
5	55	CD	PERCENT	55	num	6	SENT_21	[p1l1346t1932r1417b1961],
6	%	NN	PERCENT	%	dep	8	SENT_21	[p1l1346t1932r1417b1961],
7	less	RBR	O	less	advmod	8	SENT_21	[p1l1428t1930r1489b1961],
8	likely	JJ	O	likely	_	0	SENT_21	[p1l92t1980r178b2019],
9	to	TO	O	to	aux	10	SENT_21	[p1l188t1987r219b2011],
10	have	VB	O	have	xcomp	8	SENT_21	[p1l231t1980r303b2011],
11	a	DT	O	a	det	13	SENT_21	[p1l314t1991r331b2011],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_21	[p1l341t1980r522b2019],
13	exacerbation	NN	O	exacerbation	dobj	10	SENT_21	[p1l532t1980r736b2011],
14	than	IN	O	than	mark	16	SENT_21	[p1l747t1980r821b2011],
15	were	VBD	O	be	cop	16	SENT_21	[p1l831t1991r907b2011],
16	patients	NNS	O	patient	ccomp	8	SENT_21	[p1l918t1981r1046b2019],
17	receiving	VBG	O	receive	partmod	16	SENT_21	[p1l1058t1981r1204b2020],
18	placebo	NN	O	placebo	dobj	17	SENT_21	[p1l1214t1980r1345b2019],
19	,	,	O	,	_	0	SENT_21	[p1l1214t1980r1345b2019],
20	through	IN	O	through	dep	27	SENT_21	[p1l1359t1980r1490b2020],
21	week	NN	DURATION	week	pobj	20	SENT_21	[p1l90t2100r175b2130],
22	48	CD	NUMBER	48	number	23	SENT_21	[p1l183t2102r221b2130],
23	(	CD	NUMBER	(	num	24	SENT_21	[p1l234t2102r390b2135],
24	P	NN	O	p	npadvmod	25	SENT_21	[p1l234t2102r390b2135],
25	<	JJR	O	<	amod	21	SENT_21	[p1l234t2102r390b2135],
26	0.001	CD	NUMBER	0.001	num	27	SENT_21	[p1l234t2102r390b2135],
27	)	NN	O	)	rcmod	18	SENT_21	[p1l234t2102r390b2135],
28	.	.	O	.	_	0	SENT_21	[p1l234t2102r390b2135],

1	In	IN	O	in	_	0	SENT_22	[p1l402t2102r436b2130],
2	addition	NN	O	addition	prep_in	13	SENT_22	[p1l445t2100r587b2137],
3	,	,	O	,	_	0	SENT_22	[p1l445t2100r587b2137],
4	through	IN	O	through	_	0	SENT_22	[p1l599t2100r731b2139],
5	week	NN	DURATION	week	prep_through	13	SENT_22	[p1l739t2100r823b2130],
6	48	CD	NUMBER	48	num	5	SENT_22	[p1l831t2102r879b2137],
7	,	,	O	,	_	0	SENT_22	[p1l831t2102r879b2137],
8	subjects	NNS	O	subject	nsubj	13	SENT_22	[p1l891t2100r1018b2138],
9	in	IN	O	in	_	0	SENT_22	[p1l1029t2100r1061b2130],
10	the	DT	O	the	det	12	SENT_22	[p1l1071t2100r1121b2130],
11	ivacaftor	NN	O	ivacaftor	nn	12	SENT_22	[p1l1130t2099r1271b2130],
12	group	NN	O	group	prep_in	8	SENT_22	[p1l1280t2109r1375b2139],
13	scored	VBD	O	score	_	0	SENT_22	[p1l1386t2100r1490b2130],
14	8.6	CD	NUMBER	8.6	num	15	SENT_22	[p1l92t2152r141b2180],
15	points	NNS	O	point	npadvmod	16	SENT_22	[p1l151t2150r254b2188],
16	higher	JJR	O	higher	advmod	13	SENT_22	[p1l265t2150r372b2189],
17	than	IN	O	than	dep	18	SENT_22	[p1l381t2150r456b2180],
18	did	VBD	O	do	dep	16	SENT_22	[p1l467t2150r518b2180],
19	subjects	NNS	O	subject	dobj	18	SENT_22	[p1l529t2150r658b2188],
20	in	IN	O	in	_	0	SENT_22	[p1l669t2150r701b2180],
21	the	DT	O	the	det	23	SENT_22	[p1l711t2150r762b2180],
22	placebo	NN	O	placebo	nn	23	SENT_22	[p1l772t2150r898b2188],
23	group	NN	O	group	prep_in	18	SENT_22	[p1l908t2159r1005b2189],
24	on	IN	O	on	_	0	SENT_22	[p1l1016t2159r1057b2180],
25	the	DT	O	the	det	29	SENT_22	[p1l1067t2150r1118b2180],
26	respiratory	JJ	O	respiratory	amod	29	SENT_22	[p1l1128t2150r1489b2188],
27	—	NN	O	—	nn	29	SENT_22	[p1l1128t2150r1489b2188],
28	symptoms	NNS	O	symptom	nn	29	SENT_22	[p1l1128t2150r1489b2188],
29	domain	NN	O	domain	prep_on	23	SENT_22	[p1l92t2200r219b2230],
30	of	IN	O	of	_	0	SENT_22	[p1l234t2199r272b2230],
31	the	DT	O	the	det	34	SENT_22	[p1l280t2200r331b2230],
32	Cystic	JJ	MISC	cystic	amod	34	SENT_22	[p1l345t2200r443b2238],
33	Fibrosis	NNP	MISC	Fibrosis	nn	34	SENT_22	[p1l457t2200r585b2230],
34	Questionnaire	NNP	MISC	Questionnaire	prep_of	23	SENT_22	[p1l601t2200r972b2238],
35	—	CD	NUMBER	—	num	34	SENT_22	[p1l601t2200r972b2238],
36	revised	VBN	O	revise	partmod	34	SENT_22	[p1l601t2200r972b2238],
37	instrument	NN	O	instrument	dobj	36	SENT_22	[p1l986t2200r1172b2230],
38	(	CD	NUMBER	(	num	37	SENT_22	[p1l1186t2202r1213b2235],
39	a	DT	O	a	det	43	SENT_22	[p1l1186t2202r1213b2235],
40	100	CD	NUMBER	100	number	41	SENT_22	[p1l1228t2200r1387b2238],
41	—	CD	NUMBER	—	num	43	SENT_22	[p1l1228t2200r1387b2238],
42	point	NN	O	point	nn	43	SENT_22	[p1l1228t2200r1387b2238],
43	scale	NN	O	scale	dep	37	SENT_22	[p1l1400t2200r1488b2237],
44	,	,	O	,	_	0	SENT_22	[p1l1400t2200r1488b2237],
45	with	IN	O	with	_	0	SENT_22	[p1l90t2250r165b2280],
46	higher	JJR	O	higher	amod	47	SENT_22	[p1l179t2250r286b2289],
47	numbers	NNS	O	number	prep_with	37	SENT_22	[p1l299t2250r443b2280],
48	indicating	VBG	O	indicate	partmod	47	SENT_22	[p1l458t2250r626b2289],
49	a	DT	O	a	det	51	SENT_22	[p1l638t2260r655b2280],
50	lower	JJR	O	lower	amod	51	SENT_22	[p1l668t2250r759b2281],
51	effect	NN	O	effect	dobj	48	SENT_22	[p1l772t2249r864b2280],
52	of	IN	O	of	_	0	SENT_22	[p1l876t2249r915b2280],
53	symptoms	NNS	O	symptom	prep_of	51	SENT_22	[p1l922t2256r1091b2289],
54	on	IN	O	on	_	0	SENT_22	[p1l1106t2259r1147b2280],
55	the	DT	O	the	det	56	SENT_22	[p1l1161t2250r1212b2280],
56	patient	NN	O	patient	poss	58	SENT_22	[p1l1225t2250r1363b2289],
57	’s	POS	O	’s	_	0	SENT_22	[p1l1225t2250r1363b2289],
58	quality	NN	O	quality	prep_on	53	SENT_22	[p1l1378t2250r1492b2289],
59	of	IN	O	of	_	0	SENT_22	[p1l92t2299r131b2331],
60	life	NN	O	life	prep_of	58	SENT_22	[p1l134t2299r195b2335],
61	)	CD	NUMBER	)	number	62	SENT_22	[p1l134t2299r195b2335],
62	(	CD	NUMBER	(	num	63	SENT_22	[p1l210t2302r369b2335],
63	P	NN	O	p	npadvmod	64	SENT_22	[p1l210t2302r369b2335],
64	<	JJR	O	<	amod	58	SENT_22	[p1l210t2302r369b2335],
65	0.001	CD	NUMBER	0.001	num	66	SENT_22	[p1l210t2302r369b2335],
66	)	NN	O	)	nsubj	18	SENT_22	[p1l210t2302r369b2335],
67	.	.	O	.	_	0	SENT_22	[p1l210t2302r369b2335],

1	By	IN	O	by	_	0	SENT_23	[p1l381t2302r421b2339],
2	48	CD	DURATION	48	num	3	SENT_23	[p1l430t2302r469b2331],
3	weeks	NNS	NUMBER	week	prep_by	10	SENT_23	[p1l479t2300r588b2337],
4	,	,	O	,	_	0	SENT_23	[p1l479t2300r588b2337],
5	patients	NNS	O	patient	nsubj	10	SENT_23	[p1l600t2300r730b2339],
6	treated	VBN	O	treat	partmod	5	SENT_23	[p1l742t2300r856b2330],
7	with	IN	O	with	_	0	SENT_23	[p1l865t2300r940b2331],
8	ivacaftor	NN	O	ivacaftor	prep_with	6	SENT_23	[p1l950t2299r1094b2331],
9	had	VBD	O	have	aux	10	SENT_23	[p1l1103t2300r1163b2331],
10	gained	VBN	O	gain	_	0	SENT_23	[p1l1174t2300r1293b2339],
11	,	,	O	,	_	0	SENT_23	[p1l1174t2300r1293b2339],
12	on	IN	O	on	_	0	SENT_23	[p1l1306t2310r1347b2330],
13	average	NN	O	average	prep_on	10	SENT_23	[p1l1358t2310r1488b2339],
14	,	,	O	,	_	0	SENT_23	[p1l1358t2310r1488b2339],
15	2.7	CD	NUMBER	2.7	num	16	SENT_23	[p1l92t2352r140b2381],
16	kg	NN	O	kg	npadvmod	17	SENT_23	[p1l153t2350r195b2389],
17	more	RBR	O	more	advmod	13	SENT_23	[p1l206t2360r291b2381],
18	weight	NN	O	weight	dep	13	SENT_23	[p1l302t2350r414b2389],
19	than	IN	O	than	dep	20	SENT_23	[p1l425t2350r501b2380],
20	had	VBD	O	have	dep	18	SENT_23	[p1l514t2350r574b2381],
21	patients	NNS	O	patient	dobj	20	SENT_23	[p1l586t2350r716b2389],
22	receiving	VBG	O	receive	partmod	21	SENT_23	[p1l730t2350r879b2389],
23	placebo	NN	O	placebo	nsubj	26	SENT_23	[p1l890t2350r1016b2389],
24	(	CD	NUMBER	(	num	25	SENT_23	[p1l1031t2352r1191b2385],
25	P	NN	O	p	npadvmod	26	SENT_23	[p1l1031t2352r1191b2385],
26	<	JJR	O	<	xcomp	22	SENT_23	[p1l1031t2352r1191b2385],
27	0.001	CD	NUMBER	0.001	num	28	SENT_23	[p1l1031t2352r1191b2385],
28	)	NN	O	)	nsubj	20	SENT_23	[p1l1031t2352r1191b2385],
29	.	.	O	.	_	0	SENT_23	[p1l1031t2352r1191b2385],

1	The	DT	O	the	det	2	SENT_24	[p1l1204t2350r1266b2380],
2	change	NN	O	change	_	0	SENT_24	[p1l1280t2350r1396b2389],
3	from	IN	O	from	_	0	SENT_24	[p1l1409t2350r1490b2381],
4	baseline	NN	O	baseline	prep_from	2	SENT_24	[p1l92t2400r226b2431],
5	through	IN	O	through	_	0	SENT_24	[p1l238t2400r372b2439],
6	week	NN	DURATION	week	prep_through	2	SENT_24	[p1l382t2400r467b2431],
7	48	CD	NUMBER	48	num	6	SENT_24	[p1l477t2402r516b2431],
8	in	IN	O	in	_	0	SENT_24	[p1l528t2400r560b2430],
9	the	DT	O	the	det	10	SENT_24	[p1l572t2400r623b2430],
10	concentration	NN	O	concentration	prep_in	2	SENT_24	[p1l635t2400r862b2431],
11	of	IN	O	of	_	0	SENT_24	[p1l874t2400r913b2431],
12	sweat	NN	O	sweat	nn	13	SENT_24	[p1l918t2406r1011b2431],
13	chloride	NN	O	chloride	prep_of	2	SENT_24	[p1l1021t2400r1162b2437],
14	,	,	O	,	_	0	SENT_24	[p1l1021t2400r1162b2437],
15	a	DT	O	a	det	16	SENT_24	[p1l1176t2410r1193b2430],
16	measure	NN	O	measure	appos	13	SENT_24	[p1l1204t2410r1343b2431],
17	of	IN	O	of	_	0	SENT_24	[p1l1355t2400r1393b2431],
18	CFTR	NN	O	cftr	nn	19	SENT_24	[p1l1398t2402r1495b2432],
19	activity	NN	O	activity	prep_of	16	SENT_24	[p1l92t2450r214b2489],
20	,	,	O	,	_	0	SENT_24	[p1l92t2450r214b2489],
21	with	IN	O	with	_	0	SENT_24	[p1l226t2450r301b2481],
22	ivacaftor	NN	O	ivacaftor	prep_with	2	SENT_24	[p1l311t2450r455b2481],
23	as	IN	O	as	dep	22	SENT_24	[p1l464t2460r497b2480],
24	compared	VBN	O	compare	_	0	SENT_24	[p1l509t2450r672b2489],
25	with	IN	O	with	_	0	SENT_24	[p1l682t2450r756b2481],
26	placebo	NN	O	placebo	prep_compared_with	22	SENT_24	[p1l767t2450r893b2489],
27	was	VBD	O	be	cop	34	SENT_24	[p1l902t2460r965b2481],
28	-48.1	CD	NUMBER	-48.1	num	29	SENT_24	[p1l977t2452r1069b2481],
29	mmol	NN	O	mmol	npadvmod	34	SENT_24	[p1l1080t2450r1177b2481],
30	per	IN	O	per	_	0	SENT_24	[p1l1188t2460r1241b2489],
31	liter	NN	O	liter	nn	33	SENT_24	[p1l1251t2450r1317b2480],
32	(	CD	NUMBER	(	num	33	SENT_24	[p1l1328t2452r1488b2485],
33	P	NN	O	p	prep_per	29	SENT_24	[p1l1328t2452r1488b2485],
34	<	JJR	O	<	auxpass	22	SENT_24	[p1l1328t2452r1488b2485],
35	0.001	CD	NUMBER	0.001	num	36	SENT_24	[p1l1328t2452r1488b2485],
36	)	NN	O	)	nsubjpass	22	SENT_24	[p1l1328t2452r1488b2485],
37	.	.	O	.	_	0	SENT_24	[p1l1328t2452r1488b2485],

1	The	DT	O	the	det	2	SENT_25	[p1l91t2500r152b2530],
2	incidence	NN	O	incidence	nsubj	7	SENT_25	[p1l165t2500r319b2531],
3	of	IN	O	of	_	0	SENT_25	[p1l332t2500r371b2531],
4	adverse	JJ	O	adverse	amod	5	SENT_25	[p1l376t2500r496b2531],
5	events	NNS	O	event	prep_of	2	SENT_25	[p1l509t2506r609b2531],
6	was	VBD	O	be	cop	7	SENT_25	[p1l621t2510r684b2531],
7	similar	JJ	O	similar	_	0	SENT_25	[p1l697t2500r814b2530],
8	with	IN	O	with	_	0	SENT_25	[p1l824t2500r899b2531],
9	ivacaftor	NN	O	ivacaftor	prep_with	7	SENT_25	[p1l911t2500r1054b2531],
10	and	CC	O	and	_	0	SENT_25	[p1l1065t2500r1126b2531],
11	placebo	NN	O	placebo	conj_and	9	SENT_25	[p1l1138t2500r1272b2539],
12	,	,	O	,	_	0	SENT_25	[p1l1138t2500r1272b2539],
13	with	IN	O	with	_	0	SENT_25	[p1l1285t2500r1360b2531],
14	a	DT	O	a	det	16	SENT_25	[p1l1372t2510r1389b2530],
15	lower	JJR	O	lower	amod	16	SENT_25	[p1l1401t2500r1492b2531],
16	proportion	NN	O	proportion	prep_with	7	SENT_25	[p1l91t2551r271b2589],
17	of	IN	O	of	_	0	SENT_25	[p1l283t2550r321b2581],
18	serious	JJ	O	serious	amod	20	SENT_25	[p1l327t2551r442b2581],
19	adverse	JJ	O	adverse	amod	20	SENT_25	[p1l455t2550r575b2581],
20	events	NNS	O	event	prep_of	16	SENT_25	[p1l587t2557r688b2581],
21	with	IN	O	with	_	0	SENT_25	[p1l699t2550r774b2581],
22	ivacaftor	NN	O	ivacaftor	prep_with	20	SENT_25	[p1l786t2550r929b2581],
23	than	IN	O	than	prep	7	SENT_25	[p1l940t2550r1016b2581],
24	with	IN	O	with	pcomp	23	SENT_25	[p1l1026t2550r1101b2581],
25	placebo	NN	O	placebo	dep	24	SENT_25	[p1l1112t2550r1238b2589],
26	(	CD	NUMBER	(	num	25	SENT_25	[p1l1253t2552r1333b2586],
27	24	CD	NUMBER	24	num	28	SENT_25	[p1l1253t2552r1333b2586],
28	°	NN	O	°	dep	25	SENT_25	[p1l1253t2552r1333b2586],
29	/	:	O	/	punct	25	SENT_25	[p1l1253t2552r1333b2586],
30	o	NN	O	o	dep	25	SENT_25	[p1l1253t2552r1333b2586],
31	vs.	CC	O	vs.	prep	30	SENT_25	[p1l1343t2560r1385b2581],
32	42	CD	NUMBER	42	num	33	SENT_25	[p1l1398t2552r1488b2586],
33	°	CD	NUMBER	°	dep	31	SENT_25	[p1l1398t2552r1488b2586],
34	/	:	O	/	punct	25	SENT_25	[p1l1398t2552r1488b2586],
35	o	NN	O	o	dep	25	SENT_25	[p1l1398t2552r1488b2586],
36	)	NN	O	)	dep	35	SENT_25	[p1l1398t2552r1488b2586],
37	.	.	O	.	_	0	SENT_25	[p1l1398t2552r1488b2586],

1	co	NN	O	co	nn	6	SENT_26	[p1l92t2615r134b2634],
2	N	NN	O	n	nn	6	SENT_26	[p1l140t2615r157b2634],
3	c	NN	O	c	nn	6	SENT_26	[p1l163t2615r180b2634],
4	L	NN	O	l	nn	6	SENT_26	[p1l185t2615r197b2634],
5	u	NN	O	u	nn	6	SENT_26	[p1l202t2615r218b2634],
6	s	NNS	O	s	dep	7	SENT_26	[p1l224t2615r238b2634],
7	I	PRP	O	I	dep	13	SENT_26	[p1l244t2615r249b2634],
8	o	NN	O	o	nn	9	SENT_26	[p1l254t2615r275b2634],
9	N	NN	O	n	nsubj	10	SENT_26	[p1l282t2615r298b2634],
10	s	VBZ	O	s	parataxis	13	SENT_26	[p1l305t2615r319b2634],
11	Ivacaftor	NNP	O	Ivacaftor	nsubjpass	13	SENT_26	[p1l91t2656r239b2687],
12	was	VBD	O	be	auxpass	13	SENT_26	[p1l250t2666r313b2687],
13	associated	VBN	O	associate	_	0	SENT_26	[p1l328t2656r500b2687],
14	with	IN	O	with	_	0	SENT_26	[p1l512t2656r588b2687],
15	improvements	NNS	O	improvement	prep_with	13	SENT_26	[p1l602t2657r840b2695],
16	in	IN	O	in	_	0	SENT_26	[p1l854t2657r887b2686],
17	lung	NN	O	lung	nn	18	SENT_26	[p1l900t2656r976b2695],
18	function	NN	O	function	prep_in	15	SENT_26	[p1l988t2656r1131b2687],
19	at	IN	O	at	_	0	SENT_26	[p1l1144t2663r1175b2687],
20	2	CD	DURATION	2	num	21	SENT_26	[p1l1187t2659r1206b2686],
21	weeks	NNS	NUMBER	week	prep_at	13	SENT_26	[p1l1218t2656r1320b2687],
22	that	WDT	O	that	nsubjpass	24	SENT_26	[p1l1335t2656r1401b2687],
23	were	VBD	O	be	auxpass	24	SENT_26	[p1l1412t2666r1490b2687],
24	sustained	VBN	O	sustain	rcmod	21	SENT_26	[p1l93t2706r252b2737],
25	through	IN	O	through	_	0	SENT_26	[p1l267t2706r402b2745],
26	48	CD	DURATION	48	num	27	SENT_26	[p1l416t2709r456b2737],
27	weeks	NNS	NUMBER	week	prep_through	24	SENT_26	[p1l470t2706r581b2737],
28	.	.	O	.	_	0	SENT_26	[p1l470t2706r581b2737],

1	Substantial	JJ	O	substantial	amod	2	SENT_27	[p1l599t2706r787b2737],
2	improvements	NNS	O	improvement	nsubjpass	5	SENT_27	[p1l801t2707r1039b2745],
3	were	VBD	O	be	auxpass	5	SENT_27	[p1l1053t2716r1131b2737],
4	also	RB	O	also	advmod	5	SENT_27	[p1l1146t2706r1213b2737],
5	observed	VBN	O	observe	_	0	SENT_27	[p1l1228t2706r1376b2737],
6	in	IN	O	in	_	0	SENT_27	[p1l1391t2707r1423b2736],
7	the	DT	O	the	det	8	SENT_27	[p1l1438t2706r1490b2737],
8	risk	NN	O	risk	prep_in	5	SENT_27	[p1l92t2756r154b2787],
9	of	IN	O	of	_	0	SENT_27	[p1l164t2755r202b2786],
10	pulmonary	JJ	O	pulmonary	amod	11	SENT_27	[p1l205t2756r388b2795],
11	exacerbations	NNS	O	exacerbation	prep_of	8	SENT_27	[p1l398t2756r631b2793],
12	,	,	O	,	_	0	SENT_27	[p1l398t2756r631b2793],
13	patient-reported	JJ	O	patient-reported	amod	15	SENT_27	[p1l643t2756r908b2795],
14	respiratory	JJ	O	respiratory	amod	15	SENT_27	[p1l919t2756r1098b2795],
15	symptoms	NNS	O	symptom	conj_and	11	SENT_27	[p1l1107t2762r1286b2795],
16	,	,	O	,	_	0	SENT_27	[p1l1107t2762r1286b2795],
17	weight	NN	O	weight	conj_and	11	SENT_27	[p1l1297t2756r1417b2795],
18	,	,	O	,	_	0	SENT_27	[p1l1297t2756r1417b2795],
19	and	CC	O	and	_	0	SENT_27	[p1l1430t2756r1490b2786],
20	concentration	NN	O	concentration	conj_and	11	SENT_27	[p1l92t2800r327b2830],
21	of	IN	O	of	_	0	SENT_27	[p1l344t2799r383b2830],
22	sweat	NN	O	sweat	nn	23	SENT_27	[p1l393t2806r488b2830],
23	chloride	NN	O	chloride	prep_of	20	SENT_27	[p1l503t2799r650b2830],
24	.	.	O	.	_	0	SENT_27	[p1l503t2799r650b2830],

1	(	NN	O	(	_	0	SENT_28	[p1l670t2799r808b2835],
2	Funded	VBN	O	fund	partmod	1	SENT_28	[p1l670t2799r808b2835],
3	by	IN	O	by	_	0	SENT_28	[p1l824t2799r863b2839],
4	Vertex	NNP	ORGANIZATION	Vertex	nn	5	SENT_28	[p1l876t2802r982b2830],
5	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	agent	2	SENT_28	[p1l997t2799r1278b2830],
6	and	CC	O	and	_	0	SENT_28	[p1l1295t2799r1357b2830],
7	others	NNS	O	other	conj_and	5	SENT_28	[p1l1373t2799r1489b2836],
8	;	:	O	;	_	0	SENT_28	[p1l1373t2799r1489b2836],
9	VX08-770-102	NN	O	vx08-770-102	dep	1	SENT_28	[p1l91t2849r322b2877],
10	ClinicalTrials	NNS	O	clinicaltrial	dep	9	SENT_28	[p1l336t2847r637b2886],
11	.	.	O	.	_	0	SENT_28	[p1l336t2847r637b2886],

1	gov	NN	O	gov	nn	2	SENT_29	[p1l336t2847r637b2886],
2	number	NN	O	number	_	0	SENT_29	[p1l650t2847r790b2884],
3	,	,	O	,	_	0	SENT_29	[p1l650t2847r790b2884],
4	NCT00909532	NN	O	nct00909532	appos	2	SENT_29	[p1l805t2849r1068b2882],
5	.	.	O	.	_	0	SENT_29	[p1l805t2849r1068b2882],
6	)	SYM	O	)	dep	2	SENT_29	[p1l805t2849r1068b2882],

1	NENGLjMED365	NN	O	nengljmed365	_	0	SENT_30	[p1l594t2937r853b2965],
2	;	:	O	;	_	0	SENT_30	[p1l594t2937r853b2965],
3	18	CD	NUMBER	18	num	5	SENT_30	[p1l594t2937r853b2965],
4	NEjM.ORG	NN	O	nejm.org	nn	5	SENT_30	[p1l888t2943r1012b2965],
5	NOVEMBER3	NN	O	november3	dep	1	SENT_30	[p1l1049t2943r1212b2965],
6	,	,	O	,	_	0	SENT_30	[p1l1049t2943r1212b2965],
7	2011	CD	DATE	2011	appos	5	SENT_30	[p1l1223t2943r1275b2959],

1	The	DT	O	the	det	4	SENT_31	[p1l750t3000r801b3024],
2	New	NNP	O	New	nn	4	SENT_31	[p1l810t3001r872b3024],
3	England	NNP	O	England	nn	4	SENT_31	[p1l882t3000r992b3031],
4	Journal	NNP	O	Journal	_	0	SENT_31	[p1l1001t3000r1098b3024],
5	of	IN	O	of	_	0	SENT_31	[p1l1108t3000r1137b3024],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_31	[p1l1144t3000r1269b3024],

1	From	IN	O	from	dep	168	SENT_32	[p1l1532t1230r1595b1251],
2	Seattle	NNP	ORGANIZATION	Seattle	dep	168	SENT_32	[p1l1606t1227r1692b1251],
3	Children	NNP	ORGANIZATION	Children	dep	168	SENT_32	[p1l1701t1227r1829b1251],
4	's	POS	ORGANIZATION	's	dep	168	SENT_32	[p1l1701t1227r1829b1251],
5	Hospital	NNP	ORGANIZATION	Hospital	dep	168	SENT_32	[p1l1840t1227r1946b1258],
6	and	CC	ORGANIZATION	and	dep	168	SENT_32	[p1l1957t1227r2002b1251],
7	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l2014t1230r2065b1251, p1l1529t1266r1613b1294],
8	ofwashington	NNP	O	ofwashington	dep	168	SENT_32	[p1l1620t1263r1804b1294],
9	School	NNP	O	School	dep	168	SENT_32	[p1l1813t1263r1898b1287],
10	ofMedicine	NNP	O	ofMedicine	dep	168	SENT_32	[p1l1908t1263r2064b1291],
11	,	,	O	,	_	0	SENT_32	[p1l1908t1263r2064b1291],
12	Seattle	NNP	LOCATION	Seattle	dep	168	SENT_32	[p1l1530t1300r1614b1323],
13	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1623t1302r1726b1331],
14	B.W.R.	NNP	O	B.W.R.	dep	168	SENT_32	[p1l1623t1302r1726b1331],
15	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1623t1302r1726b1331],
16	;	:	O	;	_	0	SENT_32	[p1l1623t1302r1726b1331],
17	Respiratory	JJ	ORGANIZATION	respiratory	dep	168	SENT_32	[p1l1736t1302r1875b1331],
18	Biomedical	NNP	ORGANIZATION	Biomedical	dep	168	SENT_32	[p1l1883t1300r2018b1323],
19	Research	NNP	ORGANIZATION	Research	dep	168	SENT_32	[p1l2028t1302r2065b1324, p1l1530t1336r1608b1359],
20	Unit	NNP	ORGANIZATION	Unit	dep	168	SENT_32	[p1l1620t1338r1677b1364],
21	,	,	O	,	_	0	SENT_32	[p1l1620t1338r1677b1364],
22	Royal	NNP	PERSON	Royal	dep	168	SENT_32	[p1l1689t1336r1751b1367],
23	Brompton	NNP	PERSON	Brompton	dep	168	SENT_32	[p1l1763t1338r1886b1367],
24	and	CC	O	and	dep	168	SENT_32	[p1l1896t1336r1940b1359],
25	Hareﬁeld	NNP	ORGANIZATION	Hareﬁeld	dep	168	SENT_32	[p1l1952t1336r2064b1360],
26	National	NNP	ORGANIZATION	National	dep	168	SENT_32	[p1l1532t1372r1637b1396],
27	Health	NNP	ORGANIZATION	Health	dep	168	SENT_32	[p1l1649t1372r1730b1395],
28	Service	NNP	ORGANIZATION	Service	dep	168	SENT_32	[p1l1741t1374r1831b1396],
29	Foundation	NNP	ORGANIZATION	Foundation	dep	168	SENT_32	[p1l1841t1372r1984b1396],
30	Trust	NNP	ORGANIZATION	Trust	dep	168	SENT_32	[p1l1992t1374r2064b1400],
31	,	,	O	,	_	0	SENT_32	[p1l1992t1374r2064b1400],
32	London	NNP	LOCATION	London	dep	168	SENT_32	[p1l1532t1408r1625b1432],
33	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1636t1410r1707b1439],
34	J.D.	NNP	ORGANIZATION	J.D.	dep	168	SENT_32	[p1l1636t1410r1707b1439],
35	)	NNP	O	)	dep	168	SENT_32	[p1l1636t1410r1707b1439],
36	;	:	O	;	_	0	SENT_32	[p1l1636t1410r1707b1439],
37	Royal	NNP	ORGANIZATION	Royal	dep	168	SENT_32	[p1l1717t1408r1780b1439],
38	College	NNP	ORGANIZATION	College	dep	168	SENT_32	[p1l1789t1408r1880b1439],
39	ofsurgeons	NNS	O	ofsurgeon	dep	168	SENT_32	[p1l1888t1408r2035b1439],
40	in	IN	O	in	dep	168	SENT_32	[p1l2044t1411r2064b1432],
41	Ireland	NNP	LOCATION	Ireland	dep	168	SENT_32	[p1l1532t1445r1623b1473],
42	,	,	O	,	_	0	SENT_32	[p1l1532t1445r1623b1473],
43	Beaumont	NNP	LOCATION	Beaumont	dep	168	SENT_32	[p1l1635t1447r1765b1468],
44	Hospital	NNP	LOCATION	Hospital	dep	168	SENT_32	[p1l1775t1445r1880b1475],
45	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1892t1447r2009b1476],
46	N.G.M.	NNP	O	N.G.M.	dep	168	SENT_32	[p1l1892t1447r2009b1476],
47	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1892t1447r2009b1476],
48	,	,	O	,	_	0	SENT_32	[p1l1892t1447r2009b1476],
49	and	CC	O	and	dep	168	SENT_32	[p1l2019t1445r2064b1468],
50	St.	NNP	PERSON	St.	dep	168	SENT_32	[p1l1530t1483r1562b1505],
51	Vincent	NNP	PERSON	Vincent	dep	168	SENT_32	[p1l1572t1483r1692b1505],
52	's	POS	O	's	dep	168	SENT_32	[p1l1572t1483r1692b1505],
53	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l1705t1483r1835b1512],
54	Hospital	NNP	ORGANIZATION	Hospital	dep	168	SENT_32	[p1l1846t1481r1954b1512],
55	(	CD	ORGANIZATION	(	dep	168	SENT_32	[p1l1968t1483r2064b1512],
56	E.F.M.	NNP	ORGANIZATION	E.F.M.	dep	168	SENT_32	[p1l1968t1483r2064b1512],
57	,	,	O	,	_	0	SENT_32	[p1l1968t1483r2064b1512],
58	C.E.W.	NNP	O	C.E.W.	dep	168	SENT_32	[p1l1530t1520r1621b1549],
59	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1530t1520r1621b1549],
60	—	CD	NUMBER	—	dep	168	SENT_32	[p1l1632t1532r1664b1535],
61	both	DT	O	both	dep	168	SENT_32	[p1l1673t1518r1729b1541],
62	in	IN	O	in	dep	168	SENT_32	[p1l1741t1520r1761b1541],
63	Dublin	NNP	LOCATION	Dublin	dep	168	SENT_32	[p1l1774t1518r1864b1546],
64	,	,	O	,	_	0	SENT_32	[p1l1774t1518r1864b1546],
65	Ireland	NNP	LOCATION	Ireland	dep	168	SENT_32	[p1l1877t1518r1970b1546],
66	;	:	O	;	_	0	SENT_32	[p1l1877t1518r1970b1546],
67	St.	NNP	LOCATION	St.	dep	168	SENT_32	[p1l1982t1520r2013b1541],
68	Michael	NNP	LOCATION	Michael	dep	168	SENT_32	[p1l2025t1520r2065b1541, p1l1530t1554r1612b1578],
69	's	POS	LOCATION	's	dep	168	SENT_32	[p1l2025t1520r2065b1541, p1l1530t1554r1612b1578],
70	Hospital	NNP	LOCATION	Hospital	dep	168	SENT_32	[p1l1621t1554r1730b1585],
71	,	,	O	,	_	0	SENT_32	[p1l1621t1554r1730b1585],
72	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l1739t1556r1860b1585],
73	ofToronto	NNP	O	ofToronto	dep	168	SENT_32	[p1l1866t1554r1991b1578],
74	(	CD	NUMBER	(	dep	168	SENT_32	[p1l2000t1556r2064b1585],
75	E.T.	NNP	O	E.T.	dep	168	SENT_32	[p1l2000t1556r2064b1585],
76	)	NN	O	)	dep	168	SENT_32	[p1l2000t1556r2064b1585],
77	,	,	O	,	_	0	SENT_32	[p1l2000t1556r2064b1585],
78	and	CC	O	and	dep	168	SENT_32	[p1l1530t1591r1575b1615],
79	Department	NNP	O	Department	dep	168	SENT_32	[p1l1586t1593r1739b1622],
80	ofPediatrics	NNPS	O	ofPediatrics	dep	168	SENT_32	[p1l1746t1591r1907b1619],
81	,	,	O	,	_	0	SENT_32	[p1l1746t1591r1907b1619],
82	Hospital	NNP	O	Hospital	dep	168	SENT_32	[p1l1918t1591r2023b1622],
83	for	IN	O	for	dep	168	SENT_32	[p1l2031t1591r2066b1615],
84	Sick	NNP	O	Sick	dep	168	SENT_32	[p1l1530t1628r1581b1652],
85	Children	NNP	O	Children	dep	168	SENT_32	[p1l1596t1628r1704b1652],
86	(	NNP	O	(	dep	168	SENT_32	[p1l1722t1630r1786b1659],
87	F.R.	NNP	LOCATION	F.R.	dep	168	SENT_32	[p1l1722t1630r1786b1659],
88	)	NNP	O	)	dep	168	SENT_32	[p1l1722t1630r1786b1659],
89	—	CD	NUMBER	—	dep	168	SENT_32	[p1l1801t1642r1833b1645],
90	both	CC	O	both	dep	168	SENT_32	[p1l1847t1628r1904b1652],
91	in	IN	O	in	dep	168	SENT_32	[p1l1920t1630r1940b1651],
92	Toronto	NNP	LOCATION	Toronto	dep	168	SENT_32	[p1l1955t1630r2064b1656],
93	;	:	O	;	_	0	SENT_32	[p1l1955t1630r2064b1656],
94	Department	NNP	O	Department	dep	168	SENT_32	[p1l1532t1666r1689b1695],
95	ofThoracic	NNP	O	ofThoracic	dep	168	SENT_32	[p1l1697t1664r1841b1688],
96	Medicine	NNP	O	Medicine	dep	168	SENT_32	[p1l1850t1664r1975b1692],
97	,	,	O	,	_	0	SENT_32	[p1l1850t1664r1975b1692],
98	Prince	NNP	PERSON	Prince	dep	168	SENT_32	[p1l1987t1666r2065b1688],
99	Charles	NNP	PERSON	Charles	dep	168	SENT_32	[p1l1530t1701r1624b1725],
100	Hospital	NNP	PERSON	Hospital	dep	168	SENT_32	[p1l1634t1701r1739b1732],
101	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1750t1703r1849b1732],
102	S.C.B.	NNP	O	S.C.B.	dep	168	SENT_32	[p1l1750t1703r1849b1732],
103	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1750t1703r1849b1732],
104	,	,	O	,	_	0	SENT_32	[p1l1750t1703r1849b1732],
105	and	CC	O	and	dep	168	SENT_32	[p1l1857t1701r1902b1725],
106	Queensland	NNP	ORGANIZATION	Queensland	dep	168	SENT_32	[p1l1911t1701r2064b1731],
107	Children	NNP	ORGANIZATION	Children	dep	168	SENT_32	[p1l1530t1737r1655b1761],
108	's	POS	ORGANIZATION	's	dep	168	SENT_32	[p1l1530t1737r1655b1761],
109	Medical	NNP	ORGANIZATION	Medical	dep	168	SENT_32	[p1l1666t1737r1762b1761],
110	Research	NNP	ORGANIZATION	Research	dep	168	SENT_32	[p1l1773t1737r1884b1761],
111	Institute	NNP	ORGANIZATION	Institute	dep	168	SENT_32	[p1l1895t1739r2004b1765],
112	,	,	O	,	_	0	SENT_32	[p1l1895t1739r2004b1765],
113	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l2014t1739r2065b1761, p1l1529t1776r1613b1805],
114	of	IN	ORGANIZATION	of	dep	168	SENT_32	[p1l1624t1774r1651b1798],
115	Queensland	NNP	ORGANIZATION	Queensland	dep	168	SENT_32	[p1l1659t1774r1813b1804],
116	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1829t1776r1919b1805],
117	S.C.B.	NNP	O	S.C.B.	dep	168	SENT_32	[p1l1829t1776r1919b1805],
118	,	,	O	,	_	0	SENT_32	[p1l1829t1776r1919b1805],
119	C.E.W.	NNP	O	C.E.W.	dep	168	SENT_32	[p1l1932t1776r2022b1805],
120	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1932t1776r2022b1805],
121	—	CD	NUMBER	—	dep	168	SENT_32	[p1l2035t1788r2067b1791],
122	both	DT	O	both	dep	168	SENT_32	[p1l1531t1811r1586b1834],
123	in	IN	O	in	dep	168	SENT_32	[p1l1596t1813r1616b1834],
124	Brisbane	NNP	LOCATION	Brisbane	dep	168	SENT_32	[p1l1627t1811r1742b1839],
125	,	,	O	,	_	0	SENT_32	[p1l1627t1811r1742b1839],
126	Australia	NNP	LOCATION	Australia	dep	168	SENT_32	[p1l1750t1811r1870b1839],
127	;	:	O	;	_	0	SENT_32	[p1l1750t1811r1870b1839],
128	Department	NNP	ORGANIZATION	Department	dep	168	SENT_32	[p1l1881t1813r2035b1842],
129	of	IN	ORGANIZATION	of	dep	168	SENT_32	[p1l2042t1810r2070b1834],
130	Pediatrics	NNPS	ORGANIZATION	Pediatrics	dep	168	SENT_32	[p1l1532t1847r1666b1875],
131	,	,	O	,	_	0	SENT_32	[p1l1532t1847r1666b1875],
132	2nd	JJ	ORGANIZATION	2nd	dep	168	SENT_32	[p1l1680t1847r1727b1871],
133	Medical	NNP	ORGANIZATION	Medical	dep	168	SENT_32	[p1l1743t1847r1843b1871],
134	School	NNP	ORGANIZATION	School	dep	168	SENT_32	[p1l1858t1847r1953b1875],
135	,	,	O	,	_	0	SENT_32	[p1l1858t1847r1953b1875],
136	Charles	NNP	ORGANIZATION	Charles	dep	168	SENT_32	[p1l1968t1847r2064b1871],
137	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l1531t1886r1666b1914],
138	,	,	O	,	_	0	SENT_32	[p1l1531t1886r1666b1914],
139	Prague	NNP	LOCATION	Prague	dep	168	SENT_32	[p1l1677t1886r1771b1915],
140	,	,	O	,	_	0	SENT_32	[p1l1677t1886r1771b1915],
141	Czech	NNP	LOCATION	Czech	dep	168	SENT_32	[p1l1781t1883r1857b1907],
142	Republic	NNP	LOCATION	Republic	dep	168	SENT_32	[p1l1869t1883r1979b1914],
143	(	CD	NUMBER	(	dep	168	SENT_32	[p1l1989t1885r2064b1914],
144	P.D.	NNP	O	P.D.	dep	168	SENT_32	[p1l1989t1885r2064b1914],
145	)	CD	NUMBER	)	dep	168	SENT_32	[p1l1989t1885r2064b1914],
146	;	:	O	;	_	0	SENT_32	[p1l1989t1885r2064b1914],
147	Dr	NNP	O	Dr	dep	168	SENT_32	[p1l1532t1922r1562b1943],
148	von	NNP	PERSON	von	dep	168	SENT_32	[p1l1569t1928r1614b1944],
149	Haunersches	NNP	PERSON	Haunersches	dep	168	SENT_32	[p1l1626t1920r1793b1944],
150	Kinderspital	NNP	PERSON	Kinderspital	dep	168	SENT_32	[p1l1805t1920r1964b1951],
151	,	,	O	,	_	0	SENT_32	[p1l1805t1920r1964b1951],
152	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l1975t1922r2065b1944, p1l1530t1959r1573b1988],
153	of	IN	ORGANIZATION	of	dep	168	SENT_32	[p1l1583t1956r1611b1980],
154	Munich	NNP	ORGANIZATION	Munich	dep	168	SENT_32	[p1l1618t1957r1720b1985],
155	,	,	O	,	_	0	SENT_32	[p1l1618t1957r1720b1985],
156	Munich	NNP	LOCATION	Munich	dep	168	SENT_32	[p1l1734t1957r1836b1984],
157	,	,	O	,	_	0	SENT_32	[p1l1734t1957r1836b1984],
158	Germany	NNP	LOCATION	Germany	dep	168	SENT_32	[p1l1848t1959r1964b1988],
159	(	NNP	O	(	dep	168	SENT_32	[p1l1977t1959r2064b1988],
160	M.G.	NNP	LOCATION	M.G.	dep	168	SENT_32	[p1l1977t1959r2064b1988],
161	)	NNP	O	)	dep	168	SENT_32	[p1l1977t1959r2064b1988],
162	;	:	O	;	_	0	SENT_32	[p1l1977t1959r2064b1988],
163	Case	NNP	ORGANIZATION	Case	dep	168	SENT_32	[p1l1530t1995r1589b2017],
164	Western	NNP	ORGANIZATION	Western	dep	168	SENT_32	[p1l1596t1995r1700b2017],
165	Reserve	NNP	ORGANIZATION	Reserve	dep	168	SENT_32	[p1l1711t1995r1808b2017],
166	University	NNP	ORGANIZATION	University	dep	168	SENT_32	[p1l1817t1995r1942b2024],
167	School	NNP	ORGANIZATION	School	dep	168	SENT_32	[p1l1950t1993r2034b2017],
168	of	IN	O	of	_	0	SENT_32	[p1l2043t1993r2070b2017],

1	Medicine	NNP	O	Medicine	dep	4	SENT_33	[p1l1532t2099r1655b2127],
2	,	,	O	,	_	0	SENT_33	[p1l1532t2099r1655b2127],
3	Rainbow	NNP	ORGANIZATION	Rainbow	nn	4	SENT_33	[p1l1668t2099r1776b2122],
4	Babies	NNS	ORGANIZATION	baby	_	0	SENT_33	[p1l1788t2099r1869b2122],
5	and	CC	O	and	_	0	SENT_33	[p1l1880t2099r1925b2122],
6	Children	NNP	O	Children	poss	13	SENT_33	[p1l1937t2099r2064b2122],
7	's	POS	O	's	_	0	SENT_33	[p1l1937t2099r2064b2122],
8	Hospital	NNP	O	Hospital	nn	13	SENT_33	[p1l1532t2135r1642b2166],
9	,	,	O	,	_	0	SENT_33	[p1l1532t2135r1642b2166],
10	Cleveland	NNP	LOCATION	Cleveland	appos	13	SENT_33	[p1l1650t2135r1770b2159],
11	(	CD	NUMBER	(	num	13	SENT_33	[p1l1780t2137r1893b2166],
12	M.W.K.	NNP	O	M.W.K.	nn	13	SENT_33	[p1l1780t2137r1893b2166],
13	)	NN	O	)	conj_and	4	SENT_33	[p1l1780t2137r1893b2166],
14	;	:	O	;	_	0	SENT_33	[p1l1780t2137r1893b2166],
15	Stanford	NNP	ORGANIZATION	Stanford	nn	17	SENT_33	[p1l1901t2135r2005b2159],
16	University	NNP	ORGANIZATION	University	nn	17	SENT_33	[p1l2015t2137r2065b2159, p1l1529t2174r1614b2202],
17	School	NNP	ORGANIZATION	School	dep	26	SENT_33	[p1l1625t2172r1712b2195],
18	of	IN	ORGANIZATION	of	_	0	SENT_33	[p1l1724t2171r1752b2195],
19	Medicine	NNP	ORGANIZATION	Medicine	nn	24	SENT_33	[p1l1761t2172r1886b2199],
20	,	,	O	,	_	0	SENT_33	[p1l1761t2172r1886b2199],
21	Stanford	NNP	ORGANIZATION	Stanford	appos	24	SENT_33	[p1l1899t2171r2016b2200],
22	,	,	O	,	_	0	SENT_33	[p1l1899t2171r2016b2200],
23	CA	NNP	LOCATION	CA	appos	24	SENT_33	[p1l2029t2173r2066b2195],
24	(	NNP	O	(	prep_of	17	SENT_33	[p1l1533t2210r1619b2239],
25	R.M.	NNP	LOCATION	R.M.	nn	26	SENT_33	[p1l1533t2210r1619b2239],
26	)	NNP	O	)	parataxis	4	SENT_33	[p1l1533t2210r1619b2239],
27	;	:	O	;	_	0	SENT_33	[p1l1533t2210r1619b2239],
28	Centre	NNP	O	Centre	nn	31	SENT_33	[p1l1634t2210r1719b2232],
29	d’	NNP	O	d’	nn	31	SENT_33	[p1l1732t2208r1926b2239],
30	|	NN	O	|	nn	31	SENT_33	[p1l1732t2208r1926b2239],
31	nvestigation	NN	O	nvestigation	dep	41	SENT_33	[p1l1732t2208r1926b2239],
32	C	NN	O	c	prep	31	SENT_33	[p1l1942t2208r2066b2239],
33	|	JJ	O	|	amod	34	SENT_33	[p1l1942t2208r2066b2239],
34	inique	NN	O	inique	dep	32	SENT_33	[p1l1942t2208r2066b2239],
35	—	CD	NUMBER	—	num	41	SENT_33	[p1l1942t2208r2066b2239],
36	Hopital	NNP	LOCATION	Hopital	nn	41	SENT_33	[p1l1532t2245r1626b2276],
37	Necker	NNP	LOCATION	Necker	nn	41	SENT_33	[p1l1638t2245r1733b2273],
38	,	,	O	,	_	0	SENT_33	[p1l1638t2245r1733b2273],
39	Paris	NNP	LOCATION	Paris	appos	41	SENT_33	[p1l1745t2247r1805b2268],
40	(	CD	NUMBER	(	num	41	SENT_33	[p1l1817t2247r1925b2276],
41	|	NN	O	|	parataxis	4	SENT_33	[p1l1817t2247r1925b2276],
42	.	.	O	.	_	0	SENT_33	[p1l1817t2247r1925b2276],

1	S.-G	NN	O	s.-g	_	0	SENT_34	[p1l1817t2247r1925b2276],
2	.	.	O	.	_	0	SENT_34	[p1l1817t2247r1925b2276],
3	)	SYM	O	)	dep	1	SENT_34	[p1l1817t2247r1925b2276],

1	;	:	O	;	_	0	SENT_35	[p1l1817t2247r1925b2276],
2	University	NNP	O	University	nn	3	SENT_35	[p1l1936t2247r2066b2276],
3	ofAlabama	NNP	O	ofAlabama	_	0	SENT_35	[p1l1530t2281r1677b2305],
4	at	IN	O	at	_	0	SENT_35	[p1l1691t2286r1713b2305],
5	Birmingham	NNP	LOCATION	Birmingham	nn	9	SENT_35	[p1l1728t2281r1892b2313],
6	,	,	O	,	_	0	SENT_35	[p1l1728t2281r1892b2313],
7	Birmingham	NNP	LOCATION	Birmingham	appos	9	SENT_35	[p1l1908t2281r2064b2313],
8	(	CD	NUMBER	(	num	9	SENT_35	[p1l1533t2320r1644b2349],
9	S.M.R.	NNP	O	S.M.R.	prep_at	3	SENT_35	[p1l1533t2320r1644b2349],
10	)	NN	O	)	dep	9	SENT_35	[p1l1533t2320r1644b2349],
11	;	:	O	;	_	0	SENT_35	[p1l1533t2320r1644b2349],
12	Vertex	NNP	ORGANIZATION	Vertex	nn	19	SENT_35	[p1l1659t2320r1742b2342],
13	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	19	SENT_35	[p1l1758t2318r1980b2346],
14	,	,	O	,	_	0	SENT_35	[p1l1758t2318r1980b2346],
15	Cambridge	NNP	LOCATION	Cambridge	appos	19	SENT_35	[p1l1997t2320r2065b2342, p1l1531t2355r1617b2386],
16	,	,	O	,	_	0	SENT_35	[p1l1997t2320r2065b2342, p1l1531t2355r1617b2386],
17	MA	NNP	LOCATION	MA	appos	19	SENT_35	[p1l1628t2356r1671b2378],
18	(	CD	NUMBER	(	num	19	SENT_35	[p1l1681t2356r1754b2386],
19	Q.D.	NNP	O	Q.D.	prep_at	3	SENT_35	[p1l1681t2356r1754b2386],
20	,	,	O	,	_	0	SENT_35	[p1l1681t2356r1754b2386],
21	S.R.	NNP	O	S.R.	nn	26	SENT_35	[p1l1764t2356r1819b2382],
22	,	,	O	,	_	0	SENT_35	[p1l1764t2356r1819b2382],
23	K.Y.	NNP	LOCATION	K.Y.	appos	26	SENT_35	[p1l1831t2357r1881b2382],
24	,	,	O	,	_	0	SENT_35	[p1l1831t2357r1881b2382],
25	C.O.	NNP	LOCATION	C.O.	appos	26	SENT_35	[p1l1891t2356r1962b2386],
26	)	NNP	O	)	appos	19	SENT_35	[p1l1891t2356r1962b2386],
27	;	:	O	;	_	0	SENT_35	[p1l1891t2356r1962b2386],
28	and	CC	O	and	_	0	SENT_35	[p1l1972t2355r2017b2378],
29	the	DT	O	the	det	30	SENT_35	[p1l2025t2355r2065b2378],
30	Centre	NNP	O	Centre	prep_at	3	SENT_35	[p1l1530t2393r1612b2415],
31	for	IN	O	for	_	0	SENT_35	[p1l1618t2391r1653b2415],
32	Infection	NN	O	infection	prep_for	30	SENT_35	[p1l1661t2391r1769b2415],
33	and	CC	O	and	_	0	SENT_35	[p1l1778t2391r1823b2415],
34	Immunity	NN	O	immunity	prep_for	30	SENT_35	[p1l1833t2393r1959b2422],
35	,	,	O	,	_	0	SENT_35	[p1l1833t2393r1959b2422],
36	Queens	NNP	ORGANIZATION	Queens	nn	43	SENT_35	[p1l1967t2393r2064b2421],
37	University	NNP	ORGANIZATION	University	nn	43	SENT_35	[p1l1531t2430r1655b2458],
38	Belfast	NNP	ORGANIZATION	Belfast	nn	43	SENT_35	[p1l1664t2427r1752b2455],
39	,	,	O	,	_	0	SENT_35	[p1l1664t2427r1752b2455],
40	Belfast	NNP	LOCATION	Belfast	appos	43	SENT_35	[p1l1763t2427r1852b2455],
41	,	,	O	,	_	0	SENT_35	[p1l1763t2427r1852b2455],
42	United	NNP	LOCATION	United	appos	43	SENT_35	[p1l1862t2427r1943b2451],
43	Kingdom	NNP	LOCATION	Kingdom	appos	32	SENT_35	[p1l1954t2427r2064b2459],
44	(	CD	NUMBER	(	num	43	SENT_35	[p1l1533t2466r1627b2495],
45	J.S.E.	NNP	O	J.S.E.	dep	43	SENT_35	[p1l1533t2466r1627b2495],
46	)	CD	NUMBER	)	num	45	SENT_35	[p1l1533t2466r1627b2495],
47	.	.	O	.	_	0	SENT_35	[p1l1533t2466r1627b2495],

1	Address	NN	O	address	nsubj	2	SENT_36	[p1l1642t2464r1747b2488],
2	reprint	VB	O	reprint	_	0	SENT_36	[p1l1763t2466r1849b2495],
3	requests	NNS	O	request	dobj	2	SENT_36	[p1l1864t2468r1974b2495],
4	to	TO	O	to	_	0	SENT_36	[p1l1988t2468r2013b2488],
5	Dr.	NNP	O	Dr.	nn	6	SENT_36	[p1l2030t2466r2064b2488],
6	Ramsey	NNP	PERSON	Ramsey	prep_to	2	SENT_36	[p1l1532t2503r1630b2531],
7	at	IN	O	at	_	0	SENT_36	[p1l1641t2505r1664b2524],
8	the	DT	O	the	det	9	SENT_36	[p1l1673t2501r1714b2524],
9	Department	NNP	ORGANIZATION	Department	prep_at	6	SENT_36	[p1l1726t2503r1884b2531],
10	of	IN	ORGANIZATION	of	_	0	SENT_36	[p1l1894t2500r1923b2524],
11	Pediatrics	NNPS	ORGANIZATION	Pediatrics	prep_of	9	SENT_36	[p1l1931t2500r2064b2528],
12	,	,	O	,	_	0	SENT_36	[p1l1931t2500r2064b2528],
13	University	NNP	ORGANIZATION	University	nn	14	SENT_36	[p1l1531t2539r1656b2568],
14	ofwashington	NN	O	ofwashington	prep_of	9	SENT_36	[p1l1663t2537r1852b2568],
15	,	,	O	,	_	0	SENT_36	[p1l1663t2537r1852b2568],
16	4800	CD	NUMBER	4800	num	20	SENT_36	[p1l1860t2538r1923b2561],
17	Sand	NNP	O	Sand	nn	20	SENT_36	[p1l1931t2537r1991b2561],
18	Point	NNP	O	Point	nn	20	SENT_36	[p1l2003t2539r2066b2561],
19	Way	NNP	O	Way	nn	20	SENT_36	[p1l1529t2576r1581b2605],
20	NE	NN	O	ne	prep_of	9	SENT_36	[p1l1590t2576r1632b2602],
21	,	,	O	,	_	0	SENT_36	[p1l1590t2576r1632b2602],
22	Box	NNP	O	Box	conj_or	11	SENT_36	[p1l1643t2576r1686b2597],
23	5371	CD	NUMBER	5371	num	22	SENT_36	[p1l1694t2576r1756b2602],
24	,	,	O	,	_	0	SENT_36	[p1l1694t2576r1756b2602],
25	Seattle	NNP	LOCATION	Seattle	conj_or	11	SENT_36	[p1l1765t2574r1856b2602],
26	,	,	O	,	_	0	SENT_36	[p1l1765t2574r1856b2602],
27	WA	NNP	LOCATION	WA	prep_of	9	SENT_36	[p1l1864t2575r1908b2598],
28	98105-0371	CD	NUMBER	98105-0371	num	27	SENT_36	[p1l1915t2575r2064b2602],
29	,	,	O	,	_	0	SENT_36	[p1l1915t2575r2064b2602],
30	or	CC	O	or	_	0	SENT_36	[p1l1530t2618r1556b2633],
31	at	IN	O	at	advmod	11	SENT_36	[p1l1563t2614r1585b2633],
32	bonnie.ramsey@seattlechildrens.org	NN	O	bonnie.ramsey@seattlechildrens.org	conj_or	11	SENT_36	[p1l1594t2610r2064b2641],
33	.	.	O	.	_	0	SENT_36	[p1l1594t2610r2064b2641],

1	*	NN	O	*	nsubj	4	SENT_37	[p1l1529t2680r1592b2703],
2	The	DT	O	the	det	3	SENT_37	[p1l1529t2680r1592b2703],
3	members	NNS	O	member	dep	1	SENT_37	[p1l1601t2680r1721b2703],
4	ofthe	VBP	O	ofthe	_	0	SENT_37	[p1l1731t2679r1801b2703],
5	VX08-770-102	NN	O	vx08-770-102	nn	7	SENT_37	[p1l1809t2681r1986b2703],
6	Study	NNP	O	Study	nn	7	SENT_37	[p1l1995t2680r2066b2710],
7	Group	NNP	O	Group	nsubjpass	9	SENT_37	[p1l1547t2718r1627b2747],
8	are	VBP	O	be	auxpass	9	SENT_37	[p1l1642t2724r1680b2740],
9	listed	VBN	O	list	ccomp	4	SENT_37	[p1l1696t2716r1762b2740],
10	in	IN	O	in	_	0	SENT_37	[p1l1779t2718r1799b2739],
11	the	DT	O	the	det	13	SENT_37	[p1l1815t2716r1855b2740],
12	Supplementary	NNP	MISC	Supplementary	nn	13	SENT_37	[p1l1871t2716r2066b2747],
13	Appendix	NNP	MISC	Appendix	prep_in	9	SENT_37	[p1l1545t2752r1673b2783],
14	,	,	O	,	_	0	SENT_37	[p1l1545t2752r1673b2783],
15	available	JJ	O	available	acomp	9	SENT_37	[p1l1685t2752r1794b2776],
16	at	IN	O	at	_	0	SENT_37	[p1l1804t2757r1827b2776],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_37	[p1l1838t2754r1967b2783],
18	.	.	O	.	_	0	SENT_37	[p1l1838t2754r1967b2783],

1	N	NN	MISC	n	nn	3	SENT_38	[p1l1532t2818r1549b2839],
2	Englj	NNP	MISC	Englj	nn	3	SENT_38	[p1l1563t2816r1631b2847],
3	Med	NNP	O	Med	_	0	SENT_38	[p1l1645t2816r1699b2839],
4	2011	CD	DATE	2011	num	3	SENT_38	[p1l1710t2817r1941b2844],
5	;	:	O	;	_	0	SENT_38	[p1l1710t2817r1941b2844],
6	365:1663	CD	NUMBER	365:1663	number	7	SENT_38	[p1l1710t2817r1941b2844],
7	-72	CD	NUMBER	-72	dep	3	SENT_38	[p1l1710t2817r1941b2844],
8	.	.	O	.	_	0	SENT_38	[p1l1710t2817r1941b2844],

1	Copyright	NN	O	copyright	_	0	SENT_39	[p1l1530t2858r1624b2883],
2	©	CD	NUMBER	©	num	6	SENT_39	[p1l1632t2860r1653b2880],
3	2011	CD	DATE	2011	num	6	SENT_39	[p1l1662t2859r1709b2877],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_39	[p1l1718t2858r1859b2877],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_39	[p1l1867t2858r1944b2877],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_39	[p1l1950t2858r2022b2882],
7	.	.	O	.	_	0	SENT_39	[p1l1950t2858r2022b2882],

1	Downloaded	VBN	O	download	_	0	SENT_40	[p1l192t3041r362b3064],
2	from	IN	O	from	_	0	SENT_40	[p1l371t3041r436b3064],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_40	[p1l444t3041r563b3071],
4	at	IN	O	at	_	0	SENT_40	[p1l573t3045r596b3064],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_40	[p1l605t3041r787b3064],
6	on	IN	O	on	_	0	SENT_40	[p1l797t3048r829b3064],
7	January	NNP	DATE	January	prep_on	1	SENT_40	[p1l838t3041r940b3071],
8	5	CD	DATE	5	num	7	SENT_40	[p1l950t3041r973b3068],
9	,	,	DATE	,	_	0	SENT_40	[p1l950t3041r973b3068],
10	2014	CD	DATE	2014	num	7	SENT_40	[p1l984t3041r1056b3064],
11	.	.	O	.	_	0	SENT_40	[p1l984t3041r1056b3064],

1	For	IN	O	for	_	0	SENT_41	[p1l1066t3041r1113b3064],
2	personal	JJ	O	personal	amod	3	SENT_41	[p1l1121t3041r1233b3071],
3	use	NN	O	use	pobj	1	SENT_41	[p1l1243t3048r1286b3064],
4	only	RB	O	only	advmod	3	SENT_41	[p1l1296t3041r1360b3071],
5	.	.	O	.	_	0	SENT_41	[p1l1296t3041r1360b3071],

1	No	DT	O	no	det	3	SENT_42	[p1l1371t3041r1411b3064],
2	other	JJ	O	other	amod	3	SENT_42	[p1l1421t3041r1489b3064],
3	uses	NNS	O	use	_	0	SENT_42	[p1l1497t3048r1553b3064],
4	without	IN	O	without	_	0	SENT_42	[p1l1563t3041r1665b3064],
5	permission	NN	O	permission	prep_without	3	SENT_42	[p1l1673t3041r1825b3071],
6	.	.	O	.	_	0	SENT_42	[p1l1673t3041r1825b3071],

1	Copyright	NN	O	copyright	_	0	SENT_43	[p1l543t3082r677b3113],
2	©	CD	NUMBER	©	num	6	SENT_43	[p1l687t3082r710b3106],
3	2011	CD	DATE	2011	num	6	SENT_43	[p1l720t3082r782b3106],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_43	[p1l794t3082r986b3106],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_43	[p1l995t3082r1104b3106],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_43	[p1l1114t3082r1219b3113],
7	.	.	O	.	_	0	SENT_43	[p1l1114t3082r1219b3113],

1	All	DT	O	all	det	2	SENT_44	[p1l1230t3082r1271b3106],
2	rights	NNS	O	rights	nsubj	3	SENT_44	[p1l1281t3082r1355b3113],
3	reserved	VBN	O	reserve	_	0	SENT_44	[p1l1365t3082r1484b3106],
4	.	.	O	.	_	0	SENT_44	[p1l1365t3082r1484b3106],

1	The	DT	O	the	det	4	SENT_45	[p1l673t3188r718b3209],
2	NEW	NNP	O	NEW	nn	4	SENT_45	[p1l737t3190r822b3209],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_45	[p1l841t3190r1029b3209],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_45	[p1l1048t3190r1227b3216],
5	of	IN	O	of	_	0	SENT_45	[p1l1247t3188r1275b3215],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_45	[p1l1287t3190r1486b3209],

1	YSTIC	NNP	O	YSTIC	nn	2	SENT_46	[p1l333t3430r577b3486],
2	FIBROSIS	NNP	O	FIBROSIS	_	0	SENT_46	[p1l605t3430r1030b3503],
3	,	,	O	,	_	0	SENT_46	[p1l605t3430r1030b3503],
4	THE	DT	O	the	det	6	SENT_46	[p1l1057t3430r1242b3485],
5	MOST	JJS	O	most	amod	6	SENT_46	[p1l1269t3430r1519b3486],
6	COMMON	NNS	O	common	appos	2	SENT_46	[p1l1541t3429r1966b3486],
7	LEthal	JJ	O	lethal	dep	2	SENT_46	[p1l1997t3431r2133b3485, p1l337t3536r506b3615],

1	genetic	JJ	O	genetic	amod	2	SENT_47	[p1l537t3537r848b3637],
2	disease	NN	O	disease	nsubj	6	SENT_47	[p1l880t3536r1191b3615],
3	in	IN	O	in	_	0	SENT_47	[p1l1223t3537r1306b3613],
4	whites	NNS	O	whites	prep_in	2	SENT_47	[p1l1334t3536r1642b3632],
5	,	,	O	,	_	0	SENT_47	[p1l1334t3536r1642b3632],
6	affects	VBZ	O	affect	_	0	SENT_47	[p1l1679t3536r1966b3615],
7	approximately	RB	O	approximately	advmod	6	SENT_47	[p1l2000t3562r2133b3636, p1l336t3665r859b3765],

1	70,000	CD	NUMBER	70,000	num	2	SENT_48	[p1l899t3671r1186b3760],
2	people	NNS	O	people	nsubj	3	SENT_48	[p1l1228t3665r1514b3765],
3	worldwide	RB	O	worldwide	_	0	SENT_48	[p1l1553t3665r2132b3744],
4	.	.	O	.	_	0	SENT_48	[p1l1553t3665r2132b3744],

1	“	NN	O	“	_	0	SENT_49	[p1l1553t3665r2132b3744],

1	There	EX	O	there	expl	2	SENT_50	[p2l16t21r259b99],
2	is	VBZ	O	be	_	0	SENT_50	[p2l287t22r353b99],
3	no	DT	O	no	det	4	SENT_50	[p2l384t47r488b99],
4	cure	NN	O	cure	nsubj	2	SENT_50	[p2l519t48r699b100],
5	for	IN	O	for	_	0	SENT_50	[p2l727t21r849b99],
6	this	DT	O	this	det	7	SENT_50	[p2l876t21r1034b99],
7	disease	NN	O	disease	prep_for	4	SENT_50	[p2l1066t21r1396b116],
8	,	,	O	,	_	0	SENT_50	[p2l1066t21r1396b116],
9	and	CC	O	and	_	0	SENT_50	[p2l1429t21r1586b99],
10	the	DT	O	the	det	13	SENT_50	[p2l1615t21r1747b99],
11	progressive	JJ	O	progressive	amod	13	SENT_50	[p2l1774t47r2133b121, p2l21t149r173b227],
12	lung	NN	O	lung	nn	13	SENT_50	[p2l206t148r398b248],
13	disease	NN	O	disease	nsubj	20	SENT_50	[p2l429t148r737b226],
14	associated	VBN	O	associate	partmod	13	SENT_50	[p2l770t148r1211b226],
15	with	IN	O	with	_	0	SENT_50	[p2l1241t148r1435b227],
16	it	PRP	O	it	prep_with	14	SENT_50	[p2l1468t149r1526b226],
17	is	VBZ	O	be	cop	20	SENT_50	[p2l1554t149r1620b226],
18	the	DT	O	the	det	20	SENT_50	[p2l1656t148r1788b226],
19	leading	VBG	O	lead	amod	20	SENT_50	[p2l1820t148r2138b248],
20	cause	NN	O	cause	conj_and	2	SENT_50	[p2l20t302r248b354],
21	of	IN	O	of	_	0	SENT_50	[p2l276t275r374b353],
22	death	NN	O	death	prep_of	20	SENT_50	[p2l382t275r636b353],
23	.	.	O	.	_	0	SENT_50	[p2l382t275r636b353],

1	Current	JJ	DATE	current	amod	2	SENT_51	[p2l667t281r993b354],
2	treatments	NNS	O	treatment	_	0	SENT_51	[p2l1014t291r1466b353],
3	for	IN	O	for	_	0	SENT_51	[p2l1494t275r1614b353],
4	cystic	JJ	O	cystic	amod	6	SENT_51	[p2l1638t276r1869b375],
5	ﬁbrosis	NN	O	ﬁbrosis	nn	6	SENT_51	[p2l1894t275r2133b353, p2l21t403r128b480],
6	target	NN	O	target	prep_for	2	SENT_51	[p2l161t419r420b502],
7	the	DT	O	the	det	9	SENT_51	[p2l445t402r579b480],
8	secondary	JJ	O	secondary	amod	9	SENT_51	[p2l611t402r1052b502],
9	effects	NNS	O	effect	dep	2	SENT_51	[p2l1079t402r1362b480],
10	of	IN	O	of	_	0	SENT_51	[p2l1396t402r1495b480],
11	dysfunction	NN	O	dysfunction	prep_of	9	SENT_51	[p2l1508t402r2021b502],
12	of	IN	O	of	_	0	SENT_51	[p2l2052t402r2152b480],
13	the	DT	O	the	det	15	SENT_51	[p2l20t529r155b607],
14	cystic	JJ	O	cystic	amod	15	SENT_51	[p2l196t530r438b629],
15	fibrosis	NN	O	fibrosis	prep_of	11	SENT_51	[p2l477t529r807b607],
16	transmembrane	NN	O	transmembrane	nn	22	SENT_51	[p2l849t529r1544b607],
17	conductance	NN	O	conductance	nn	22	SENT_51	[p2l1585t529r2134b608],
18	regulator	NN	O	regulator	nn	22	SENT_51	[p2l20t656r426b756],
19	(	CD	NUMBER	(	num	22	SENT_51	[p2l464t662r767b747],
20	CFTR	NNP	ORGANIZATION	CFTR	nn	22	SENT_51	[p2l464t662r767b747],
21	)	NN	O	)	nn	22	SENT_51	[p2l464t662r767b747],
22	protein	NN	O	protein	dep	9	SENT_51	[p2l808t657r1148b756],
23	.	.	O	.	_	0	SENT_51	[p2l808t657r1148b756],

1	The	DT	O	the	dep	104	SENT_52	[p2l145t783r305b861],
2	CFTR	NNP	ORGANIZATION	CFTR	dep	104	SENT_52	[p2l340t789r589b866],
3	protein	NN	O	protein	dep	104	SENT_52	[p2l612t784r922b883],
4	is	VBZ	O	be	dep	104	SENT_52	[p2l955t784r1021b861],
5	an	DT	O	a	dep	104	SENT_52	[p2l1057t809r1160b861],
6	epithelial	JJ	O	epithelial	dep	104	SENT_52	[p2l1194t783r1593b883],
7	ion	NN	O	ion	dep	104	SENT_52	[p2l1627t784r1761b861],
8	channel	NN	O	channel	dep	104	SENT_52	[p2l1796t783r2134b861],
9	contributing	VBG	O	contribute	dep	104	SENT_52	[p2l20t910r560b1010],
10	to	TO	O	to	dep	104	SENT_52	[p2l593t926r674b988],
11	the	DT	O	the	dep	104	SENT_52	[p2l712t910r844b988],
12	regulation	NN	O	regulation	dep	104	SENT_52	[p2l880t910r1323b1010],
13	of	IN	O	of	dep	104	SENT_52	[p2l1360t910r1460b988],
14	absorption	NN	O	absorption	dep	104	SENT_52	[p2l1477t910r1942b1010],
15	and	CC	O	and	dep	104	SENT_52	[p2l1977t910r2134b988],
16	secretion	NN	O	secretion	dep	104	SENT_52	[p2l21t1038r408b1115],
17	of	IN	O	of	dep	104	SENT_52	[p2l467t1037r566b1115],
18	salt	NN	O	salt	dep	104	SENT_52	[p2l607t1037r758b1115],
19	and	CC	O	and	dep	104	SENT_52	[p2l809t1037r967b1115],
20	water	NN	O	water	dep	104	SENT_52	[p2l1020t1054r1258b1116],
21	in	IN	O	in	dep	104	SENT_52	[p2l1312t1038r1395b1114],
22	various	JJ	O	various	dep	104	SENT_52	[p2l1448t1038r1756b1116],
23	tissues	NNS	O	tissue	dep	104	SENT_52	[p2l1817t1038r2129b1132],
24	,	,	O	,	_	0	SENT_52	[p2l1817t1038r2129b1132],
25	including	VBG	O	include	dep	104	SENT_52	[p2l19t1164r429b1264],
26	the	DT	O	the	dep	104	SENT_52	[p2l466t1164r598b1242],
27	lung	NN	O	lung	dep	104	SENT_52	[p2l638t1164r849b1264],
28	,	,	O	,	_	0	SENT_52	[p2l638t1164r849b1264],
29	sweat	NN	O	sweat	dep	104	SENT_52	[p2l898t1181r1139b1243],
30	glands	NNS	O	gland	dep	104	SENT_52	[p2l1174t1164r1483b1264],
31	,	,	O	,	_	0	SENT_52	[p2l1174t1164r1483b1264],
32	pancreas	NN	O	pancreas	dep	104	SENT_52	[p2l1528t1190r1931b1264],
33	,	,	O	,	_	0	SENT_52	[p2l1528t1190r1931b1264],
34	and	CC	O	and	dep	104	SENT_52	[p2l1977t1164r2134b1242],
35	gastrointestinal	JJ	O	gastrointestinal	dep	104	SENT_52	[p2l20t1291r699b1391],
36	tract	NN	O	tract	dep	104	SENT_52	[p2l736t1296r1050b1369],
37	.45	CD	NUMBER	.45	dep	104	SENT_52	[p2l736t1296r1050b1369],
38	Cystic	JJ	MISC	cystic	dep	104	SENT_52	[p2l1090t1292r1345b1391],
39	fibrosis	NN	O	fibrosis	dep	104	SENT_52	[p2l1381t1291r1703b1369],
40	is	VBZ	O	be	dep	104	SENT_52	[p2l1741t1292r1807b1369],
41	caused	VBN	O	cause	dep	104	SENT_52	[p2l1846t1291r2134b1370],
42	by	IN	O	by	dep	104	SENT_52	[p2l20t1418r117b1518],
43	mutations	NNS	O	mutation	dep	104	SENT_52	[p2l153t1419r586b1497],
44	in	IN	O	in	dep	104	SENT_52	[p2l627t1419r710b1495],
45	CFT	NNP	O	CFT	dep	104	SENT_52	[p2l750t1424r906b1495],
46	R	NN	O	r	dep	104	SENT_52	[p2l902t1426r965b1498],
47	that	WDT	O	that	dep	104	SENT_52	[p2l999t1418r1170b1496],
48	affect	VBP	O	affect	dep	104	SENT_52	[p2l1205t1418r1449b1496],
49	the	DT	O	the	dep	104	SENT_52	[p2l1485t1418r1617b1496],
50	quantity	NN	O	quantity	dep	104	SENT_52	[p2l1658t1419r2017b1518],
51	of	IN	O	of	dep	104	SENT_52	[p2l2053t1418r2152b1496],
52	the	DT	O	the	dep	104	SENT_52	[p2l20t1545r153b1623],
53	protein	NN	O	protein	dep	104	SENT_52	[p2l195t1546r505b1645],
54	that	WDT	O	that	dep	104	SENT_52	[p2l549t1545r721b1623],
55	reaches	VBZ	O	reach	dep	104	SENT_52	[p2l759t1545r1076b1623],
56	the	DT	O	the	dep	104	SENT_52	[p2l1122t1545r1255b1623],
57	cell	NN	O	cell	dep	104	SENT_52	[p2l1299t1545r1444b1623],
58	surface	NN	O	surface	dep	104	SENT_52	[p2l1489t1545r1794b1624],
59	or	CC	O	or	dep	104	SENT_52	[p2l1838t1571r1927b1623],
60	that	IN	O	that	dep	104	SENT_52	[p2l1968t1545r2139b1623],
61	affect	VBP	O	affect	dep	104	SENT_52	[p2l19t1673r264b1752],
62	the	DT	O	the	dep	104	SENT_52	[p2l300t1673r432b1752],
63	function	NN	O	function	dep	104	SENT_52	[p2l472t1673r838b1752],
64	of	IN	O	of	dep	104	SENT_52	[p2l878t1673r978b1752],
65	CFTR	NNP	ORGANIZATION	CFTR	dep	104	SENT_52	[p2l1000t1679r1250b1757],
66	channels	NNS	O	channel	dep	104	SENT_52	[p2l1280t1673r1660b1752],
67	at	IN	O	at	dep	104	SENT_52	[p2l1702t1690r1781b1752],
68	the	DT	O	the	dep	104	SENT_52	[p2l1816t1673r1948b1752],
69	cell	NN	O	cell	dep	104	SENT_52	[p2l1990t1673r2134b1752],
70	surface	NN	O	surface	dep	104	SENT_52	[p2l21t1801r457b1879],
71	.67	CD	NUMBER	.67	dep	104	SENT_52	[p2l21t1801r457b1879],
72	The	DT	O	the	dep	104	SENT_52	[p2l497t1801r659b1879],
73	missense	NN	O	missense	dep	104	SENT_52	[p2l703t1802r1103b1879],
74	mutation	NN	O	mutation	dep	104	SENT_52	[p2l1147t1802r1546b1879],
75	GSSID	NN	O	gssid	dep	104	SENT_52	[p2l1590t1808r1845b1879],
76	is	VBZ	O	be	dep	104	SENT_52	[p2l1887t1802r1953b1879],
77	the	DT	O	the	dep	104	SENT_52	[p2l2000t1801r2134b1879],
78	most	RBS	O	most	dep	104	SENT_52	[p2l20t1944r239b2005],
79	prevalent	JJ	O	prevalent	dep	104	SENT_52	[p2l274t1927r678b2027],
80	example	NN	O	example	dep	104	SENT_52	[p2l716t1927r1076b2027],
81	of	IN	O	of	dep	104	SENT_52	[p2l1119t1927r1220b2005],
82	the	DT	O	the	dep	104	SENT_52	[p2l1244t1927r1378b2005],
83	latter	JJ	O	latter	dep	104	SENT_52	[p2l1419t1927r1714b2005],
84	.8	CD	NUMBER	.8	dep	104	SENT_52	[p2l1419t1927r1714b2005],
85	Approximately	RB	O	approximately	dep	104	SENT_52	[p2l1752t1928r2132b2027, p2l20t2054r306b2154],
86	4	CD	NUMBER	4	dep	104	SENT_52	[p2l349t2060r398b2132],
87	to	TO	O	to	dep	104	SENT_52	[p2l448t2071r529b2132],
88	5	CD	PERCENT	5	dep	104	SENT_52	[p2l583t2059r713b2133],
89	%	NN	PERCENT	%	dep	104	SENT_52	[p2l583t2059r713b2133],
90	of	IN	O	of	dep	104	SENT_52	[p2l763t2054r862b2132],
91	patients	NNS	O	patient	dep	104	SENT_52	[p2l892t2055r1232b2154],
92	with	IN	O	with	dep	104	SENT_52	[p2l1279t2054r1473b2133],
93	cystic	JJ	O	cystic	dep	104	SENT_52	[p2l1524t2055r1760b2154],
94	fibrosis	NN	O	fibrosis	dep	104	SENT_52	[p2l1809t2054r2132b2132],
95	have	VBP	O	have	dep	104	SENT_52	[p2l20t2182r209b2262],
96	the	DT	O	the	dep	104	SENT_52	[p2l246t2182r378b2261],
97	GSSID	NN	O	gssid	dep	104	SENT_52	[p2l415t2189r665b2260],
98	mutation	NN	O	mutation	dep	104	SENT_52	[p2l701t2183r1092b2262],
99	on	IN	O	on	dep	104	SENT_52	[p2l1128t2208r1234b2261],
100	at	IN	O	at	dep	104	SENT_52	[p2l1269t2199r1348b2261],
101	least	JJS	O	least	dep	104	SENT_52	[p2l1378t2182r1576b2261],
102	one	CD	NUMBER	one	dep	104	SENT_52	[p2l1608t2208r1759b2261],
103	allele	NN	O	allele	dep	104	SENT_52	[p2l1794t2182r2134b2261],
104	.19	CD	NUMBER	.19	_	0	SENT_52	[p2l1794t2182r2134b2261],

1	Ivacaftor	NNP	O	Ivacaftor	nn	3	SENT_53	[p2l147t2309r525b2388],
2	(	CD	NUMBER	(	num	3	SENT_53	[p2l563t2315r916b2400],
3	VX	NN	O	vx	nsubj	13	SENT_53	[p2l563t2315r916b2400],
4	—	NN	O	—	nn	6	SENT_53	[p2l563t2315r916b2400],
5	770	CD	NUMBER	770	num	6	SENT_53	[p2l563t2315r916b2400],
6	)	NN	O	)	dep	3	SENT_53	[p2l563t2315r916b2400],
7	is	VBZ	O	be	cop	13	SENT_53	[p2l957t2310r1022b2387],
8	an	DT	O	a	det	13	SENT_53	[p2l1060t2335r1163b2387],
9	investigational	JJ	O	investigational	amod	13	SENT_53	[p2l1198t2309r1854b2409],
10	,	,	O	,	_	0	SENT_53	[p2l1198t2309r1854b2409],
11	orally	RB	O	orally	advmod	12	SENT_53	[p2l1896t2309r2138b2409],
12	bioavailable	JJ	O	bioavailable	amod	13	SENT_53	[p2l20t2436r525b2515],
13	agent	NN	O	agent	_	0	SENT_53	[p2l580t2453r816b2536],
14	that	WDT	O	that	nsubjpass	16	SENT_53	[p2l866t2436r1038b2514],
15	is	VBZ	O	be	auxpass	16	SENT_53	[p2l1087t2437r1152b2514],
16	designed	VBN	O	design	rcmod	13	SENT_53	[p2l1210t2436r1591b2536],
17	to	TO	O	to	aux	18	SENT_53	[p2l1646t2453r1728b2514],
18	increase	VB	O	increase	xcomp	16	SENT_53	[p2l1783t2437r2134b2514],
19	the	DT	O	the	det	20	SENT_53	[p2l20t2564r153b2643],
20	time	NN	O	time	dobj	18	SENT_53	[p2l187t2565r379b2643],
21	that	IN	O	that	complm	29	SENT_53	[p2l414t2564r586b2643],
22	activated	VBN	O	activate	amod	24	SENT_53	[p2l614t2564r990b2643],
23	CFTR	NN	ORGANIZATION	cftr	nn	24	SENT_53	[p2l1025t2570r1274b2648],
24	channels	NNS	O	channel	nsubj	29	SENT_53	[p2l1299t2564r1679b2643],
25	at	IN	O	at	_	0	SENT_53	[p2l1715t2581r1793b2643],
26	the	DT	O	the	det	28	SENT_53	[p2l1823t2564r1954b2643],
27	cell	NN	O	cell	nn	28	SENT_53	[p2l1990t2564r2134b2643],
28	surface	NN	O	surface	prep_at	24	SENT_53	[p2l21t2691r331b2770],
29	remain	VBP	O	remain	ccomp	18	SENT_53	[p2l370t2692r677b2769],
30	open	JJ	O	open	acomp	29	SENT_53	[p2l717t2717r927b2791],
31	(	CD	NUMBER	(	tmod	30	SENT_53	[p2l971t2698r1039b2782],
32	a	DT	O	a	det	34	SENT_53	[p2l971t2698r1039b2782],
33	“	NN	O	“	nn	34	SENT_53	[p2l1081t2692r1710b2791],
34	potentiator	NN	O	potentiator	dep	30	SENT_53	[p2l1081t2692r1710b2791],
35	”	CD	NUMBER	”	num	36	SENT_53	[p2l1081t2692r1710b2791],
36	)	NN	O	)	dep	34	SENT_53	[p2l1081t2692r1710b2791],
37	.	.	O	.	_	0	SENT_53	[p2l1081t2692r1710b2791],

1	Ivacaftor	NNP	O	Ivacaftor	nsubjpass	3	SENT_54	[p2l1753t2691r2137b2770],
2	was	VBD	O	be	auxpass	3	SENT_54	[p2l15t2845r175b2897],
3	shown	VBN	O	show	_	0	SENT_54	[p2l215t2818r491b2897],
4	to	TO	O	to	aux	5	SENT_54	[p2l529t2835r608b2896],
5	augment	VB	O	augment	xcomp	3	SENT_54	[p2l646t2835r1016b2918],
6	the	DT	O	the	det	10	SENT_54	[p2l1048t2818r1178b2896],
7	chloride	NN	O	chloride	nn	10	SENT_54	[p2l1215t2818r1985b2918],
8	—	NN	O	—	nn	10	SENT_54	[p2l1215t2818r1985b2918],
9	transport	NN	O	transport	nn	10	SENT_54	[p2l1215t2818r1985b2918],
10	activity	NN	O	activity	dobj	5	SENT_54	[p2l2016t2845r2133b2896, p2l20t2946r236b3045],
11	of	IN	O	of	_	0	SENT_54	[p2l267t2945r366b3023],
12	G551D	NN	O	g551d	prep_of	10	SENT_54	[p2l381t2951r969b3028],
13	.	.	O	.	_	0	SENT_54	[p2l381t2951r969b3028],

1	—	NN	O	—	_	0	SENT_55	[p2l381t2951r969b3028],
2	.	.	O	.	_	0	SENT_55	[p2l381t2951r969b3028],

1	CFTR	NNP	ORGANIZATION	CFTR	nn	2	SENT_56	[p2l381t2951r969b3028],
2	protein	NN	O	protein	nsubj	12	SENT_56	[p2l990t2946r1302b3045],
3	in	FW	O	in	nn	4	SENT_56	[p2l1335t2946r1418b3022],
4	vitro	FW	O	vitro	advmod	6	SENT_56	[p2l1447t2946r1743b3024],
5	.1	FW	NUMBER	.1	nn	6	SENT_56	[p2l1447t2946r1743b3024],
6	°	FW	O	°	rcmod	2	SENT_56	[p2l1447t2946r1743b3024],
7	A	DT	O	a	det	8	SENT_56	[p2l1774t2953r1840b3022],
8	small	JJ	O	small	dep	6	SENT_56	[p2l1871t2945r2128b3040],
9	,	,	O	,	_	0	SENT_56	[p2l1871t2945r2128b3040],
10	randomized	VBN	O	randomize	partmod	2	SENT_56	[p2l20t3072r574b3167],
11	,	,	O	,	_	0	SENT_56	[p2l20t3072r574b3167],
12	controlled	VBN	O	control	_	0	SENT_56	[p2l630t3072r1077b3150],
13	study	NN	O	study	dobj	12	SENT_56	[p2l1129t3072r1362b3172],
14	of	IN	O	of	_	0	SENT_56	[p2l1408t3072r1508b3150],
15	subjects	NNS	O	subject	prep_of	13	SENT_56	[p2l1541t3072r1888b3172],
16	with	IN	O	with	_	0	SENT_56	[p2l1936t3072r2134b3151],
17	cystic	JJ	O	cystic	amod	18	SENT_56	[p2l20t3200r257b3299],
18	fibrosis	NN	O	fibrosis	prep_with	15	SENT_56	[p2l294t3199r616b3277],
19	and	CC	O	and	_	0	SENT_56	[p2l655t3199r812b3277],
20	at	IN	O	at	quantmod	22	SENT_56	[p2l849t3216r927b3277],
21	least	JJS	O	least	mwe	20	SENT_56	[p2l958t3199r1156b3277],
22	one	CD	NUMBER	one	num	23	SENT_56	[p2l1189t3225r1340b3277],
23	G55lD	NN	O	g55ld	prep_of	13	SENT_56	[p2l1378t3205r1882b3279],
24	.	.	O	.	_	0	SENT_56	[p2l1378t3205r1882b3279],

1	—	NN	O	—	_	0	SENT_57	[p2l1378t3205r1882b3279],
2	.	.	O	.	_	0	SENT_57	[p2l1378t3205r1882b3279],

1	CFTR	NNP	ORGANIZATION	CFTR	nn	2	SENT_58	[p2l1378t3205r1882b3279],
2	allele	NN	O	allele	nsubj	3	SENT_58	[p2l1911t3199r2134b3277],
3	evaluated	VBD	O	evaluate	_	0	SENT_58	[p2l20t3326r421b3405],
4	the	DT	O	the	det	6	SENT_58	[p2l462t3326r594b3404],
5	safety	NN	O	safety	nn	6	SENT_58	[p2l637t3326r889b3426],
6	profile	NN	O	profile	dobj	3	SENT_58	[p2l923t3326r1210b3426],
7	of	IN	O	of	_	0	SENT_58	[p2l1252t3326r1351b3404],
8	ivacaftor	NN	O	ivacaftor	prep_of	6	SENT_58	[p2l1373t3326r1748b3405],
9	over	IN	O	over	_	0	SENT_58	[p2l1786t3352r1963b3405],
10	the	DT	O	the	det	11	SENT_58	[p2l2001t3326r2134b3404],
11	course	NN	O	course	prep_over	3	SENT_58	[p2l20t3479r286b3532],
12	of	IN	O	of	_	0	SENT_58	[p2l313t3453r411b3531],
13	14	CD	DURATION	14	number	15	SENT_58	[p2l422t3459r511b3531],
14	to	TO	DURATION	to	dep	15	SENT_58	[p2l538t3470r617b3531],
15	28	CD	DURATION	28	num	16	SENT_58	[p2l645t3459r741b3531],
16	days	NNS	NUMBER	day	prep_of	11	SENT_58	[p2l770t3453r946b3553],
17	of	IN	O	of	_	0	SENT_58	[p2l976t3453r1073b3531],
18	treatment	NN	O	treatment	prep_of	16	SENT_58	[p2l1081t3458r1574b3531],
19	.	.	O	.	_	0	SENT_58	[p2l1081t3458r1574b3531],

1	“	NN	O	“	npadvmod	7	SENT_59	[p2l1081t3458r1574b3531],
2	In	IN	O	in	_	0	SENT_59	[p2l1599t3461r1685b3530],
3	that	DT	O	that	det	4	SENT_59	[p2l1712t3453r1877b3531],
4	study	NN	O	study	prep_in	7	SENT_59	[p2l1900t3453r2128b3553],
5	,	,	O	,	_	0	SENT_59	[p2l1900t3453r2128b3553],
6	ivacaftor	NN	O	ivacaftor	nsubj	7	SENT_59	[p2l19t3580r389b3659],
7	led	VBD	O	lead	_	0	SENT_59	[p2l416t3580r539b3658],
8	to	TO	O	to	_	0	SENT_59	[p2l571t3596r651b3658],
9	significant	JJ	O	significant	amod	10	SENT_59	[p2l686t3580r1146b3680],
10	changes	NNS	O	change	prep_to	7	SENT_59	[p2l1173t3580r1515b3680],
11	from	IN	O	from	_	0	SENT_59	[p2l1548t3580r1756b3658],
12	baseline	NN	O	baseline	prep_from	7	SENT_59	[p2l1788t3580r2134b3658],
13	in	IN	O	in	_	0	SENT_59	[p2l19t3708r102b3784],
14	forced	JJ	O	forced	amod	16	SENT_59	[p2l150t3707r418b3785],
15	expiratory	JJ	O	expiratory	amod	16	SENT_59	[p2l466t3708r905b3807],
16	volume	NN	O	volume	prep_in	12	SENT_59	[p2l944t3707r1255b3786],
17	in	IN	O	in	_	0	SENT_59	[p2l1302t3708r1385b3784],
18	1	CD	DURATION	1	num	20	SENT_59	[p2l1436t3713r1480b3784],
19	second	JJ	NUMBER	second	amod	20	SENT_59	[p2l1529t3707r1826b3785],
20	(	NN	O	(	prep_in	16	SENT_59	[p2l1878t3714r2129b3811],
21	FEV1	NN	O	fev1	dep	7	SENT_59	[p2l1878t3714r2129b3811],
22	)	CD	NUMBER	)	num	21	SENT_59	[p2l1878t3714r2129b3811],

1	and	CC	O	and	_	0	SENT_60	[p3l19t18r177b96],
2	in	IN	O	in	dep	1	SENT_60	[p3l209t19r292b95],
3	two	CD	NUMBER	two	num	4	SENT_60	[p3l325t35r483b97],
4	biomarkers	NNS	O	biomarker	pobj	2	SENT_60	[p3l517t18r1003b97],
5	of	IN	O	of	_	0	SENT_60	[p3l1039t18r1138b96],
6	CFTR	NN	O	cftr	nn	7	SENT_60	[p3l1152t24r1403b101],
7	activity	NN	O	activity	prep_of	4	SENT_60	[p3l1425t19r1735b118],
8	—	CD	NUMBER	—	num	10	SENT_60	[p3l1760t63r1867b71],
9	sweat	NN	O	sweat	nn	10	SENT_60	[p3l1897t35r2139b97],
10	chloride	NN	O	chloride	dep	7	SENT_60	[p3l20t145r369b223],
11	and	CC	O	and	_	0	SENT_60	[p3l434t145r591b223],
12	nasal	JJ	O	nasal	amod	15	SENT_60	[p3l656t145r882b223],
13	potential	JJ	O	potential	amod	15	SENT_60	[p3l945t145r1333b245],
14	difference	NN	O	difference	nn	15	SENT_60	[p3l1399t145r1831b223],
15	—	NN	O	—	conj_and	7	SENT_60	[p3l1892t190r2000b198],
16	at	IN	O	at	_	0	SENT_60	[p3l2060t162r2139b223],
17	several	JJ	O	several	amod	19	SENT_60	[p3l21t272r313b351],
18	dose	NN	O	dose	nn	19	SENT_60	[p3l359t272r553b350],
19	levels	NNS	O	level	prep_at	15	SENT_60	[p3l599t272r854b351],
20	.	.	O	.	_	0	SENT_60	[p3l599t272r854b351],

1	The	DT	O	the	det	2	SENT_61	[p3l903t272r1062b350],
2	trial	NN	O	trial	nsubjpass	6	SENT_61	[p3l1110t272r1287b350],
3	reported	VBN	O	report	partmod	2	SENT_61	[p3l1333t272r1700b372],
4	here	RB	O	here	advmod	3	SENT_61	[p3l1746t272r1927b350],
5	was	VBD	O	be	auxpass	6	SENT_61	[p3l1969t299r2131b351],
6	designed	VBN	O	design	_	0	SENT_61	[p3l20t399r409b499],
7	to	TO	O	to	aux	8	SENT_61	[p3l455t415r537b477],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_61	[p3l584t399r936b478],
9	the	DT	O	the	det	10	SENT_61	[p3l982t399r1117b477],
10	efficacy	NN	O	efficacy	dobj	8	SENT_61	[p3l1164t399r1506b499],
11	and	CC	O	and	_	0	SENT_61	[p3l1546t399r1706b477],
12	safety	NN	O	safety	conj_and	10	SENT_61	[p3l1753t399r2010b499],
13	of	IN	O	of	_	0	SENT_61	[p3l2052t399r2153b477],
14	ivacaftor	NN	O	ivacaftor	nn	15	SENT_61	[p3l19t526r403b605],
15	treatment	NN	O	treatment	prep_of	10	SENT_61	[p3l445t542r876b604],
16	for	IN	O	for	_	0	SENT_61	[p3l917t526r1041b604],
17	up	RB	DURATION	up	quantmod	19	SENT_61	[p3l1084t552r1188b626],
18	to	TO	DURATION	to	dep	19	SENT_61	[p3l1235t543r1317b604],
19	48	CD	DURATION	48	num	20	SENT_61	[p3l1363t532r1464b604],
20	weeks	NNS	NUMBER	week	prep_for	15	SENT_61	[p3l1508t526r1772b605],
21	in	IN	O	in	_	0	SENT_61	[p3l1819t527r1903b603],
22	subjects	NNS	O	subject	prep_in	8	SENT_61	[p3l1950t526r2133b605, p3l6t654r211b753],
23	With	IN	O	with	_	0	SENT_61	[p3l246t653r444b732],
24	cystic	JJ	O	cystic	amod	25	SENT_61	[p3l483t654r724b753],
25	fibrosis	NN	O	fibrosis	prep_with	22	SENT_61	[p3l761t653r1092b731],
26	who	WP	O	who	nsubj	27	SENT_61	[p3l1127t653r1312b732],
27	had	VBD	O	have	rcmod	22	SENT_61	[p3l1351t653r1508b731],
28	a	DT	O	a	det	29	SENT_61	[p3l1545t680r1590b731],
29	G551D	NN	O	g551d	dobj	27	SENT_61	[p3l1627t659r2081b731],
30	.	.	O	.	_	0	SENT_61	[p3l1627t659r2081b731],

1	—	NN	O	—	_	0	SENT_62	[p3l1627t659r2081b731],
2	.	.	O	.	_	0	SENT_62	[p3l1627t659r2081b731],

1	CFT	NNP	O	CFT	nn	2	SENT_63	[p3l1627t659r2081b731],
2	R	NNP	O	R	_	0	SENT_63	[p3l2077t661r2140b733],
3	mutation	NN	O	mutation	dep	2	SENT_63	[p3l20t759r442b836],
4	.	.	O	.	_	0	SENT_63	[p3l20t759r442b836],

1	METHODS	NNS	O	method	_	0	SENT_64	[p3l806t1054r1346b1113],

1	sruov	NN	O	sruov	nn	2	SENT_65	[p3l20t1287r275b1336],
2	OVERSIGHT	NN	O	oversight	_	0	SENT_65	[p3l307t1287r766b1336],

1	We	PRP	O	we	nsubj	2	SENT_66	[p3l16t1392r146b1462],
2	conducted	VBD	O	conduct	_	0	SENT_66	[p3l172t1384r592b1463],
3	a	DT	O	a	det	4	SENT_66	[p3l616t1411r660b1462],
4	phase	NN	O	phase	dobj	2	SENT_66	[p3l681t1384r920b1484],
5	3	CD	NUMBER	3	tmod	2	SENT_66	[p3l945t1390r1011b1479],
6	,	,	O	,	_	0	SENT_66	[p3l945t1390r1011b1479],
7	randomized	VBN	O	randomize	dep	2	SENT_66	[p3l1041t1384r1559b1479],
8	,	,	O	,	_	0	SENT_66	[p3l1041t1384r1559b1479],
9	double	JJ	O	double	dep	2	SENT_66	[p3l1590t1384r2129b1479],
10	—	RB	O	—	advmod	11	SENT_66	[p3l1590t1384r2129b1479],
11	blind	JJ	O	blind	dep	9	SENT_66	[p3l1590t1384r2129b1479],
12	,	,	O	,	_	0	SENT_66	[p3l1590t1384r2129b1479],
13	placebo	NN	O	placebo	nn	14	SENT_66	[p3l19t1511r867b1611],
14	—	NN	O	—	nsubj	25	SENT_66	[p3l19t1511r867b1611],
15	controlled	VBN	O	control	partmod	14	SENT_66	[p3l19t1511r867b1611],
16	,	,	O	,	_	0	SENT_66	[p3l19t1511r867b1611],
17	international	JJ	O	international	amod	18	SENT_66	[p3l905t1511r1478b1589],
18	study	NN	O	study	dobj	15	SENT_66	[p3l1513t1511r1746b1611],
19	of	IN	O	of	_	0	SENT_66	[p3l1775t1511r1876b1589],
20	orally	RB	O	orally	advmod	21	SENT_66	[p3l1891t1511r2139b1611],
21	administered	VBN	O	administer	amod	22	SENT_66	[p3l19t1638r570b1716],
22	ivacaftor	NN	O	ivacaftor	prep_of	18	SENT_66	[p3l596t1638r958b1717],
23	(	CD	NUMBER	(	num	25	SENT_66	[p3l986t1644r1323b1733],
24	VX	NN	O	vx	nn	25	SENT_66	[p3l986t1644r1323b1733],
25	—	NN	O	—	xcomp	2	SENT_66	[p3l986t1644r1323b1733],
26	770	CD	NUMBER	770	dep	25	SENT_66	[p3l986t1644r1323b1733],
27	,	,	O	,	_	0	SENT_66	[p3l986t1644r1323b1733],
28	Vertex	NNP	ORGANIZATION	Vertex	nn	30	SENT_66	[p3l1351t1646r1614b1716],
29	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	30	SENT_66	[p3l1636t1638r2132b1717, p3l20t1765r288b1856],
30	)	NN	O	)	appos	25	SENT_66	[p3l1636t1638r2132b1717, p3l20t1765r288b1856],
31	.	.	O	.	_	0	SENT_66	[p3l1636t1638r2132b1717, p3l20t1765r288b1856],

1	The	DT	O	the	det	2	SENT_67	[p3l322t1765r480b1843],
2	protocol	NN	O	protocol	nsubjpass	18	SENT_67	[p3l510t1765r884b1865],
3	,	,	O	,	_	0	SENT_67	[p3l510t1765r884b1865],
4	available	JJ	O	available	amod	2	SENT_67	[p3l920t1765r1281b1844],
5	with	IN	O	with	_	0	SENT_67	[p3l1309t1765r1499b1844],
6	the	DT	O	the	det	8	SENT_67	[p3l1532t1765r1662b1843],
7	full	JJ	O	full	amod	8	SENT_67	[p3l1693t1765r1838b1844],
8	text	NN	O	text	prep_with	4	SENT_67	[p3l1870t1782r2026b1843],
9	of	IN	O	of	_	0	SENT_67	[p3l2054t1765r2152b1843],
10	this	DT	O	this	det	11	SENT_67	[p3l20t1892r179b1970],
11	article	NN	O	article	prep_of	8	SENT_67	[p3l230t1892r497b1970],
12	at	IN	O	at	_	0	SENT_67	[p3l545t1909r624b1970],
13	NEJM.org	NN	O	nejm.org	prep_at	11	SENT_67	[p3l666t1900r1107b1992],
14	,	,	O	,	_	0	SENT_67	[p3l666t1900r1107b1992],
15	Was	VBD	O	be	auxpass	16	SENT_67	[p3l1157t1919r1319b1971],
16	reviewed	VBN	O	review	_	0	SENT_67	[p3l1371t1892r1747b1971],
17	and	CC	O	and	_	0	SENT_67	[p3l1796t1892r1953b1970],
18	approved	VBN	O	approve	conj_and	16	SENT_67	[p3l2001t1918r2133b1992, p3l19t2019r307b2119],
19	by	IN	O	by	_	0	SENT_67	[p3l348t2019r444b2119],
20	the	DT	O	the	det	23	SENT_67	[p3l481t2019r613b2097],
21	institutional	JJ	O	institutional	amod	23	SENT_67	[p3l653t2019r1185b2098],
22	review	NN	O	review	nn	23	SENT_67	[p3l1225t2020r1503b2098],
23	board	NN	O	board	agent	16	SENT_67	[p3l1541t2019r1788b2097],
24	at	IN	O	at	_	0	SENT_67	[p3l1828t2036r1907b2097],
25	each	DT	O	each	det	27	SENT_67	[p3l1943t2019r2134b2097],
26	participating	VBG	O	participate	amod	27	SENT_67	[p3l19t2147r578b2246],
27	center	NN	O	center	prep_at	23	SENT_67	[p3l626t2163r906b2241],
28	,	,	O	,	_	0	SENT_67	[p3l626t2163r906b2241],
29	and	CC	O	and	_	0	SENT_67	[p3l963t2146r1120b2224],
30	each	DT	O	each	det	32	SENT_67	[p3l1173t2146r1363b2224],
31	subject	JJ	O	subject	dep	32	SENT_67	[p3l1417t2146r1715b2246],
32	provided	VBN	O	provide	conj_and	23	SENT_67	[p3l1761t2146r2134b2246],
33	Written	VBN	O	write	partmod	32	SENT_67	[p3l7t2275r324b2353],
34	informed	VBN	O	inform	amod	35	SENT_67	[p3l368t2273r772b2353],
35	consent	NN	O	consent	dobj	33	SENT_67	[p3l817t2291r1155b2353],
36	or	CC	O	or	_	0	SENT_67	[p3l1195t2300r1285b2353],
37	written	VBN	O	write	conj_or	35	SENT_67	[p3l1322t2275r1638b2353],
38	or	CC	O	or	_	0	SENT_67	[p3l1684t2300r1773b2353],
39	oral	JJ	O	oral	amod	40	SENT_67	[p3l1815t2274r1983b2353],
40	assent	NN	O	assent	conj_or	37	SENT_67	[p3l2027t2300r2147b2352, p3l13t2419r211b2481],
41	.	.	O	.	_	0	SENT_67	[p3l2027t2300r2147b2352, p3l13t2419r211b2481],

1	The	DT	O	the	det	2	SENT_68	[p3l255t2402r417b2480],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_68	[p3l458t2402r821b2502],
3	was	VBD	O	be	auxpass	4	SENT_68	[p3l858t2428r1021b2481],
4	designed	VBN	O	design	_	0	SENT_68	[p3l1066t2402r1451b2503],
5	by	IN	O	by	_	0	SENT_68	[p3l1493t2402r1591b2502],
6	the	DT	O	the	det	11	SENT_68	[p3l1629t2402r1762b2480],
7	sponsor	NN	O	sponsor	nn	11	SENT_68	[p3l1806t2428r2152b2502],
8	(	CD	NUMBER	(	num	11	SENT_68	[p3l17t2537r319b2621],
9	Vertex	NNP	ORGANIZATION	Vertex	nn	11	SENT_68	[p3l17t2537r319b2621],
10	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	11	SENT_68	[p3l373t2530r1115b2621],
11	)	NN	O	)	agent	4	SENT_68	[p3l373t2530r1115b2621],
12	in	IN	O	in	_	0	SENT_68	[p3l1178t2531r1262b2608],
13	collaboration	NN	O	collaboration	prep_in	11	SENT_68	[p3l1322t2530r1897b2609],
14	with	IN	O	with	_	0	SENT_68	[p3l1952t2530r2148b2610],
15	the	DT	O	the	det	17	SENT_68	[p3l12t2659r146b2738],
16	academic	JJ	O	academic	amod	17	SENT_68	[p3l177t2659r580b2738],
17	authors	NNS	O	author	prep_with	4	SENT_68	[p3l609t2659r959b2738],
18	.	.	O	.	_	0	SENT_68	[p3l609t2659r959b2738],

1	Site	NN	O	site	nn	2	SENT_69	[p3l999t2660r1149b2738],
2	investigators	NNS	O	investigator	nsubj	3	SENT_69	[p3l1180t2660r1731b2760],
3	collected	VBN	O	collect	_	0	SENT_69	[p3l1766t2659r2148b2738],
4	the	DT	O	the	det	5	SENT_69	[p3l12t2787r146b2865],
5	data	NNS	O	datum	dobj	3	SENT_69	[p3l176t2787r382b2883],
6	,	,	O	,	_	0	SENT_69	[p3l176t2787r382b2883],
7	which	WDT	O	which	nsubjpass	9	SENT_69	[p3l412t2787r676b2866],
8	were	VBD	O	be	auxpass	9	SENT_69	[p3l700t2813r903b2866],
9	analyzed	VBN	O	analyze	rcmod	5	SENT_69	[p3l931t2787r1313b2887],
10	by	IN	O	by	_	0	SENT_69	[p3l1343t2787r1440b2887],
11	the	DT	O	the	det	12	SENT_69	[p3l1465t2787r1599b2865],
12	sponsor	NN	O	sponsor	agent	9	SENT_69	[p3l1629t2813r1992b2887],
13	.	.	O	.	_	0	SENT_69	[p3l1629t2813r1992b2887],

1	All	PDT	O	all	predet	3	SENT_70	[p3l2023t2787r2149b2865],
2	the	DT	O	the	det	3	SENT_70	[p3l12t2916r146b2994],
3	authors	NNS	O	author	nsubj	4	SENT_70	[p3l183t2916r507b2995],
4	had	VBD	O	have	_	0	SENT_70	[p3l547t2916r704b2995],
5	full	JJ	O	full	amod	6	SENT_70	[p3l742t2915r891b2995],
6	access	NN	O	access	dobj	4	SENT_70	[p3l928t2942r1195b2995],
7	to	TO	O	to	_	0	SENT_70	[p3l1236t2933r1317b2995],
8	the	DT	O	the	det	9	SENT_70	[p3l1357t2916r1491b2995],
9	data	NNS	O	datum	prep_to	6	SENT_70	[p3l1530t2916r1735b2995],
10	.	.	O	.	_	0	SENT_70	[p3l1530t2916r1735b2995],

1	The	DT	O	the	det	3	SENT_71	[p3l1775t2916r1937b2994],
2	lead	NN	O	lead	nn	3	SENT_71	[p3l1974t2916r2148b2995],
3	author	NN	O	author	nsubj	4	SENT_71	[p3l11t3043r295b3123],
4	Wrote	VBD	O	write	_	0	SENT_71	[p3l342t3060r590b3123],
5	the	DT	O	the	det	7	SENT_71	[p3l646t3043r779b3121],
6	first	JJ	ORDINAL	first	amod	7	SENT_71	[p3l834t3042r1018b3121],
7	draft	NN	O	draft	nsubj	15	SENT_71	[p3l1069t3042r1283b3122],
8	of	IN	O	of	_	0	SENT_71	[p3l1333t3042r1433b3122],
9	the	DT	O	the	det	10	SENT_71	[p3l1469t3043r1603b3121],
10	manuscript	NN	O	manuscript	prep_of	7	SENT_71	[p3l1657t3044r2153b3143],
11	and	CC	O	and	_	0	SENT_71	[p3l11t3172r170b3251],
12	all	PDT	O	all	predet	14	SENT_71	[p3l224t3172r329b3250],
13	the	DT	O	the	det	14	SENT_71	[p3l383t3172r517b3250],
14	authors	NNS	O	author	conj_and	10	SENT_71	[p3l571t3172r895b3251],
15	participated	VBD	O	participate	ccomp	4	SENT_71	[p3l950t3172r1471b3272],
16	in	IN	O	in	_	0	SENT_71	[p3l1524t3173r1608b3250],
17	subsequent	JJ	O	subsequent	amod	18	SENT_71	[p3l1664t3172r2153b3272],
18	revisions	NNS	O	revision	prep_in	15	SENT_71	[p3l12t3301r411b3379],
19	.	.	O	.	_	0	SENT_71	[p3l12t3301r411b3379],

1	The	DT	O	the	det	3	SENT_72	[p3l442t3300r602b3379],
2	first	JJ	ORDINAL	first	amod	3	SENT_72	[p3l633t3299r814b3378],
3	author	NN	O	author	nsubj	10	SENT_72	[p3l838t3300r1135b3396],
4	,	,	O	,	_	0	SENT_72	[p3l838t3300r1135b3396],
5	after	IN	O	after	_	0	SENT_72	[p3l1170t3299r1370b3378],
6	consultation	NN	O	consultation	prep_after	10	SENT_72	[p3l1398t3300r1929b3379],
7	with	IN	O	with	_	0	SENT_72	[p3l1954t3300r2148b3380],
8	coauthors	NNS	O	coauthor	prep_with	6	SENT_72	[p3l12t3429r462b3525],
9	,	,	O	,	_	0	SENT_72	[p3l12t3429r462b3525],
10	made	VBD	O	make	_	0	SENT_72	[p3l499t3429r732b3508],
11	the	DT	O	the	det	12	SENT_72	[p3l764t3429r897b3507],
12	decision	NN	O	decision	dobj	10	SENT_72	[p3l929t3429r1283b3508],
13	to	TO	O	to	aux	14	SENT_72	[p3l1315t3446r1397b3508],
14	submit	VB	O	submit	infmod	12	SENT_72	[p3l1431t3429r1731b3508],
15	the	DT	O	the	det	16	SENT_72	[p3l1758t3429r1892b3508],
16	manuscript	NN	O	manuscript	dobj	14	SENT_72	[p3l1923t3455r2147b3507, p3l12t3558r312b3657],
17	for	IN	O	for	_	0	SENT_72	[p3l342t3556r467b3636],
18	publication	NN	O	publication	prep_for	16	SENT_72	[p3l497t3557r1012b3657],
19	.	.	O	.	_	0	SENT_72	[p3l497t3557r1012b3657],

1	All	PDT	O	all	predet	3	SENT_73	[p3l1049t3557r1175b3635],
2	the	DT	O	the	det	3	SENT_73	[p3l1211t3557r1344b3635],
3	authors	NNS	O	author	nsubj	4	SENT_73	[p3l1379t3557r1704b3636],
4	vouch	VBP	O	vouch	_	0	SENT_73	[p3l1737t3557r1991b3637],
5	for	IN	O	for	_	0	SENT_73	[p3l2027t3556r2151b3636],
6	the	DT	O	the	det	7	SENT_73	[p3l12t3685r146b3763],
7	accuracy	NN	O	accuracy	prep_for	4	SENT_73	[p3l196t3711r571b3785],
8	and	CC	O	and	_	0	SENT_73	[p3l616t3685r775b3764],
9	completeness	NN	O	completeness	prep_for	4	SENT_73	[p3l826t3685r1408b3785],
10	of	IN	O	of	_	0	SENT_73	[p3l1462t3684r1562b3764],
11	the	DT	O	the	det	13	SENT_73	[p3l1595t3685r1729b3763],
12	reported	VBN	O	report	amod	13	SENT_73	[p3l1780t3685r2148b3785],
13	data	NNS	O	datum	prep_of	7	SENT_73	[p4l12t21r197b100],
14	and	CC	O	and	_	0	SENT_73	[p4l226t21r385b100],
15	for	IN	O	for	_	0	SENT_73	[p4l416t20r540b100],
16	the	DT	O	the	det	17	SENT_73	[p4l569t21r702b99],
17	fidelity	NN	O	fidelity	conj_and	7	SENT_73	[p4l734t20r1043b121],
18	of	IN	O	of	_	0	SENT_73	[p4l1070t20r1171b100],
19	the	DT	O	the	det	20	SENT_73	[p4l1184t21r1318b99],
20	study	NN	O	study	prep_of	17	SENT_73	[p4l1351t21r1595b121],
21	,	,	O	,	_	0	SENT_73	[p4l1351t21r1595b121],
22	as	IN	O	as	mark	23	SENT_73	[p4l1631t47r1717b99],
23	reported	VBN	O	report	dep	20	SENT_73	[p4l1751t21r2143b121],
24	,	,	O	,	_	0	SENT_73	[p4l1751t21r2143b121],
25	to	TO	O	to	_	0	SENT_73	[p4l12t167r94b229],
26	the	DT	O	the	det	27	SENT_73	[p4l131t150r264b228],
27	protocol	NN	O	protocol	prep_to	4	SENT_73	[p4l298t150r684b250],
28	.	.	O	.	_	0	SENT_73	[p4l298t150r684b250],

1	STU	NNP	O	STU	nn	4	SENT_74	[p4l12t426r155b476],
2	DY	NNP	O	DY	nn	4	SENT_74	[p4l174t427r269b475],
3	SUBJECTS	NNS	O	subject	nn	4	SENT_74	[p4l301t426r681b497],
4	Subjects	NNS	O	subject	nsubj	6	SENT_74	[p4l14t526r363b627],
5	were	VBD	O	be	cop	6	SENT_74	[p4l407t552r610b606],
6	eligible	JJ	O	eligible	_	0	SENT_74	[p4l656t526r968b628],
7	for	IN	O	for	_	0	SENT_74	[p4l1013t525r1138b606],
8	inclusion	NN	O	inclusion	prep_for	6	SENT_74	[p4l1179t526r1574b606],
9	if	IN	O	if	mark	13	SENT_74	[p4l1619t525r1697b604],
10	they	PRP	O	they	nsubj	13	SENT_74	[p4l1725t526r1909b627],
11	were	VBD	O	be	cop	13	SENT_74	[p4l1945t552r2148b606],
12	12	CD	DURATION	12	num	13	SENT_74	[p4l15t661r114b733],
13	years	NNS	NUMBER	year	ccomp	6	SENT_74	[p4l143t681r364b756],
14	of	IN	O	of	_	0	SENT_74	[p4l400t654r500b735],
15	age	NN	O	age	prep_of	13	SENT_74	[p4l514t682r658b757],
16	or	CC	O	or	_	0	SENT_74	[p4l692t681r781b735],
17	older	JJR	O	older	conj_or	6	SENT_74	[p4l812t655r1048b752],
18	,	,	O	,	_	0	SENT_74	[p4l812t655r1048b752],
19	had	VBD	O	have	aux	20	SENT_74	[p4l1086t655r1243b735],
20	received	VBN	O	receive	conj_or	6	SENT_74	[p4l1276t655r1624b735],
21	a	DT	O	a	det	22	SENT_74	[p4l1656t682r1700b734],
22	diagnosis	NN	O	diagnosis	dobj	20	SENT_74	[p4l1732t655r2145b757],
23	of	IN	O	of	_	0	SENT_74	[p4l12t782r113b862],
24	cystic	JJ	O	cystic	amod	25	SENT_74	[p4l128t784r367b883],
25	fibrosis	NN	O	fibrosis	prep_of	22	SENT_74	[p4l399t782r830b879],
26	,	,	O	,	_	0	SENT_74	[p4l399t782r830b879],
27	”	NN	O	”	nsubj	28	SENT_74	[p4l399t782r830b879],
28	had	VBD	O	have	parataxis	20	SENT_74	[p4l864t783r1021b862],
29	the	DT	O	the	det	31	SENT_74	[p4l1055t783r1188b861],
30	G551D	NN	O	g551d	nn	31	SENT_74	[p4l1222t790r1474b861],
31	mutation	NN	O	mutation	dobj	28	SENT_74	[p4l1506t784r1901b863],
32	on	IN	O	on	_	0	SENT_74	[p4l1935t809r2042b862],
33	at	IN	O	at	quantmod	35	SENT_74	[p4l2074t800r2153b861],
34	least	JJS	O	least	mwe	33	SENT_74	[p4l11t912r211b991],
35	one	CD	NUMBER	one	num	37	SENT_74	[p4l251t938r403b991],
36	CFTR	NNP	MISC	CFTR	nn	37	SENT_74	[p4l447t919r664b992],
37	allele	NN	O	allele	prep_on	31	SENT_74	[p4l701t912r948b1008],
38	,	,	O	,	_	0	SENT_74	[p4l701t912r948b1008],
39	and	CC	O	and	_	0	SENT_74	[p4l998t912r1156b991],
40	had	VBD	O	have	conj_and	6	SENT_74	[p4l1201t912r1358b991],
41	an	DT	O	a	det	42	SENT_74	[p4l1401t938r1505b990],
42	FEV1	NN	O	fev1	dobj	40	SENT_74	[p4l1548t920r1747b1016],
43	of	IN	O	of	_	0	SENT_74	[p4l1791t911r1892b991],
44	40	CD	NUMBER	40	number	46	SENT_74	[p4l1916t918r2019b991],
45	to	TO	O	to	dep	46	SENT_74	[p4l2065t929r2147b991],
46	90	CD	PERCENT	90	num	47	SENT_74	[p4l12t1046r203b1120],
47	%	NN	PERCENT	%	prep_of	42	SENT_74	[p4l12t1046r203b1120],
48	of	IN	O	of	_	0	SENT_74	[p4l248t1039r349b1119],
49	the	DT	O	the	det	51	SENT_74	[p4l376t1040r510b1118],
50	predicted	VBN	O	predict	amod	51	SENT_74	[p4l554t1040r960b1140],
51	value	NN	O	value	prep_of	47	SENT_74	[p4l1001t1040r1221b1120],
52	for	IN	O	for	_	0	SENT_74	[p4l1267t1039r1391b1119],
53	persons	NNS	O	person	prep_for	51	SENT_74	[p4l1432t1066r1770b1140],
54	of	IN	O	of	_	0	SENT_74	[p4l1818t1039r1919b1119],
55	their	PRP$	O	they	poss	56	SENT_74	[p4l1946t1040r2152b1118],
56	age	NN	O	age	prep_of	53	SENT_74	[p4l11t1195r179b1270],
57	,	,	O	,	_	0	SENT_74	[p4l11t1195r179b1270],
58	sex	NN	O	sex	conj_and	56	SENT_74	[p4l235t1195r393b1265],
59	,	,	O	,	_	0	SENT_74	[p4l235t1195r393b1265],
60	and	CC	O	and	_	0	SENT_74	[p4l447t1169r606b1248],
61	height	NN	O	height	conj_and	56	SENT_74	[p4l656t1169r1030b1270],
62	.	.	O	.	_	0	SENT_74	[p4l656t1169r1030b1270],

1	”	NN	O	”	nn	2	SENT_75	[p4l656t1169r1030b1270],
2	Subjects	NNS	O	subject	nsubjpass	5	SENT_75	[p4l1085t1169r1434b1269],
3	were	VBD	O	be	auxpass	5	SENT_75	[p4l1482t1195r1685b1248],
4	randomly	RB	O	randomly	advmod	5	SENT_75	[p4l1735t1169r2152b1269],
5	assigned	VBN	O	assign	_	0	SENT_75	[p4l11t1297r419b1399],
6	,	,	O	,	_	0	SENT_75	[p4l11t1297r419b1399],
7	in	IN	O	in	_	0	SENT_75	[p4l460t1298r545b1375],
8	a	DT	O	a	det	10	SENT_75	[p4l581t1324r625b1376],
9	1:1	CD	NUMBER	1:1	num	10	SENT_75	[p4l664t1303r787b1377],
10	ratio	NN	O	ratio	prep_in	5	SENT_75	[p4l825t1298r1051b1394],
11	,	,	O	,	_	0	SENT_75	[p4l825t1298r1051b1394],
12	to	TO	O	to	aux	13	SENT_75	[p4l1093t1314r1176b1377],
13	receive	VB	O	receive	xcomp	5	SENT_75	[p4l1213t1298r1511b1377],
14	ivacaftor	NN	O	ivacaftor	dobj	13	SENT_75	[p4l1546t1296r1952b1394],
15	,	,	O	,	_	0	SENT_75	[p4l1546t1296r1952b1394],
16	at	IN	O	at	advmod	14	SENT_75	[p4l1993t1314r2074b1376],
17	a	DT	O	a	det	18	SENT_75	[p4l2105t1324r2149b1376],
18	dose	NN	O	dose	pobj	16	SENT_75	[p4l12t1426r211b1506],
19	of	IN	O	of	_	0	SENT_75	[p4l254t1425r355b1506],
20	150	CD	NUMBER	150	num	21	SENT_75	[p4l382t1432r534b1506],
21	mg	NN	O	mg	prep_of	16	SENT_75	[p4l577t1452r717b1528],
22	every	DT	SET	every	det	24	SENT_75	[p4l756t1452r983b1527],
23	12	CD	SET	12	num	24	SENT_75	[p4l1024t1432r1123b1504],
24	hours	NNS	NUMBER	hour	dep	14	SENT_75	[p4l1166t1426r1441b1523],
25	,	,	O	,	_	0	SENT_75	[p4l1166t1426r1441b1523],
26	or	CC	O	or	_	0	SENT_75	[p4l1489t1452r1579b1506],
27	placebo	NN	O	placebo	dobj	13	SENT_75	[p4l1617t1426r1978b1527],
28	,	,	O	,	_	0	SENT_75	[p4l1617t1426r1978b1527],
29	for	IN	O	for	_	0	SENT_75	[p4l2025t1425r2151b1506],
30	48	CD	DURATION	48	num	31	SENT_75	[p4l10t1561r112b1634],
31	Weeks	NNS	DURATION	week	prep_for	13	SENT_75	[p4l140t1555r428b1634],
32	.	.	O	.	_	0	SENT_75	[p4l140t1555r428b1634],

1	Throughout	IN	O	throughout	_	0	SENT_76	[p4l459t1555r983b1656],
2	the	DT	O	the	det	3	SENT_76	[p4l1008t1555r1142b1633],
3	study	NN	O	study	prep_throughout	7	SENT_76	[p4l1173t1555r1417b1655],
4	,	,	O	,	_	0	SENT_76	[p4l1173t1555r1417b1655],
5	all	DT	O	all	det	6	SENT_76	[p4l1452t1555r1557b1633],
6	subjects	NNS	O	subject	nsubj	7	SENT_76	[p4l1588t1555r1930b1655],
7	continued	VBD	O	continue	_	0	SENT_76	[p4l1962t1581r2147b1634, p4l12t1683r291b1762],
8	to	TO	O	to	aux	9	SENT_76	[p4l338t1700r420b1762],
9	take	VB	O	take	xcomp	7	SENT_76	[p4l468t1683r651b1763],
10	their	PRP$	O	they	poss	12	SENT_76	[p4l697t1683r906b1761],
11	prestudy	JJ	O	prestudy	amod	12	SENT_76	[p4l947t1683r1329b1783],
12	medications	NNS	O	medication	dobj	9	SENT_76	[p4l1369t1683r1905b1762],
13	with	IN	O	with	_	0	SENT_76	[p4l1949t1683r2148b1762],
14	the	DT	O	the	det	15	SENT_76	[p4l12t1811r146b1889],
15	exception	NN	O	exception	prep_with	9	SENT_76	[p4l176t1812r587b1911],
16	of	IN	O	of	_	0	SENT_76	[p4l617t1810r717b1890],
17	hypertonic	JJ	O	hypertonic	amod	18	SENT_76	[p4l729t1811r1192b1911],
18	saline	NN	O	saline	prep_of	15	SENT_76	[p4l1222t1811r1497b1907],
19	,	,	O	,	_	0	SENT_76	[p4l1222t1811r1497b1907],
20	which	WDT	O	which	nsubjpass	23	SENT_76	[p4l1527t1811r1791b1891],
21	was	VBD	O	be	auxpass	23	SENT_76	[p4l1816t1837r1979b1891],
22	not	RB	O	not	neg	23	SENT_76	[p4l2010t1828r2153b1890],
23	permitted	VBN	O	permit	rcmod	18	SENT_76	[p4l11t1940r463b2040],
24	,	,	O	,	_	0	SENT_76	[p4l11t1940r463b2040],
25	since	IN	O	since	mark	29	SENT_76	[p4l513t1941r729b2018],
26	it	PRP	O	it	nsubj	29	SENT_76	[p4l771t1941r831b2018],
27	does	VBZ	O	do	aux	29	SENT_76	[p4l869t1940r1064b2019],
28	not	RB	O	not	neg	29	SENT_76	[p4l1109t1957r1252b2019],
29	have	VB	O	have	advcl	7	SENT_76	[p4l1290t1940r1481b2019],
30	regulatory	JJ	O	regulatory	amod	33	SENT_76	[p4l1524t1940r1975b2041],
31	ap	NN	O	ap	nn	33	SENT_76	[p4l2013t1966r2146b2040],
32	—	NN	O	—	nn	33	SENT_76	[p4l2013t1966r2146b2040],
33	proval	NN	O	proval	dobj	29	SENT_76	[p4l11t2067r278b2167],
34	in	IN	O	in	_	0	SENT_76	[p4l311t2068r394b2145],
35	the	DT	O	the	det	37	SENT_76	[p4l428t2067r562b2145],
36	United	NNP	LOCATION	United	nn	37	SENT_76	[p4l595t2067r884b2146],
37	States	NNPS	LOCATION	States	prep_in	33	SENT_76	[p4l919t2073r1169b2146],
38	as	IN	O	as	_	0	SENT_76	[p4l1204t2093r1290b2145],
39	a	DT	O	a	det	40	SENT_76	[p4l1325t2093r1370b2145],
40	therapy	NN	O	therapy	prep_as	29	SENT_76	[p4l1402t2067r1726b2167],
41	for	IN	O	for	_	0	SENT_76	[p4l1754t2066r1878b2146],
42	cystic	JJ	O	cystic	amod	43	SENT_76	[p4l1909t2068r2148b2167],
43	fibrosis	NN	O	fibrosis	prep_for	40	SENT_76	[p4l12t2195r363b2276],
44	.	.	O	.	_	0	SENT_76	[p4l12t2195r363b2276],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_77	[p4l397t2196r1074b2281],
2	was	VBD	O	be	auxpass	3	SENT_77	[p4l1099t2223r1263b2276],
3	stratified	VBN	O	stratify	_	0	SENT_77	[p4l1296t2195r1693b2276],
4	according	VBG	O	accord	_	0	SENT_77	[p4l1722t2196r2152b2298],
5	to	TO	O	to	prepc_according_to	3	SENT_77	[p4l12t2342r95b2404],
6	age	NN	O	age	nn	7	SENT_77	[p4l137t2351r283b2426],
7	(	NN	O	(	pobj	3	SENT_77	[p4l329t2331r508b2416],
8	<	JJR	O	<	amod	7	SENT_77	[p4l329t2331r508b2416],
9	18	CD	DURATION	18	num	10	SENT_77	[p4l329t2331r508b2416],
10	years	NNS	NUMBER	year	tmod	8	SENT_77	[p4l547t2351r772b2425],
11	vs.	CC	O	vs.	prep	7	SENT_77	[p4l810t2351r922b2404],
12	218	CD	DURATION	218	num	13	SENT_77	[p4l966t2331r1125b2404],
13	years	NNS	NUMBER	year	dep	11	SENT_77	[p4l1164t2332r1416b2425],
14	)	RB	O	)	dep	13	SENT_77	[p4l1164t2332r1416b2425],
15	and	CC	O	and	_	0	SENT_77	[p4l1461t2325r1622b2404],
16	pulmonary	JJ	O	pulmonary	amod	18	SENT_77	[p4l1661t2325r2152b2425],
17	function	NN	O	function	nn	18	SENT_77	[p4l12t2452r389b2533],
18	(	NN	O	(	conj_and	14	SENT_77	[p4l427t2459r695b2544],
19	<	JJR	O	<	dep	18	SENT_77	[p4l427t2459r695b2544],
20	70	CD	NUMBER	70	num	21	SENT_77	[p4l427t2459r695b2544],
21	°	NN	O	°	dep	19	SENT_77	[p4l427t2459r695b2544],
22	/	:	O	/	punct	23	SENT_77	[p4l427t2459r695b2544],
23	o	NN	O	o	dep	21	SENT_77	[p4l427t2459r695b2544],
24	VS.	NNP	O	VS.	dep	23	SENT_77	[p4l723t2479r835b2533],
25	2700/0	CD	NUMBER	2700/0	num	24	SENT_77	[p4l874t2458r1120b2533],
26	of	IN	O	of	_	0	SENT_77	[p4l1154t2452r1256b2532],
27	the	DT	O	the	det	30	SENT_77	[p4l1272t2453r1408b2532],
28	predicted	VBN	O	predict	amod	30	SENT_77	[p4l1440t2453r1855b2554],
29	FEV1	NN	O	fev1	nn	30	SENT_77	[p4l1888t2460r2143b2557],
30	)	NN	O	)	prep_of	7	SENT_77	[p4l1888t2460r2143b2557],
31	.	.	O	.	_	0	SENT_77	[p4l1888t2460r2143b2557],

1	END	NN	O	end	nn	2	SENT_78	[p4l17t2730r177b2779],
2	pomrs	NNS	O	pomr	nsubj	11	SENT_78	[p4l216t2729r509b2780],
3	The	DT	O	the	det	7	SENT_78	[p4l8t2828r170b2906],
4	primary	JJ	O	primary	amod	7	SENT_78	[p4l207t2829r559b2928],
5	efficacy	NN	O	efficacy	nn	7	SENT_78	[p4l592t2827r931b2928],
6	end	NN	O	end	nn	7	SENT_78	[p4l965t2828r1119b2907],
7	point	NN	O	point	dep	2	SENT_78	[p4l1154t2829r1386b2928],
8	was	VBD	O	be	cop	11	SENT_78	[p4l1414t2854r1578b2908],
9	the	DT	O	the	det	11	SENT_78	[p4l1618t2828r1752b2906],
10	absolute	JJ	O	absolute	amod	11	SENT_78	[p4l1789t2828r2148b2907],
11	change	NN	O	change	_	0	SENT_78	[p4l12t2957r316b3059],
12	from	IN	O	from	_	0	SENT_78	[p4l345t2956r555b3037],
13	baseline	NN	O	baseline	prep_from	11	SENT_78	[p4l584t2957r934b3037],
14	through	IN	O	through	_	0	SENT_78	[p4l964t2957r1310b3059],
15	Week	NN	DATE	week	prep_through	11	SENT_78	[p4l1334t2957r1557b3037],
16	24	CD	DATE	24	num	15	SENT_78	[p4l1581t2963r1679b3037],
17	in	IN	O	in	_	0	SENT_78	[p4l1706t2958r1790b3035],
18	the	DT	O	the	det	19	SENT_78	[p4l1819t2957r1952b3036],
19	percent	NN	O	percent	prep_in	15	SENT_78	[p4l1979t2983r2147b3058, p4l12t3103r194b3165],
20	of	IN	O	of	_	0	SENT_78	[p4l225t3085r326b3165],
21	predicted	VBN	O	predict	amod	22	SENT_78	[p4l342t3086r750b3187],
22	FEV1	NN	O	fev1	prep_of	19	SENT_78	[p4l784t3094r1006b3190],
23	.	.	O	.	_	0	SENT_78	[p4l784t3094r1006b3190],

1	Secondary	JJ	O	secondary	amod	3	SENT_79	[p4l1050t3086r1500b3186],
2	end	NN	O	end	nn	3	SENT_79	[p4l1532t3086r1687b3165],
3	points	NNS	O	point	nsubj	4	SENT_79	[p4l1721t3087r1993b3187],
4	included	VBD	O	include	_	0	SENT_79	[p4l2031t3087r2147b3164, p4l12t3215r290b3295],
5	the	DT	O	the	det	6	SENT_79	[p4l318t3215r451b3294],
6	change	NN	O	change	dobj	4	SENT_79	[p4l480t3215r784b3317],
7	from	IN	O	from	_	0	SENT_79	[p4l812t3214r1021b3295],
8	baseline	NN	O	baseline	prep_from	4	SENT_79	[p4l1051t3215r1400b3295],
9	through	IN	O	through	_	0	SENT_79	[p4l1429t3215r1775b3317],
10	Week	NN	DATE	week	prep_through	4	SENT_79	[p4l1800t3215r2022b3295],
11	48	CD	DATE	48	num	10	SENT_79	[p4l2044t3221r2145b3295],
12	in	IN	O	in	_	0	SENT_79	[p4l11t3345r95b3422],
13	the	DT	O	the	det	14	SENT_79	[p4l134t3344r267b3423],
14	percent	NN	O	percent	prep_in	4	SENT_79	[p4l304t3361r629b3445],
15	of	IN	O	of	_	0	SENT_79	[p4l662t3343r763b3423],
16	predicted	VBN	O	predict	amod	17	SENT_79	[p4l781t3344r1186b3445],
17	FEV1	NN	O	fev1	prep_of	14	SENT_79	[p4l1223t3352r1444b3448],
18	;	:	O	;	_	0	SENT_79	[p4l1223t3352r1444b3448],
19	the	DT	O	the	det	20	SENT_79	[p4l1487t3344r1621b3423],
20	time	NN	O	time	prep_in	4	SENT_79	[p4l1660t3345r1854b3423],
21	to	TO	O	to	_	0	SENT_79	[p4l1893t3361r1974b3423],
22	the	DT	O	the	det	26	SENT_79	[p4l2014t3344r2148b3423],
23	first	JJ	ORDINAL	first	amod	26	SENT_79	[p4l12t3472r197b3552],
24	pulmonary	JJ	O	pulmonary	amod	26	SENT_79	[p4l229t3473r711b3574],
25	exacerbation	NN	O	exacerbation	nn	26	SENT_79	[p4l745t3473r1369b3553],
26	“	NN	O	“	prep_to	20	SENT_79	[p4l745t3473r1369b3553],
27	through	IN	O	through	_	0	SENT_79	[p4l1408t3473r1758b3575],
28	Week	NN	DURATION	week	prep_through	26	SENT_79	[p4l1792t3473r2017b3553],
29	24	CD	NUMBER	24	num	28	SENT_79	[p4l2050t3479r2148b3553],
30	and	CC	O	and	_	0	SENT_79	[p4l11t3602r170b3681],
31	Week	NN	DURATION	week	conj_and	14	SENT_79	[p4l205t3602r430b3682],
32	48	CD	NUMBER	48	num	31	SENT_79	[p4l464t3608r590b3698],
33	;	:	O	;	_	0	SENT_79	[p4l464t3608r590b3698],
34	subject	JJ	O	subject	amod	35	SENT_79	[p4l636t3602r1334b3702],
35	—	NN	O	—	nsubj	36	SENT_79	[p4l636t3602r1334b3702],
36	reported	VBD	O	report	parataxis	4	SENT_79	[p4l636t3602r1334b3702],
37	respiratory	JJ	O	respiratory	amod	38	SENT_79	[p4l1374t3603r1848b3702],
38	symptoms	NNS	O	symptom	dobj	36	SENT_79	[p4l1884t3628r2146b3702, p5l12t38r225b100],

1	through	IN	O	through	_	0	SENT_80	[p5l264t21r615b122],
2	week	NN	DURATION	week	prep_through	23	SENT_80	[p5l647t21r872b100],
3	24	CD	NUMBER	24	num	2	SENT_80	[p5l904t27r1002b100],
4	and	CC	O	and	_	0	SENT_80	[p5l1038t21r1197b100],
5	week	NN	DURATION	week	prep_through	23	SENT_80	[p5l1229t21r1453b100],
6	48	CD	NUMBER	48	num	5	SENT_80	[p5l1484t27r1611b117],
7	,	,	O	,	_	0	SENT_80	[p5l1484t27r1611b117],
8	as	IN	O	as	nsubj	23	SENT_80	[p5l1653t47r1739b99],
9	assessed	VBN	O	assess	partmod	8	SENT_80	[p5l1777t21r2148b100],
10	with	IN	O	with	_	0	SENT_80	[p5l7t148r207b228],
11	the	DT	O	the	det	12	SENT_80	[p5l258t148r394b226],
12	use	NN	O	use	prep_with	9	SENT_80	[p5l444t174r588b228],
13	of	IN	O	of	_	0	SENT_80	[p5l639t147r741b227],
14	the	DT	O	the	det	16	SENT_80	[p5l773t148r908b226],
15	respiratory	JJ	O	respiratory	amod	16	SENT_80	[p5l959t149r1444b248],
16	domain	NN	O	domain	prep_of	12	SENT_80	[p5l1491t148r1827b227],
17	of	IN	O	of	_	0	SENT_80	[p5l1879t147r1980b227],
18	the	DT	O	the	det	22	SENT_80	[p5l2013t148r2148b226],
19	Cystic	JJ	MISC	cystic	amod	22	SENT_80	[p5l12t278r270b377],
20	Fibrosis	NNP	MISC	Fibrosis	nn	22	SENT_80	[p5l312t277r649b356],
21	Questionnaire	NNP	MISC	Questionnaire	nn	22	SENT_80	[p5l695t277r1676b376],
22	—	NNP	O	—	prep_of	16	SENT_80	[p5l695t277r1676b376],
23	revised	VBD	O	revise	_	0	SENT_80	[p5l695t277r1676b376],
24	(	CD	NUMBER	(	num	25	SENT_80	[p5l1723t282r2145b376],
25	CFQ	NNP	O	CFQ	dobj	23	SENT_80	[p5l1723t282r2145b376],
26	.	.	O	.	_	0	SENT_80	[p5l1723t282r2145b376],

1	—	NN	O	—	_	0	SENT_81	[p5l1723t282r2145b376],
2	.	.	O	.	_	0	SENT_81	[p5l1723t282r2145b376],

1	R	NN	O	r	_	0	SENT_82	[p5l1723t282r2145b376],
2	)	CD	NUMBER	)	number	3	SENT_82	[p5l1723t282r2145b376],
3	15	CD	NUMBER	15	num	4	SENT_82	[p5l1723t282r2145b376],
4	(	NN	O	(	dep	1	SENT_82	[p5l17t406r302b497],
5	which	WDT	O	which	nsubjpass	7	SENT_82	[p5l17t406r302b497],
6	is	VBZ	O	be	auxpass	7	SENT_82	[p5l330t407r395b484],
7	scored	VBN	O	score	dep	1	SENT_82	[p5l429t406r705b485],
8	on	IN	O	on	_	0	SENT_82	[p5l735t432r841b485],
9	a	DT	O	a	det	13	SENT_82	[p5l869t432r914b484],
10	100	CD	NUMBER	100	number	11	SENT_82	[p5l945t407r1360b506],
11	—	CD	NUMBER	—	num	13	SENT_82	[p5l945t407r1360b506],
12	point	NN	O	point	nn	13	SENT_82	[p5l945t407r1360b506],
13	scale	NN	O	scale	prep_on	7	SENT_82	[p5l1386t406r1616b502],
14	,	,	O	,	_	0	SENT_82	[p5l1386t406r1616b502],
15	with	IN	O	with	_	0	SENT_82	[p5l1647t406r1842b485],
16	higher	JJR	O	higher	amod	17	SENT_82	[p5l1871t406r2151b507],
17	numbers	NNS	O	number	prep_with	7	SENT_82	[p5l12t534r392b614],
18	indicating	VBG	O	indicate	partmod	17	SENT_82	[p5l438t534r882b636],
19	a	DT	O	a	det	21	SENT_82	[p5l922t561r967b613],
20	lower	JJR	O	lower	amod	21	SENT_82	[p5l1008t534r1247b614],
21	effect	NN	O	effect	dobj	18	SENT_82	[p5l1290t533r1533b613],
22	of	IN	O	of	_	0	SENT_82	[p5l1573t533r1673b614],
23	symptoms	NNS	O	symptom	prep_of	21	SENT_82	[p5l1701t551r2146b635],
24	on	IN	O	on	_	0	SENT_82	[p5l12t688r119b741],
25	the	DT	O	the	det	26	SENT_82	[p5l159t662r292b740],
26	patient	NN	O	patient	poss	28	SENT_82	[p5l329t663r695b762],
27	’s	POS	O	’s	_	0	SENT_82	[p5l329t663r695b762],
28	quality	NN	O	quality	prep_on	23	SENT_82	[p5l736t662r1037b762],
29	of	IN	O	of	_	0	SENT_82	[p5l1071t661r1172b741],
30	life	NN	O	life	prep_of	28	SENT_82	[p5l1191t661r1328b740],
31	and	CC	O	and	_	0	SENT_82	[p5l1366t662r1525b741],
32	4	CD	NUMBER	4	num	33	SENT_82	[p5l1562t669r1612b741],
33	points	NNS	O	point	conj_and	21	SENT_82	[p5l1649t663r1921b762],
34	considered	VBN	O	consider	partmod	33	SENT_82	[p5l1962t688r2147b741, p5l13t790r320b869],
35	to	TO	O	to	aux	42	SENT_82	[p5l357t807r439b869],
36	be	VB	O	be	cop	42	SENT_82	[p5l478t790r574b869],
37	a	DT	O	a	det	42	SENT_82	[p5l611t816r655b868],
38	minimal	JJ	O	minimal	amod	42	SENT_82	[p5l690t790r1064b868],
39	clinically	RB	O	clinically	advmod	40	SENT_82	[p5l1101t790r1494b890],
40	important	JJ	O	important	amod	42	SENT_82	[p5l1526t791r1970b890],
41	difference	NN	O	difference	nn	42	SENT_82	[p5l2001t789r2147b869, p5l12t918r373b1015],
42	)	NN	O	)	xcomp	34	SENT_82	[p5l2001t789r2147b869, p5l12t918r373b1015],
43	;	:	O	;	_	0	SENT_82	[p5l2001t789r2147b869, p5l12t918r373b1015],
44	the	DT	O	the	det	45	SENT_82	[p5l422t919r555b998],
45	change	NN	O	change	dobj	18	SENT_82	[p5l600t919r907b1021],
46	in	IN	O	in	_	0	SENT_82	[p5l951t920r1035b997],
47	weight	NN	O	weight	prep_in	45	SENT_82	[p5l1074t919r1370b1021],
48	from	IN	O	from	_	0	SENT_82	[p5l1409t918r1621b999],
49	baseline	NN	O	baseline	prep_from	47	SENT_82	[p5l1666t919r2020b999],
50	to	TO	O	to	_	0	SENT_82	[p5l2065t936r2147b999],
51	week	NN	DURATION	week	prep_to	49	SENT_82	[p5l7t1048r232b1128],
52	24	CD	NUMBER	24	num	51	SENT_82	[p5l259t1054r358b1128],
53	and	CC	O	and	_	0	SENT_82	[p5l388t1048r547b1128],
54	week	NN	DURATION	week	conj_and	51	SENT_82	[p5l573t1048r798b1128],
55	48	CD	NUMBER	48	num	54	SENT_82	[p5l823t1054r950b1145],
56	;	:	O	;	_	0	SENT_82	[p5l823t1054r950b1145],
57	and	CC	O	and	_	0	SENT_82	[p5l985t1048r1143b1128],
58	the	DT	O	the	det	59	SENT_82	[p5l1175t1048r1309b1127],
59	change	NN	O	change	conj_and	21	SENT_82	[p5l1341t1048r1648b1150],
60	from	IN	O	from	_	0	SENT_82	[p5l1679t1047r1891b1128],
61	baseline	NN	O	baseline	prep_from	59	SENT_82	[p5l1923t1048r2147b1128, p5l11t1177r169b1256],
62	in	IN	O	in	_	0	SENT_82	[p5l196t1178r280b1255],
63	the	DT	O	the	det	64	SENT_82	[p5l308t1177r441b1256],
64	concentration	NN	O	concentration	prep_in	61	SENT_82	[p5l470t1178r1061b1256],
65	of	IN	O	of	_	0	SENT_82	[p5l1090t1176r1190b1256],
66	sweat	NN	O	sweat	nn	67	SENT_82	[p5l1201t1194r1442b1257],
67	chloride	NN	O	chloride	prep_of	64	SENT_82	[p5l1466t1177r1835b1272],
68	,	,	O	,	_	0	SENT_82	[p5l1466t1177r1835b1272],
69	a	DT	O	a	det	70	SENT_82	[p5l1867t1203r1913b1255],
70	mea1664	NN	O	mea1664	appos	67	SENT_82	[p5l1939t1203r2147b1256, p5l149t1347r225b1370],

1	N	NN	O	n	nn	3	SENT_83	[p5l937t1358r951b1373],
2	ENGLJ	NN	O	englj	nn	3	SENT_83	[p5l965t1358r1043b1380],
3	MED	NN	O	med	_	0	SENT_83	[p5l1058t1358r1110b1373],
4	365	CD	NUMBER	365	dep	3	SENT_83	[p5l1120t1352r1196b1380],
5	;	:	O	;	_	0	SENT_83	[p5l1120t1352r1196b1380],
6	18	CD	NUMBER	18	num	7	SENT_83	[p5l1120t1352r1196b1380],
7	NEJM.ORG	NN	O	nejm.org	dep	4	SENT_83	[p5l1231t1358r1355b1380],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	7	SENT_83	[p5l1392t1358r1527b1374],
9	3	CD	DATE	3	num	8	SENT_83	[p5l1537t1358r1555b1380],
10	,	,	DATE	,	_	0	SENT_83	[p5l1537t1358r1555b1380],
11	2011	CD	DATE	2011	num	8	SENT_83	[p5l1567t1358r1618b1374],

1	The	DT	O	the	det	4	SENT_84	[p5l935t1391r986b1415],
2	New	NNP	O	New	nn	4	SENT_84	[p5l995t1392r1057b1415],
3	England	NNP	O	England	nn	4	SENT_84	[p5l1066t1391r1177b1422],
4	Joumal	NNP	O	Joumal	_	0	SENT_84	[p5l1186t1391r1283b1415],
5	of	IN	O	of	_	0	SENT_84	[p5l1293t1391r1322b1415],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_84	[p5l1329t1391r1454b1415],

1	Downloaded	VBN	O	download	_	0	SENT_85	[p5l377t1432r547b1455],
2	from	IN	O	from	_	0	SENT_85	[p5l556t1432r621b1455],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_85	[p5l629t1432r748b1462],
4	at	IN	O	at	_	0	SENT_85	[p5l758t1436r781b1455],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_85	[p5l789t1432r972b1455],
6	on	IN	O	on	_	0	SENT_85	[p5l981t1439r1014b1455],
7	January	NNP	DATE	January	prep_on	1	SENT_85	[p5l1022t1432r1125b1462],
8	5	CD	DATE	5	num	7	SENT_85	[p5l1135t1432r1158b1459],
9	,	,	DATE	,	_	0	SENT_85	[p5l1135t1432r1158b1459],
10	2014	CD	DATE	2014	num	7	SENT_85	[p5l1168t1432r1241b1455],
11	.	.	O	.	_	0	SENT_85	[p5l1168t1432r1241b1455],

1	For	IN	O	for	_	0	SENT_86	[p5l1251t1432r1298b1455],
2	personal	JJ	O	personal	amod	3	SENT_86	[p5l1306t1432r1418b1462],
3	use	NN	O	use	pobj	1	SENT_86	[p5l1427t1439r1471b1455],
4	only	RB	O	only	advmod	3	SENT_86	[p5l1480t1432r1545b1462],
5	.	.	O	.	_	0	SENT_86	[p5l1480t1432r1545b1462],

1	No	DT	O	no	det	3	SENT_87	[p5l1556t1432r1595b1455],
2	other	JJ	O	other	amod	3	SENT_87	[p5l1605t1432r1673b1455],
3	uses	NNS	O	use	_	0	SENT_87	[p5l1682t1439r1738b1455],
4	without	IN	O	without	_	0	SENT_87	[p5l1748t1432r1849b1455],
5	permission	NN	O	permission	prep_without	3	SENT_87	[p5l1857t1432r2010b1462],
6	.	.	O	.	_	0	SENT_87	[p5l1857t1432r2010b1462],

1	Copyright	NN	O	copyright	_	0	SENT_88	[p5l728t1473r862b1504],
2	©	CD	NUMBER	©	num	6	SENT_88	[p5l871t1473r895b1497],
3	2011	CD	DATE	2011	num	6	SENT_88	[p5l905t1473r967b1497],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_88	[p5l979t1473r1170b1497],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_88	[p5l1180t1473r1288b1497],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_88	[p5l1299t1473r1404b1504],
7	.	.	O	.	_	0	SENT_88	[p5l1299t1473r1404b1504],

1	All	DT	O	all	det	2	SENT_89	[p5l1415t1473r1456b1497],
2	rights	NNS	O	rights	nsubj	3	SENT_89	[p5l1465t1473r1540b1504],
3	reserved	VBN	O	reserve	_	0	SENT_89	[p5l1550t1473r1668b1497],
4	.	.	O	.	_	0	SENT_89	[p5l1550t1473r1668b1497],

1	A	DT	O	a	det	3	SENT_90	[p5l715t1579r734b1598],
2	CFTR	NNP	O	CFTR	nn	3	SENT_90	[p5l747t1579r831b1598],
3	POTENTIATOR	NNP	O	POTENTIATOR	_	0	SENT_90	[p5l844t1579r1082b1598],
4	FOR	IN	O	for	_	0	SENT_90	[p5l1095t1579r1159b1598],
5	CYSTIC	NNP	O	CYSTIC	nn	6	SENT_90	[p5l1171t1579r1282b1598],
6	FIBROSIS	NNP	O	FIBROSIS	prep_for	3	SENT_90	[p5l1297t1579r1445b1598],

1	sure	RB	O	sure	advmod	2	SENT_91	[p5l21t1818r196b1871],
2	of	IN	O	of	_	0	SENT_91	[p5l232t1791r331b1871],
3	CFTR	NNP	O	CFTR	nn	5	SENT_91	[p5l347t1798r595b1875],
4	channel	NN	O	channel	nn	5	SENT_91	[p5l620t1792r955b1870],
5	function	NN	O	function	pobj	2	SENT_91	[p5l989t1791r1372b1888],
6	,	,	O	,	_	0	SENT_91	[p5l989t1791r1372b1888],
7	through	IN	O	through	_	0	SENT_91	[p5l1413t1792r1756b1893],
8	week	NN	DURATION	week	prep_through	5	SENT_91	[p5l1787t1792r2007b1871],
9	24	CD	NUMBER	24	num	8	SENT_91	[p5l2037t1798r2134b1871],
10	and	CC	O	and	_	0	SENT_91	[p5l20t1919r174b1997],
11	week	NN	DURATION	week	conj_and	8	SENT_91	[p5l198t1919r417b1998],
12	48	CD	NUMBER	48	num	11	SENT_91	[p5l439t1925r563b1997],
13	.	.	O	.	_	0	SENT_91	[p5l439t1925r563b1997],

1	Tertiary	JJ	O	tertiary	amod	4	SENT_92	[p5l593t1920r929b2018],
2	efficacy	NN	O	efficacy	nn	4	SENT_92	[p5l953t1918r1282b2018],
3	end	NN	O	end	nn	4	SENT_92	[p5l1305t1919r1456b1997],
4	points	NNS	O	point	nsubj	5	SENT_92	[p5l1482t1920r1746b2018],
5	included	VBD	O	include	_	0	SENT_92	[p5l1775t1919r2134b1998],
6	the	DT	O	the	det	7	SENT_92	[p5l21t2046r152b2124],
7	number	NN	O	number	dobj	5	SENT_92	[p5l182t2046r517b2125],
8	and	CC	O	and	_	0	SENT_92	[p5l543t2046r700b2125],
9	duration	NN	O	duration	dobj	5	SENT_92	[p5l729t2046r1093b2125],
10	of	IN	O	of	_	0	SENT_92	[p5l1122t2045r1222b2125],
11	pulmonary	JJ	O	pulmonary	amod	12	SENT_92	[p5l1231t2046r1707b2145],
12	exacerbations	NNS	O	exacerbation	prep_of	7	SENT_92	[p5l1733t2046r2133b2125, p5l21t2174r242b2268],
13	,	,	O	,	_	0	SENT_92	[p5l1733t2046r2133b2125, p5l21t2174r242b2268],
14	the	DT	O	the	det	16	SENT_92	[p5l272t2173r399b2251],
15	total	JJ	O	total	amod	16	SENT_92	[p5l423t2173r610b2251],
16	number	NN	O	number	conj_and	7	SENT_92	[p5l633t2173r956b2252],
17	of	IN	O	of	_	0	SENT_92	[p5l977t2172r1075b2251],
18	days	NNS	DURATION	day	prep_of	16	SENT_92	[p5l1081t2173r1256b2272],
19	of	IN	O	of	_	0	SENT_92	[p5l1283t2172r1380b2251],
20	hospitalization	NN	O	hospitalization	prep_of	18	SENT_92	[p5l1385t2173r1996b2272],
21	for	IN	O	for	_	0	SENT_92	[p5l2020t2172r2138b2251],
22	pulmonary	JJ	O	pulmonary	amod	23	SENT_92	[p5l18t2300r502b2399],
23	exacerbations	NNS	O	exacerbation	prep_for	20	SENT_92	[p5l531t2300r1151b2395],
24	,	,	O	,	_	0	SENT_92	[p5l531t2300r1151b2395],
25	and	CC	O	and	_	0	SENT_92	[p5l1188t2300r1347b2378],
26	the	DT	O	the	det	27	SENT_92	[p5l1379t2300r1513b2378],
27	need	NN	O	need	dobj	5	SENT_92	[p5l1546t2300r1749b2378],
28	for	IN	O	for	_	0	SENT_92	[p5l1781t2299r1905b2379],
29	antibiotic	JJ	O	antibiotic	amod	30	SENT_92	[p5l1934t2301r2133b2378, p5l21t2428r259b2507],
30	therapy	NN	O	therapy	prep_for	27	SENT_92	[p5l295t2428r615b2528],
31	for	IN	O	for	_	0	SENT_92	[p5l647t2427r769b2507],
32	sinopulmonary	JJ	O	sinopulmonary	amod	33	SENT_92	[p5l804t2428r1461b2528],
33	signs	NNS	O	sign	prep_for	5	SENT_92	[p5l1494t2429r1712b2529],
34	or	CC	O	or	_	0	SENT_92	[p5l1751t2454r1840b2507],
35	symptoms	NNS	O	symptom	conj_or	33	SENT_92	[p5l1874t2454r2133b2528, p5l21t2572r255b2633],
36	.	.	O	.	_	0	SENT_92	[p5l1874t2454r2133b2528, p5l21t2572r255b2633],

1	Safety	NN	O	safety	nsubjpass	4	SENT_93	[p5l298t2554r557b2654],
2	was	VBD	O	be	auxpass	4	SENT_93	[p5l583t2581r745b2634],
3	also	RB	O	also	advmod	4	SENT_93	[p5l781t2555r951b2633],
4	evaluated	VBN	O	evaluate	_	0	SENT_93	[p5l988t2555r1412b2634],
5	.	.	O	.	_	0	SENT_93	[p5l988t2555r1412b2634],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_94	[p5l20t2828r507b2878],
2	ANALYSIS	NN	O	analysis	nsubj	13	SENT_94	[p5l537t2828r911b2878],
3	On	IN	O	on	_	0	SENT_94	[p5l20t2932r146b3005],
4	the	DT	O	the	det	5	SENT_94	[p5l187t2926r319b3004],
5	basis	NN	O	basis	prep_on	13	SENT_94	[p5l361t2926r572b3004],
6	of	IN	O	of	_	0	SENT_94	[p5l616t2925r715b3004],
7	previous	JJ	O	previous	amod	8	SENT_94	[p5l736t2927r1097b3025],
8	data	NNS	O	datum	prep_of	5	SENT_94	[p5l1141t2926r1323b3004],
9	on	IN	O	on	_	0	SENT_94	[p5l1363t2952r1469b3004],
10	iVacaftor	NN	O	ivacaftor	prep_on	8	SENT_94	[p5l1509t2925r1980b3021],
11	,11	CD	NUMBER	,11	num	10	SENT_94	[p5l1509t2925r1980b3021],
12	we	PRP	O	we	nsubj	13	SENT_94	[p5l2017t2952r2134b3005],
13	estimated	VBD	O	estimate	_	0	SENT_94	[p5l21t3053r440b3131],
14	that	IN	O	that	complm	27	SENT_94	[p5l481t3053r652b3131],
15	with	IN	O	with	_	0	SENT_94	[p5l683t3053r878b3132],
16	a	DT	O	a	det	17	SENT_94	[p5l918t3079r962b3131],
17	sample	NN	O	sample	prep_with	27	SENT_94	[p5l1002t3053r1303b3152],
18	of	IN	O	of	_	0	SENT_94	[p5l1343t3052r1444b3132],
19	at	IN	O	at	quantmod	21	SENT_94	[p5l1464t3070r1543b3131],
20	least	JJS	O	least	mwe	19	SENT_94	[p5l1577t3053r1775b3131],
21	80	CD	NUMBER	80	num	22	SENT_94	[p5l1811t3059r1910b3131],
22	subjects	NNS	O	subject	prep_of	17	SENT_94	[p5l1954t3053r2133b3132, p5l7t3182r231b3280],
23	,	,	O	,	_	0	SENT_94	[p5l1954t3053r2133b3132, p5l7t3182r231b3280],
24	the	DT	O	the	det	25	SENT_94	[p5l275t3181r408b3259],
25	study	NN	O	study	nsubj	27	SENT_94	[p5l447t3181r676b3280],
26	would	MD	O	would	aux	27	SENT_94	[p5l705t3181r970b3260],
27	have	VB	O	have	ccomp	13	SENT_94	[p5l1008t3181r1197b3260],
28	80	CD	PERCENT	80	number	29	SENT_94	[p5l1235t3186r1422b3260],
29	%	NN	PERCENT	%	amod	30	SENT_94	[p5l1235t3186r1422b3260],
30	power	NN	O	power	dobj	27	SENT_94	[p5l1458t3207r1725b3280],
31	to	TO	O	to	aux	32	SENT_94	[p5l1760t3198r1841b3259],
32	detect	VB	O	detect	infmod	30	SENT_94	[p5l1882t3181r2139b3259],
33	a	DT	O	a	det	34	SENT_94	[p5l20t3335r64b3387],
34	change	NN	O	change	dobj	32	SENT_94	[p5l100t3309r403b3410],
35	of	IN	O	of	_	0	SENT_94	[p5l441t3308r541b3388],
36	4.5	CD	PERCENT	4.5	num	38	SENT_94	[p5l558t3316r682b3388],
37	percentage	NN	PERCENT	percentage	nn	38	SENT_94	[p5l720t3326r1188b3410],
38	points	NNS	PERCENT	point	prep_of	34	SENT_94	[p5l1224t3310r1491b3409],
39	in	IN	O	in	_	0	SENT_94	[p5l1530t3310r1613b3387],
40	the	DT	O	the	det	41	SENT_94	[p5l1650t3309r1783b3387],
41	percent	NN	O	percent	prep_in	32	SENT_94	[p5l1818t3326r2139b3409],
42	of	IN	O	of	_	0	SENT_94	[p5l21t3435r121b3515],
43	predicted	VBN	O	predict	amod	44	SENT_94	[p5l148t3436r556b3536],
44	FEV1	NN	O	fev1	prep_of	41	SENT_94	[p5l601t3444r823b3539],
45	.	.	O	.	_	0	SENT_94	[p5l601t3444r823b3539],

1	All	DT	O	all	det	2	SENT_95	[p5l872t3436r998b3513],
2	subjects	NNS	O	subject	nsubjpass	14	SENT_95	[p5l1045t3436r1389b3535],
3	who	WP	O	who	nsubj	4	SENT_95	[p5l1433t3436r1616b3515],
4	received	VBD	O	receive	rcmod	2	SENT_95	[p5l1664t3436r2014b3515],
5	at	IN	O	at	quantmod	7	SENT_95	[p5l2060t3453r2139b3514],
6	least	JJS	O	least	mwe	5	SENT_95	[p5l19t3564r217b3642],
7	one	CD	NUMBER	one	num	8	SENT_95	[p5l255t3590r406b3643],
8	dose	NN	O	dose	dobj	4	SENT_95	[p5l449t3564r643b3643],
9	of	IN	O	of	_	0	SENT_95	[p5l687t3563r786b3643],
10	a	DT	O	a	det	12	SENT_95	[p5l810t3590r854b3642],
11	study	NN	O	study	nn	12	SENT_95	[p5l896t3564r1125b3664],
12	drug	NN	O	drug	prep_of	8	SENT_95	[p5l1164t3564r1367b3665],
13	were	VBD	O	be	auxpass	14	SENT_95	[p5l1401t3590r1602b3643],
14	included	VBN	O	include	_	0	SENT_95	[p5l1645t3564r2010b3643],
15	in	IN	O	in	_	0	SENT_95	[p5l2052t3565r2135b3642],
16	the	DT	O	the	det	17	SENT_95	[p5l21t3692r152b3770],
17	analyses	NNS	O	analysis	prep_in	14	SENT_95	[p5l187t3692r570b3791],
18	.	.	O	.	_	0	SENT_95	[p5l187t3692r570b3791],

1	The	DT	O	the	det	3	SENT_96	[p5l607t3692r767b3770],
2	primary	JJ	O	primary	amod	3	SENT_96	[p5l800t3693r1149b3791],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_96	[p5l1179t3692r1517b3791],
4	was	VBD	O	be	auxpass	5	SENT_96	[p5l1550t3718r1712b3771],
5	based	VBN	O	base	_	0	SENT_96	[p5l1749t3692r1994b3770],
6	on	IN	O	on	_	0	SENT_96	[p5l2029t3718r2134b3770],
7	a	DT	O	a	det	9	SENT_96	[p6l20t47r64b99],
8	mixed-effects	JJ	O	mixed-effects	amod	9	SENT_96	[p6l117t20r710b99],
9	model	NN	O	model	prep_on	5	SENT_96	[p6l768t21r1038b99],
10	for	IN	O	for	_	0	SENT_96	[p6l1091t20r1216b99],
11	repeated	VBN	O	repeat	amod	12	SENT_96	[p6l1269t21r1640b120],
12	measures	NNS	O	measure	prep_for	9	SENT_96	[p6l1694t47r2129b100],
13	.	.	O	.	_	0	SENT_96	[p6l1694t47r2129b100],

1	The	DT	O	the	det	4	SENT_97	[p6l17t149r177b227],
2	primary	JJ	O	primary	amod	4	SENT_97	[p6l227t150r575b248],
3	end	NN	O	end	nn	4	SENT_97	[p6l623t149r775b227],
4	point	NN	O	point	nsubj	10	SENT_97	[p6l824t150r1054b248],
5	and	CC	O	and	_	0	SENT_97	[p6l1099t149r1256b227],
6	key	JJ	O	key	amod	9	SENT_97	[p6l1307t149r1451b248],
7	secondary	JJ	O	secondary	amod	9	SENT_97	[p6l1499t149r1935b248],
8	end	NN	O	end	nn	9	SENT_97	[p6l1982t149r2135b227],
9	points	NNS	O	point	nsubj	10	SENT_97	[p6l18t278r291b377],
10	(	VBP	O	(	_	0	SENT_97	[p6l342t277r728b368],
11	absolute	JJ	O	absolute	amod	12	SENT_97	[p6l342t277r728b368],
12	change	NN	O	change	dobj	10	SENT_97	[p6l773t277r1081b378],
13	from	IN	O	from	_	0	SENT_97	[p6l1125t276r1337b356],
14	baseline	NN	O	baseline	prep_from	12	SENT_97	[p6l1382t277r1738b356],
15	through	IN	O	through	_	0	SENT_97	[p6l1783t277r2134b378],
16	week	NN	DURATION	week	prep_through	10	SENT_97	[p6l16t405r238b484],
17	24	CD	NUMBER	24	num	16	SENT_97	[p6l281t411r379b483],
18	in	IN	O	in	_	0	SENT_97	[p6l426t406r508b482],
19	the	DT	O	the	det	20	SENT_97	[p6l557t405r688b483],
20	score	NN	NUMBER	score	prep_in	16	SENT_97	[p6l738t431r958b483],
21	on	IN	O	on	_	0	SENT_97	[p6l1006t431r1111b483],
22	the	DT	O	the	det	25	SENT_97	[p6l1160t405r1292b483],
23	CFQ-R	NN	MISC	cfq-r	nn	25	SENT_97	[p6l1339t411r1633b503],
24	respiratory	JJ	O	respiratory	amod	25	SENT_97	[p6l1670t406r2139b504],
25	domain	NN	O	domain	prep_on	20	SENT_97	[p6l21t532r377b627],
26	,	,	O	,	_	0	SENT_97	[p6l21t532r377b627],
27	with	IN	O	with	_	0	SENT_97	[p6l430t532r627b611],
28	pooled	JJ	O	pooled	amod	29	SENT_97	[p6l677t532r972b631],
29	data	NNS	O	datum	prep_with	10	SENT_97	[p6l1025t532r1210b610],
30	from	IN	O	from	_	0	SENT_97	[p6l1260t531r1471b610],
31	the	DT	O	the	det	32	SENT_97	[p6l1523t532r1657b610],
32	children	NNS	O	child	poss	34	SENT_97	[p6l1710t532r2133b610],
33	’s	POS	O	’s	_	0	SENT_97	[p6l1710t532r2133b610],
34	version	NN	O	version	prep_from	10	SENT_97	[p6l16t661r322b739],
35	and	CC	O	and	_	0	SENT_97	[p6l370t660r528b739],
36	the	DT	O	the	det	40	SENT_97	[p6l576t660r709b738],
37	adolescent	JJ	O	adolescent	amod	40	SENT_97	[p6l757t660r1476b739],
38	—	NN	O	—	nn	40	SENT_97	[p6l757t660r1476b739],
39	adult	JJ	O	adult	amod	40	SENT_97	[p6l757t660r1476b739],
40	version	NN	O	version	prep_from	10	SENT_97	[p6l1516t661r1823b739],
41	of	IN	O	of	_	0	SENT_97	[p6l1872t659r1972b739],
42	the	DT	O	the	det	43	SENT_97	[p6l2002t660r2134b739],
43	instrument	NN	O	instrument	prep_of	40	SENT_97	[p6l20t789r507b883],
44	;	:	O	;	_	0	SENT_97	[p6l20t789r507b883],
45	absolute	JJ	O	absolute	amod	46	SENT_97	[p6l531t788r874b867],
46	change	NN	O	change	dep	40	SENT_97	[p6l896t788r1191b889],
47	from	IN	O	from	_	0	SENT_97	[p6l1212t787r1417b867],
48	baseline	NN	O	baseline	prep_from	46	SENT_97	[p6l1438t788r1776b867],
49	through	IN	O	through	_	0	SENT_97	[p6l1798t788r2134b889],
50	week	NN	DURATION	week	prep_through	48	SENT_97	[p6l16t915r241b994],
51	24	CD	NUMBER	24	num	50	SENT_97	[p6l275t921r373b993],
52	in	IN	O	in	_	0	SENT_97	[p6l410t916r494b992],
53	the	DT	O	the	det	54	SENT_97	[p6l532t915r667b993],
54	concentration	NN	O	concentration	prep_in	50	SENT_97	[p6l706t916r1312b993],
55	of	IN	O	of	_	0	SENT_97	[p6l1351t914r1451b993],
56	sweat	NN	O	sweat	nn	57	SENT_97	[p6l1472t932r1718b994],
57	chloride	NN	O	chloride	prep_of	54	SENT_97	[p6l1752t915r2131b1010],
58	;	:	O	;	_	0	SENT_97	[p6l1752t915r2131b1010],
59	time	NN	O	time	dep	40	SENT_97	[p6l21t1044r215b1121],
60	to	TO	O	to	_	0	SENT_97	[p6l269t1060r351b1122],
61	first	JJ	ORDINAL	first	amod	63	SENT_97	[p6l405t1042r593b1121],
62	pulmonary	JJ	O	pulmonary	amod	63	SENT_97	[p6l639t1043r1125b1143],
63	exacerbation	NN	O	exacerbation	prep_to	59	SENT_97	[p6l1174t1043r1728b1122],
64	through	IN	O	through	_	0	SENT_97	[p6l1781t1043r2135b1144],
65	week	NN	DURATION	week	prep_through	10	SENT_97	[p6l16t1171r241b1250],
66	48	CD	NUMBER	48	num	65	SENT_97	[p6l286t1177r413b1266],
67	;	:	O	;	_	0	SENT_97	[p6l286t1177r413b1266],
68	and	CC	O	and	_	0	SENT_97	[p6l467t1171r626b1250],
69	absolute	JJ	O	absolute	amod	70	SENT_97	[p6l675t1171r1038b1250],
70	change	NN	O	change	nsubjpass	80	SENT_97	[p6l1089t1171r1399b1272],
71	in	IN	O	in	_	0	SENT_97	[p6l1449t1172r1532b1249],
72	weight	NN	O	weight	prep_in	70	SENT_97	[p6l1578t1171r1876b1272],
73	from	IN	O	from	_	0	SENT_97	[p6l1922t1170r2134b1250],
74	baseline	NN	O	baseline	prep_from	72	SENT_97	[p6l21t1299r371b1377],
75	at	IN	O	at	_	0	SENT_97	[p6l409t1316r488b1377],
76	week	NN	DURATION	week	nn	78	SENT_97	[p6l517t1299r739b1378],
77	48	CD	NUMBER	48	num	78	SENT_97	[p6l771t1305r900b1389],
78	)	NN	O	)	prep_at	74	SENT_97	[p6l771t1305r900b1389],
79	were	VBD	O	be	auxpass	80	SENT_97	[p6l940t1325r1141b1378],
80	analyzed	VBN	O	analyze	conj_and	10	SENT_97	[p6l1179t1299r1557b1398],
81	with	IN	O	with	_	0	SENT_97	[p6l1590t1299r1784b1378],
82	the	DT	O	the	det	83	SENT_97	[p6l1823t1299r1955b1377],
83	use	NN	O	use	prep_with	80	SENT_97	[p6l1994t1325r2134b1378],
84	of	IN	O	of	_	0	SENT_97	[p6l21t1426r119b1506],
85	a	DT	O	a	det	88	SENT_97	[p6l125t1453r169b1505],
86	multistage	JJ	O	multistage	amod	88	SENT_97	[p6l193t1427r634b1528],
87	gatekeeping	NN	O	gatekeeping	nn	88	SENT_97	[p6l660t1427r1165b1528],
88	procedure	NN	O	procedure	prep_of	83	SENT_97	[p6l1186t1427r1626b1527],
89	.	.	O	.	_	0	SENT_97	[p6l1186t1427r1626b1527],

1	The	DT	O	the	det	2	SENT_98	[p6l1654t1427r1811b1505],
2	change	NN	O	change	nsubjpass	9	SENT_98	[p6l1838t1427r2134b1528],
3	in	IN	O	in	_	0	SENT_98	[p6l20t1556r102b1632],
4	FEV1	NN	O	fev1	prep_in	2	SENT_98	[p6l130t1562r324b1658],
5	through	IN	O	through	_	0	SENT_98	[p6l354t1555r697b1656],
6	day	NN	DURATION	day	prep_through	4	SENT_98	[p6l728t1555r872b1654],
7	15	CD	NUMBER	15	num	6	SENT_98	[p6l900t1561r994b1634],
8	was	VBD	O	be	auxpass	9	SENT_98	[p6l1022t1581r1183b1634],
9	analyzed	VBN	O	analyze	_	0	SENT_98	[p6l1214t1555r1587b1654],
10	with	IN	O	with	_	0	SENT_98	[p6l1612t1555r1805b1634],
11	the	DT	O	the	det	12	SENT_98	[p6l1834t1555r1966b1633],
12	use	NN	O	use	prep_with	9	SENT_98	[p6l1995t1581r2134b1634],
13	of	IN	O	of	_	0	SENT_98	[p6l21t1681r121b1760],
14	linear	JJ	O	linear	amod	15	SENT_98	[p6l160t1682r416b1760],
15	comparisons	NNS	O	comparison	prep_of	12	SENT_98	[p6l472t1683r1033b1781],
16	between	IN	O	between	_	0	SENT_98	[p6l1094t1682r1457b1761],
17	the	DT	O	the	det	19	SENT_98	[p6l1516t1682r1650b1760],
18	treatment	NN	O	treatment	nn	19	SENT_98	[p6l1709t1699r2140b1760],
19	groups	NNS	O	group	prep_between	15	SENT_98	[p6l20t1836r314b1911],
20	at	IN	O	at	_	0	SENT_98	[p6l355t1827r433b1888],
21	the	DT	DATE	the	det	24	SENT_98	[p6l467t1810r600b1889],
22	day	NN	DATE	day	nn	24	SENT_98	[p6l639t1810r786b1910],
23	15	CD	NUMBER	15	num	24	SENT_98	[p6l823t1816r917b1889],
24	visit	NN	O	visit	prep_at	9	SENT_98	[p6l955t1811r1155b1889],
25	.	.	O	.	_	0	SENT_98	[p6l955t1811r1155b1889],

1	Further	JJ	O	further	amod	2	SENT_99	[p6l1198t1810r1522b1889],
2	details	NNS	O	detail	nsubjpass	7	SENT_99	[p6l1558t1810r1840b1889],
3	of	IN	O	of	_	0	SENT_99	[p6l1882t1809r1981b1889],
4	the	DT	O	the	det	5	SENT_99	[p6l2001t1810r2134b1888],
5	methods	NNS	O	method	prep_of	2	SENT_99	[p6l20t1938r392b2016],
6	are	VBP	O	be	auxpass	7	SENT_99	[p6l439t1964r567b2016],
7	provided	VBN	O	provide	_	0	SENT_99	[p6l611t1938r984b2037],
8	in	IN	O	in	_	0	SENT_99	[p6l1028t1939r1111b2015],
9	the	DT	O	the	det	12	SENT_99	[p6l1157t1938r1289b2016],
10	statistical	JJ	O	statistical	amod	12	SENT_99	[p6l1336t1938r1750b2016],
11	analysis	NN	O	analysis	nn	12	SENT_99	[p6l1794t1938r2132b2037],
12	plan	NN	O	plan	prep_in	7	SENT_99	[p6l18t2066r205b2165],
13	included	VBD	O	include	partmod	12	SENT_99	[p6l231t2066r592b2145],
14	with	IN	O	with	_	0	SENT_99	[p6l614t2066r806b2145],
15	the	DT	O	the	det	16	SENT_99	[p6l834t2066r965b2144],
16	protocol	NN	O	protocol	prep_with	13	SENT_99	[p6l990t2066r1345b2165],
17	and	CC	O	and	_	0	SENT_99	[p6l1371t2066r1527b2144],
18	in	IN	O	in	_	0	SENT_99	[p6l1553t2067r1635b2143],
19	the	DT	O	the	det	21	SENT_99	[p6l1662t2066r1793b2144],
20	Supplementary	NNP	MISC	Supplementary	nn	21	SENT_99	[p6l1823t2066r2133b2165, p6l20t2210r385b2292],
21	Appendix	NNP	MISC	Appendix	prep_in	7	SENT_99	[p6l419t2193r864b2292],
22	,	,	O	,	_	0	SENT_99	[p6l419t2193r864b2292],
23	both	DT	O	both	dep	24	SENT_99	[p6l913t2193r1113b2271],
24	of	IN	O	of	nsubj	27	SENT_99	[p6l1156t2192r1256b2271],
25	which	WDT	O	which	pobj	24	SENT_99	[p6l1276t2193r1542b2272],
26	are	VBP	O	be	cop	27	SENT_99	[p6l1583t2219r1714b2271],
27	available	JJ	O	available	rcmod	21	SENT_99	[p6l1756t2193r2134b2272],
28	at	IN	O	at	_	0	SENT_99	[p6l20t2338r99b2399],
29	N	NN	O	n	nn	30	SENT_99	[p6l129t2329r203b2400],
30	EJM.org	NN	O	ejm.org	prep_at	27	SENT_99	[p6l207t2329r579b2422],
31	.	.	O	.	_	0	SENT_99	[p6l207t2329r579b2422],

1	RESULTS	NNS	O	result	_	0	SENT_100	[p6l841t2618r1314b2676],

1	SUBJECTS	NNS	O	subject	nsubjpass	5	SENT_101	[p6l20t2850r395b2921],
2	The	DT	O	the	det	3	SENT_101	[p6l16t2950r177b3029],
3	study	NN	O	study	dep	1	SENT_101	[p6l205t2950r434b3050],
4	was	VBD	O	be	auxpass	5	SENT_101	[p6l451t2976r612b3029],
5	conducted	VBN	O	conduct	_	0	SENT_101	[p6l642t2950r1082b3029],
6	from	IN	O	from	_	0	SENT_101	[p6l1108t2949r1318b3029],
7	June	NNP	DATE	June	prep_from	5	SENT_101	[p6l1334t2958r1526b3041],
8	2009	CD	DATE	2009	num	7	SENT_101	[p6l1553t2956r1759b3029],
9	through	IN	O	through	_	0	SENT_101	[p6l1787t2950r2134b3051],
10	January	NNP	DATE	January	prep_through	5	SENT_101	[p6l10t3084r345b3176],
11	2011	CD	DATE	2011	num	10	SENT_101	[p6l369t3083r594b3155],
12	.	.	O	.	_	0	SENT_101	[p6l369t3083r594b3155],

1	The	DT	O	the	det	2	SENT_102	[p6l625t3077r785b3154],
2	screening	NN	O	screening	nsubjpass	14	SENT_102	[p6l815t3078r1249b3177],
3	,	,	O	,	_	0	SENT_102	[p6l815t3078r1249b3177],
4	randomization	NN	O	randomization	nsubjpass	14	SENT_102	[p6l1283t3077r1944b3172],
5	,	,	O	,	_	0	SENT_102	[p6l1283t3077r1944b3172],
6	and	CC	O	and	_	0	SENT_102	[p6l1978t3077r2135b3155],
7	follow	VB	O	follow	dep	10	SENT_102	[p6l20t3204r423b3305],
8	—	CD	NUMBER	—	npadvmod	9	SENT_102	[p6l20t3204r423b3305],
9	up	IN	O	up	advmod	7	SENT_102	[p6l20t3204r423b3305],
10	of	IN	O	of	nsubjpass	14	SENT_102	[p6l454t3204r553b3284],
11	the	DT	O	the	det	12	SENT_102	[p6l565t3205r696b3283],
12	subjects	NNS	O	subject	pobj	10	SENT_102	[p6l727t3205r1061b3305],
13	are	VBP	O	be	auxpass	14	SENT_102	[p6l1092t3231r1220b3283],
14	shown	VBN	O	show	_	0	SENT_102	[p6l1251t3205r1529b3284],
15	in	IN	O	in	_	0	SENT_102	[p6l1558t3206r1640b3283],
16	Figure	NNP	O	Figure	prep_in	14	SENT_102	[p6l1668t3206r1943b3306],
17	1	CD	NUMBER	1	num	16	SENT_102	[p6l1977t3211r2021b3283],
18	in	IN	O	in	_	0	SENT_102	[p6l2052t3206r2134b3283],
19	the	DT	O	the	det	21	SENT_102	[p6l21t3333r149b3411],
20	Supplementary	NNP	O	Supplementary	nn	21	SENT_102	[p6l176t3333r796b3432],
21	Appendix	NNP	O	Appendix	prep_in	14	SENT_102	[p6l813t3333r1234b3432],
22	.	.	O	.	_	0	SENT_102	[p6l813t3333r1234b3432],

1	The	DT	O	the	det	3	SENT_103	[p6l1261t3333r1417b3411],
2	study	NN	O	study	nn	3	SENT_103	[p6l1443t3333r1664b3432],
3	population	NN	O	population	nsubj	4	SENT_103	[p6l1683t3333r2135b3432],
4	consisted	VBD	O	consist	_	0	SENT_103	[p6l21t3460r429b3538],
5	of	IN	O	of	_	0	SENT_103	[p6l480t3459r580b3538],
6	161	CD	NUMBER	161	num	7	SENT_103	[p6l617t3466r760b3539],
7	subjects	NNS	O	subject	prep_of	4	SENT_103	[p6l814t3460r1157b3559],
8	who	WP	O	who	nsubj	9	SENT_103	[p6l1206t3460r1390b3539],
9	underwent	VBD	O	undergo	rcmod	7	SENT_103	[p6l1442t3460r1912b3539],
10	randomization	NN	O	randomization	dobj	9	SENT_103	[p6l1958t3486r2133b3538, p6l21t3588r513b3667],
11	and	CC	O	and	_	0	SENT_103	[p6l548t3588r705b3667],
12	received	VBD	O	receive	rcmod	7	SENT_103	[p6l740t3588r1084b3667],
13	at	IN	O	at	quantmod	15	SENT_103	[p6l1118t3605r1197b3666],
14	least	JJS	O	least	mwe	13	SENT_103	[p6l1226t3588r1425b3666],
15	one	CD	NUMBER	one	num	16	SENT_103	[p6l1455t3614r1606b3667],
16	dose	NN	O	dose	dobj	12	SENT_103	[p6l1643t3588r1836b3667],
17	of	IN	O	of	_	0	SENT_103	[p6l1872t3587r1972b3667],
18	iva	NN	O	iva	prep_of	16	SENT_103	[p6l1988t3589r2133b3667],
19	—	CD	NUMBER	—	num	18	SENT_103	[p6l1988t3589r2133b3667],

1	caftor	NN	O	caftor	_	0	SENT_104	[p7l21t31r274b111],
2	(	CD	NUMBER	(	number	3	SENT_104	[p7l305t38r426b123],
3	83	CD	NUMBER	83	num	4	SENT_104	[p7l305t38r426b123],
4	subjects	NNS	O	subject	dep	1	SENT_104	[p7l460t32r821b132],
5	)	JJ	O	)	amod	8	SENT_104	[p7l460t32r821b132],
6	or	CC	O	or	_	0	SENT_104	[p7l856t58r944b111],
7	placebo	NN	O	placebo	conj_or	5	SENT_104	[p7l969t32r1294b132],
8	(	NN	O	(	dep	1	SENT_104	[p7l1330t38r1508b123],
9	78	CD	NUMBER	78	num	10	SENT_104	[p7l1330t38r1508b123],
10	)	NN	O	)	dep	8	SENT_104	[p7l1330t38r1508b123],
11	.	.	O	.	_	0	SENT_104	[p7l1330t38r1508b123],

1	The	DT	O	the	det	3	SENT_105	[p7l1540t32r1699b110],
2	mean	NN	O	mean	nn	3	SENT_105	[p7l1729t58r1964b110],
3	age	NN	O	age	nsubj	9	SENT_105	[p7l1992t58r2134b133],
4	of	IN	O	of	_	0	SENT_105	[p7l21t158r120b237],
5	the	DT	O	the	det	6	SENT_105	[p7l134t159r266b237],
6	subjects	NNS	O	subject	prep_of	3	SENT_105	[p7l300t159r637b258],
7	was	VBD	O	be	cop	9	SENT_105	[p7l666t185r828b238],
8	25.5	CD	DURATION	25.5	num	9	SENT_105	[p7l862t165r1035b237],
9	years	NNS	NUMBER	year	_	0	SENT_105	[p7l1066t185r1309b258],
10	,	,	O	,	_	0	SENT_105	[p7l1066t185r1309b258],
11	and	CC	O	and	_	0	SENT_105	[p7l1346t159r1503b237],
12	the	DT	O	the	det	14	SENT_105	[p7l1535t159r1667b237],
13	mean	NN	O	mean	nn	14	SENT_105	[p7l1698t185r1935b237],
14	percent	NN	O	percent	nsubj	19	SENT_105	[p7l1965t185r2133b258, p7l21t303r200b364],
15	of	IN	O	of	_	0	SENT_105	[p7l227t285r326b365],
16	predicted	VBN	O	predict	amod	17	SENT_105	[p7l337t286r739b386],
17	FEV1	NN	O	fev1	prep_of	14	SENT_105	[p7l769t294r966b389],
18	was	VBD	O	be	cop	19	SENT_105	[p7l992t312r1154b365],
19	63.6	CD	NUMBER	63.6	conj_and	9	SENT_105	[p7l1188t292r1389b381],
20	;	:	O	;	_	0	SENT_105	[p7l1188t292r1389b381],
21	a	DT	O	a	det	22	SENT_105	[p7l1423t312r1467b364],
22	total	NN	O	total	nsubj	30	SENT_105	[p7l1498t286r1694b365],
23	of	IN	O	of	_	0	SENT_105	[p7l1726t285r1825b365],
24	52	CD	PERCENT	52	num	25	SENT_105	[p7l1841t291r2022b365],
25	%	NN	PERCENT	%	prep_of	22	SENT_105	[p7l1841t291r2022b365],
26	of	IN	O	of	_	0	SENT_105	[p7l2054t285r2153b365],
27	the	DT	O	the	det	28	SENT_105	[p7l21t413r152b490],
28	subjects	NNS	O	subject	prep_of	25	SENT_105	[p7l195t413r533b512],
29	were	VBD	O	be	cop	30	SENT_105	[p7l571t439r773b491],
30	Women	NNS	O	woman	parataxis	9	SENT_105	[p7l809t438r1124b491],
31	or	CC	O	or	_	0	SENT_105	[p7l1166t438r1254b491],
32	girls	NNS	O	girl	conj_or	30	SENT_105	[p7l1292t413r1480b513],
33	(	RB	O	(	dep	34	SENT_105	[p7l1527t413r1789b503],
34	Table	NNP	O	Table	dep	30	SENT_105	[p7l1527t413r1789b503],
35	1	CD	NUMBER	1	number	36	SENT_105	[p7l1836t419r1931b503],
36	)	CD	NUMBER	)	num	34	SENT_105	[p7l1836t419r1931b503],
37	.	.	O	.	_	0	SENT_105	[p7l1836t419r1931b503],

1	The	DT	O	the	det	3	SENT_106	[p7l1974t413r2134b490],
2	mean	JJ	O	mean	amod	3	SENT_106	[p7l20t567r256b619],
3	concentrations	NNS	O	concentration	nsubj	12	SENT_106	[p7l305t542r939b620],
4	of	IN	O	of	_	0	SENT_106	[p7l990t540r1089b620],
5	sweat	NN	O	sweat	nn	6	SENT_106	[p7l1120t558r1360b620],
6	chloride	NN	O	chloride	prep_of	3	SENT_106	[p7l1404t541r1751b620],
7	and	CC	O	and	_	0	SENT_106	[p7l1798t541r1955b620],
8	the	DT	O	the	det	10	SENT_106	[p7l2002t541r2134b619],
9	mean	NN	O	mean	nn	10	SENT_106	[p7l20t693r256b745],
10	weights	NNS	O	weight	prep_of	3	SENT_106	[p7l284t668r616b768],
11	were	VBD	O	be	cop	12	SENT_106	[p7l647t694r848b747],
12	similar	JJ	O	similar	_	0	SENT_106	[p7l882t668r1187b745],
13	in	IN	O	in	_	0	SENT_106	[p7l1215t669r1298b745],
14	the	DT	O	the	det	16	SENT_106	[p7l1331t668r1463b745],
15	two	CD	NUMBER	two	num	16	SENT_106	[p7l1496t684r1653b746],
16	groups	NNS	O	group	prep_in	12	SENT_106	[p7l1687t693r2005b768],
17	.	.	O	.	_	0	SENT_106	[p7l1687t693r2005b768],

1	At	IN	O	at	_	0	SENT_107	[p7l2040t675r2139b745],
2	the	DT	O	the	det	3	SENT_107	[p7l12t795r144b873],
3	time	NN	O	time	prep_at	29	SENT_107	[p7l173t796r366b873],
4	of	IN	O	of	_	0	SENT_107	[p7l395t794r495b874],
5	study	NN	O	study	nn	6	SENT_107	[p7l507t795r737b895],
6	entry	NN	O	entry	prep_of	3	SENT_107	[p7l761t812r996b895],
7	,	,	O	,	_	0	SENT_107	[p7l761t812r996b895],
8	12	CD	NUMBER	12	num	9	SENT_107	[p7l1034t801r1131b873],
9	subjects	NNS	O	subject	dep	16	SENT_107	[p7l1162t795r1501b895],
10	in	IN	O	in	_	0	SENT_107	[p7l1531t796r1614b873],
11	the	DT	O	the	det	12	SENT_107	[p7l1644t795r1776b873],
12	placebo	NN	O	placebo	prep_in	9	SENT_107	[p7l1803t795r2132b895],
13	group	NN	O	group	dep	16	SENT_107	[p7l11t950r263b1025],
14	(	CD	PERCENT	(	num	13	SENT_107	[p7l311t929r546b1015],
15	15	CD	PERCENT	15	num	16	SENT_107	[p7l311t929r546b1015],
16	%	NN	PERCENT	%	dep	29	SENT_107	[p7l311t929r546b1015],
17	)	CD	NUMBER	)	num	16	SENT_107	[p7l311t929r546b1015],
18	and	CC	O	and	_	0	SENT_107	[p7l592t924r750b1003],
19	8	CD	NUMBER	8	num	16	SENT_107	[p7l792t930r838b1003],
20	in	IN	O	in	_	0	SENT_107	[p7l881t925r964b1002],
21	the	DT	O	the	det	23	SENT_107	[p7l1006t924r1138b1002],
22	ivacaftor	NN	O	ivacaftor	nn	23	SENT_107	[p7l1180t923r1556b1003],
23	group	NN	O	group	prep_in	16	SENT_107	[p7l1595t950r1847b1025],
24	(	CD	PERCENT	(	number	25	SENT_107	[p7l1895t929r2128b1015],
25	10	CD	PERCENT	10	dep	26	SENT_107	[p7l1895t929r2128b1015],
26	%	NN	PERCENT	%	dep	23	SENT_107	[p7l1895t929r2128b1015],
27	)	CD	NUMBER	)	nsubj	29	SENT_107	[p7l1895t929r2128b1015],
28	were	VBD	O	be	aux	29	SENT_107	[p7l7t1078r208b1131],
29	using	VBG	O	use	_	0	SENT_107	[p7l239t1053r477b1153],
30	inhaled	VBN	O	inhale	dep	29	SENT_107	[p7l504t1052r828b1131],
31	hypertonic	JJ	O	hypertonic	amod	32	SENT_107	[p7l859t1052r1322b1152],
32	saline	NN	O	saline	dobj	30	SENT_107	[p7l1355t1052r1628b1148],
33	,	,	O	,	_	0	SENT_107	[p7l1355t1052r1628b1148],
34	which	WDT	O	which	dobj	36	SENT_107	[p7l1661t1052r1924b1131],
35	they	PRP	O	they	nsubj	36	SENT_107	[p7l1955t1052r2138b1152],
36	discontinued	VBD	O	discontinue	rcmod	32	SENT_107	[p7l12t1180r563b1259],
37	before	IN	O	before	_	0	SENT_107	[p7l594t1179r859b1259],
38	receiving	VBG	O	receive	prepc_before	36	SENT_107	[p7l889t1181r1274b1281],
39	the	DT	O	the	det	41	SENT_107	[p7l1301t1180r1432b1258],
40	first	JJ	ORDINAL	first	amod	41	SENT_107	[p7l1462t1179r1644b1258],
41	dose	NN	O	dose	dobj	38	SENT_107	[p7l1668t1180r1861b1259],
42	of	IN	O	of	_	0	SENT_107	[p7l1891t1179r1991b1259],
43	the	DT	O	the	det	45	SENT_107	[p7l2002t1180r2133b1258],
44	study	NN	O	study	nn	45	SENT_107	[p7l12t1308r242b1408],
45	drug	NN	O	drug	prep_of	41	SENT_107	[p7l281t1308r504b1409],
46	.	.	O	.	_	0	SENT_107	[p7l281t1308r504b1409],

1	Confirmatory	JJ	O	confirmatory	amod	2	SENT_108	[p7l552t1307r1150b1408],
2	genotyping	NN	O	genotyping	nsubj	3	SENT_108	[p7l1187t1309r1678b1409],
3	identified	VBD	O	identify	_	0	SENT_108	[p7l1716t1307r2134b1387],
4	1	CD	NUMBER	1	num	5	SENT_108	[p7l15t1442r59b1514],
5	subject	NN	O	subject	dobj	3	SENT_108	[p7l94t1436r394b1536],
6	in	IN	O	in	_	0	SENT_108	[p7l421t1437r504b1514],
7	the	DT	O	the	det	9	SENT_108	[p7l538t1436r670b1514],
8	placebo	NN	O	placebo	nn	9	SENT_108	[p7l703t1436r1031b1536],
9	group	NN	O	group	prep_in	5	SENT_108	[p7l1066t1462r1319b1537],
10	who	WP	O	who	nsubj	12	SENT_108	[p7l1348t1436r1531b1515],
11	was	VBD	O	be	cop	12	SENT_108	[p7l1562t1462r1724b1515],
12	homozygous	JJ	O	homozygous	rcmod	5	SENT_108	[p7l1760t1436r2132b1536, p7l11t1590r211b1665],
13	for	IN	O	for	_	0	SENT_108	[p7l243t1563r366b1643],
14	F508del	NN	O	f508del	prep_for	12	SENT_108	[p7l390t1564r938b1644],
15	.	.	O	.	_	0	SENT_108	[p7l390t1564r938b1644],

1	—	NN	O	—	_	0	SENT_109	[p7l390t1564r938b1644],
2	.	.	O	.	_	0	SENT_109	[p7l390t1564r938b1644],

1	CFTR	NNP	ORGANIZATION	CFTR	_	0	SENT_110	[p7l390t1564r938b1644],
2	despite	IN	O	despite	dep	1	SENT_110	[p7l961t1564r1262b1664],
3	a	DT	O	a	det	5	SENT_110	[p7l1290t1590r1335b1642],
4	previous	JJ	O	previous	amod	5	SENT_110	[p7l1361t1565r1723b1664],
5	test	NN	O	test	pobj	2	SENT_110	[p7l1755t1581r1909b1642],
6	indicating	VBG	O	indicate	partmod	5	SENT_110	[p7l1932t1564r2132b1643, p7l12t1693r279b1793],
7	a	DT	O	a	det	9	SENT_110	[p7l307t1718r351b1770],
8	G551D	NN	O	g551d	nn	9	SENT_110	[p7l381t1699r633b1770],
9	allele	NN	O	allele	dobj	6	SENT_110	[p7l662t1692r909b1771],
10	.	.	O	.	_	0	SENT_110	[p7l662t1692r909b1771],

1	Data	NNS	O	datum	nsubjpass	6	SENT_111	[p7l944t1699r1145b1770],
2	from	IN	O	from	_	0	SENT_111	[p7l1174t1691r1384b1771],
3	this	DT	O	this	det	4	SENT_111	[p7l1416t1692r1576b1770],
4	subject	NN	O	subject	prep_from	1	SENT_111	[p7l1610t1692r1910b1792],
5	were	VBD	O	be	auxpass	6	SENT_111	[p7l1931t1718r2133b1771],
6	included	VBN	O	include	_	0	SENT_111	[p7l11t1820r377b1899],
7	in	IN	O	in	_	0	SENT_111	[p7l411t1821r495b1897],
8	the	DT	O	the	det	9	SENT_111	[p7l529t1820r662b1898],
9	analyses	NNS	O	analysis	prep_in	6	SENT_111	[p7l697t1820r1080b1919],
10	.	.	O	.	_	0	SENT_111	[p7l697t1820r1080b1919],

1	A	DT	O	a	det	2	SENT_112	[p7l136t1956r202b2026],
2	total	NN	O	total	nsubj	24	SENT_112	[p7l243t1948r443b2027],
3	of	IN	O	of	_	0	SENT_112	[p7l487t1947r588b2027],
4	77	CD	NUMBER	77	num	5	SENT_112	[p7l613t1956r713b2027],
5	subjects	NNS	O	subject	prep_of	2	SENT_112	[p7l759t1948r1104b2048],
6	in	IN	O	in	_	0	SENT_112	[p7l1148t1949r1233b2026],
7	the	DT	O	the	det	9	SENT_112	[p7l1276t1948r1411b2026],
8	ivacaftor	NN	O	ivacaftor	nn	9	SENT_112	[p7l1453t1947r1836b2027],
9	group	NN	O	group	prep_in	5	SENT_112	[p7l1876t1974r2132b2049],
10	(	CD	PERCENT	(	num	12	SENT_112	[p7l16t2081r248b2167],
11	93	CD	PERCENT	93	num	12	SENT_112	[p7l16t2081r248b2167],
12	%	NN	PERCENT	%	dep	22	SENT_112	[p7l16t2081r248b2167],
13	)	CD	NUMBER	)	dep	12	SENT_112	[p7l16t2081r248b2167],
14	and	CC	O	and	_	0	SENT_112	[p7l299t2076r456b2155],
15	68	CD	NUMBER	68	conj_and	13	SENT_112	[p7l502t2082r601b2155],
16	in	IN	O	in	_	0	SENT_112	[p7l648t2077r731b2154],
17	the	DT	O	the	det	18	SENT_112	[p7l777t2076r909b2154],
18	placebo	NN	O	placebo	prep_in	13	SENT_112	[p7l953t2076r1283b2176],
19	group	NN	O	group	dep	22	SENT_112	[p7l1329t2102r1581b2177],
20	(	CD	PERCENT	(	num	19	SENT_112	[p7l1632t2081r1867b2167],
21	87	CD	PERCENT	87	num	22	SENT_112	[p7l1632t2081r1867b2167],
22	%	NN	PERCENT	%	dep	5	SENT_112	[p7l1632t2081r1867b2167],
23	)	CD	NUMBER	)	dep	22	SENT_112	[p7l1632t2081r1867b2167],
24	completed	VBN	O	complete	_	0	SENT_112	[p7l1919t2102r2132b2155, p7l9t2203r271b2303],
25	48	CD	DURATION	48	num	26	SENT_112	[p7l311t2209r412b2282],
26	Weeks	NNS	DURATION	week	dobj	24	SENT_112	[p7l452t2203r713b2283],
27	of	IN	O	of	_	0	SENT_112	[p7l757t2202r857b2282],
28	treatment	NN	O	treatment	prep_of	26	SENT_112	[p7l880t2220r1325b2282],
29	.	.	O	.	_	0	SENT_112	[p7l880t2220r1325b2282],

1	The	DT	O	the	det	3	SENT_113	[p7l1369t2203r1529b2281],
2	mean	JJ	O	mean	amod	3	SENT_113	[p7l1571t2229r1808b2281],
3	rate	NN	O	rate	nsubj	12	SENT_113	[p7l1850t2220r2010b2281],
4	of	IN	O	of	_	0	SENT_113	[p7l2052t2202r2152b2282],
5	adherence	NN	O	adherence	prep_of	3	SENT_113	[p7l11t2332r454b2411],
6	to	TO	O	to	_	0	SENT_113	[p7l513t2349r595b2411],
7	the	DT	O	the	det	9	SENT_113	[p7l655t2332r789b2410],
8	study	NN	O	study	nn	9	SENT_113	[p7l849t2332r1083b2432],
9	drug	NN	O	drug	prep_to	5	SENT_113	[p7l1137t2332r1344b2433],
10	was	VBD	O	be	cop	12	SENT_113	[p7l1394t2358r1559b2411],
11	91	CD	PERCENT	91	num	12	SENT_113	[p7l1619t2337r1799b2411],
12	%	NN	PERCENT	%	_	0	SENT_113	[p7l1619t2337r1799b2411],
13	in	IN	O	in	_	0	SENT_113	[p7l1855t2333r1940b2410],
14	the	DT	O	the	det	16	SENT_113	[p7l1998t2332r2133b2410],
15	ivacaftor	NN	O	ivacaftor	nn	16	SENT_113	[p7l11t2459r395b2539],
16	group	NN	O	group	prep_in	12	SENT_113	[p7l434t2486r691b2561],
17	and	CC	O	and	_	0	SENT_113	[p7l733t2460r893b2539],
18	89	CD	PERCENT	89	num	19	SENT_113	[p7l936t2465r1125b2539],
19	%	NN	PERCENT	%	conj_and	12	SENT_113	[p7l936t2465r1125b2539],
20	in	IN	O	in	_	0	SENT_113	[p7l1166t2461r1251b2538],
21	the	DT	O	the	det	23	SENT_113	[p7l1293t2460r1427b2538],
22	placebo	NN	O	placebo	nn	23	SENT_113	[p7l1469t2460r1804b2560],
23	group	NN	O	group	prep_in	19	SENT_113	[p7l1848t2486r2128b2561],
24	.	.	O	.	_	0	SENT_113	[p7l1848t2486r2128b2561],

1	Of	IN	O	of	_	0	SENT_114	[p7l11t2586r132b2666],
2	the	DT	O	the	det	4	SENT_114	[p7l155t2587r288b2665],
3	145	CD	NUMBER	145	num	4	SENT_114	[p7l333t2593r471b2666],
4	subjects	NNS	O	subject	prep_of	21	SENT_114	[p7l517t2587r856b2687],
5	who	WP	O	who	nsubj	6	SENT_114	[p7l895t2587r1078b2667],
6	completed	VBD	O	complete	rcmod	4	SENT_114	[p7l1121t2587r1566b2687],
7	48	CD	DURATION	48	num	8	SENT_114	[p7l1606t2593r1707b2666],
8	weeks	NNS	NUMBER	week	dobj	6	SENT_114	[p7l1746t2587r2007b2667],
9	of	IN	O	of	_	0	SENT_114	[p7l2051t2586r2151b2666],
10	treatment	NN	O	treatment	prep_of	8	SENT_114	[p7l12t2733r456b2812],
11	,	,	O	,	_	0	SENT_114	[p7l12t2733r456b2812],
12	only	RB	O	only	advmod	15	SENT_114	[p7l503t2716r687b2816],
13	1	CD	NUMBER	1	num	15	SENT_114	[p7l727t2722r771b2794],
14	subject	JJ	O	subject	amod	15	SENT_114	[p7l814t2716r1114b2816],
15	(	NN	O	(	nsubj	21	SENT_114	[p7l1155t2717r1265b2807],
16	in	IN	O	in	_	0	SENT_114	[p7l1155t2717r1265b2807],
17	the	DT	O	the	det	19	SENT_114	[p7l1307t2716r1439b2794],
18	placebo	NN	O	placebo	nn	19	SENT_114	[p7l1480t2716r1808b2816],
19	group	NN	O	group	prep_in	15	SENT_114	[p7l1850t2723r2128b2817],
20	)	CD	NUMBER	)	dep	19	SENT_114	[p7l1850t2723r2128b2817],
21	declined	VBD	O	decline	_	0	SENT_114	[p7l12t2844r373b2922],
22	to	TO	O	to	aux	23	SENT_114	[p7l414t2860r496b2922],
23	enter	VB	O	enter	xcomp	21	SENT_114	[p7l538t2860r755b2922],
24	the	DT	O	the	det	28	SENT_114	[p7l793t2844r926b2922],
25	open	JJ	O	open	amod	28	SENT_114	[p7l968t2844r1415b2943],
26	—	NN	O	—	nn	28	SENT_114	[p7l968t2844r1415b2943],
27	label	NN	O	label	nn	28	SENT_114	[p7l968t2844r1415b2943],
28	extension	NN	O	extension	dobj	23	SENT_114	[p7l1456t2845r1866b2922],
29	study	NN	O	study	nn	32	SENT_114	[p7l1908t2844r2138b2943],
30	(	CD	NUMBER	(	num	32	SENT_114	[p7l16t2978r688b3062],
31	VXO8-770-105	NN	O	vxo8-770-105	nn	32	SENT_114	[p7l16t2978r688b3062],
32	)	NN	O	)	dep	28	SENT_114	[p7l16t2978r688b3062],
33	.	.	O	.	_	0	SENT_114	[p7l16t2978r688b3062],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_115	[p7l12t3246r377b3296],
2	EFFICACY	NN	O	efficacy	npadvmod	8	SENT_115	[p7l414t3246r782b3296],
3	Through	IN	O	through	_	0	SENT_115	[p7l7t3345r374b3446],
4	Week	NN	DURATION	week	prep_through	8	SENT_115	[p7l394t3345r612b3424],
5	24	CD	NUMBER	24	num	4	SENT_115	[p7l632t3351r749b3441],
6	,	,	O	,	_	0	SENT_115	[p7l632t3351r749b3441],
7	there	EX	O	there	expl	8	SENT_115	[p7l779t3345r989b3424],
8	was	VBD	O	be	dep	49	SENT_115	[p7l1010t3371r1169b3424],
9	an	DT	O	a	det	10	SENT_115	[p7l1195t3371r1297b3423],
10	increase	NN	O	increase	nsubj	8	SENT_115	[p7l1321t3346r1661b3423],
11	from	IN	O	from	_	0	SENT_115	[p7l1686t3344r1891b3424],
12	baseline	NN	O	baseline	prep_from	8	SENT_115	[p7l1917t3345r2132b3424, p7l10t3473r164b3551],
13	of	IN	O	of	_	0	SENT_115	[p7l192t3472r290b3552],
14	10.4	CD	PERCENT	10.4	num	16	SENT_115	[p7l302t3479r468b3552],
15	percentage	NN	PERCENT	percentage	nn	16	SENT_115	[p7l494t3490r947b3574],
16	points	NNS	PERCENT	point	prep_of	12	SENT_115	[p7l973t3474r1234b3573],
17	in	IN	O	in	_	0	SENT_115	[p7l1263t3474r1345b3551],
18	the	DT	O	the	det	19	SENT_115	[p7l1373t3473r1501b3552],
19	percent	NN	O	percent	prep_in	16	SENT_115	[p7l1528t3490r1840b3573],
20	of	IN	O	of	_	0	SENT_115	[p7l1862t3472r1960b3552],
21	predicted	VBN	O	predict	amod	22	SENT_115	[p7l1967t3499r2132b3573, p7l12t3600r274b3679],
22	FEV1	NN	O	fev1	prep_of	19	SENT_115	[p7l311t3608r510b3703],
23	in	IN	O	in	_	0	SENT_115	[p7l547t3601r631b3677],
24	the	DT	O	the	det	26	SENT_115	[p7l670t3600r804b3678],
25	ivacaftor	NN	O	ivacaftor	nn	26	SENT_115	[p7l842t3599r1222b3679],
26	group	NN	O	group	prep_in	22	SENT_115	[p7l1257t3626r1533b3701],
27	,	,	O	,	_	0	SENT_115	[p7l1257t3626r1533b3701],
28	as	IN	O	as	_	0	SENT_115	[p7l1577t3626r1663b3678],
29	compared	VBN	O	compare	prepc_as	8	SENT_115	[p7l1704t3600r2134b3700],
30	with	IN	O	with	pcomp	29	SENT_115	[p8l7t20r197b99],
31	a	DT	O	a	det	32	SENT_115	[p8l225t46r269b98],
32	decrease	NN	O	decrease	pobj	30	SENT_115	[p8l297t20r650b99],
33	of	IN	O	of	prep	32	SENT_115	[p8l680t19r777b99],
34	0.2	CD	NUMBER	0.2	num	36	SENT_115	[p8l788t26r910b99],
35	percentage	NN	O	percentage	nn	36	SENT_115	[p8l939t37r1392b121],
36	points	NNS	O	point	dep	44	SENT_115	[p8l1420t21r1680b120],
37	in	IN	O	in	_	0	SENT_115	[p8l1711t21r1792b98],
38	the	DT	O	the	det	39	SENT_115	[p8l1821t20r1950b99],
39	placebo	NN	O	placebo	prep_in	36	SENT_115	[p8l1978t20r2132b120, p8l12t148r202b227],
40	group	NN	O	group	dep	44	SENT_115	[p8l229t174r474b249],
41	—	CD	NUMBER	—	num	40	SENT_115	[p8l497t193r605b201],
42	a	DT	O	a	det	44	SENT_115	[p8l626t174r670b226],
43	treatment	NN	O	treatment	nn	44	SENT_115	[p8l694t165r1105b226],
44	effect	NN	O	effect	dep	33	SENT_115	[p8l1126t147r1359b227],
45	of	IN	O	of	_	0	SENT_115	[p8l1380t147r1479b227],
46	10.6	CD	NUMBER	10.6	num	48	SENT_115	[p8l1489t154r1655b227],
47	percentage	NN	O	percentage	nn	48	SENT_115	[p8l1680t165r2134b249],
48	points	NNS	O	point	prep_of	44	SENT_115	[p8l9t277r274b376],
49	(	VBP	O	(	_	0	SENT_115	[p8l307t282r691b367],
50	P	NN	O	p	dep	51	SENT_115	[p8l307t282r691b367],
51	<	JJR	O	<	dobj	49	SENT_115	[p8l307t282r691b367],
52	0.001	CD	NUMBER	0.001	num	55	SENT_115	[p8l307t282r691b367],
53	)	NN	O	)	nn	55	SENT_115	[p8l307t282r691b367],
54	(	CD	NUMBER	(	num	55	SENT_115	[p8l728t277r902b377],
55	Fig	NN	O	fig	nsubj	49	SENT_115	[p8l728t277r902b377],
56	.	.	O	.	_	0	SENT_115	[p8l728t277r902b377],

1	1A	NN	O	1a	_	0	SENT_116	[p8l938t282r1098b367],
2	)	NN	O	)	dep	1	SENT_116	[p8l938t282r1098b367],
3	.	.	O	.	_	0	SENT_116	[p8l938t282r1098b367],

1	The	DT	O	the	det	2	SENT_117	[p8l1126t276r1284b354],
2	improvement	NN	O	improvement	nsubj	7	SENT_117	[p8l1311t277r1874b376],
3	in	IN	O	in	_	0	SENT_117	[p8l1894t277r1976b354],
4	the	DT	O	the	det	6	SENT_117	[p8l2003t276r2133b354],
5	ivacaftor	NN	O	ivacaftor	nn	6	SENT_117	[p8l11t402r386b482],
6	group	NN	O	group	prep_in	2	SENT_117	[p8l413t429r665b504],
7	reflected	VBD	O	reflect	_	0	SENT_117	[p8l697t402r1075b482],
8	a	DT	O	a	det	10	SENT_117	[p8l1104t429r1149b481],
9	mean	JJ	O	mean	amod	10	SENT_117	[p8l1177t429r1414b481],
10	increase	NN	O	increase	dobj	7	SENT_117	[p8l1444t404r1795b481],
11	in	IN	O	in	_	0	SENT_117	[p8l1825t404r1908b480],
12	FEV1	NN	O	fev1	prep_in	7	SENT_117	[p8l1937t411r2134b506],
13	of	IN	O	of	_	0	SENT_117	[p8l12t529r112b609],
14	0.367	CD	NUMBER	0.367	num	15	SENT_117	[p8l135t536r362b609],
15	liters	NNS	O	liter	prep_of	12	SENT_117	[p8l403t530r641b626],
16	,	,	O	,	_	0	SENT_117	[p8l403t530r641b626],
17	as	IN	O	as	mark	18	SENT_117	[p8l687t556r772b608],
18	compared	VBN	O	compare	advcl	7	SENT_117	[p8l816t530r1243b630],
19	with	IN	O	with	_	0	SENT_117	[p8l1279t530r1474b610],
20	an	DT	O	a	det	21	SENT_117	[p8l1515t556r1617b608],
21	increase	NN	O	increase	prep_with	18	SENT_117	[p8l1658t531r2010b608],
22	of	IN	O	of	_	0	SENT_117	[p8l2051t529r2151b609],
23	0.006	CD	NUMBER	0.006	num	24	SENT_117	[p8l11t665r241b738],
24	liters	NNS	O	liter	prep_of	21	SENT_117	[p8l269t659r476b737],
25	in	IN	O	in	_	0	SENT_117	[p8l506t660r588b737],
26	the	DT	O	the	det	28	SENT_117	[p8l617t659r747b737],
27	placebo	NN	O	placebo	nn	28	SENT_117	[p8l774t659r1097b759],
28	group	NN	O	group	prep_in	24	SENT_117	[p8l1126t685r1374b760],
29	(	NN	O	(	nn	31	SENT_117	[p8l1409t666r1848b750],
30	treatment	NN	O	treatment	nn	31	SENT_117	[p8l1409t666r1848b750],
31	effect	NN	O	effect	dobj	18	SENT_117	[p8l1872t658r2128b755],
32	,	,	O	,	_	0	SENT_117	[p8l1872t658r2128b755],
33	0.361	CD	NUMBER	0.361	num	34	SENT_117	[p8l11t793r234b866],
34	liters	NNS	O	liter	appos	31	SENT_117	[p8l263t787r495b883],
35	;	:	O	;	_	0	SENT_117	[p8l263t787r495b883],
36	P	NN	O	p	dep	37	SENT_117	[p8l527t793r885b878],
37	<	JJR	O	<	dep	31	SENT_117	[p8l527t793r885b878],
38	0.001	CD	NUMBER	0.001	num	39	SENT_117	[p8l527t793r885b878],
39	)	NN	O	)	dep	37	SENT_117	[p8l527t793r885b878],
40	through	IN	O	through	_	0	SENT_117	[p8l920t787r1263b888],
41	week	NN	DURATION	week	prep_through	18	SENT_117	[p8l1289t787r1509b866],
42	24	CD	NUMBER	24	num	41	SENT_117	[p8l1534t793r1652b883],
43	,	,	O	,	_	0	SENT_117	[p8l1534t793r1652b883],
44	which	WDT	O	which	nsubj	45	SENT_117	[p8l1682t787r1941b866],
45	corresponded	VBD	O	correspond	rcmod	41	SENT_117	[p8l1971t813r2132b866, p8l11t915r452b1015],
46	to	TO	O	to	_	0	SENT_117	[p8l493t932r575b994],
47	a	DT	O	a	det	49	SENT_117	[p8l618t941r662b993],
48	relative	JJ	O	relative	amod	49	SENT_117	[p8l703t915r1012b994],
49	change	NN	O	change	prep_to	45	SENT_117	[p8l1056t915r1360b1016],
50	from	IN	O	from	_	0	SENT_117	[p8l1404t914r1613b994],
51	baseline	NN	O	baseline	prep_from	49	SENT_117	[p8l1657t915r2008b994],
52	of	IN	O	of	_	0	SENT_117	[p8l2052t914r2152b994],
53	17.2	CD	PERCENT	17.2	num	54	SENT_117	[p8l15t1049r265b1122],
54	%	NN	PERCENT	%	prep_of	51	SENT_117	[p8l15t1049r265b1122],
55	in	IN	O	in	_	0	SENT_117	[p8l310t1044r393b1121],
56	the	DT	O	the	det	58	SENT_117	[p8l439t1043r572b1121],
57	ivacaftor	NN	O	ivacaftor	nn	58	SENT_117	[p8l618t1042r994b1122],
58	group	NN	O	group	prep_in	54	SENT_117	[p8l1037t1069r1289b1144],
59	as	IN	O	as	prep	45	SENT_117	[p8l1336t1069r1421b1121],
60	compared	VBN	O	compare	_	0	SENT_117	[p8l1471t1043r1897b1143],
61	with	IN	O	with	prepc_compared_with	45	SENT_117	[p8l1939t1043r2134b1122],
62	0.1	CD	PERCENT	0.1	num	63	SENT_117	[p8l11t1176r215b1250],
63	%	NN	PERCENT	%	pobj	45	SENT_117	[p8l11t1176r215b1250],
64	in	IN	O	in	_	0	SENT_117	[p8l249t1172r332b1249],
65	the	DT	O	the	det	67	SENT_117	[p8l368t1171r501b1249],
66	placebo	NN	O	placebo	nn	67	SENT_117	[p8l535t1171r864b1271],
67	group	NN	O	group	prep_in	63	SENT_117	[p8l901t1197r1175b1272],
68	.	.	O	.	_	0	SENT_117	[p8l901t1197r1175b1272],

1	An	DT	O	a	det	2	SENT_118	[p8l1213t1179r1336b1249],
2	effect	NN	O	effect	nsubjpass	6	SENT_118	[p8l1372t1170r1614b1249],
3	of	IN	O	of	_	0	SENT_118	[p8l1645t1170r1745b1250],
4	ivacaftor	NN	O	ivacaftor	prep_of	2	SENT_118	[p8l1761t1170r2137b1250],
5	was	VBD	O	be	auxpass	6	SENT_118	[p8l7t1324r169b1378],
6	noted	VBN	O	note	_	0	SENT_118	[p8l212t1298r454b1377],
7	by	IN	O	by	_	0	SENT_118	[p8l496t1298r593b1398],
8	day	NN	DURATION	day	agent	6	SENT_118	[p8l630t1298r777b1398],
9	15	CD	NUMBER	15	num	8	SENT_118	[p8l817t1304r911b1377],
10	of	IN	O	of	_	0	SENT_118	[p8l956t1297r1056b1377],
11	treatment	NN	O	treatment	nn	14	SENT_118	[p8l1079t1315r1503b1376],
12	(	NN	O	(	nn	14	SENT_118	[p8l1543t1305r1992b1389],
13	treatment	NN	O	treatment	nn	14	SENT_118	[p8l1543t1305r1992b1389],
14	effect	NN	O	effect	prep_of	8	SENT_118	[p8l2029t1297r2132b1376, p8l11t1426r186b1523],
15	,	,	O	,	_	0	SENT_118	[p8l2029t1297r2132b1376, p8l11t1426r186b1523],
16	9.3	CD	NUMBER	9.3	num	18	SENT_118	[p8l220t1433r338b1506],
17	percentage	NN	O	percentage	nn	18	SENT_118	[p8l368t1444r829b1528],
18	points	NNS	O	point	appos	14	SENT_118	[p8l856t1428r1145b1527],
19	;	:	O	;	_	0	SENT_118	[p8l856t1428r1145b1527],
20	P	NN	O	p	dep	21	SENT_118	[p8l1175t1433r1557b1518],
21	<	JJR	O	<	dep	18	SENT_118	[p8l1175t1433r1557b1518],
22	0.001	CD	NUMBER	0.001	num	23	SENT_118	[p8l1175t1433r1557b1518],
23	)	NN	O	)	dep	21	SENT_118	[p8l1175t1433r1557b1518],
24	.	.	O	.	_	0	SENT_118	[p8l1175t1433r1557b1518],

1	A	DT	O	a	det	4	SENT_119	[p8l1587t1435r1653b1505],
2	significant	JJ	O	significant	amod	4	SENT_119	[p8l1679t1426r2138b1528],
3	treatment	NN	O	treatment	nn	4	SENT_119	[p8l12t1572r435b1634],
4	effect	NN	O	effect	nsubjpass	6	SENT_119	[p8l469t1554r710b1633],
5	was	VBD	O	be	auxpass	6	SENT_119	[p8l738t1581r901b1634],
6	maintained	VBN	O	maintain	_	0	SENT_119	[p8l941t1555r1437b1634],
7	throughout	IN	O	throughout	_	0	SENT_119	[p8l1475t1555r1968b1656],
8	the	DT	O	the	det	9	SENT_119	[p8l2001t1555r2133b1634],
9	study	NN	O	study	prep_throughout	6	SENT_119	[p8l12t1683r255b1783],
10	,	,	O	,	_	0	SENT_119	[p8l12t1683r255b1783],
11	with	IN	O	with	_	0	SENT_119	[p8l296t1683r491b1762],
12	a	DT	O	a	det	13	SENT_119	[p8l531t1709r575b1761],
13	change	NN	O	change	prep_with	6	SENT_119	[p8l614t1683r919b1784],
14	in	IN	O	in	_	0	SENT_119	[p8l959t1684r1042b1761],
15	the	DT	O	the	det	16	SENT_119	[p8l1082t1683r1214b1761],
16	percent	NN	O	percent	prep_in	13	SENT_119	[p8l1253t1700r1575b1783],
17	of	IN	O	of	_	0	SENT_119	[p8l1611t1682r1711b1762],
18	predicted	VBN	O	predict	prepc_of	16	SENT_119	[p8l1730t1683r2134b1783],
19	FEV1	NN	O	fev1	dobj	18	SENT_119	[p8l9t1818r210b1913],
20	from	IN	O	from	_	0	SENT_119	[p8l258t1809r471b1889],
21	baseline	NN	O	baseline	prep_from	19	SENT_119	[p8l521t1810r880b1889],
22	through	IN	O	through	_	0	SENT_119	[p8l929t1810r1284b1911],
23	week	NN	DURATION	week	prep_through	18	SENT_119	[p8l1329t1810r1555b1889],
24	48	CD	NUMBER	48	num	23	SENT_119	[p8l1597t1816r1700b1889],
25	that	WDT	O	that	nsubj	30	SENT_119	[p8l1752t1810r1928b1888],
26	was	VBD	O	be	cop	30	SENT_119	[p8l1966t1836r2131b1889],
27	10.5	CD	NUMBER	10.5	num	29	SENT_119	[p8l15t1944r180b2017],
28	percentage	NN	O	percentage	nn	29	SENT_119	[p8l212t1955r673b2039],
29	points	NNS	O	point	npadvmod	30	SENT_119	[p8l702t1939r967b2038],
30	greater	JJR	O	greater	rcmod	23	SENT_119	[p8l999t1955r1298b2039],
31	with	IN	O	with	_	0	SENT_119	[p8l1321t1938r1514b2017],
32	ivacaftor	NN	O	ivacaftor	prep_with	30	SENT_119	[p8l1543t1937r1912b2017],
33	than	IN	O	than	prep	30	SENT_119	[p8l1939t1938r2133b2016],
34	with	IN	O	with	pcomp	33	SENT_119	[p8l7t2066r205b2145],
35	placebo	NN	O	placebo	pobj	34	SENT_119	[p8l249t2066r585b2165],
36	(	CD	NUMBER	(	num	37	SENT_119	[p8l636t2072r1038b2156],
37	P	NN	O	p	dep	42	SENT_119	[p8l636t2072r1038b2156],
38	<	JJR	O	<	dep	37	SENT_119	[p8l636t2072r1038b2156],
39	0.001	CD	NUMBER	0.001	num	40	SENT_119	[p8l636t2072r1038b2156],
40	)	NN	O	)	dep	42	SENT_119	[p8l636t2072r1038b2156],
41	(	CD	NUMBER	(	num	42	SENT_119	[p8l1094t2066r1358b2156],
42	Table	NNP	O	Table	dep	35	SENT_119	[p8l1094t2066r1358b2156],
43	1	CD	NUMBER	1	num	42	SENT_119	[p8l1407t2072r1451b2143],
44	in	IN	O	in	_	0	SENT_119	[p8l1497t2067r1581b2143],
45	the	DT	O	the	det	48	SENT_119	[p8l1627t2066r1762b2144],
46	Supplementary	NNP	O	Supplementary	nn	48	SENT_119	[p8l1810t2066r2132b2165, p8l11t2210r376b2293],
47	Appendix	NNP	O	Appendix	nn	48	SENT_119	[p8l406t2193r879b2293],
48	)	NN	O	)	prep_in	42	SENT_119	[p8l406t2193r879b2293],
49	.	.	O	.	_	0	SENT_119	[p8l406t2193r879b2293],

1	The	DT	O	the	det	2	SENT_120	[p8l919t2193r1082b2271],
2	distribution	NN	O	distribution	nsubj	11	SENT_120	[p8l1121t2193r1640b2273],
3	of	IN	O	of	_	0	SENT_120	[p8l1679t2192r1779b2272],
4	individual	JJ	O	individual	amod	5	SENT_120	[p8l1798t2193r2132b2273, p8l11t2322r138b2401],
5	changes	NNS	O	change	prep_of	2	SENT_120	[p8l160t2322r496b2423],
6	from	IN	O	from	_	0	SENT_120	[p8l521t2321r726b2401],
7	baseline	NN	O	baseline	prep_from	5	SENT_120	[p8l749t2322r1087b2401],
8	through	IN	O	through	_	0	SENT_120	[p8l1111t2322r1447b2423],
9	week	NN	DURATION	week	prep_through	7	SENT_120	[p8l1465t2322r1683b2401],
10	24	CD	NUMBER	24	num	9	SENT_120	[p8l1700t2328r1796b2401],
11	showed	VBD	O	show	_	0	SENT_120	[p8l1820t2322r2133b2401],
12	that	IN	O	that	complm	24	SENT_120	[p8l12t2449r184b2527],
13	nearly	RB	O	nearly	quantmod	14	SENT_120	[p8l213t2449r477b2549],
14	75	CD	PERCENT	75	num	15	SENT_120	[p8l508t2454r691b2528],
15	%	NN	PERCENT	%	nsubj	24	SENT_120	[p8l508t2454r691b2528],
16	of	IN	O	of	_	0	SENT_120	[p8l726t2448r826b2528],
17	the	DT	O	the	det	18	SENT_120	[p8l843t2449r975b2527],
18	subjects	NNS	O	subject	prep_of	15	SENT_120	[p8l1012t2449r1351b2549],
19	who	WP	O	who	nsubjpass	21	SENT_120	[p8l1383t2449r1566b2529],
20	were	VBD	O	be	auxpass	21	SENT_120	[p8l1598t2475r1800b2529],
21	treated	VBN	O	treat	rcmod	18	SENT_120	[p8l1836t2449r2134b2528],
22	with	IN	O	with	_	0	SENT_120	[p8l7t2577r202b2657],
23	ivacaftor	NN	O	ivacaftor	prep_with	21	SENT_120	[p8l234t2576r609b2657],
24	had	VBD	O	have	ccomp	11	SENT_120	[p8l639t2577r795b2656],
25	a	DT	O	a	det	27	SENT_120	[p8l826t2603r871b2655],
26	mean	JJ	O	mean	amod	27	SENT_120	[p8l901t2603r1138b2655],
27	improvement	NN	O	improvement	dobj	24	SENT_120	[p8l1170t2578r1743b2677],
28	of	IN	O	of	_	0	SENT_120	[p8l1771t2576r1871b2656],
29	5	CD	NUMBER	5	num	31	SENT_120	[p8l1887t2585r1930b2656],
30	percentage	NN	O	percentage	nn	31	SENT_120	[p8l1964t2603r2132b2677, p8l12t2723r338b2807],
31	points	NNS	O	point	prep_of	27	SENT_120	[p8l368t2707r638b2806],
32	or	CC	O	or	_	0	SENT_120	[p8l672t2732r760b2785],
33	more	JJR	O	more	conj_or	27	SENT_120	[p8l789t2732r1008b2785],
34	(	CD	NUMBER	(	num	35	SENT_120	[p8l1045t2707r1227b2807],
35	Fig	NN	O	fig	dep	33	SENT_120	[p8l1045t2707r1227b2807],
36	.	.	O	.	_	0	SENT_120	[p8l1045t2707r1227b2807],

1	2	CD	NUMBER	2	_	0	SENT_121	[p8l1267t2712r1314b2784],
2	in	IN	O	in	_	0	SENT_121	[p8l1347t2707r1430b2784],
3	the	DT	O	the	det	6	SENT_121	[p8l1462t2706r1594b2785],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_121	[p8l1628t2706r2132b2806, p8l12t2851r181b2934],
5	Appendix	NNP	O	Appendix	nn	6	SENT_121	[p8l204t2834r670b2934],
6	)	NN	O	)	prep_in	1	SENT_121	[p8l204t2834r670b2934],
7	.	.	O	.	_	0	SENT_121	[p8l204t2834r670b2934],

1	The	DT	O	the	det	2	SENT_122	[p8l702t2834r862b2912],
2	change	NN	O	change	nsubjpass	11	SENT_122	[p8l893t2834r1199b2935],
3	in	IN	O	in	_	0	SENT_122	[p8l1228t2835r1311b2912],
4	the	DT	O	the	det	5	SENT_122	[p8l1342t2834r1475b2912],
5	percent	NN	O	percent	prep_in	2	SENT_122	[p8l1504t2851r1826b2934],
6	of	IN	O	of	_	0	SENT_122	[p8l1852t2833r1952b2913],
7	predicted	VBN	O	predict	amod	8	SENT_122	[p8l1962t2860r2132b2934, p8l12t2961r273b3040],
8	FEV1	NN	O	fev1	prep_of	5	SENT_122	[p8l305t2969r503b3064],
9	was	VBD	O	be	auxpass	11	SENT_122	[p8l533t2987r695b3040],
10	also	RB	O	also	advmod	11	SENT_122	[p8l731t2961r902b3040],
11	analyzed	VBN	O	analyze	_	0	SENT_122	[p8l938t2961r1317b3060],
12	within	IN	O	within	_	0	SENT_122	[p8l1347t2961r1631b3040],
13	predefined	JJ	O	predefined	amod	14	SENT_122	[p8l1664t2960r2133b3061],
14	subgroups	NNS	O	subgroup	prep_within	11	SENT_122	[p8l12t3089r483b3190],
15	,	,	O	,	_	0	SENT_122	[p8l12t3089r483b3190],
16	including	VBG	O	include	_	0	SENT_122	[p8l525t3089r936b3190],
17	subgroups	NNS	O	subgroup	prep_including	11	SENT_122	[p8l971t3089r1417b3190],
18	defined	VBN	O	define	partmod	17	SENT_122	[p8l1457t3088r1783b3168],
19	according	VBG	O	accord	_	0	SENT_122	[p8l1820t3089r2132b3168, p8l11t3217r150b3317],
20	to	TO	O	to	prepc_according_to	18	SENT_122	[p8l187t3233r268b3295],
21	baseline	NN	O	baseline	nn	22	SENT_122	[p8l310t3216r662b3295],
22	FEV1	NN	O	fev1	pobj	18	SENT_122	[p8l701t3224r920b3319],
23	,	,	O	,	_	0	SENT_122	[p8l701t3224r920b3319],
24	age	NN	O	age	pobj	18	SENT_122	[p8l965t3242r1132b3317],
25	,	,	O	,	_	0	SENT_122	[p8l965t3242r1132b3317],
26	and	CC	O	and	_	0	SENT_122	[p8l1176t3216r1334b3295],
27	sex	NN	O	sex	conj_and	22	SENT_122	[p8l1375t3242r1531b3295],
28	.	.	O	.	_	0	SENT_122	[p8l1375t3242r1531b3295],

1	The	DT	O	the	det	2	SENT_123	[p8l1573t3216r1733b3294],
2	effect	NN	O	effect	nsubj	10	SENT_123	[p8l1774t3215r2016b3294],
3	of	IN	O	of	_	0	SENT_123	[p8l2051t3215r2151b3295],
4	ivacaftor	NN	O	ivacaftor	prep_of	2	SENT_123	[p8l11t3343r386b3423],
5	as	IN	O	as	_	0	SENT_123	[p8l423t3370r509b3422],
6	compared	VBN	O	compare	prepc_as	4	SENT_123	[p8l552t3344r978b3444],
7	with	IN	O	with	pcomp	6	SENT_123	[p8l1014t3344r1209b3423],
8	placebo	NN	O	placebo	pobj	7	SENT_123	[p8l1249t3344r1578b3444],
9	was	VBD	O	be	cop	10	SENT_123	[p8l1615t3370r1778b3423],
10	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_123	[p8l1822t3343r2132b3445, p8l12t3489r193b3550],
11	in	IN	O	in	_	0	SENT_123	[p8l214t3473r296b3550],
12	each	DT	O	each	det	13	SENT_123	[p8l324t3472r513b3550],
13	subgroup	NN	O	subgroup	prep_in	10	SENT_123	[p8l541t3472r936b3573],
14	that	WDT	O	that	nsubjpass	16	SENT_123	[p8l965t3472r1134b3550],
15	was	VBD	O	be	auxpass	16	SENT_123	[p8l1151t3498r1311b3551],
16	analyzed	VBN	O	analyze	rcmod	13	SENT_123	[p8l1339t3472r1711b3572],
17	(	RB	O	(	dep	18	SENT_123	[p8l1743t3472r2000b3563],
18	Table	NNP	O	Table	dep	13	SENT_123	[p8l1743t3472r2000b3563],
19	2	CD	NUMBER	2	number	20	SENT_123	[p8l2029t3478r2128b3563],
20	)	CD	NUMBER	)	num	18	SENT_123	[p8l2029t3478r2128b3563],
21	.	.	O	.	_	0	SENT_123	[p8l2029t3478r2128b3563],

1	N	NN	O	n	nn	2	SENT_124	[p8l545t3659r559b3674],
2	ENGL	NN	ORGANIZATION	engl	_	0	SENT_124	[p8l574t3659r652b3681],
3	}	CD	NUMBER	}	num	4	SENT_124	[p8l574t3659r652b3681],
4	MED	NN	O	med	dep	2	SENT_124	[p8l666t3659r718b3674],
5	5	CD	NUMBER	5	dep	4	SENT_124	[p8l759t3653r804b3681],
6	;	:	O	;	_	0	SENT_124	[p8l759t3653r804b3681],
7	18	CD	NUMBER	18	num	8	SENT_124	[p8l759t3653r804b3681],
8	NEJM.ORG	NN	O	nejm.org	dep	4	SENT_124	[p8l840t3659r964b3681],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_124	[p8l1001t3659r1136b3675],
10	3	CD	DATE	3	num	9	SENT_124	[p8l1146t3659r1164b3681],
11	,	,	DATE	,	_	0	SENT_124	[p8l1146t3659r1164b3681],
12	2011	CD	DATE	2011	num	9	SENT_124	[p8l1175t3659r1227b3675],
13	1665	CD	DATE	1665	dep	2	SENT_124	[p8l1940t3648r2015b3672],

1	e	LS	O	e	dep	4	SENT_125	[p8l739t3700r753b3716],
2	New	NNP	O	New	nn	4	SENT_125	[p8l762t3693r824b3716],
3	England	NNP	O	England	nn	4	SENT_125	[p8l833t3692r944b3723],
4	Journal	NNP	O	Journal	_	0	SENT_125	[p8l953t3692r1050b3716],
5	of	IN	O	of	prep	4	SENT_125	[p8l1060t3692r1089b3716],
6	Medicine	NNP	O	Medicine	dep	4	SENT_125	[p8l1095t3692r1220b3716],

1	Downloaded	VBN	O	download	_	0	SENT_126	[p8l144t3733r314b3756],
2	from	IN	O	from	_	0	SENT_126	[p8l323t3733r387b3756],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_126	[p8l396t3733r514b3763],
4	at	IN	O	at	_	0	SENT_126	[p8l524t3737r547b3756],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_126	[p8l556t3733r739b3756],
6	on	IN	O	on	_	0	SENT_126	[p8l748t3740r780b3756],
7	January	NNP	DATE	January	prep_on	1	SENT_126	[p8l789t3733r892b3763],
8	5	CD	DATE	5	num	7	SENT_126	[p8l902t3733r924b3760],
9	,	,	DATE	,	_	0	SENT_126	[p8l902t3733r924b3760],
10	2014	CD	DATE	2014	num	7	SENT_126	[p8l935t3733r1007b3756],
11	.	.	O	.	_	0	SENT_126	[p8l935t3733r1007b3756],

1	For	IN	O	for	_	0	SENT_127	[p8l1018t3733r1064b3756],
2	personal	JJ	O	personal	amod	3	SENT_127	[p8l1072t3733r1185b3763],
3	use	NN	O	use	pobj	1	SENT_127	[p8l1194t3740r1238b3756],
4	only	RB	O	only	advmod	3	SENT_127	[p8l1247t3733r1312b3763],
5	.	.	O	.	_	0	SENT_127	[p8l1247t3733r1312b3763],

1	No	DT	O	no	det	3	SENT_128	[p8l1323t3733r1362b3756],
2	other	JJ	O	other	amod	3	SENT_128	[p8l1372t3733r1440b3756],
3	uses	NNS	O	use	_	0	SENT_128	[p8l1449t3740r1505b3756],
4	without	IN	O	without	_	0	SENT_128	[p8l1515t3733r1616b3756],
5	permission	NN	O	permission	prep_without	3	SENT_128	[p8l1624t3733r1777b3763],
6	.	.	O	.	_	0	SENT_128	[p8l1624t3733r1777b3763],

1	Copyright	NN	O	copyright	_	0	SENT_129	[p8l494t3774r629b3805],
2	©	CD	NUMBER	©	num	6	SENT_129	[p8l638t3774r661b3798],
3	2011	CD	DATE	2011	num	6	SENT_129	[p8l672t3774r734b3798],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_129	[p8l746t3774r937b3798],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_129	[p8l947t3774r1055b3798],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_129	[p8l1065t3774r1170b3805],
7	.	.	O	.	_	0	SENT_129	[p8l1065t3774r1170b3805],

1	All	DT	O	all	det	2	SENT_130	[p8l1182t3774r1223b3798],
2	rights	NNS	O	rights	nsubj	3	SENT_130	[p8l1232t3774r1307b3805],
3	reserved	VBN	O	reserve	_	0	SENT_130	[p8l1316t3774r1435b3798],
4	.	.	O	.	_	0	SENT_130	[p8l1316t3774r1435b3798],

1	At	IN	O	at	_	0	SENT_131	[p9l136t299r236b370],
2	Week	NN	DURATION	week	prep_at	28	SENT_131	[p9l269t291r493b371],
3	48	CD	NUMBER	48	num	2	SENT_131	[p9l529t298r657b388],
4	,	,	O	,	_	0	SENT_131	[p9l529t298r657b388],
5	a	DT	O	a	det	6	SENT_131	[p9l703t318r748b370],
6	total	NN	O	total	nsubj	28	SENT_131	[p9l788t291r987b371],
7	of	IN	O	of	_	0	SENT_131	[p9l1029t290r1130b371],
8	67	CD	PERCENT	67	num	9	SENT_131	[p9l1153t296r1339b371],
9	%	NN	PERCENT	%	prep_of	6	SENT_131	[p9l1153t296r1339b371],
10	of	IN	O	of	_	0	SENT_131	[p9l1381t290r1481b371],
11	subjects	NNS	O	subject	prep_of	9	SENT_131	[p9l1506t291r1848b392],
12	in	IN	O	in	_	0	SENT_131	[p9l1891t292r1976b370],
13	the	DT	O	the	det	15	SENT_131	[p9l2017t291r2152b370],
14	ivacaftor	NN	O	ivacaftor	nn	15	SENT_131	[p9l9t419r397b500],
15	group	NN	O	group	prep_in	11	SENT_131	[p9l443t446r726b522],
16	,	,	O	,	_	0	SENT_131	[p9l443t446r726b522],
17	as	IN	O	as	_	0	SENT_131	[p9l780t447r868b499],
18	compared	VBN	O	compare	prepc_as	6	SENT_131	[p9l920t420r1358b521],
19	with	IN	O	with	pcomp	18	SENT_131	[p9l1403t420r1603b500],
20	41	CD	PERCENT	41	num	21	SENT_131	[p9l1651t425r1833b500],
21	%	NN	PERCENT	%	pobj	19	SENT_131	[p9l1651t425r1833b500],
22	in	IN	O	in	_	0	SENT_131	[p9l1880t421r1966b498],
23	the	DT	O	the	det	25	SENT_131	[p9l2016t420r2152b499],
24	placebo	NN	O	placebo	nn	25	SENT_131	[p9l8t549r340b650],
25	group	NN	O	group	prep_in	21	SENT_131	[p9l383t575r661b651],
26	,	,	O	,	_	0	SENT_131	[p9l383t575r661b651],
27	were	VBD	O	be	cop	28	SENT_131	[p9l705t575r908b629],
28	free	JJ	O	free	_	0	SENT_131	[p9l951t548r1115b628],
29	from	IN	O	from	_	0	SENT_131	[p9l1157t548r1369b629],
30	pulmonary	JJ	O	pulmonary	amod	31	SENT_131	[p9l1411t549r1894b650],
31	exacerbations	NNS	O	exacerbation	prep_from	28	SENT_131	[p9l1933t576r2150b628, p9l10t679r436b776],
32	,	,	O	,	_	0	SENT_131	[p9l1933t576r2150b628, p9l10t679r436b776],
33	corresponding	VBG	O	correspond	xcomp	28	SENT_131	[p9l485t679r1122b781],
34	to	TO	O	to	_	0	SENT_131	[p9l1162t696r1244b759],
35	a	DT	O	a	det	37	SENT_131	[p9l1288t705r1333b758],
36	hazard	NN	O	hazard	nn	37	SENT_131	[p9l1374t679r1673b759],
37	ratio	NN	O	ratio	prep_to	33	SENT_131	[p9l1716t680r1915b759],
38	with	IN	O	with	_	0	SENT_131	[p9l1955t679r2152b759],
39	ivacaftor	NN	O	ivacaftor	prep_with	37	SENT_131	[p9l9t808r389b889],
40	of	IN	O	of	_	0	SENT_131	[p9l425t808r525b889],
41	0.455	CD	NUMBER	0.455	number	42	SENT_131	[p9l545t816r767b889],
42	(	CD	NUMBER	(	num	43	SENT_131	[p9l814t815r1266b906],
43	P	NN	O	p	prep_of	39	SENT_131	[p9l814t815r1266b906],
44	=	JJ	O	=	amod	46	SENT_131	[p9l814t815r1266b906],
45	0.001	CD	NUMBER	0.001	tmod	44	SENT_131	[p9l814t815r1266b906],
46	)	NN	O	)	dobj	33	SENT_131	[p9l814t815r1266b906],
47	,	,	O	,	_	0	SENT_131	[p9l814t815r1266b906],
48	or	CC	O	or	_	0	SENT_131	[p9l1312t835r1401b889],
49	a	DT	O	a	det	52	SENT_131	[p9l1435t836r1480b888],
50	55	CD	PERCENT	55	number	51	SENT_131	[p9l1519t814r1701b889],
51	%	NN	PERCENT	%	amod	52	SENT_131	[p9l1519t814r1701b889],
52	reduction	NN	O	reduction	conj_or	46	SENT_131	[p9l1739t809r2152b889],
53	in	IN	O	in	_	0	SENT_131	[p9l9t939r93b1016],
54	the	DT	O	the	det	55	SENT_131	[p9l135t938r268b1017],
55	risk	NN	O	risk	prep_in	52	SENT_131	[p9l309t938r475b1018],
56	of	IN	O	of	_	0	SENT_131	[p9l511t937r612b1018],
57	pulmonary	JJ	O	pulmonary	amod	60	SENT_131	[p9l633t938r1117b1039],
58	exacerbation	NN	O	exacerbation	nn	60	SENT_131	[p9l1154t938r1704b1018],
59	(	CD	NUMBER	(	num	60	SENT_131	[p9l1749t939r1933b1040],
60	Fig	NN	O	fig	prep_of	55	SENT_131	[p9l1749t939r1933b1040],
61	.	.	O	.	_	0	SENT_131	[p9l1749t939r1933b1040],

1	1B	NN	O	1b	_	0	SENT_132	[p9l1985t944r2146b1030],
2	)	NN	O	)	dep	1	SENT_132	[p9l1985t944r2146b1030],
3	.	.	O	.	_	0	SENT_132	[p9l1985t944r2146b1030],

1	There	EX	O	there	expl	2	SENT_133	[p9l6t1067r253b1145],
2	were	VBD	O	be	_	0	SENT_133	[p9l295t1093r498b1146],
3	99	CD	NUMBER	99	num	4	SENT_133	[p9l545t1073r645b1146],
4	exacerbations	NNS	O	exacerbation	nsubj	2	SENT_133	[p9l693t1067r1286b1146],
5	(	RB	O	(	advmod	2	SENT_133	[p9l1339t1068r1451b1158],
6	in	IN	O	in	_	0	SENT_133	[p9l1339t1068r1451b1158],
7	44	CD	NUMBER	44	num	8	SENT_133	[p9l1495t1073r1601b1146],
8	subjects	NNS	O	subject	prep_in	2	SENT_133	[p9l1648t1067r2016b1167],
9	)	RB	O	)	advmod	8	SENT_133	[p9l1648t1067r2016b1167],
10	in	IN	O	in	_	0	SENT_133	[p9l2068t1068r2151b1145],
11	the	DT	O	the	det	13	SENT_133	[p9l10t1197r144b1276],
12	placebo	NN	O	placebo	nn	13	SENT_133	[p9l183t1197r515b1298],
13	group	NN	O	group	prep_in	8	SENT_133	[p9l556t1223r833b1299],
14	,	,	O	,	_	0	SENT_133	[p9l556t1223r833b1299],
15	as	IN	O	as	_	0	SENT_133	[p9l878t1223r964b1276],
16	compared	VBN	O	compare	prepc_as	2	SENT_133	[p9l1007t1197r1437b1298],
17	With	IN	O	with	pcomp	16	SENT_133	[p9l1473t1197r1670b1277],
18	47	CD	NUMBER	47	num	19	SENT_133	[p9l1708t1203r1807b1277],
19	exacerbations	NNS	O	exacerbation	pobj	17	SENT_133	[p9l1849t1223r2150b1276, p9l10t1326r326b1406],
20	(	RB	O	(	advmod	19	SENT_133	[p9l370t1327r482b1418],
21	in	IN	O	in	_	0	SENT_133	[p9l370t1327r482b1418],
22	28	CD	NUMBER	28	num	23	SENT_133	[p9l519t1332r618b1406],
23	subjects	NNS	O	subject	prep_in	19	SENT_133	[p9l659t1326r1027b1427],
24	)	RB	O	)	advmod	23	SENT_133	[p9l659t1326r1027b1427],
25	in	IN	O	in	_	0	SENT_133	[p9l1068t1327r1152b1404],
26	the	DT	O	the	det	28	SENT_133	[p9l1189t1326r1324b1405],
27	ivacaftor	NN	O	ivacaftor	nn	28	SENT_133	[p9l1360t1325r1739b1406],
28	group	NN	O	group	prep_in	23	SENT_133	[p9l1772t1352r2050b1428],
29	.	.	O	.	_	0	SENT_133	[p9l1772t1352r2050b1428],

1	A	DT	O	a	det	2	SENT_134	[p9l2088t1334r2154b1404],
2	total	NN	O	total	nsubj	31	SENT_134	[p9l10t1456r209b1536],
3	of	IN	O	of	_	0	SENT_134	[p9l248t1455r349b1536],
4	31	CD	NUMBER	31	num	5	SENT_134	[p9l370t1462r466b1536],
5	events	NNS	O	event	prep_of	2	SENT_134	[p9l506t1473r772b1536],
6	(	RB	O	(	advmod	5	SENT_134	[p9l818t1457r930b1548],
7	in	IN	O	in	_	0	SENT_134	[p9l818t1457r930b1548],
8	23	CD	NUMBER	23	num	9	SENT_134	[p9l969t1463r1067b1536],
9	subjects	NNS	O	subject	prep_in	5	SENT_134	[p9l1111t1456r1480b1557],
10	)	RB	O	)	advmod	9	SENT_134	[p9l1111t1456r1480b1557],
11	in	IN	O	in	_	0	SENT_134	[p9l1524t1457r1607b1535],
12	the	DT	O	the	det	14	SENT_134	[p9l1647t1456r1780b1535],
13	placebo	NN	O	placebo	nn	14	SENT_134	[p9l1818t1456r2150b1557],
14	group	NN	O	group	prep_in	9	SENT_134	[p9l12t1611r279b1686],
15	,	,	O	,	_	0	SENT_134	[p9l12t1611r279b1686],
16	as	IN	O	as	mark	2	SENT_134	[p9l315t1611r399b1663],
17	compared	VBN	O	compare	_	0	SENT_134	[p9l433t1585r849b1685],
18	with	IN	O	with	_	0	SENT_134	[p9l875t1585r1066b1664],
19	21	CD	NUMBER	21	num	20	SENT_134	[p9l1096t1591r1194b1663],
20	events	NNS	O	event	prep_compared_with	2	SENT_134	[p9l1226t1602r1482b1664],
21	(	RB	O	(	advmod	2	SENT_134	[p9l1520t1586r1628b1676],
22	in	IN	O	in	_	0	SENT_134	[p9l1520t1586r1628b1676],
23	11	CD	NUMBER	11	num	24	SENT_134	[p9l1662t1591r1757b1663],
24	subjects	NNS	O	subject	prep_in	2	SENT_134	[p9l1789t1585r2143b1685],
25	)	RB	O	)	advmod	2	SENT_134	[p9l1789t1585r2143b1685],
26	in	IN	O	in	_	0	SENT_134	[p9l11t1714r95b1791],
27	the	DT	O	the	det	29	SENT_134	[p9l157t1713r291b1792],
28	ivacaftor	NN	O	ivacaftor	nn	29	SENT_134	[p9l352t1712r730b1793],
29	group	NN	O	group	prep_in	2	SENT_134	[p9l789t1739r1065b1815],
30	,	,	O	,	_	0	SENT_134	[p9l789t1739r1065b1815],
31	led	VBD	O	lead	_	0	SENT_134	[p9l1132t1713r1259b1793],
32	to	TO	O	to	_	0	SENT_134	[p9l1321t1730r1403b1793],
33	hospitalization	NN	O	hospitalization	prep_to	31	SENT_134	[p9l1466t1713r2142b1814],
34	.	.	O	.	_	0	SENT_134	[p9l1466t1713r2142b1814],

1	The	DT	O	the	det	4	SENT_135	[p9l8t1841r168b1919],
2	mean	JJ	O	mean	amod	4	SENT_135	[p9l200t1867r437b1919],
3	(	NN	O	(	nn	4	SENT_135	[p9l474t1847r699b1932],
4	iSD	NN	O	isd	nsubj	25	SENT_135	[p9l474t1847r699b1932],
5	)	CD	NUMBER	)	num	7	SENT_135	[p9l474t1847r699b1932],
6	total	JJ	O	total	amod	7	SENT_135	[p9l737t1841r932b1920],
7	number	NN	O	number	nsubj	18	SENT_135	[p9l963t1841r1299b1921],
8	of	IN	O	of	_	0	SENT_135	[p9l1329t1840r1429b1920],
9	days	NNS	DURATION	day	prep_of	7	SENT_135	[p9l1443t1841r1626b1941],
10	of	IN	O	of	_	0	SENT_135	[p9l1661t1840r1760b1920],
11	hospitalization	NN	O	hospitalization	prep_of	9	SENT_135	[p9l1774t1841r2147b1941, p9l11t1970r305b2048],
12	for	IN	O	for	_	0	SENT_135	[p9l354t1968r476b2048],
13	pulmonary	JJ	O	pulmonary	amod	14	SENT_135	[p9l521t1969r995b2069],
14	exacerbations	NNS	O	exacerbation	prep_for	11	SENT_135	[p9l1040t1969r1621b2048],
15	per	IN	O	per	_	0	SENT_135	[p9l1670t1995r1809b2069],
16	subject	JJ	O	subject	amod	17	SENT_135	[p9l1857t1969r2153b2069],
17	(	NN	O	(	prep_per	14	SENT_135	[p9l17t2098r532b2189],
18	normalized	VBD	O	normalize	rcmod	4	SENT_135	[p9l17t2098r532b2189],
19	to	TO	O	to	_	0	SENT_135	[p9l565t2115r646b2177],
20	a	DT	O	a	det	23	SENT_135	[p9l680t2124r725b2176],
21	48-week	JJ	DURATION	48-week	amod	23	SENT_135	[p9l755t2098r1111b2178],
22	period	NN	O	period	nn	23	SENT_135	[p9l1137t2098r1439b2198],
23	)	NN	O	)	prep_to	18	SENT_135	[p9l1137t2098r1439b2198],
24	was	VBD	O	be	cop	25	SENT_135	[p9l1472t2124r1634b2178],
25	3.9	CD	NUMBER	3.9	_	0	SENT_135	[p9l1670t2104r2031b2177],
26	i	FW	O	i	dep	25	SENT_135	[p9l1670t2104r2031b2177],
27	'	''	O	'	_	0	SENT_135	[p9l1670t2104r2031b2177],
28	13.6	CD	NUMBER	13.6	npadvmod	25	SENT_135	[p9l1670t2104r2031b2177],
29	in	IN	O	in	_	0	SENT_135	[p9l2065t2099r2148b2176],
30	the	DT	O	the	det	32	SENT_135	[p9l12t2227r144b2306],
31	ivacaftor	NN	O	ivacaftor	nn	32	SENT_135	[p9l181t2226r551b2307],
32	group	NN	O	group	prep_in	25	SENT_135	[p9l586t2253r858b2329],
33	,	,	O	,	_	0	SENT_135	[p9l586t2253r858b2329],
34	as	IN	O	as	_	0	SENT_135	[p9l901t2254r986b2306],
35	compared	VBN	O	compare	prepc_as	25	SENT_135	[p9l1027t2227r1448b2328],
36	with	IN	O	with	pcomp	35	SENT_135	[p9l1482t2227r1675b2307],
37	4.2	CD	NUMBER	4.2	num	38	SENT_135	[p9l1712t2234r2026b2307],
38	i8	NN	O	i8	pobj	36	SENT_135	[p9l1712t2234r2026b2307],
39	.7	CD	NUMBER	.7	dep	50	SENT_135	[p9l1712t2234r2026b2307],
40	in	IN	O	in	_	0	SENT_135	[p9l2066t2228r2148b2305],
41	the	DT	O	the	det	45	SENT_135	[p9l12t2356r141b2434],
42	placebo	NN	O	placebo	nn	45	SENT_135	[p9l174t2356r489b2456],
43	group	NN	O	group	nn	45	SENT_135	[p9l525t2382r768b2457],
44	(	CD	NUMBER	(	num	45	SENT_135	[p9l808t2362r1156b2447],
45	P	NN	O	p	prep_in	39	SENT_135	[p9l808t2362r1156b2447],
46	=	JJ	O	=	amod	45	SENT_135	[p9l808t2362r1156b2447],
47	0.03	CD	NUMBER	0.03	tmod	46	SENT_135	[p9l808t2362r1156b2447],
48	)	CD	NUMBER	)	dep	50	SENT_135	[p9l808t2362r1156b2447],
49	(	CD	NUMBER	(	num	50	SENT_135	[p9l1200t2356r1447b2447],
50	Table	NNP	O	Table	dep	38	SENT_135	[p9l1200t2356r1447b2447],
51	2	CD	NUMBER	2	num	50	SENT_135	[p9l1482t2362r1529b2434],
52	in	IN	O	in	_	0	SENT_135	[p9l1563t2357r1645b2434],
53	the	DT	O	the	det	56	SENT_135	[p9l1679t2356r1808b2434],
54	Supplementary	NNP	O	Supplementary	nn	56	SENT_135	[p9l1845t2356r2147b2456, p9l12t2501r359b2584],
55	Appendix	NNP	O	Appendix	nn	56	SENT_135	[p9l387t2484r856b2584],
56	)	NN	O	)	prep_in	50	SENT_135	[p9l387t2484r856b2584],
57	.	.	O	.	_	0	SENT_135	[p9l387t2484r856b2584],

1	Subjects	NNS	O	subject	nsubj	2	SENT_136	[p9l144t2612r501b2712],
2	treated	VBN	O	treat	_	0	SENT_136	[p9l544t2612r851b2691],
3	with	IN	O	with	_	0	SENT_136	[p9l887t2612r1087b2692],
4	ivacaftor	NN	O	ivacaftor	prep_with	2	SENT_136	[p9l1127t2611r1534b2708],
5	,	,	O	,	_	0	SENT_136	[p9l1127t2611r1534b2708],
6	as	IN	O	as	mark	13	SENT_136	[p9l1580t2638r1667b2690],
7	compared	VBN	O	compare	_	0	SENT_136	[p9l1711t2612r2148b2712],
8	with	IN	O	with	prepc_compared_with	13	SENT_136	[p9l7t2741r207b2820],
9	those	DT	O	those	nsubj	10	SENT_136	[p9l255t2741r492b2820],
10	receiving	VBG	O	receive	pcomp	13	SENT_136	[p9l539t2742r941b2842],
11	placebo	NN	O	placebo	dobj	10	SENT_136	[p9l983t2741r1344b2841],
12	,	,	O	,	_	0	SENT_136	[p9l983t2741r1344b2841],
13	had	VBD	O	have	dep	4	SENT_136	[p9l1397t2741r1557b2820],
14	an	DT	O	a	det	16	SENT_136	[p9l1604t2767r1708b2819],
15	improVe	NNP	O	improVe	nn	16	SENT_136	[p9l1755t2742r2147b2841],
16	—	NN	O	—	dobj	13	SENT_136	[p9l1755t2742r2147b2841],

1	Table	NNP	O	Table	_	0	SENT_137	[p10l406t58r480b83],
2	1	CD	NUMBER	1	dep	1	SENT_137	[p10l490t61r512b83],
3	.	.	O	.	_	0	SENT_137	[p10l490t61r512b83],

1	Baseline	NN	O	baseline	nn	2	SENT_138	[p10l523t58r636b83],
2	Characteristics	NNS	O	characteristic	_	0	SENT_138	[p10l645t58r848b83],
3	of	IN	O	of	_	0	SENT_138	[p10l857t58r889b83],
4	the	DT	O	the	det	5	SENT_138	[p10l891t58r935b83],
5	Subjects	NNS	O	subject	prep_of	2	SENT_138	[p10l944t58r1085b91],
6	.	.	O	.	_	0	SENT_138	[p10l944t58r1085b91],

1	‘	SYM	O	‘	dep	3	SENT_139	[p10l944t58r1085b91],
2	-	:	O	-	_	0	SENT_139	[p10l944t58r1085b91],
3	"	``	O	"	_	0	SENT_139	[p10l944t58r1085b91],
4	‘	IN	O	‘	prep	3	SENT_139	[p10l944t58r1085b91],

1	lvacaftor	NN	O	lvacaftor	nn	5	SENT_140	[p10l1557t133r1675b159],
2	Total	JJ	O	total	amod	5	SENT_140	[p10l1880t133r1947b159],
3	Characteristic	JJ	O	characteristic	amod	5	SENT_140	[p10l406t171r595b196],
4	(	NN	O	(	nn	5	SENT_140	[p10l1564t173r1594b204],
5	N	NN	O	n	_	0	SENT_140	[p10l1564t173r1594b204],
6	=	JJ	O	=	dep	5	SENT_140	[p10l1602t173r1665b204],
7	83	CD	NUMBER	83	number	8	SENT_140	[p10l1602t173r1665b204],
8	)	CD	NUMBER	)	num	13	SENT_140	[p10l1602t173r1665b204],
9	(	NN	O	(	nn	13	SENT_140	[p10l1856t173r1886b204],
10	N	NN	O	n	nn	13	SENT_140	[p10l1856t173r1886b204],
11	=	JJ	O	=	amod	13	SENT_140	[p10l1894t183r1911b192],
12	161	CD	NUMBER	161	num	13	SENT_140	[p10l1918t173r1973b204],
13	)	NN	O	)	dep	6	SENT_140	[p10l1918t173r1973b204],

1	Sex	NN	O	sex	nn	3	SENT_141	[p10l407t247r452b270],
2	—	CD	NUMBER	—	num	3	SENT_141	[p10l460t261r494b263],
3	no.	NN	O	no.	_	0	SENT_141	[p10l504t254r544b270],
4	(	CD	PERCENT	(	num	5	SENT_141	[p10l557t246r602b278],
5	%	NN	PERCENT	%	dep	3	SENT_141	[p10l557t246r602b278],
6	)	CD	NUMBER	)	dep	3	SENT_141	[p10l557t246r602b278],

1	Male	JJ	O	male	dep	9	SENT_142	[p10l459t303r524b328],
2	39	CD	NUMBER	39	number	3	SENT_142	[p10l1563t305r1593b328],
3	(	CD	NUMBER	(	dep	1	SENT_142	[p10l1606t305r1656b336],
4	47	CD	NUMBER	47	num	5	SENT_142	[p10l1606t305r1656b336],
5	)	NN	O	)	dep	3	SENT_142	[p10l1606t305r1656b336],
6	77	CD	NUMBER	77	num	7	SENT_142	[p10l1864t305r1893b328],
7	(	NN	O	(	dep	9	SENT_142	[p10l1906t305r1956b336],
8	48	CD	NUMBER	48	num	9	SENT_142	[p10l1906t305r1956b336],
9	)	CD	NUMBER	)	dep	14	SENT_142	[p10l1906t305r1956b336],
10	Female	JJ	O	female	amod	11	SENT_142	[p10l459t361r556b386],
11	44	CD	NUMBER	44	dep	9	SENT_142	[p10l1561t363r1593b385],
12	(	CD	NUMBER	(	number	13	SENT_142	[p10l1606t363r1656b394],
13	53	CD	NUMBER	53	dep	11	SENT_142	[p10l1606t363r1656b394],
14	)	NN	O	)	dep	16	SENT_142	[p10l1606t363r1656b394],
15	84	CD	NUMBER	84	num	14	SENT_142	[p10l1862t362r1893b386],
16	(	NN	O	(	dep	23	SENT_142	[p10l1906t363r1956b394],
17	52	CD	NUMBER	52	num	16	SENT_142	[p10l1906t363r1956b394],
18	)	CD	NUMBER	)	num	23	SENT_142	[p10l1906t363r1956b394],
19	Non-Hispanic	JJ	O	non-hispanic	amod	23	SENT_142	[p10l409t421r600b451],
20	or	CC	O	or	_	0	SENT_142	[p10l609t427r637b443],
21	white	JJ	O	white	conj_or	19	SENT_142	[p10l645t418r718b443],
22	—	JJ	O	—	amod	23	SENT_142	[p10l726t434r760b436],
23	no.	NN	O	no.	dep	26	SENT_142	[p10l770t427r810b443],
24	(	CD	PERCENT	(	num	25	SENT_142	[p10l824t419r890b451],
25	%	NN	PERCENT	%	dep	23	SENT_142	[p10l824t419r890b451],
26	)	NN	O	)	dep	33	SENT_142	[p10l824t419r890b451],
27	'	''	O	'	_	0	SENT_142	[p10l824t419r890b451],
28	i	FW	O	i	nn	29	SENT_142	[p10l824t419r890b451],
29	‘	FW	O	‘	dep	26	SENT_142	[p10l824t419r890b451],
30	81	CD	NUMBER	81	number	31	SENT_142	[p10l1562t420r1592b444],
31	(	CD	NUMBER	(	dep	29	SENT_142	[p10l1606t420r1656b451],
32	98	CD	NUMBER	98	num	33	SENT_142	[p10l1606t420r1656b451],
33	)	NN	O	)	dep	41	SENT_142	[p10l1606t420r1656b451],
34	158	CD	NUMBER	158	num	35	SENT_142	[p10l1847t420r1893b444],
35	(	NN	O	(	dep	33	SENT_142	[p10l1906t420r1956b451],
36	98	CD	NUMBER	98	number	37	SENT_142	[p10l1906t420r1956b451],
37	)	CD	NUMBER	)	num	39	SENT_142	[p10l1906t420r1956b451],
38	Geographic	JJ	O	geographic	amod	39	SENT_142	[p10l407t476r565b509],
39	distribution	NN	O	distribution	dep	35	SENT_142	[p10l575t476r732b501],
40	—	CD	NUMBER	—	num	41	SENT_142	[p10l742t491r776b494],
41	no.	NN	O	no.	dep	44	SENT_142	[p10l786t485r825b501],
42	(	CD	PERCENT	(	num	43	SENT_142	[p10l839t477r884b509],
43	%	NN	PERCENT	%	dep	41	SENT_142	[p10l839t477r884b509],
44	)	CD	NUMBER	)	_	0	SENT_142	[p10l839t477r884b509],

1	North	NNP	LOCATION	North	nn	2	SENT_143	[p10l459t534r536b559],
2	America	NNP	LOCATION	America	dep	9	SENT_143	[p10l546t535r658b559],
3	50	CD	NUMBER	50	number	4	SENT_143	[p10l1562t535r1594b559],
4	(	CD	NUMBER	(	dep	2	SENT_143	[p10l1606t535r1656b567],
5	60	CD	NUMBER	60	dep	4	SENT_143	[p10l1606t535r1656b567],
6	)	NN	O	)	dep	9	SENT_143	[p10l1606t535r1656b567],
7	100	CD	NUMBER	100	num	6	SENT_143	[p10l1847t535r1894b559],
8	(	CD	NUMBER	(	num	9	SENT_143	[p10l1906t536r1956b567],
9	62	CD	NUMBER	62	dep	15	SENT_143	[p10l1906t536r1956b567],
10	)	CD	NUMBER	)	num	11	SENT_143	[p10l1906t536r1956b567],
11	Europe	NNP	ORGANIZATION	Europe	dep	9	SENT_143	[p10l459t593r554b624],
12	23	CD	NUMBER	23	num	11	SENT_143	[p10l1562t593r1591b616],
13	(	CD	NUMBER	(	number	14	SENT_143	[p10l1606t593r1656b624],
14	28	CD	NUMBER	28	dep	11	SENT_143	[p10l1606t593r1656b624],
15	)	NN	O	)	dep	17	SENT_143	[p10l1606t593r1656b624],
16	42	CD	NUMBER	42	num	15	SENT_143	[p10l1861t593r1893b616],
17	(	NN	O	(	dep	20	SENT_143	[p10l1906t593r1956b624],
18	25	CD	NUMBER	25	num	17	SENT_143	[p10l1906t593r1956b624],
19	)	CD	NUMBER	)	num	20	SENT_143	[p10l1906t593r1956b624],
20	Australia	NNP	LOCATION	Australia	dep	28	SENT_143	[p10l456t649r576b674],
21	10	CD	NUMBER	10	num	20	SENT_143	[p10l1564t650r1594b674],
22	(	CD	NUMBER	(	number	23	SENT_143	[p10l1606t651r1656b682],
23	12	CD	NUMBER	12	num	24	SENT_143	[p10l1606t651r1656b682],
24	)	NN	O	)	dep	20	SENT_143	[p10l1606t651r1656b682],
25	19	CD	NUMBER	19	num	26	SENT_143	[p10l1864t651r1893b674],
26	(	CD	NUMBER	(	dep	24	SENT_143	[p10l1906t651r1956b682],
27	12	CD	NUMBER	12	num	28	SENT_143	[p10l1906t651r1956b682],
28	)	NN	O	)	_	0	SENT_143	[p10l1906t651r1956b682],

1	Age	NNP	O	Age	_	0	SENT_144	[p10l406t708r457b740],
2	—	CD	NUMBER	—	num	3	SENT_144	[p10l466t722r499b724],
3	yr	NN	DURATION	yr	dep	1	SENT_144	[p10l507t715r532b740],

1	Mean	NN	O	mean	_	0	SENT_145	[p10l459t766r532b789],
2	24.7	CD	NUMBER	24.7	number	3	SENT_145	[p10l1286t766r1342b789],
3	26.2	CD	NUMBER	26.2	dep	1	SENT_145	[p10l1587t766r1642b789],
4	25.5	CD	NUMBER	25.5	num	5	SENT_145	[p10l1874t766r1928b789],
5	Range	NNP	O	Range	dep	3	SENT_145	[p10l459t824r541b855],
6	12-53	CD	NUMBER	12-53	num	5	SENT_145	[p10l1276t824r1353b847],
7	12-53	CD	NUMBER	12-53	num	8	SENT_145	[p10l1576t824r1653b847],
8	12-53	CD	NUMBER	12-53	dep	1	SENT_145	[p10l1863t824r1941b847],

1	Age	NNP	O	Age	nn	2	SENT_146	[p10l406t881r457b913],
2	distribution	NN	O	distribution	_	0	SENT_146	[p10l467t879r624b905],
3	—	CD	NUMBER	—	num	4	SENT_146	[p10l634t895r668b897],
4	no.	NN	O	no.	dep	2	SENT_146	[p10l678t888r718b905],
5	(	CD	PERCENT	(	num	6	SENT_146	[p10l732t881r776b912],
6	%	NN	PERCENT	%	dep	4	SENT_146	[p10l732t881r776b912],
7	)	CD	NUMBER	)	dep	2	SENT_146	[p10l732t881r776b912],

1	<	JJR	O	<	dep	11	SENT_147	[p10l457t939r506b962],
2	18	CD	DURATION	18	num	3	SENT_147	[p10l457t939r506b962],
3	yr	NN	DURATION	yr	dep	1	SENT_147	[p10l515t946r540b970],
4	17	CD	NUMBER	17	number	5	SENT_147	[p10l1268t939r1297b962],
5	(	CD	NUMBER	(	num	6	SENT_147	[p10l1310t939r1360b970],
6	22	CD	NUMBER	22	dep	3	SENT_147	[p10l1310t939r1360b970],
7	)	NN	O	)	dep	11	SENT_147	[p10l1310t939r1360b970],
8	19	CD	NUMBER	19	num	7	SENT_147	[p10l1568t939r1597b962],
9	(	CD	NUMBER	(	num	11	SENT_147	[p10l1610t939r1660b970],
10	23	CD	NUMBER	23	num	11	SENT_147	[p10l1610t939r1660b970],
11	)	NN	O	)	dep	17	SENT_147	[p10l1610t939r1660b970],
12	35	CD	NUMBER	35	number	13	SENT_147	[p10l1863t939r1893b962],
13	(	CD	NUMBER	(	dep	11	SENT_147	[p10l1906t939r1956b970],
14	22	CD	NUMBER	22	num	15	SENT_147	[p10l1906t939r1956b970],
15	)	NN	O	)	dep	13	SENT_147	[p10l1906t939r1956b970],
16	218	CD	DURATION	218	num	17	SENT_147	[p10l457t996r506b1020],
17	yr	NN	DURATION	yr	dep	19	SENT_147	[p10l515t1004r540b1028],
18	51	CD	NUMBER	51	num	19	SENT_147	[p10l1267t997r1296b1020],
19	(	NN	O	(	dep	23	SENT_147	[p10l1310t996r1360b1028],
20	78	CD	NUMBER	78	number	21	SENT_147	[p10l1310t996r1360b1028],
21	)	CD	NUMBER	)	dep	19	SENT_147	[p10l1310t996r1360b1028],
22	54	CD	NUMBER	54	dep	21	SENT_147	[p10l1567t997r1597b1020],
23	(	NN	O	(	dep	25	SENT_147	[p10l1610t997r1660b1028],
24	77	CD	NUMBER	77	num	23	SENT_147	[p10l1610t997r1660b1028],
25	)	NN	O	)	dep	27	SENT_147	[p10l1610t997r1660b1028],
26	125	CD	NUMBER	125	num	25	SENT_147	[p10l1847t997r1892b1020],
27	(	NN	O	(	dep	30	SENT_147	[p10l1906t996r1956b1028],
28	78	CD	NUMBER	78	num	27	SENT_147	[p10l1906t996r1956b1028],
29	)	CD	NUMBER	)	num	30	SENT_147	[p10l1906t996r1956b1028],
30	Height	NN	O	height	dep	32	SENT_147	[p10l409t1052r500b1086],
31	—	CD	NUMBER	—	num	32	SENT_147	[p10l508t1068r542b1070],
32	cm	NN	O	cm	_	0	SENT_147	[p10l551t1061r590b1078],

1	Mean	NN	O	mean	dep	8	SENT_148	[p10l459t1112r532b1135],
2	166.5	CD	NUMBER	166.5	num	1	SENT_148	[p10l1280t1112r1349b1135],
3	167.7	CD	NUMBER	167.7	number	4	SENT_148	[p10l1580t1112r1651b1135],
4	167.1	CD	NUMBER	167.1	dep	1	SENT_148	[p10l1868t1112r1937b1135],
5	Range	NNP	O	Range	dep	4	SENT_148	[p10l459t1170r541b1201],
6	142.2-189	CD	NUMBER	142.2-189	num	5	SENT_148	[p10l1234t1169r1396b1193],
7	.8	CD	NUMBER	.8	dep	8	SENT_148	[p10l1234t1169r1396b1193],
8	142.8-185	CD	NUMBER	142.8-185	dep	11	SENT_148	[p10l1534t1169r1697b1193],
9	.0	CD	NUMBER	.0	dep	8	SENT_148	[p10l1534t1169r1697b1193],
10	142.2-189	CD	NUMBER	142.2-189	num	11	SENT_148	[p10l1822t1169r1984b1193],
11	.8	CD	NUMBER	.8	_	0	SENT_148	[p10l1822t1169r1984b1193],

1	Weight	NNP	O	Weight	_	0	SENT_149	[p10l406t1225r503b1259],
2	—	CD	NUMBER	—	num	3	SENT_149	[p10l511t1241r545b1243],
3	kg	NN	O	kg	dep	1	SENT_149	[p10l555t1225r584b1259],

1	Mean	NN	O	mean	_	0	SENT_150	[p10l459t1285r532b1308],
2	61.2	CD	NUMBER	61.2	num	1	SENT_150	[p10l1287t1285r1342b1308],
3	61.7	CD	NUMBER	61.7	number	4	SENT_150	[p10l1587t1285r1642b1308],
4	61.5	CD	NUMBER	61.5	num	5	SENT_150	[p10l1874t1285r1928b1308],
5	Range	NNP	O	Range	dep	1	SENT_150	[p10l459t1343r541b1374],
6	31.9	CD	NUMBER	31.9	number	7	SENT_150	[p10l1241t1342r1388b1366],
7	—	CD	NUMBER	—	num	5	SENT_150	[p10l1241t1342r1388b1366],
8	109.9	CD	NUMBER	109.9	number	9	SENT_150	[p10l1241t1342r1388b1366],
9	30.2	CD	NUMBER	30.2	num	10	SENT_150	[p10l1541t1342r1688b1366],
10	—	NN	O	—	dep	5	SENT_150	[p10l1541t1342r1688b1366],
11	107.2	CD	NUMBER	107.2	num	13	SENT_150	[p10l1541t1342r1688b1366],
12	30.2-109	CD	NUMBER	30.2-109	num	13	SENT_150	[p10l1829t1342r1976b1366],
13	.9	NN	NUMBER	.9	dep	1	SENT_150	[p10l1829t1342r1976b1366],

1	Body-mass	JJ	O	body-mass	amod	2	SENT_151	[p10l409t1398r556b1431],
2	indexi	NNS	O	indexus	_	0	SENT_151	[p10l568t1398r656b1431],

1	Mean	NN	O	mean	_	0	SENT_152	[p10l459t1458r532b1481],
2	21.9	CD	NUMBER	21.9	num	1	SENT_152	[p10l1286t1458r1342b1481],
3	21.7	CD	NUMBER	21.7	number	4	SENT_152	[p10l1586t1458r1642b1481],
4	21.8	CD	NUMBER	21.8	dep	1	SENT_152	[p10l1874t1458r1930b1481],
5	Range	NNP	O	Range	dep	4	SENT_152	[p10l459t1516r541b1547],
6	15.2-38	CD	NUMBER	15.2-38	num	5	SENT_152	[p10l1251t1515r1380b1539],
7	.6	CD	NUMBER	.6	number	8	SENT_152	[p10l1251t1515r1380b1539],
8	14.8-38	CD	NUMBER	14.8-38	dep	1	SENT_152	[p10l1551t1515r1680b1539],
9	.9	CD	NUMBER	.9	dep	8	SENT_152	[p10l1551t1515r1680b1539],
10	14.8-38	CD	NUMBER	14.8-38	number	11	SENT_152	[p10l1838t1515r1967b1539],
11	.9	CD	NUMBER	.9	num	12	SENT_152	[p10l1838t1515r1967b1539],
12	Positive	JJ	O	positive	dep	1	SENT_152	[p10l409t1574r513b1597],
13	for	IN	O	for	_	0	SENT_152	[p10l522t1571r560b1597],
14	Pseudomonas	FW	PERSON	pseudomonas	nn	17	SENT_152	[p10l571t1571r749b1597],
15	aeruginosa	FW	O	aeruginosa	nn	17	SENT_152	[p10l758t1573r898b1605],
16	—	FW	O	—	nn	17	SENT_152	[p10l907t1587r940b1589],
17	no.	FW	O	no.	prep_for	12	SENT_152	[p10l950t1580r990b1597],
18	(	CD	PERCENT	(	num	19	SENT_152	[p10l1004t1573r1049b1604],
19	%	NN	PERCENT	%	dep	17	SENT_152	[p10l1004t1573r1049b1604],
20	)	CD	NUMBER	)	number	21	SENT_152	[p10l1004t1573r1049b1604],
21	64	CD	NUMBER	64	dep	1	SENT_152	[p10l1563t1573r1593b1597],
22	(	NN	O	(	dep	21	SENT_152	[p10l1606t1573r1656b1604],
23	77	CD	NUMBER	77	num	24	SENT_152	[p10l1606t1573r1656b1604],
24	)	NN	O	)	dep	1	SENT_152	[p10l1606t1573r1656b1604],
25	122	CD	NUMBER	122	num	26	SENT_152	[p10l1847t1574r1893b1596],
26	(	NN	O	(	dep	24	SENT_152	[p10l1906t1573r1956b1604],
27	76	CD	NUMBER	76	number	28	SENT_152	[p10l1906t1573r1956b1604],
28	)	CD	NUMBER	)	dep	1	SENT_152	[p10l1906t1573r1956b1604],
29	Non	NNP	O	Non	dep	28	SENT_152	[p10l409t1631r665b1655],
30	.	.	O	.	_	0	SENT_152	[p10l409t1631r665b1655],

1	—	NN	O	—	_	0	SENT_153	[p10l409t1631r665b1655],
2	.	.	O	.	_	0	SENT_153	[p10l409t1631r665b1655],

1	G551D-CFTR	NN	O	g551d-cftr	nn	2	SENT_154	[p10l409t1631r665b1655],
2	allele	NN	O	allele	dep	10	SENT_154	[p10l674t1629r743b1655],
3	—	CD	NUMBER	—	num	4	SENT_154	[p10l751t1645r785b1647],
4	no.	NN	O	no.	dep	2	SENT_154	[p10l795t1638r835b1655],
5	(	CD	PERCENT	(	num	6	SENT_154	[p10l849t1629r909b1662],
6	%	NN	PERCENT	%	dep	4	SENT_154	[p10l849t1629r909b1662],
7	)	CD	NUMBER	)	number	8	SENT_154	[p10l849t1629r909b1662],
8	§	CD	NUMBER	§	num	6	SENT_154	[p10l849t1629r909b1662],
9	Class	NN	O	class	dep	10	SENT_154	[p10l457t1687r528b1712],
10	I	PRP	O	I	dep	16	SENT_154	[p10l541t1689r544b1712],
11	10	CD	NUMBER	10	number	12	SENT_154	[p10l1564t1689r1593b1712],
12	(	CD	NUMBER	(	dep	10	SENT_154	[p10l1606t1689r1655b1720],
13	12	CD	NUMBER	12	num	14	SENT_154	[p10l1606t1689r1655b1720],
14	)	NN	O	)	dep	12	SENT_154	[p10l1606t1689r1655b1720],
15	21	CD	NUMBER	21	num	16	SENT_154	[p10l1862t1689r1892b1712],
16	(	CD	NUMBER	(	dep	23	SENT_154	[p10l1906t1689r1956b1720],
17	13	CD	NUMBER	13	num	20	SENT_154	[p10l1906t1689r1956b1720],
18	)	NN	O	)	nn	20	SENT_154	[p10l1906t1689r1956b1720],
19	Class	NN	O	class	nn	20	SENT_154	[p10l457t1745r528b1770],
20	H1	NN	O	h1	dep	16	SENT_154	[p10l541t1744r575b1777],
21	]	CD	NUMBER	]	number	22	SENT_154	[p10l541t1744r575b1777],
22	70	CD	NUMBER	70	dep	20	SENT_154	[p10l1563t1746r1593b1770],
23	(	NN	O	(	dep	25	SENT_154	[p10l1606t1746r1656b1778],
24	84	CD	NUMBER	84	num	23	SENT_154	[p10l1606t1746r1656b1778],
25	)	NN	O	)	dep	31	SENT_154	[p10l1606t1746r1656b1778],
26	132	CD	NUMBER	132	num	25	SENT_154	[p10l1847t1747r1893b1770],
27	(	NN	O	(	nn	31	SENT_154	[p10l1906t1746r1956b1778],
28	82	CD	NUMBER	82	num	31	SENT_154	[p10l1906t1746r1956b1778],
29	)	CD	NUMBER	)	num	31	SENT_154	[p10l1906t1746r1956b1778],
30	Class	NNP	O	Class	nn	31	SENT_154	[p10l457t1802r528b1827],
31	|	NNP	O	|	_	0	SENT_154	[p10l541t1800r578b1836],
32	|	VBD	O	|	rcmod	31	SENT_154	[p10l541t1800r578b1836],
33	|	CD	NUMBER	|	number	34	SENT_154	[p10l541t1800r578b1836],
34	|	CD	NUMBER	|	num	38	SENT_154	[p10l541t1800r578b1836],
35	|	NN	O	|	nn	38	SENT_154	[p10l541t1800r578b1836],
36	o	NN	O	o	nn	38	SENT_154	[p10l1578t1804r1593b1828],
37	1	CD	NUMBER	1	num	38	SENT_154	[p10l1881t1805r1892b1827],
38	(	NN	O	(	dobj	32	SENT_154	[p10l1906t1804r1939b1835],
39	1	CD	NUMBER	1	number	40	SENT_154	[p10l1906t1804r1939b1835],
40	)	CD	NUMBER	)	num	41	SENT_154	[p10l1906t1804r1939b1835],
41	Class	NN	O	class	dep	38	SENT_154	[p10l457t1860r528b1885],
42	IV	CD	NUMBER	iv	number	43	SENT_154	[p10l541t1862r566b1885],
43	2	CD	NUMBER	2	num	41	SENT_154	[p10l1579t1862r1593b1885],
44	(	NN	O	(	dep	55	SENT_154	[p10l1606t1862r1639b1893],
45	2	CD	NUMBER	2	num	44	SENT_154	[p10l1606t1862r1639b1893],
46	)	CD	NUMBER	)	number	47	SENT_154	[p10l1606t1862r1639b1893],
47	4	CD	NUMBER	4	dep	44	SENT_154	[p10l1878t1862r1893b1885],
48	(	NN	O	(	nn	52	SENT_154	[p10l1906t1862r1939b1893],
49	2	CD	NUMBER	2	num	52	SENT_154	[p10l1906t1862r1939b1893],
50	)	CD	NUMBER	)	num	52	SENT_154	[p10l1906t1862r1939b1893],
51	Class	NNP	O	Class	nn	52	SENT_154	[p10l457t1918r528b1943],
52	V	NNP	O	V	dep	47	SENT_154	[p10l537t1920r557b1943],
53	o	NN	O	o	dep	55	SENT_154	[p10l1578t1919r1593b1943],
54	1	CD	NUMBER	1	num	53	SENT_154	[p10l1881t1920r1892b1942],
55	(	NN	O	(	dep	64	SENT_154	[p10l1906t1920r1939b1950],
56	1	CD	NUMBER	1	num	55	SENT_154	[p10l1906t1920r1939b1950],
57	)	CD	NUMBER	)	num	60	SENT_154	[p10l1906t1920r1939b1950],
58	Unknown	JJ	O	unknown	amod	60	SENT_154	[p10l459t1975r586b2001],
59	1	CD	NUMBER	1	tmod	58	SENT_154	[p10l1581t1978r1592b2000],
60	(	NN	O	(	dep	55	SENT_154	[p10l1606t1977r1639b2008],
61	1	CD	NUMBER	1	num	62	SENT_154	[p10l1606t1977r1639b2008],
62	)	NN	O	)	dep	60	SENT_154	[p10l1606t1977r1639b2008],
63	2	CD	NUMBER	2	num	64	SENT_154	[p10l1879t1978r1893b2000],
64	(	NN	O	(	dep	66	SENT_154	[p10l1906t1977r1939b2008],
65	1	CD	NUMBER	1	num	66	SENT_154	[p10l1906t1977r1939b2008],
66	)	NN	O	)	dep	38	SENT_154	[p10l1906t1977r1939b2008],

1	1666	CD	DATE	1666	num	4	SENT_155	[p10l94t2114r170b2137],
2	N	NN	O	n	nn	4	SENT_155	[p10l882t2125r896b2140],
3	ENGLJ	NN	O	englj	nn	4	SENT_155	[p10l910t2125r988b2147],
4	MED	NN	O	med	_	0	SENT_155	[p10l1003t2125r1055b2140],
5	365	CD	NUMBER	365	dep	4	SENT_155	[p10l1065t2119r1141b2147],
6	;	:	O	;	_	0	SENT_155	[p10l1065t2119r1141b2147],
7	18	CD	NUMBER	18	num	8	SENT_155	[p10l1065t2119r1141b2147],
8	NEJM.ORG	NN	O	nejm.org	dep	5	SENT_155	[p10l1177t2125r1301b2147],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_155	[p10l1337t2125r1472b2141],
10	3,2011	CD	DATE	3,2011	num	9	SENT_155	[p10l1483t2125r1563b2147],

1	The	DT	O	the	det	4	SENT_156	[p10l880t2158r931b2182],
2	New	NNP	O	New	nn	4	SENT_156	[p10l940t2159r1002b2182],
3	England	NNP	O	England	nn	4	SENT_156	[p10l1012t2158r1122b2189],
4	Journal	NNP	O	Journal	_	0	SENT_156	[p10l1131t2158r1228b2182],
5	of	IN	O	of	_	0	SENT_156	[p10l1238t2158r1267b2182],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_156	[p10l1274t2158r1399b2182],

1	Downloaded	VBN	O	download	_	0	SENT_157	[p10l322t2199r492b2222],
2	from	IN	O	from	_	0	SENT_157	[p10l501t2199r566b2222],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_157	[p10l574t2199r693b2229],
4	at	IN	O	at	_	0	SENT_157	[p10l703t2203r726b2222],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_157	[p10l735t2199r917b2222],
6	on	IN	O	on	_	0	SENT_157	[p10l927t2206r959b2222],
7	J	NN	O	j	nn	8	SENT_157	[p10l968t2199r980b2222],
8	anuaiy	NN	O	anuaiy	prep_on	5	SENT_157	[p10l982t2206r1070b2229],
9	5	CD	NUMBER	5	num	8	SENT_157	[p10l1080t2199r1103b2226],
10	,	,	O	,	_	0	SENT_157	[p10l1080t2199r1103b2226],
11	2014	CD	DATE	2014	dobj	1	SENT_157	[p10l1114t2199r1186b2222],
12	.	.	O	.	_	0	SENT_157	[p10l1114t2199r1186b2222],

1	For	IN	O	for	_	0	SENT_158	[p10l1196t2199r1243b2222],
2	personal	JJ	O	personal	amod	3	SENT_158	[p10l1251t2199r1363b2229],
3	use	NN	O	use	pobj	1	SENT_158	[p10l1373t2206r1416b2222],
4	only	RB	O	only	advmod	3	SENT_158	[p10l1426t2199r1490b2229],
5	.	.	O	.	_	0	SENT_158	[p10l1426t2199r1490b2229],

1	No	DT	O	no	det	3	SENT_159	[p10l1501t2199r1541b2222],
2	other	JJ	O	other	amod	3	SENT_159	[p10l1551t2199r1619b2222],
3	uses	NNS	O	use	_	0	SENT_159	[p10l1627t2206r1683b2222],
4	without	IN	O	without	_	0	SENT_159	[p10l1693t2199r1795b2222],
5	permission	NN	O	permission	prep_without	3	SENT_159	[p10l1803t2199r1955b2229],
6	.	.	O	.	_	0	SENT_159	[p10l1803t2199r1955b2229],

1	Copyright	NN	O	copyright	_	0	SENT_160	[p10l673t2240r807b2271],
2	©	CD	NUMBER	©	num	6	SENT_160	[p10l817t2240r840b2264],
3	2011	CD	DATE	2011	num	6	SENT_160	[p10l850t2240r912b2264],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_160	[p10l924t2240r1116b2264],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_160	[p10l1125t2240r1234b2264],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_160	[p10l1244t2240r1349b2271],
7	.	.	O	.	_	0	SENT_160	[p10l1244t2240r1349b2271],

1	All	DT	O	all	det	2	SENT_161	[p10l1360t2240r1401b2264],
2	rights	NNS	O	rights	nsubj	3	SENT_161	[p10l1411t2240r1485b2271],
3	reserved	VBN	O	reserve	_	0	SENT_161	[p10l1495t2240r1614b2264],
4	.	.	O	.	_	0	SENT_161	[p10l1495t2240r1614b2264],

1	A	DT	O	a	det	3	SENT_162	[p10l714t2283r734b2302],
2	CFTR	NNP	O	CFTR	nn	3	SENT_162	[p10l747t2283r830b2302],
3	POTENTIATOR	NNP	O	POTENTIATOR	_	0	SENT_162	[p10l843t2283r1081b2302],
4	FOR	IN	O	for	_	0	SENT_162	[p10l1094t2283r1158b2302],
5	CYSTIC	NNP	O	CYSTIC	nn	6	SENT_162	[p10l1170t2283r1281b2302],
6	FIBROSIS	NNP	O	FIBROSIS	prep_for	3	SENT_162	[p10l1296t2283r1444b2302],

1	Table	NNP	O	Table	_	0	SENT_163	[p10l263t2404r337b2429],
2	1	CD	NUMBER	1	dep	1	SENT_163	[p10l347t2407r369b2429],
3	.	.	O	.	_	0	SENT_163	[p10l347t2407r369b2429],

1	(	RB	O	(	advmod	2	SENT_164	[p10l380t2404r548b2437],
2	Continued	VBN	O	continue	_	0	SENT_164	[p10l380t2404r548b2437],
3	.	.	O	.	_	0	SENT_164	[p10l380t2404r548b2437],
4	)	SYM	O	)	dep	2	SENT_164	[p10l380t2404r548b2437],

1	Ivacaﬁor	NNP	O	Ivacaﬁor	nn	5	SENT_165	[p10l1414t2479r1532b2505],
2	Total	NNP	O	Total	nn	5	SENT_165	[p10l1737t2479r1804b2505],
3	Characteristic	NNP	O	Characteristic	nn	5	SENT_165	[p10l263t2517r452b2542],
4	(	CD	NUMBER	(	num	5	SENT_165	[p10l1421t2519r1451b2550],
5	N	NN	O	n	nsubj	6	SENT_165	[p10l1421t2519r1451b2550],
6	=	JJ	O	=	_	0	SENT_165	[p10l1459t2519r1522b2550],
7	83	CD	NUMBER	83	number	8	SENT_165	[p10l1459t2519r1522b2550],
8	)	CD	NUMBER	)	num	15	SENT_165	[p10l1459t2519r1522b2550],
9	(	NN	O	(	nn	15	SENT_165	[p10l1712t2519r1742b2550],
10	N	NN	O	n	nn	15	SENT_165	[p10l1712t2519r1742b2550],
11	=	JJ	O	=	amod	15	SENT_165	[p10l1750t2529r1767b2538],
12	161	CD	NUMBER	161	number	13	SENT_165	[p10l1774t2519r1830b2550],
13	)	CD	NUMBER	)	num	15	SENT_165	[p10l1774t2519r1830b2550],
14	FEV1	NN	PERCENT	fev1	nn	15	SENT_165	[p10l266t2585r328b2614],
15	%	NN	PERCENT	%	dobj	6	SENT_165	[p10l314t2642r340b2667],
16	of	IN	O	of	_	0	SENT_165	[p10l350t2640r380b2666],
17	predicted	VBN	O	predict	amod	18	SENT_165	[p10l386t2641r511b2673],
18	value	NN	O	value	prep_of	15	SENT_165	[p10l522t2641r593b2666],

1	Mean	NN	O	mean	dep	9	SENT_166	[p10l366t2701r439b2724],
2	63.7	CD	NUMBER	63.7	number	3	SENT_166	[p10l1144t2700r1199b2724],
3	63.5	CD	NUMBER	63.5	dep	1	SENT_166	[p10l1444t2700r1498b2724],
4	63.6	CD	NUMBER	63.6	num	5	SENT_166	[p10l1731t2700r1787b2724],
5	Range	NNP	O	Range	dep	3	SENT_166	[p10l366t2758r448b2789],
6	31.6-97	CD	NUMBER	31.6-97	num	5	SENT_166	[p10l1106t2758r1235b2781],
7	.1	CD	NUMBER	.1	dep	9	SENT_166	[p10l1106t2758r1235b2781],
8	37.3-98	CD	NUMBER	37.3-98	num	9	SENT_166	[p10l1406t2758r1536b2781],
9	.2	NN	NUMBER	.2	_	0	SENT_166	[p10l1406t2758r1536b2781],
10	31.6-98	CD	NUMBER	31.6-98	num	11	SENT_166	[p10l1694t2758r1824b2781],
11	.2	NN	NUMBER	.2	dep	9	SENT_166	[p10l1694t2758r1824b2781],

1	Distribution	NN	O	distribution	nn	3	SENT_167	[p10l316t2814r477b2839],
2	—	CD	NUMBER	—	num	3	SENT_167	[p10l487t2829r521b2832],
3	no.	NN	O	no.	dep	17	SENT_167	[p10l531t2823r570b2839],
4	(	CD	PERCENT	(	num	5	SENT_167	[p10l584t2815r629b2847],
5	%	NN	PERCENT	%	dep	3	SENT_167	[p10l584t2815r629b2847],
6	)	CD	NUMBER	)	num	11	SENT_167	[p10l584t2815r629b2847],
7	<	JJR	O	<	amod	11	SENT_167	[p10l364t2873r442b2898],
8	70	CD	PERCENT	70	num	9	SENT_167	[p10l364t2873r442b2898],
9	%	NN	PERCENT	%	dep	7	SENT_167	[p10l364t2873r442b2898],
10	ofpredicted	JJ	O	ofpredicted	amod	11	SENT_167	[p10l452t2871r613b2904],
11	value	NN	O	value	dep	5	SENT_167	[p10l624t2871r694b2897],
12	270	CD	PERCENT	270	num	13	SENT_167	[p10l364t2930r442b2955],
13	%	NN	PERCENT	%	dep	17	SENT_167	[p10l364t2930r442b2955],
14	ofpredicted	JJ	O	ofpredicted	amod	17	SENT_167	[p10l452t2929r613b2962],
15	value	NN	O	value	nn	17	SENT_167	[p10l623t2929r694b2954],
16	Sweat	NN	O	sweat	nn	17	SENT_167	[p10l264t2989r344b3012],
17	chloride	NN	O	chloride	_	0	SENT_167	[p10l354t2987r463b3012],
18	—	CD	NUMBER	—	num	19	SENT_167	[p10l471t3002r505b3005],
19	mmol/liter	NN	O	mmol/liter	dep	17	SENT_167	[p10l515t2987r662b3020],

1	Mean	NN	O	mean	dep	9	SENT_168	[p10l316t3047r389b3070],
2	100.1	CD	NUMBER	100.1	num	1	SENT_168	[p10l1137t3046r1206b3070],
3	100.4	CD	NUMBER	100.4	number	4	SENT_168	[p10l1437t3046r1507b3070],
4	100.2	CD	NUMBER	100.2	dep	1	SENT_168	[p10l1724t3046r1795b3070],
5	Range	NNP	O	Range	dep	4	SENT_168	[p10l316t3104r398b3135],
6	58.0-121	CD	NUMBER	58.0-121	num	5	SENT_168	[p10l1098t3104r1243b3127],
7	.5	CD	NUMBER	.5	dep	9	SENT_168	[p10l1098t3104r1243b3127],
8	74.5-128	CD	NUMBER	74.5-128	num	9	SENT_168	[p10l1399t3104r1546b3128],
9	.0	CD	NUMBER	.0	_	0	SENT_168	[p10l1399t3104r1546b3128],
10	58.0-128	CD	NUMBER	58.0-128	num	11	SENT_168	[p10l1685t3104r1833b3128],
11	.0	NN	NUMBER	.0	dep	9	SENT_168	[p10l1685t3104r1833b3128],

1	*	NN	O	*	nn	2	SENT_169	[p10l237t3189r252b3204],
2	None	NN	O	none	nsubj	10	SENT_169	[p10l265t3189r337b3212],
3	ofthe	NN	O	ofthe	nn	4	SENT_169	[p10l348t3187r426b3212],
4	characteristics	NNS	O	characteristic	nsubj	5	SENT_169	[p10l437t3187r632b3212],
5	differed	VBD	O	differ	rcmod	2	SENT_169	[p10l644t3187r745b3212],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_169	[p10l759t3187r920b3220],
7	between	IN	O	between	_	0	SENT_169	[p10l932t3187r1042b3212],
8	the	DT	O	the	det	9	SENT_169	[p10l1054t3187r1096b3212],
9	groups	NNS	O	group	prep_between	5	SENT_169	[p10l1108t3196r1201b3220],
10	(	VBP	O	(	_	0	SENT_169	[p10l1216t3189r1316b3220],
11	P	NN	O	p	dep	12	SENT_169	[p10l1216t3189r1316b3220],
12	>	JJR	O	>	dobj	10	SENT_169	[p10l1216t3189r1316b3220],
13	0.05	CD	NUMBER	0.05	advmod	10	SENT_169	[p10l1216t3189r1316b3220],
14	for	IN	O	for	mark	17	SENT_169	[p10l1328t3187r1366b3212],
15	all	DT	O	all	det	16	SENT_169	[p10l1377t3187r1404b3212],
16	comparisons	NNS	O	comparison	nsubj	17	SENT_169	[p10l1417t3189r1613b3220],
17	)	VBP	O	)	advcl	10	SENT_169	[p10l1417t3189r1613b3220],
18	.	.	O	.	_	0	SENT_169	[p10l1417t3189r1613b3220],

1	FEV1	NN	O	fev1	nsubj	2	SENT_170	[p10l1628t3189r1690b3218],
2	denotes	VBZ	O	denote	_	0	SENT_170	[p10l1702t3187r1809b3212],
3	forced	JJ	O	forced	amod	5	SENT_170	[p10l1820t3187r1904b3212],
4	expiratow	NN	O	expiratow	nn	5	SENT_170	[p10l263t3226r396b3257],
5	volume	NN	O	volume	dobj	2	SENT_170	[p10l406t3224r507b3249],
6	in	IN	O	in	_	0	SENT_170	[p10l520t3226r541b3249],
7	1	CD	DURATION	1	num	8	SENT_170	[p10l556t3226r567b3249],
8	second	NN	NUMBER	second	prep_in	5	SENT_170	[p10l581t3224r684b3249],
9	.	.	O	.	_	0	SENT_170	[p10l581t3224r684b3249],

1	1	CD	NUMBER	1	number	2	SENT_171	[p10l238t3263r254b3294],
2	‘	CD	NUMBER	‘	num	3	SENT_171	[p10l238t3263r254b3294],
3	Race	NN	O	race	nsubj	9	SENT_171	[p10l265t3263r326b3286],
4	or	CC	O	or	_	0	SENT_171	[p10l337t3270r365b3286],
5	ethnic	JJ	O	ethnic	amod	6	SENT_171	[p10l376t3261r459b3286],
6	group	NN	O	group	nsubj	9	SENT_171	[p10l470t3270r549b3294],
7	was	VBD	O	be	cop	9	SENT_171	[p10l560t3270r611b3286],
8	self	NN	O	self	nn	9	SENT_171	[p10l624t3261r803b3294],
9	—	NN	O	—	_	0	SENT_171	[p10l624t3261r803b3294],
10	reported	VBD	O	report	rcmod	9	SENT_171	[p10l624t3261r803b3294],
11	.	.	O	.	_	0	SENT_171	[p10l624t3261r803b3294],

1	It	PRP	O	it	nsubj	7	SENT_172	[p10l238t3300r254b3331],
2	The	DT	O	the	det	4	SENT_172	[p10l261t3298r312b3323],
3	body-mass	JJ	O	body-mass	amod	4	SENT_172	[p10l324t3298r470b3331],
4	index	NN	O	index	nsubj	7	SENT_172	[p10l483t3298r554b3323],
5	is	VBZ	O	be	cop	7	SENT_172	[p10l566t3300r585b3323],
6	the	DT	O	the	det	7	SENT_172	[p10l596t3298r639b3323],
7	weight	NN	O	weight	_	0	SENT_172	[p10l649t3298r739b3331],
8	in	IN	O	in	_	0	SENT_172	[p10l752t3300r773b3323],
9	kilograms	NNS	O	kilogram	prep_in	7	SENT_172	[p10l787t3298r919b3331],
10	divided	VBN	O	divide	partmod	9	SENT_172	[p10l931t3298r1029b3323],
11	by	IN	O	by	_	0	SENT_172	[p10l1043t3298r1071b3331],
12	the	DT	O	the	det	15	SENT_172	[p10l1081t3298r1123b3323],
13	square	JJ	O	square	amod	15	SENT_172	[p10l1135t3307r1225b3331],
14	ofthe	NN	O	ofthe	nn	15	SENT_172	[p10l1237t3298r1315b3323],
15	height	NN	O	height	agent	10	SENT_172	[p10l1327t3298r1411b3331],
16	in	IN	O	in	_	0	SENT_172	[p10l1423t3300r1445b3323],
17	meters	NNS	O	meter	prep_in	15	SENT_172	[p10l1459t3303r1559b3323],
18	.	.	O	.	_	0	SENT_172	[p10l1459t3303r1559b3323],

1	§	NN	O	§	nsubjpass	38	SENT_173	[p10l238t3334r248b3368],
2	The	DT	O	the	det	3	SENT_173	[p10l261t3335r312b3360],
3	classes	NNS	O	class	nsubjpass	8	SENT_173	[p10l323t3335r419b3360],
4	of	IN	O	of	_	0	SENT_173	[p10l431t3334r461b3360],
5	CFTR	NNP	O	CFTR	nn	6	SENT_173	[p10l469t3337r541b3360],
6	mutations	NNS	O	mutation	prep_of	3	SENT_173	[p10l553t3337r690b3360],
7	are	VBP	O	be	auxpass	8	SENT_173	[p10l703t3343r743b3360],
8	based	VBN	O	base	rcmod	1	SENT_173	[p10l756t3335r833b3360],
9	on	IN	O	on	_	0	SENT_173	[p10l846t3344r878b3360],
10	their	PRP$	O	they	poss	12	SENT_173	[p10l890t3335r953b3360],
11	molecular	JJ	O	molecular	amod	12	SENT_173	[p10l965t3335r1099b3360],
12	mechanisms	NNS	O	mechanism	prep_on	8	SENT_173	[p10l1111t3335r1284b3360],
13	in	IN	O	in	_	0	SENT_173	[p10l1297t3337r1319b3360],
14	the	DT	O	the	det	15	SENT_173	[p10l1331t3335r1373b3360],
15	cell	NN	O	cell	prep_in	8	SENT_173	[p10l1384t3335r1436b3365],
16	,	,	O	,	_	0	SENT_173	[p10l1384t3335r1436b3365],
17	as	IN	O	as	mark	18	SENT_173	[p10l1449t3344r1476b3360],
18	classified	VBN	O	classify	dep	15	SENT_173	[p10l1488t3334r1613b3360],
19	by	IN	O	by	_	0	SENT_173	[p10l1627t3335r1655b3368],
20	Welsh	NNP	O	Welsh	prep_by	18	SENT_173	[p10l1665t3335r1747b3360],
21	et	FW	O	et	nn	25	SENT_173	[p10l1760t3339r1784b3360],
22	al.	FW	O	al.	nn	25	SENT_173	[p10l1795t3334r1850b3360],
23	”	FW	O	”	nn	25	SENT_173	[p10l1795t3334r1850b3360],
24	ﬂ	FW	O	ﬂ	nn	25	SENT_173	[p10l238t3372r254b3404],
25	]	FW	O	]	dobj	18	SENT_173	[p10l238t3372r254b3404],
26	One	CD	NUMBER	one	num	27	SENT_173	[p10l263t3374r320b3397],
27	subject	NN	O	subject	dep	25	SENT_173	[p10l332t3372r429b3405],
28	in	IN	O	in	_	0	SENT_173	[p10l441t3374r462b3397],
29	the	DT	O	the	det	31	SENT_173	[p10l474t3372r517b3397],
30	placebo	NN	O	placebo	nn	31	SENT_173	[p10l529t3372r633b3405],
31	group	NN	O	group	prep_in	18	SENT_173	[p10l645t3381r724b3405],
32	who	WP	O	who	nsubj	34	SENT_173	[p10l735t3372r792b3397],
33	was	VBD	O	be	cop	34	SENT_173	[p10l802t3381r853b3397],
34	homozygous	JJ	O	homozygous	rcmod	31	SENT_173	[p10l866t3372r1040b3405],
35	for	IN	O	for	_	0	SENT_173	[p10l1052t3372r1090b3397],
36	G551D-CFTR	NN	O	g551d-cftr	prep_for	34	SENT_173	[p10l1101t3374r1280b3397],
37	is	VBZ	O	be	auxpass	38	SENT_173	[p10l1292t3374r1311b3397],
38	included	VBN	O	include	_	0	SENT_173	[p10l1324t3372r1438b3397],
39	here	RB	O	here	advmod	38	SENT_173	[p10l1452t3372r1516b3397],
40	.	.	O	.	_	0	SENT_173	[p10l1452t3372r1516b3397],

1	|	NN	O	|	nsubjpass	15	SENT_174	[p10l241t3407r247b3443],
2	|	CD	NUMBER	|	number	3	SENT_174	[p10l241t3407r247b3443],
3	One	CD	NUMBER	one	dep	4	SENT_174	[p10l263t3411r320b3435],
4	subject	NN	O	subject	amod	1	SENT_174	[p10l332t3409r429b3443],
5	in	IN	O	in	_	0	SENT_174	[p10l441t3411r462b3434],
6	the	DT	O	the	det	8	SENT_174	[p10l474t3409r517b3435],
7	placebo	NN	O	placebo	nn	8	SENT_174	[p10l529t3409r633b3442],
8	group	NN	O	group	prep_in	4	SENT_174	[p10l645t3418r724b3443],
9	who	WP	O	who	nsubj	11	SENT_174	[p10l735t3409r792b3435],
10	was	VBD	O	be	cop	11	SENT_174	[p10l802t3418r853b3435],
11	homozygous	JJ	O	homozygous	rcmod	8	SENT_174	[p10l866t3409r1040b3443],
12	for	IN	O	for	_	0	SENT_174	[p10l1052t3409r1090b3435],
13	F508del-CFTR	NN	O	f508del-cftr	prep_for	11	SENT_174	[p10l1102t3409r1288b3435],
14	is	VBZ	O	be	auxpass	15	SENT_174	[p10l1300t3412r1319b3435],
15	included	VBN	O	include	_	0	SENT_174	[p10l1333t3409r1447b3435],
16	here	RB	O	here	advmod	15	SENT_174	[p10l1460t3409r1525b3435],
17	.	.	O	.	_	0	SENT_174	[p10l1460t3409r1525b3435],

1	ment	NN	O	ment	_	0	SENT_175	[p10l10t3635r232b3697],
2	in	IN	O	in	_	0	SENT_175	[p10l261t3619r345b3696],
3	scores	NNS	O	score	prep_in	1	SENT_175	[p10l380t3644r646b3697],
4	on	IN	O	on	_	0	SENT_175	[p10l683t3644r789b3697],
5	the	DT	O	the	det	6	SENT_175	[p10l824t3618r958b3697],
6	CFQ	NNP	O	CFQ	prep_on	1	SENT_175	[p10l992t3624r1288b3716],
7	.	.	O	.	_	0	SENT_175	[p10l992t3624r1288b3716],

1	—	NN	O	—	_	0	SENT_176	[p10l992t3624r1288b3716],
2	.	.	O	.	_	0	SENT_176	[p10l992t3624r1288b3716],

1	R	NN	O	r	_	0	SENT_177	[p10l992t3624r1288b3716],
2	respiratory	JJ	O	respiratory	amod	3	SENT_177	[p10l1313t3619r1786b3719],
3	domain	NN	O	domain	dep	1	SENT_177	[p10l1817t3618r2149b3697],

1	(	NN	O	(	_	0	SENT_178	[p11l15t20r486b121],
2	indicating	VBG	O	indicate	partmod	1	SENT_178	[p11l15t20r486b121],
3	a	DT	O	a	det	4	SENT_178	[p11l514t47r559b99],
4	reduction	NN	O	reduction	dobj	2	SENT_178	[p11l589t20r999b99],
5	in	IN	O	in	_	0	SENT_178	[p11l1031t21r1114b98],
6	respiratory	JJ	O	respiratory	amod	8	SENT_178	[p11l1147t21r1619b121],
7	symptoms	NNS	O	symptom	nn	8	SENT_178	[p11l1648t27r2144b121],
8	)	NN	O	)	prep_in	4	SENT_178	[p11l1648t27r2144b121],
9	.	.	O	.	_	0	SENT_178	[p11l1648t27r2144b121],

1	From	IN	O	from	_	0	SENT_179	[p11l9t156r240b227],
2	baseline	NN	O	baseline	prep_from	9	SENT_179	[p11l281t148r642b227],
3	to	TO	O	to	_	0	SENT_179	[p11l683t165r766b227],
4	week	NN	DURATION	week	prep_to	2	SENT_179	[p11l803t148r1031b228],
5	48	CD	NUMBER	48	num	4	SENT_179	[p11l1065t154r1195b244],
6	,	,	O	,	_	0	SENT_179	[p11l1065t154r1195b244],
7	the	DT	O	the	det	8	SENT_179	[p11l1241t148r1377b227],
8	scores	NNS	O	score	nsubj	9	SENT_179	[p11l1419t174r1689b227],
9	increased	VBN	O	increase	_	0	SENT_179	[p11l1731t148r2149b227],
10	by	IN	O	by	_	0	SENT_179	[p11l11t277r109b378],
11	5.9	CD	NUMBER	5.9	num	12	SENT_179	[p11l138t283r260b356],
12	points	NNS	O	point	prep_by	9	SENT_179	[p11l292t278r563b378],
13	in	IN	O	in	_	0	SENT_179	[p11l596t278r681b355],
14	the	DT	O	the	det	16	SENT_179	[p11l713t277r846b356],
15	ivacaftor	NN	O	ivacaftor	nn	16	SENT_179	[p11l878t277r1257b357],
16	group	NN	O	group	prep_in	9	SENT_179	[p11l1285t303r1563b378],
17	,	,	O	,	_	0	SENT_179	[p11l1285t303r1563b378],
18	as	IN	O	as	_	0	SENT_179	[p11l1600t304r1685b356],
19	compared	VBN	O	compare	prepc_as	9	SENT_179	[p11l1720t277r2150b378],
20	with	IN	O	with	pcomp	19	SENT_179	[p11l6t405r199b484],
21	a	DT	O	a	det	22	SENT_179	[p11l230t432r274b484],
22	decrease	NN	O	decrease	pobj	20	SENT_179	[p11l305t405r666b484],
23	of	IN	O	of	_	0	SENT_179	[p11l699t405r798b484],
24	2.7	CD	NUMBER	2.7	num	25	SENT_179	[p11l811t411r935b484],
25	points	NNS	O	point	prep_of	22	SENT_179	[p11l965t406r1231b506],
26	in	IN	O	in	_	0	SENT_179	[p11l1264t406r1347b483],
27	the	DT	O	the	det	32	SENT_179	[p11l1379t405r1511b484],
28	placebo	NN	O	placebo	nn	32	SENT_179	[p11l1541t405r1866b506],
29	group	NN	O	group	nn	32	SENT_179	[p11l1898t431r2149b506],
30	(	NN	O	(	nn	32	SENT_179	[p11l15t540r455b625],
31	treatment	NN	O	treatment	nn	32	SENT_179	[p11l15t540r455b625],
32	effect	NN	O	effect	prep_in	25	SENT_179	[p11l481t533r737b629],
33	,	,	O	,	_	0	SENT_179	[p11l481t533r737b629],
34	8.6	CD	NUMBER	8.6	num	35	SENT_179	[p11l774t539r898b612],
35	points	NNS	O	point	appos	32	SENT_179	[p11l928t534r1217b634],
36	;	:	O	;	_	0	SENT_179	[p11l928t534r1217b634],
37	P	NN	O	p	dep	38	SENT_179	[p11l1249t539r1607b624],
38	<	JJR	O	<	dep	35	SENT_179	[p11l1249t539r1607b624],
39	0.001	CD	NUMBER	0.001	num	40	SENT_179	[p11l1249t539r1607b624],
40	)	NN	O	)	dep	38	SENT_179	[p11l1249t539r1607b624],
41	(	CD	NUMBER	(	num	42	SENT_179	[p11l1647t534r1823b634],
42	Fig	NN	O	fig	dep	38	SENT_179	[p11l1647t534r1823b634],
43	.	.	O	.	_	0	SENT_179	[p11l1647t534r1823b634],

1	1C	NN	O	1c	_	0	SENT_180	[p11l1862t539r2016b624],
2	)	NN	O	)	dep	1	SENT_180	[p11l1862t539r2016b624],
3	.	.	O	.	_	0	SENT_180	[p11l1862t539r2016b624],

1	By	IN	O	by	_	0	SENT_181	[p11l2051t540r2154b634],
2	week	NN	DURATION	week	prep_by	11	SENT_181	[p11l6t661r224b741],
3	48	CD	NUMBER	48	num	2	SENT_181	[p11l245t667r369b757],
4	,	,	O	,	_	0	SENT_181	[p11l245t667r369b757],
5	subjects	NNS	O	subject	appos	2	SENT_181	[p11l404t661r730b762],
6	in	IN	O	in	_	0	SENT_181	[p11l760t662r841b739],
7	the	DT	O	the	det	9	SENT_181	[p11l869t661r999b740],
8	ivacaftor	NN	O	ivacaftor	nn	9	SENT_181	[p11l1026t661r1388b740],
9	group	NN	O	group	prep_in	5	SENT_181	[p11l1413t687r1658b762],
10	had	VBD	O	have	aux	11	SENT_181	[p11l1687t661r1841b740],
11	gained	VBN	O	gain	_	0	SENT_181	[p11l1868t661r2149b762],
12	3.1	CD	NUMBER	3.1	num	13	SENT_181	[p11l11t795r135b868],
13	kg	NN	O	kg	dobj	11	SENT_181	[p11l172t789r299b890],
14	,	,	O	,	_	0	SENT_181	[p11l172t789r299b890],
15	as	IN	O	as	_	0	SENT_181	[p11l341t816r427b868],
16	compared	VBN	O	compare	prepc_as	11	SENT_181	[p11l466t789r896b890],
17	with	IN	O	with	pcomp	16	SENT_181	[p11l928t789r1125b868],
18	a	DT	O	a	det	19	SENT_181	[p11l1161t816r1205b868],
19	gain	NN	O	gain	pobj	17	SENT_181	[p11l1240t790r1430b890],
20	of	IN	O	of	_	0	SENT_181	[p11l1467t789r1568b868],
21	0.4	CD	NUMBER	0.4	num	22	SENT_181	[p11l1587t795r1712b868],
22	kg	NN	O	kg	prep_of	19	SENT_181	[p11l1748t789r1856b890],
23	in	IN	O	in	_	0	SENT_181	[p11l1889t790r1974b867],
24	the	DT	O	the	det	29	SENT_181	[p11l2013t789r2149b868],
25	placebo	NN	O	placebo	nn	29	SENT_181	[p11l9t917r347b1018],
26	group	NN	O	group	nn	29	SENT_181	[p11l376t943r634b1018],
27	(	NN	O	(	nn	29	SENT_181	[p11l669t924r1131b1009],
28	treatment	NN	O	treatment	nn	29	SENT_181	[p11l669t924r1131b1009],
29	effect	NN	O	effect	prep_in	22	SENT_181	[p11l1154t917r1425b1013],
30	,	,	O	,	_	0	SENT_181	[p11l1154t917r1425b1013],
31	2.7	CD	NUMBER	2.7	num	32	SENT_181	[p11l1459t923r1587b996],
32	kg	NN	O	kg	appos	29	SENT_181	[p11l1616t917r1746b1018],
33	;	:	O	;	_	0	SENT_181	[p11l1616t917r1746b1018],
34	P	NN	O	p	dep	32	SENT_181	[p11l1777t923r2144b1008],
35	<	JJR	O	<	dep	34	SENT_181	[p11l1777t923r2144b1008],
36	0.001	CD	NUMBER	0.001	num	39	SENT_181	[p11l1777t923r2144b1008],
37	)	NN	O	)	nn	39	SENT_181	[p11l1777t923r2144b1008],
38	(	CD	NUMBER	(	num	39	SENT_181	[p11l15t1047r196b1147],
39	Fig	NN	O	fig	nsubj	11	SENT_181	[p11l15t1047r196b1147],
40	.	.	O	.	_	0	SENT_181	[p11l15t1047r196b1147],

1	1D	NN	O	1d	_	0	SENT_182	[p11l245t1052r415b1138],
2	)	NN	O	)	dep	1	SENT_182	[p11l245t1052r415b1138],
3	.	.	O	.	_	0	SENT_182	[p11l245t1052r415b1138],

1	CFTR	NNP	ORGANIZATION	CFTR	nn	2	SENT_183	[p11l11t1323r201b1373],
2	FUNCTION	NNP	O	FUNCTION	dep	16	SENT_183	[p11l240t1322r657b1373],
3	Through	IN	DATE	through	_	0	SENT_183	[p11l7t1422r386b1523],
4	week	NN	DATE	week	prep_through	16	SENT_183	[p11l428t1422r653b1502],
5	24	CD	DATE	24	num	4	SENT_183	[p11l695t1428r816b1518],
6	,	,	O	,	_	0	SENT_183	[p11l695t1428r816b1518],
7	the	DT	O	the	det	8	SENT_183	[p11l869t1422r1002b1501],
8	change	NN	O	change	nsubj	16	SENT_183	[p11l1050t1422r1357b1523],
9	from	IN	O	from	_	0	SENT_183	[p11l1405t1422r1617b1501],
10	baseline	NN	O	baseline	prep_from	8	SENT_183	[p11l1664t1422r2019b1501],
11	in	IN	O	in	_	0	SENT_183	[p11l2065t1423r2149b1500],
12	sweat	NN	O	sweat	nn	13	SENT_183	[p11l12t1567r249b1629],
13	chloride	NN	O	chloride	prep_in	10	SENT_183	[p11l275t1550r613b1629],
14	was	VBD	O	be	cop	16	SENT_183	[p11l639t1577r799b1630],
15	-48.7	CD	NUMBER	-48.7	num	16	SENT_183	[p11l830t1556r1067b1629],
16	mmol	NN	O	mmol	_	0	SENT_183	[p11l1098t1550r1348b1629],
17	per	IN	O	per	_	0	SENT_183	[p11l1376t1576r1513b1651],
18	liter	NN	O	liter	prep_per	16	SENT_183	[p11l1539t1550r1707b1629],
19	in	IN	O	in	_	0	SENT_183	[p11l1734t1551r1816b1628],
20	the	DT	O	the	det	22	SENT_183	[p11l1846t1550r1976b1629],
21	ivacaftor	NN	O	ivacaftor	nn	22	SENT_183	[p11l2006t1551r2148b1629, p11l11t1678r260b1757],
22	group	NN	O	group	prep_in	18	SENT_183	[p11l290t1704r538b1779],
23	and	CC	O	and	_	0	SENT_183	[p11l571t1678r727b1757],
24	-0.8	CD	NUMBER	-0.8	num	25	SENT_183	[p11l759t1684r944b1757],
25	mmol	NN	O	mmol	conj_and	16	SENT_183	[p11l979t1678r1228b1757],
26	per	IN	O	per	_	0	SENT_183	[p11l1260t1704r1397b1779],
27	liter	NN	O	liter	prep_per	25	SENT_183	[p11l1426t1678r1594b1757],
28	in	IN	O	in	_	0	SENT_183	[p11l1623t1679r1706b1756],
29	the	DT	O	the	det	34	SENT_183	[p11l1739t1678r1869b1757],
30	placebo	NN	O	placebo	nn	34	SENT_183	[p11l1901t1678r2148b1779, p11l11t1806r115b1885],
31	group	NN	O	group	nn	34	SENT_183	[p11l150t1832r404b1907],
32	(	NN	O	(	nn	34	SENT_183	[p11l445t1813r897b1897],
33	treatment	NN	O	treatment	nn	34	SENT_183	[p11l445t1813r897b1897],
34	effect	NN	O	effect	prep_in	27	SENT_183	[p11l926t1806r1191b1902],
35	,	,	O	,	_	0	SENT_183	[p11l926t1806r1191b1902],
36	-47.9	CD	NUMBER	-47.9	num	37	SENT_183	[p11l1229t1812r1457b1885],
37	mmol	NN	O	mmol	conj_and	16	SENT_183	[p11l1492t1806r1747b1885],
38	per	IN	O	per	_	0	SENT_183	[p11l1779t1832r1920b1907],
39	liter	NN	O	liter	prep_per	37	SENT_183	[p11l1950t1806r2145b1902],
40	;	:	O	;	_	0	SENT_183	[p11l1950t1806r2145b1902],
41	P	NN	O	p	dep	42	SENT_183	[p11l8t1940r365b2026],
42	<	JJR	O	<	conj_and	16	SENT_183	[p11l8t1940r365b2026],
43	0.001	CD	NUMBER	0.001	num	44	SENT_183	[p11l8t1940r365b2026],
44	)	NN	O	)	dep	42	SENT_183	[p11l8t1940r365b2026],
45	(	CD	NUMBER	(	num	46	SENT_183	[p11l402t1935r577b2035],
46	Fig	NN	O	fig	dep	42	SENT_183	[p11l402t1935r577b2035],
47	.	.	O	.	_	0	SENT_183	[p11l402t1935r577b2035],

1	2A	NN	O	2a	_	0	SENT_184	[p11l609t1940r773b2025],
2	)	NN	O	)	dep	1	SENT_184	[p11l609t1940r773b2025],
3	.	.	O	.	_	0	SENT_184	[p11l609t1940r773b2025],

1	The	DT	O	the	det	3	SENT_185	[p11l802t1934r960b2013],
2	mean	NN	O	mean	nn	3	SENT_185	[p11l988t1960r1222b2013],
3	values	NNS	O	value	nsubj	11	SENT_185	[p11l1245t1934r1501b2013],
4	for	IN	O	for	_	0	SENT_185	[p11l1530t1934r1651b2013],
5	sweat	NN	O	sweat	nn	6	SENT_185	[p11l1677t1951r1915b2014],
6	chloride	NN	O	chloride	prep_for	3	SENT_185	[p11l1937t1934r2148b2013, p11l10t2062r170b2141],
7	were	VBD	O	be	cop	11	SENT_185	[p11l198t2088r398b2141],
8	47.8	CD	NUMBER	47.8	num	11	SENT_185	[p11l430t2068r594b2141],
9	and	CC	O	and	_	0	SENT_185	[p11l629t2062r785b2141],
10	100.0	CD	NUMBER	100.0	num	11	SENT_185	[p11l821t2068r1044b2141],
11	mmol	NN	O	mmol	_	0	SENT_185	[p11l1077t2062r1329b2141],
12	per	IN	O	per	_	0	SENT_185	[p11l1359t2088r1498b2163],
13	liter	NN	O	liter	prep_per	11	SENT_185	[p11l1527t2062r1696b2141],
14	in	IN	O	in	_	0	SENT_185	[p11l1725t2063r1808b2140],
15	the	DT	O	the	det	19	SENT_185	[p11l1842t2062r1972b2141],
16	ivacaftor	NN	O	ivacaftor	nn	19	SENT_185	[p11l2004t2063r2148b2141, p11l11t2190r262b2269],
17	and	CC	O	and	_	0	SENT_185	[p11l288t2190r444b2269],
18	placebo	NN	O	placebo	nn	19	SENT_185	[p11l471t2190r795b2291],
19	groups	NNS	O	group	prep_in	11	SENT_185	[p11l825t2216r1140b2291],
20	,	,	O	,	_	0	SENT_185	[p11l825t2216r1140b2291],
21	respectively	RB	O	respectively	advmod	11	SENT_185	[p11l1173t2190r1676b2291],
22	,	,	O	,	_	0	SENT_185	[p11l1173t2190r1676b2291],
23	at	IN	O	at	_	0	SENT_185	[p11l1709t2207r1788b2269],
24	week	NN	DURATION	week	prep_at	11	SENT_185	[p11l1807t2190r2028b2270],
25	24	CD	NUMBER	24	number	26	SENT_185	[p11l2052t2196r2149b2269],
26	(	CD	NUMBER	(	num	27	SENT_185	[p11l15t2319r199b2419],
27	Fig	NN	O	fig	dep	11	SENT_185	[p11l15t2319r199b2419],
28	.	.	O	.	_	0	SENT_185	[p11l15t2319r199b2419],

1	2B	NN	O	2b	_	0	SENT_186	[p11l244t2324r407b2410],
2	)	NN	O	)	dep	1	SENT_186	[p11l244t2324r407b2410],
3	.	.	O	.	_	0	SENT_186	[p11l244t2324r407b2410],

1	A	DT	O	a	det	3	SENT_187	[p11l446t2326r512b2396],
2	treatment	NN	O	treatment	nn	3	SENT_187	[p11l547t2335r974b2397],
3	effect	NN	O	effect	nsubjpass	12	SENT_187	[p11l1006t2318r1249b2397],
4	was	VBD	O	be	auxpass	6	SENT_187	[p11l1277t2345r1440b2397],
5	initially	RB	O	initially	advmod	6	SENT_187	[p11l1479t2318r1816b2419],
6	seen	VBN	O	see	_	0	SENT_187	[p11l1850t2344r2039b2397],
7	at	IN	O	at	_	0	SENT_187	[p11l2075t2335r2154b2397],
8	day	NN	DURATION	day	prep_at	6	SENT_187	[p11l11t2446r155b2547],
9	15	CD	NUMBER	15	num	8	SENT_187	[p11l179t2452r273b2525],
10	and	CC	O	and	_	0	SENT_187	[p11l301t2446r456b2525],
11	was	VBD	O	be	auxpass	12	SENT_187	[p11l478t2473r638b2525],
12	maintained	VBN	O	maintain	conj_and	6	SENT_187	[p11l665t2446r1149b2525],
13	through	IN	O	through	_	0	SENT_187	[p11l1175t2446r1516b2547],
14	week	NN	DURATION	week	nn	18	SENT_187	[p11l1537t2446r1756b2526],
15	48	CD	NUMBER	48	num	18	SENT_187	[p11l1776t2452r1876b2525],
16	(	NN	O	(	nn	18	SENT_187	[p11l1909t2453r2148b2537, p11l10t2591r230b2653],
17	treatment	NN	O	treatment	nn	18	SENT_187	[p11l1909t2453r2148b2537, p11l10t2591r230b2653],
18	effect	NN	O	effect	prep_through	12	SENT_187	[p11l258t2574r516b2670],
19	,	,	O	,	_	0	SENT_187	[p11l258t2574r516b2670],
20	-48.1	CD	NUMBER	-48.1	conj_and	6	SENT_187	[p11l553t2580r815b2670],
21	;	:	O	;	_	0	SENT_187	[p11l553t2580r815b2670],
22	P	NN	O	p	dep	23	SENT_187	[p11l851t2580r1234b2666],
23	<	JJR	O	<	dep	20	SENT_187	[p11l851t2580r1234b2666],
24	0.001	CD	NUMBER	0.001	num	25	SENT_187	[p11l851t2580r1234b2666],
25	)	NN	O	)	dep	23	SENT_187	[p11l851t2580r1234b2666],
26	.	.	O	.	_	0	SENT_187	[p11l851t2580r1234b2666],

1	SAFETY	NN	O	safety	nsubj	14	SENT_188	[p11l10t2851r297b2901],
2	AND	CC	O	and	_	0	SENT_188	[p11l327t2851r498b2901],
3	ADVERSE-EVENT	JJ	O	adverse-event	amod	4	SENT_188	[p11l530t2851r1181b2901],
4	PROFILE	NN	O	profile	conj_and	1	SENT_188	[p11l1218t2850r1540b2901],
5	The	DT	O	the	det	6	SENT_188	[p11l7t2954r168b3033],
6	incidence	NN	O	incidence	dep	4	SENT_188	[p11l202t2954r610b3033],
7	of	IN	O	of	_	0	SENT_188	[p11l644t2954r745b3033],
8	adverse	JJ	O	adverse	amod	9	SENT_188	[p11l760t2954r1076b3033],
9	events	NNS	O	event	prep_of	1	SENT_188	[p11l1111t2971r1377b3033],
10	through	IN	O	through	_	0	SENT_188	[p11l1413t2954r1764b3055],
11	week	NN	DURATION	week	prep_through	9	SENT_188	[p11l1793t2954r2018b3034],
12	48	CD	NUMBER	48	num	11	SENT_188	[p11l2045t2960r2148b3033],
13	was	VBD	O	be	cop	14	SENT_188	[p11l6t3113r169b3165],
14	similar	JJ	O	similar	_	0	SENT_188	[p11l206t3086r514b3165],
15	in	IN	O	in	_	0	SENT_188	[p11l543t3087r627b3164],
16	the	DT	O	the	det	22	SENT_188	[p11l660t3086r794b3165],
17	two	CD	NUMBER	two	num	18	SENT_188	[p11l827t3103r985b3166],
18	groups	NNS	O	group	dep	19	SENT_188	[p11l1020t3112r1317b3187],
19	(	RB	O	(	amod	22	SENT_188	[p11l1357t3086r1621b3178],
20	Table	NNP	O	Table	nn	22	SENT_188	[p11l1357t3086r1621b3178],
21	3	CD	NUMBER	3	amod	22	SENT_188	[p11l1657t3092r1756b3178],
22	)	NN	O	)	prep_in	14	SENT_188	[p11l1657t3092r1756b3178],
23	.	.	O	.	_	0	SENT_188	[p11l1657t3092r1756b3178],

1	As	IN	O	as	_	0	SENT_189	[p11l1791t3094r1898b3165],
2	compared	VBN	O	compare	prepc_as	11	SENT_189	[p11l1934t3112r2148b3165, p11l9t3218r253b3319],
3	with	IN	O	with	pcomp	2	SENT_189	[p11l276t3218r473b3298],
4	the	DT	O	the	det	6	SENT_189	[p11l500t3218r634b3297],
5	placebo	NN	O	placebo	nn	6	SENT_189	[p11l660t3218r992b3319],
6	group	NN	O	group	pobj	3	SENT_189	[p11l1020t3244r1297b3319],
7	,	,	O	,	_	0	SENT_189	[p11l1020t3244r1297b3319],
8	the	DT	O	the	det	10	SENT_189	[p11l1331t3218r1464b3297],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_189	[p11l1491t3218r1870b3297],
10	group	NN	O	group	nsubj	11	SENT_189	[p11l1894t3244r2148b3319],
11	had	VBD	O	have	_	0	SENT_189	[p11l10t3350r167b3429],
12	a	DT	O	a	det	14	SENT_189	[p11l205t3377r249b3429],
13	higher	JJR	O	higher	amod	14	SENT_189	[p11l286t3350r569b3451],
14	incidence	NN	O	incidence	nsubj	18	SENT_189	[p11l604t3350r1011b3429],
15	of	IN	O	of	_	0	SENT_189	[p11l1051t3350r1152b3429],
16	adverse	JJ	O	adverse	amod	17	SENT_189	[p11l1170t3350r1487b3429],
17	events	NNS	O	event	prep_of	14	SENT_189	[p11l1526t3367r1791b3429],
18	leading	VBG	O	lead	ccomp	11	SENT_189	[p11l1831t3350r2153b3451],
19	to	TO	O	to	_	0	SENT_189	[p11l11t3495r92b3557],
20	interruption	NN	O	interruption	prep_to	18	SENT_189	[p11l141t3479r672b3579],
21	of	IN	O	of	_	0	SENT_189	[p11l721t3478r822b3557],
22	the	DT	O	the	det	24	SENT_189	[p11l852t3478r985b3557],
23	study	NN	O	study	nn	24	SENT_189	[p11l1036t3478r1267b3579],
24	drug	NN	O	drug	prep_of	20	SENT_189	[p11l1311t3478r1517b3579],
25	(	CD	PERCENT	(	number	26	SENT_189	[p11l1567t3483r1781b3569],
26	13	CD	PERCENT	13	num	27	SENT_189	[p11l1567t3483r1781b3569],
27	%	NN	PERCENT	%	dobj	18	SENT_189	[p11l1567t3483r1781b3569],
28	vs.	CC	O	vs.	prep	27	SENT_189	[p11l1824t3505r1934b3557],
29	6	CD	PERCENT	6	num	30	SENT_189	[p11l1989t3484r2144b3570],
30	%	NN	PERCENT	%	dep	28	SENT_189	[p11l1989t3484r2144b3570],
31	)	CD	NUMBER	)	number	32	SENT_189	[p11l1989t3484r2144b3570],
32	(	CD	NUMBER	(	num	30	SENT_189	[p11l15t3606r279b3698],
33	Table	NNP	O	Table	tmod	11	SENT_189	[p11l15t3606r279b3698],
34	3	CD	NUMBER	3	num	33	SENT_189	[p11l314t3612r359b3685],
35	in	IN	O	in	_	0	SENT_189	[p11l395t3607r478b3684],
36	the	DT	O	the	det	39	SENT_189	[p11l510t3606r645b3685],
37	Supplementary	NNP	O	Supplementary	nn	39	SENT_189	[p11l679t3606r1331b3707],
38	Appendix	NNP	O	Appendix	nn	39	SENT_189	[p11l1354t3606r1824b3707],
39	)	NN	O	)	prep_in	33	SENT_189	[p11l1354t3606r1824b3707],
40	.	.	O	.	_	0	SENT_189	[p11l1354t3606r1824b3707],

1	All	PDT	O	all	predet	3	SENT_190	[p11l1857t3606r1984b3684],
2	the	DT	O	the	det	3	SENT_190	[p11l2016t3606r2149b3685],
3	subjects	NNS	O	subject	nsubj	8	SENT_190	[p12l12t20r353b121],
4	who	WP	O	who	nsubj	5	SENT_190	[p12l392t20r576b100],
5	interrupted	VBD	O	interrupt	rcmod	3	SENT_190	[p12l618t20r1109b121],
6	treatment	NN	O	treatment	dobj	5	SENT_190	[p12l1150t37r1577b99],
7	were	VBD	O	be	cop	8	SENT_190	[p12l1608t46r1812b99],
8	able	JJ	O	able	_	0	SENT_190	[p12l1852t20r2024b99],
9	to	TO	O	to	aux	10	SENT_190	[p12l2065t37r2148b99],
10	resume	VB	O	resume	dep	8	SENT_190	[p12l10t174r325b227],
11	taking	VBG	O	take	xcomp	10	SENT_190	[p12l375t148r658b249],
12	the	DT	O	the	det	14	SENT_190	[p12l704t148r837b227],
13	study	NN	O	study	nn	14	SENT_190	[p12l889t148r1120b249],
14	drug	NN	O	drug	dobj	11	SENT_190	[p12l1166t148r1371b249],
15	and	CC	O	and	_	0	SENT_190	[p12l1416t148r1575b227],
16	to	TO	O	to	aux	17	SENT_190	[p12l1625t165r1707b227],
17	complete	VB	O	complete	conj_and	10	SENT_190	[p12l1758t148r2149b249],
18	the	DT	O	the	det	19	SENT_190	[p12l11t276r144b355],
19	trial	NN	O	trial	dobj	17	SENT_190	[p12l179t276r381b372],
20	,	,	O	,	_	0	SENT_190	[p12l179t276r381b372],
21	with	IN	O	with	_	0	SENT_190	[p12l415t276r612b356],
22	the	DT	O	the	det	23	SENT_190	[p12l647t276r780b355],
23	exception	NN	O	exception	prep_with	8	SENT_190	[p12l815t277r1229b377],
24	of	IN	O	of	_	0	SENT_190	[p12l1263t276r1364b355],
25	one	CD	NUMBER	one	num	26	SENT_190	[p12l1380t302r1532b355],
26	subject	NN	O	subject	prep_of	23	SENT_190	[p12l1568t276r1870b377],
27	in	IN	O	in	_	0	SENT_190	[p12l1898t277r1981b354],
28	the	DT	O	the	det	30	SENT_190	[p12l2016t276r2149b355],
29	placebo	NN	O	placebo	nn	30	SENT_190	[p12l9t404r340b505],
30	group	NN	O	group	prep_in	26	SENT_190	[p12l379t430r633b505],
31	who	WP	O	who	nsubj	33	SENT_190	[p12l668t404r851b483],
32	subsequently	RB	O	subsequently	advmod	33	SENT_190	[p12l892t404r1457b505],
33	withdrew	VBD	O	withdraw	rcmod	23	SENT_190	[p12l1486t404r1904b484],
34	from	IN	O	from	_	0	SENT_190	[p12l1938t404r2150b483],
35	the	DT	O	the	det	36	SENT_190	[p12l11t532r144b611],
36	study	NN	O	study	prep_from	33	SENT_190	[p12l201t532r433b633],
37	owing	VBG	O	owe	partmod	36	SENT_190	[p12l483t533r755b633],
38	to	TO	O	to	_	0	SENT_190	[p12l807t549r889b611],
39	severe	JJ	O	severe	amod	41	SENT_190	[p12l947t559r1206b611],
40	respiratory	JJ	O	respiratory	amod	41	SENT_190	[p12l1262t533r1737b633],
41	distress	NN	O	distress	prep_to	37	SENT_190	[p12l1787t532r2144b611],
42	.	.	O	.	_	0	SENT_190	[p12l1787t532r2144b611],

1	Subjects	NNS	O	subject	nsubj	6	SENT_191	[p12l12t660r361b761],
2	in	IN	O	in	_	0	SENT_191	[p12l402t661r486b738],
3	the	DT	O	the	det	5	SENT_191	[p12l526t660r659b739],
4	ivacaftor	NN	O	ivacaftor	nn	5	SENT_191	[p12l698t660r1077b739],
5	group	NN	O	group	prep_in	1	SENT_191	[p12l1112t686r1367b761],
6	had	VBD	O	have	_	0	SENT_191	[p12l1407t660r1565b739],
7	a	DT	O	a	det	11	SENT_191	[p12l1603t687r1648b739],
8	lower	JJR	O	lower	amod	11	SENT_191	[p12l1684t660r1924b739],
9	inci	NN	O	incus	nn	11	SENT_191	[p12l1959t661r2148b739],
10	—	NN	O	—	nn	11	SENT_191	[p12l1959t661r2148b739],
11	dence	NN	O	dence	nsubj	15	SENT_191	[p12l11t788r257b867],
12	of	IN	O	of	_	0	SENT_191	[p12l305t788r405b867],
13	adverse	JJ	O	adverse	amod	14	SENT_191	[p12l432t788r750b867],
14	events	NNS	O	event	prep_of	11	SENT_191	[p12l798t805r1062b867],
15	leading	VBG	O	lead	ccomp	6	SENT_191	[p12l1110t788r1432b889],
16	to	TO	O	to	_	0	SENT_191	[p12l1475t805r1558b867],
17	discontinuation	NN	O	discontinuation	prep_to	15	SENT_191	[p12l1606t788r2148b867, p12l11t917r181b995],
18	of	IN	O	of	_	0	SENT_191	[p12l223t916r323b995],
19	the	DT	O	the	det	22	SENT_191	[p12l346t916r480b995],
20	study	NN	O	study	nn	22	SENT_191	[p12l523t916r754b1017],
21	drug	NN	O	drug	nn	22	SENT_191	[p12l791t916r997b1017],
22	(	NN	O	(	prep_of	17	SENT_191	[p12l1039t922r1194b1008],
23	1	CD	PERCENT	1	num	24	SENT_191	[p12l1039t922r1194b1008],
24	%	NN	PERCENT	%	tmod	6	SENT_191	[p12l1039t922r1194b1008],
25	vs.	CC	O	vs.	prep	24	SENT_191	[p12l1230t943r1339b996],
26	5	CD	PERCENT	5	num	27	SENT_191	[p12l1388t922r1569b1008],
27	%	NN	PERCENT	%	dep	25	SENT_191	[p12l1388t922r1569b1008],
28	)	CD	NUMBER	)	dep	27	SENT_191	[p12l1388t922r1569b1008],
29	.	.	O	.	_	0	SENT_191	[p12l1388t922r1569b1008],

1	Overall	RB	O	overall	advmod	6	SENT_192	[p12l1615t916r1948b1012],
2	,	,	O	,	_	0	SENT_192	[p12l1615t916r1948b1012],
3	five	CD	NUMBER	five	num	5	SENT_192	[p12l1995t916r2149b995],
4	adverse	JJ	O	adverse	amod	5	SENT_192	[p12l10t1045r326b1124],
5	events	NNS	O	event	nsubj	6	SENT_192	[p12l361t1062r626b1124],
6	led	VBD	O	lead	_	0	SENT_192	[p12l661t1045r788b1124],
7	to	TO	O	to	_	0	SENT_192	[p12l821t1062r903b1124],
8	discontinuation	NN	O	discontinuation	prep_to	6	SENT_192	[p12l939t1045r1649b1124],
9	:	:	O	:	_	0	SENT_192	[p12l939t1045r1649b1124],
10	four	CD	NUMBER	four	nsubj	16	SENT_192	[p12l1687t1045r1868b1124],
11	in	IN	O	in	_	0	SENT_192	[p12l1898t1046r1982b1123],
12	the	DT	O	the	det	14	SENT_192	[p12l2016t1045r2149b1124],
13	placebo	NN	O	placebo	nn	14	SENT_192	[p12l9t1173r340b1274],
14	group	NN	O	group	prep_in	10	SENT_192	[p12l382t1199r636b1274],
15	(	CD	NUMBER	(	dep	14	SENT_192	[p12l682t1173r1122b1265],
16	increased	VBD	O	increase	parataxis	6	SENT_192	[p12l682t1173r1122b1265],
17	hepatic	JJ	O	hepatic	amod	19	SENT_192	[p12l1162t1173r1475b1274],
18	enzyme	NN	O	enzyme	nn	19	SENT_192	[p12l1515t1199r1847b1274],
19	levels	NNS	O	level	dobj	16	SENT_192	[p12l1887t1173r2144b1269],
20	,	,	O	,	_	0	SENT_192	[p12l1887t1173r2144b1269],
21	atrioventricular	JJ	O	atrioventricular	amod	22	SENT_192	[p12l10t1301r685b1380],
22	block	NN	O	block	dobj	16	SENT_192	[p12l721t1301r977b1397],
23	,	,	O	,	_	0	SENT_192	[p12l721t1301r977b1397],
24	panic	NN	O	panic	nn	25	SENT_192	[p12l1020t1302r1257b1402],
25	attack	NN	O	attack	dobj	16	SENT_192	[p12l1295t1301r1579b1397],
26	,	,	O	,	_	0	SENT_192	[p12l1295t1301r1579b1397],
27	and	CC	O	and	_	0	SENT_192	[p12l1623t1301r1782b1380],
28	respiratory	JJ	O	respiratory	amod	30	SENT_192	[p12l1821t1302r2148b1402, p12l11t1446r184b1530],
29	failure	NN	O	failure	nn	30	SENT_192	[p12l223t1429r528b1520],
30	)	NN	O	)	dobj	16	SENT_192	[p12l223t1429r528b1520],
31	and	CC	O	and	_	0	SENT_192	[p12l577t1429r736b1508],
32	one	CD	NUMBER	one	conj_and	30	SENT_192	[p12l780t1455r932b1508],
33	in	IN	O	in	_	0	SENT_192	[p12l976t1430r1059b1507],
34	the	DT	O	the	det	35	SENT_192	[p12l1104t1429r1238b1508],
35	ivacaftor	NN	O	ivacaftor	prep_in	16	SENT_192	[p12l1281t1429r1660b1508],
36	group	NN	O	group	nsubj	38	SENT_192	[p12l1700t1455r1955b1530],
37	(	CD	NUMBER	(	num	36	SENT_192	[p12l2005t1430r2148b1521, p12l11t1557r334b1636],
38	increased	VBD	O	increase	rcmod	35	SENT_192	[p12l2005t1430r2148b1521, p12l11t1557r334b1636],
39	hepatic	JJ	O	hepatic	amod	41	SENT_192	[p12l389t1557r702b1658],
40	enzyme	NN	O	enzyme	nn	41	SENT_192	[p12l759t1583r1091b1658],
41	levels	NNS	O	level	nsubj	42	SENT_192	[p12l1145t1557r1430b1648],
42	)	VBP	O	)	ccomp	38	SENT_192	[p12l1145t1557r1430b1648],
43	.	.	O	.	_	0	SENT_192	[p12l1145t1557r1430b1648],

1	Adverse	JJ	O	adverse	amod	2	SENT_193	[p12l1487t1557r1825b1636],
2	events	NNS	O	event	nsubjpass	16	SENT_193	[p12l1882t1574r2147b1636],
3	occurring	VBG	O	occur	partmod	2	SENT_193	[p12l11t1686r436b1786],
4	in	IN	O	in	_	0	SENT_193	[p12l464t1686r547b1763],
5	at	IN	O	at	quantmod	7	SENT_193	[p12l579t1702r659b1764],
6	least	JJS	O	least	mwe	5	SENT_193	[p12l685t1685r885b1764],
7	10	CD	PERCENT	10	num	8	SENT_193	[p12l915t1691r1097b1764],
8	%	NN	PERCENT	%	prep_in	3	SENT_193	[p12l915t1691r1097b1764],
9	of	IN	O	of	_	0	SENT_193	[p12l1130t1685r1231b1764],
10	the	DT	O	the	det	11	SENT_193	[p12l1245t1685r1378b1764],
11	subjects	NNS	O	subject	prep_of	8	SENT_193	[p12l1412t1685r1754b1786],
12	in	IN	O	in	_	0	SENT_193	[p12l1787t1686r1871b1763],
13	either	DT	O	either	det	14	SENT_193	[p12l1904t1685r2153b1764],
14	group	NN	O	group	prep_in	11	SENT_193	[p12l10t1839r264b1914],
15	are	VBP	O	be	auxpass	16	SENT_193	[p12l295t1839r425b1892],
16	shown	VBN	O	show	_	0	SENT_193	[p12l457t1813r741b1893],
17	in	IN	O	in	_	0	SENT_193	[p12l770t1814r854b1891],
18	Table	NNP	O	Table	prep_in	16	SENT_193	[p12l881t1813r1113b1892],
19	4	CD	NUMBER	4	num	18	SENT_193	[p12l1141t1819r1192b1892],
20	in	IN	O	in	_	0	SENT_193	[p12l1221t1814r1305b1891],
21	the	DT	O	the	det	23	SENT_193	[p12l1336t1813r1469b1892],
22	Supplementary	NNP	O	Supplementary	nn	23	SENT_193	[p12l1502t1813r2154b1914],
23	Appendix	NNP	O	Appendix	prep_in	16	SENT_193	[p12l6t1941r431b2042],
24	.	.	O	.	_	0	SENT_193	[p12l6t1941r431b2042],

1	Pulmonary	JJ	O	pulmonary	amod	2	SENT_194	[p12l459t1941r924b2042],
2	exacerbation	NN	O	exacerbation	nsubj	14	SENT_194	[p12l945t1941r1491b2037],
3	,	,	O	,	_	0	SENT_194	[p12l945t1941r1491b2037],
4	cough	NN	O	cough	appos	2	SENT_194	[p12l1522t1941r1798b2042],
5	,	,	O	,	_	0	SENT_194	[p12l1522t1941r1798b2042],
6	hemop	NN	O	hemop	nn	8	SENT_194	[p12l1827t1941r2148b2042],
7	—	NN	O	—	nn	8	SENT_194	[p12l1827t1941r2148b2042],
8	tysis	NN	O	tysis	conj_and	4	SENT_194	[p12l11t2070r221b2170],
9	,	,	O	,	_	0	SENT_194	[p12l11t2070r221b2170],
10	and	CC	O	and	_	0	SENT_194	[p12l253t2069r411b2148],
11	decreased	VBD	O	decrease	amod	13	SENT_194	[p12l439t2069r858b2148],
12	pulmonary	JJ	O	pulmonary	amod	13	SENT_194	[p12l884t2069r1359b2170],
13	function	NN	O	function	conj_and	4	SENT_194	[p12l1382t2069r1746b2148],
14	occurred	VBD	O	occur	_	0	SENT_194	[p12l1774t2069r2149b2148],
15	less	RBR	O	less	advmod	16	SENT_194	[p12l9t2197r166b2276],
16	frequently	RB	O	frequently	advmod	14	SENT_194	[p12l203t2197r646b2298],
17	in	IN	O	in	_	0	SENT_194	[p12l675t2198r759b2275],
18	the	DT	O	the	det	20	SENT_194	[p12l795t2197r928b2276],
19	ivacaftor	NN	O	ivacaftor	nn	20	SENT_194	[p12l963t2197r1342b2276],
20	group	NN	O	group	prep_in	14	SENT_194	[p12l1374t2223r1628b2298],
21	than	IN	O	than	_	0	SENT_194	[p12l1664t2197r1862b2276],
22	in	IN	O	in	_	0	SENT_194	[p12l1896t2198r1980b2275],
23	the	DT	O	the	det	25	SENT_194	[p12l2016t2197r2149b2276],
24	placebo	NN	O	placebo	nn	25	SENT_194	[p12l9t2325r334b2426],
25	group	NN	O	group	prep_in	27	SENT_194	[p12l365t2351r615b2426],
26	(	CD	NUMBER	(	number	27	SENT_194	[p12l652t2332r778b2417],
27	25	CD	NUMBER	25	prep_than	14	SENT_194	[p12l652t2332r778b2417],
28	percentage	NN	O	percentage	nn	31	SENT_194	[p12l811t2326r1536b2426],
29	—	CD	NUMBER	—	num	31	SENT_194	[p12l811t2326r1536b2426],
30	point	NN	O	point	nn	31	SENT_194	[p12l811t2326r1536b2426],
31	difference	NN	O	difference	dep	27	SENT_194	[p12l1562t2325r1988b2404],
32	between	IN	O	between	_	0	SENT_194	[p12l2019t2325r2148b2404, p12l11t2470r264b2533],
33	the	DT	O	the	det	34	SENT_194	[p12l298t2453r429b2532],
34	groups	NNS	O	group	prep_between	31	SENT_194	[p12l462t2479r752b2554],
35	in	IN	O	in	_	0	SENT_194	[p12l787t2454r870b2531],
36	incidence	NN	O	incidence	prep_in	34	SENT_194	[p12l902t2453r1321b2549],
37	;	:	O	;	_	0	SENT_194	[p12l902t2453r1321b2549],
38	minimum	NN	O	minimum	dep	31	SENT_194	[p12l1358t2454r1787b2532],
39	10	CD	PERCENT	10	number	40	SENT_194	[p12l1824t2459r2003b2532],
40	%	NN	PERCENT	%	amod	41	SENT_194	[p12l1824t2459r2003b2532],
41	incidence	NN	O	incidence	dep	38	SENT_194	[p12l2035t2454r2148b2531, p12l11t2581r337b2660],
42	in	IN	O	in	prep	14	SENT_194	[p12l371t2582r456b2659],
43	either	CC	O	either	dep	42	SENT_194	[p12l491t2581r745b2660],
44	group	NN	O	group	conj	42	SENT_194	[p12l776t2588r1088b2682],
45	)	CD	NUMBER	)	num	44	SENT_194	[p12l776t2588r1088b2682],
46	.	.	O	.	_	0	SENT_194	[p12l776t2588r1088b2682],

1	Adverse	JJ	O	adverse	amod	2	SENT_195	[p12l1124t2581r1468b2660],
2	events	NNS	O	event	nsubj	12	SENT_195	[p12l1504t2598r1774b2660],
3	that	WDT	O	that	nsubj	4	SENT_195	[p12l1811t2581r1988b2660],
4	occurred	VBD	O	occur	rcmod	2	SENT_195	[p12l2017t2607r2148b2660, p12l11t2709r285b2788],
5	more	RBR	O	more	advmod	6	SENT_195	[p12l312t2735r530b2788],
6	frequently	RB	O	frequently	advmod	4	SENT_195	[p12l557t2709r990b2810],
7	in	IN	O	in	_	0	SENT_195	[p12l1012t2710r1096b2787],
8	the	DT	O	the	det	10	SENT_195	[p12l1123t2709r1254b2788],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_195	[p12l1281t2709r1652b2788],
10	group	NN	O	group	prep_in	4	SENT_195	[p12l1675t2735r1925b2810],
11	were	VBD	O	be	cop	12	SENT_195	[p12l1950t2735r2149b2788],
12	headache	NN	O	headache	_	0	SENT_195	[p12l10t2837r437b2933],
13	,	,	O	,	_	0	SENT_195	[p12l10t2837r437b2933],
14	upper	JJ	O	upper	amod	17	SENT_195	[p12l471t2863r722b2938],
15	respiratory	JJ	O	respiratory	amod	17	SENT_195	[p12l748t2838r1224b2938],
16	tract	NN	O	tract	nn	17	SENT_195	[p12l1249t2854r1449b2916],
17	infection	NN	O	infection	conj_and	12	SENT_195	[p12l1472t2837r1887b2933],
18	,	,	O	,	_	0	SENT_195	[p12l1472t2837r1887b2933],
19	nasal	JJ	O	nasal	amod	20	SENT_195	[p12l1921t2837r2150b2916],
20	congestion	NN	O	congestion	conj_and	12	SENT_195	[p12l11t2966r518b3066],
21	,	,	O	,	_	0	SENT_195	[p12l11t2966r518b3066],
22	rash	NN	O	rash	conj_and	12	SENT_195	[p12l571t2965r782b3061],
23	,	,	O	,	_	0	SENT_195	[p12l571t2965r782b3061],
24	and	CC	O	and	_	0	SENT_195	[p12l833t2965r994b3044],
25	dizziness	NN	O	dizziness	conj_and	12	SENT_195	[p12l1042t2965r1478b3061],
26	;	:	O	;	_	0	SENT_195	[p12l1042t2965r1478b3061],
27	none	NN	O	none	nsubjpass	32	SENT_195	[p12l1528t2991r1742b3044],
28	of	IN	O	of	_	0	SENT_195	[p12l1790t2965r1891b3044],
29	these	DT	O	these	det	30	SENT_195	[p12l1920t2965r2149b3044],
30	events	NNS	O	event	prep_of	27	SENT_195	[p12l11t3111r282b3175],
31	were	VBD	O	be	auxpass	32	SENT_195	[p12l328t3120r534b3175],
32	considered	VBN	O	consider	parataxis	12	SENT_195	[p12l584t3094r1061b3174],
33	to	TO	O	to	aux	35	SENT_195	[p12l1110t3111r1192b3174],
34	be	VB	O	be	cop	35	SENT_195	[p12l1243t3094r1341b3174],
35	serious	JJ	O	serious	xcomp	32	SENT_195	[p12l1391t3095r1702b3174],
36	or	CC	O	or	_	0	SENT_195	[p12l1753t3120r1843b3174],
37	led	VBN	O	lead	parataxis	12	SENT_195	[p12l1887t3094r2016b3174],
38	to	TO	O	to	_	0	SENT_195	[p12l2065t3111r2148b3174],
39	discontinuation	NN	O	discontinuation	prep_to	37	SENT_195	[p12l11t3223r712b3302],
40	of	IN	O	of	_	0	SENT_195	[p12l750t3223r852b3302],
41	the	DT	O	the	det	43	SENT_195	[p12l871t3223r1006b3302],
42	study	NN	O	study	nn	43	SENT_195	[p12l1046t3223r1282b3324],
43	drug	NN	O	drug	prep_of	39	SENT_195	[p12l1315t3223r1543b3324],
44	.	.	O	.	_	0	SENT_195	[p12l1315t3223r1543b3324],

1	N	NN	O	n	nn	3	SENT_196	[p12l545t3410r559b3425],
2	ENGLJ	NN	O	englj	nn	3	SENT_196	[p12l573t3410r651b3432],
3	MED	NN	O	med	_	0	SENT_196	[p12l666t3410r718b3425],
4	5	CD	NUMBER	5	dep	3	SENT_196	[p12l759t3404r804b3432],
5	;	:	O	;	_	0	SENT_196	[p12l759t3404r804b3432],
6	18	CD	NUMBER	18	num	8	SENT_196	[p12l759t3404r804b3432],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_196	[p12l839t3410r963b3432],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_196	[p12l1000t3410r1135b3426],
9	3,2011	CD	DATE	3,2011	number	10	SENT_196	[p12l1145t3410r1226b3432],
10	1667	CD	DATE	1667	dep	8	SENT_196	[p12l1940t3399r2016b3422],

1	e	LS	O	e	dep	4	SENT_197	[p12l739t3451r753b3467],
2	New	NNP	O	New	nn	4	SENT_197	[p12l762t3444r824b3467],
3	England	NNP	O	England	nn	4	SENT_197	[p12l833t3443r944b3474],
4	Journal	NNP	O	Journal	_	0	SENT_197	[p12l952t3443r1050b3467],
5	of	IN	O	of	prep	4	SENT_197	[p12l1059t3443r1088b3467],
6	Medicine	NNP	O	Medicine	dep	4	SENT_197	[p12l1095t3443r1220b3467],

1	Downloaded	VBN	O	download	_	0	SENT_198	[p12l144t3484r314b3507],
2	from	IN	O	from	_	0	SENT_198	[p12l323t3484r387b3507],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_198	[p12l396t3484r514b3514],
4	at	IN	O	at	_	0	SENT_198	[p12l524t3488r547b3507],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_198	[p12l556t3484r738b3507],
6	on	IN	O	on	_	0	SENT_198	[p12l748t3491r780b3507],
7	January	NNP	DATE	January	prep_on	1	SENT_198	[p12l789t3484r892b3514],
8	5	CD	DATE	5	num	7	SENT_198	[p12l902t3484r924b3512],
9	,	,	DATE	,	_	0	SENT_198	[p12l902t3484r924b3512],
10	2014	CD	DATE	2014	num	7	SENT_198	[p12l935t3484r1007b3507],
11	.	.	O	.	_	0	SENT_198	[p12l935t3484r1007b3507],

1	For	IN	O	for	_	0	SENT_199	[p12l1018t3484r1064b3507],
2	personal	JJ	O	personal	amod	3	SENT_199	[p12l1072t3484r1184b3514],
3	use	NN	O	use	pobj	1	SENT_199	[p12l1194t3491r1237b3507],
4	only	RB	O	only	advmod	3	SENT_199	[p12l1247t3484r1312b3514],
5	.	.	O	.	_	0	SENT_199	[p12l1247t3484r1312b3514],

1	No	DT	O	no	det	3	SENT_200	[p12l1322t3484r1362b3507],
2	other	JJ	O	other	amod	3	SENT_200	[p12l1372t3484r1440b3507],
3	uses	NNS	O	use	_	0	SENT_200	[p12l1448t3491r1504b3507],
4	without	IN	O	without	_	0	SENT_200	[p12l1515t3484r1616b3507],
5	permission	NN	O	permission	prep_without	3	SENT_200	[p12l1624t3484r1776b3514],
6	.	.	O	.	_	0	SENT_200	[p12l1624t3484r1776b3514],

1	Copyright	NN	O	copyright	_	0	SENT_201	[p12l494t3525r629b3556],
2	©	CD	NUMBER	©	num	6	SENT_201	[p12l638t3525r661b3549],
3	2011	CD	DATE	2011	num	6	SENT_201	[p12l671t3525r734b3549],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_201	[p12l746t3525r937b3549],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_201	[p12l947t3525r1055b3549],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_201	[p12l1065t3525r1170b3556],
7	.	.	O	.	_	0	SENT_201	[p12l1065t3525r1170b3556],

1	All	DT	O	all	det	2	SENT_202	[p12l1181t3525r1223b3549],
2	rights	NNS	O	rights	nsubj	3	SENT_202	[p12l1232t3525r1306b3556],
3	reserved	VBN	O	reserve	_	0	SENT_202	[p12l1316t3525r1435b3549],
4	.	.	O	.	_	0	SENT_202	[p12l1316t3525r1435b3549],

1	The	DT	O	the	det	4	SENT_203	[p12l816t3567r862b3588],
2	NEW	NNP	O	NEW	nn	4	SENT_203	[p12l880t3569r966b3588],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_203	[p12l985t3569r1173b3588],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_203	[p12l1192t3569r1372b3595],
5	of	IN	O	of	_	0	SENT_203	[p12l1391t3567r1419b3594],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_203	[p12l1432t3569r1630b3588],

1	Absolute	JJ	O	absolute	amod	2	SENT_204	[p13l139t450r162b563],
2	Change	NNP	O	Change	nsubj	7	SENT_204	[p13l139t343r170b441],
3	in	IN	O	in	_	0	SENT_204	[p13l139t312r162b334],
4	Percent	NN	O	percent	prep_in	2	SENT_204	[p13l141t205r162b300],
5	of	IN	O	of	_	0	SENT_204	[p13l174t467r198b496],
6	P	NN	O	p	prep_of	4	SENT_204	[p13l176t446r197b461],
7	ed	VBD	O	ed	_	0	SENT_204	[p13l174t406r198b435],
8	cted	JJ	O	cted	amod	10	SENT_204	[p13l174t344r198b396],
9	FEV1	NN	O	fev1	nn	10	SENT_204	[p13l176t273r206b332],
10	Proportion	NN	O	proportion	dobj	7	SENT_204	[p13l1169t461r1199b595],
11	of	IN	O	of	_	0	SENT_204	[p13l1168t421r1192b451],
12	Event-free	JJ	O	event-free	amod	13	SENT_204	[p13l1168t289r1192b416],
13	Subjects	NNS	O	subject	prep_of	10	SENT_204	[p13l1168t172r1199b280],

1	Day	NN	DURATION	day	nn	4	SENT_205	[p13l339t641r387b669],
2	Wk	NN	DURATION	wk	nn	4	SENT_205	[p13l423t638r464b662],
3	Wk	NN	DURATION	wk	nn	4	SENT_205	[p13l533t638r574b662],
4	Wk	NN	DURATION	wk	_	0	SENT_205	[p13l642t638r684b662],
5	Wk	NN	DURATION	wk	dep	4	SENT_205	[p13l752t638r793b662],
6	15	CD	NUMBER	15	num	5	SENT_205	[p13l348t676r376b697],
7	3	CD	DATE	3	number	8	SENT_205	[p13l437t675r451b698],
8	16	CD	DATE	16	num	10	SENT_205	[p13l540t676r569b698],
9	24	CD	DATE	24	number	10	SENT_205	[p13l648t676r679b697],
10	32	CD	DATE	32	dep	5	SENT_205	[p13l758t676r787b697],

1	O	NN	O	o	_	0	SENT_206	[p13l122t774r143b800],

1	I-H	NN	O	i-h	_	0	SENT_207	[p13l176t988r205b995],
2	.3	NN	NUMBER	.3	dep	1	SENT_207	[p13l178t997r198b1019],
3	.	.	O	.	_	0	SENT_207	[p13l175t1021r197b1042],

1	E	NN	O	e	_	0	SENT_208	[p13l175t1021r197b1042],
2	o	NN	O	o	nn	3	SENT_208	[p13l182t1044r198b1059],
3	n.	NN	O	n.	dep	1	SENT_208	[p13l182t1061r205b1075],
4	.	.	O	.	_	0	SENT_208	[p13l176t1077r205b1084],

1	.	.	O	.	_	0	SENT_209	[p13l176t1077r205b1084],

1	9	CD	NUMBER	9	_	0	SENT_210	[p13l182t1094r198b1118],
2	.	.	O	.	_	0	SENT_210	[p13l182t1094r198b1118],

1	’	NN	O	’	nn	2	SENT_211	[p13l182t1094r198b1118],
2	o	NN	O	o	_	0	SENT_211	[p13l182t1120r198b1135],
3	U	NNP	O	U	nn	4	SENT_211	[p13l182t1136r198b1149],
4	V	NNP	O	V	dep	2	SENT_211	[p13l176t1150r198b1165],
5	)	IN	O	)	amod	4	SENT_211	[p13l176t1150r198b1165],

1	N	NN	O	n	_	0	SENT_212	[p13l521t1277r589b1297],
2	=	JJ	O	=	amod	1	SENT_212	[p13l521t1277r589b1297],
3	57	CD	NUMBER	57	number	5	SENT_212	[p13l521t1277r589b1297],
4	N	NN	O	n	dep	5	SENT_212	[p13l630t1267r697b1287],
5	=	JJ	O	=	amod	1	SENT_212	[p13l630t1267r697b1287],
6	65	CD	NUMBER	65	num	7	SENT_212	[p13l630t1267r697b1287],
7	N	NN	O	n	npadvmod	10	SENT_212	[p13l740t1266r808b1286],
8	=	JJ	O	=	amod	7	SENT_212	[p13l740t1266r808b1286],
9	64	CD	NUMBER	64	tmod	8	SENT_212	[p13l740t1266r808b1286],
10	=	JJ	O	=	dep	1	SENT_212	[p13l872t1258r887b1265],

1	.5	RB	NUMBER	.5	dep	4	SENT_213	[p13l139t832r162b853],
2	as	IN	O	as	_	0	SENT_213	[p13l147t856r162b869],
3	E	NN	O	e	prep_as	1	SENT_213	[p13l147t872r162b894],
4	O	NN	O	o	dep	6	SENT_213	[p13l147t896r162b911],
5	9	CD	NUMBER	9	num	4	SENT_213	[p13l141t912r162b942],
6	E	NN	O	e	_	0	SENT_213	[p13l147t943r170b965],
7	‘	CD	NUMBER	‘	num	6	SENT_213	[p13l147t943r170b965],
8	3	CD	NUMBER	3	num	10	SENT_213	[p13l143t967r162b993],
9	E	NN	O	e	nn	10	SENT_213	[p13l139t993r162b1024],
10	D.	NNP	O	D.	dep	19	SENT_213	[p13l147t1026r169b1041],
11	in	IN	O	in	prep	10	SENT_213	[p13l146t1043r162b1056],
12	in	IN	O	in	pcomp	11	SENT_213	[p13l147t1057r162b1070],
13	X	NN	O	x	nn	16	SENT_213	[p13l141t1072r162b1087],
14	‘	CD	NUMBER	‘	num	16	SENT_213	[p13l141t1098r162b1123],
15	F	NN	O	f	nn	16	SENT_213	[p13l141t1098r162b1123],
16	O	NN	O	o	pobj	12	SENT_213	[p13l141t1125r169b1147],
17	’	CD	NUMBER	’	num	18	SENT_213	[p13l141t1125r169b1147],
18	u.	NN	O	u.	dep	19	SENT_213	[p13l141t1148r162b1162],
19	U	NNP	O	U	dep	25	SENT_213	[p13l141t1165r162b1182],
20	.5	CD	NUMBER	.5	num	19	SENT_213	[p13l139t1193r162b1214],
21	an	DT	O	a	det	23	SENT_213	[p13l147t1224r162b1237],
22	N	NN	O	n	nn	23	SENT_213	[p13l147t1238r170b1253],
23	)	NN	O	)	dep	19	SENT_213	[p13l147t1238r170b1253],
24	:	:	O	:	_	0	SENT_213	[p13l147t1256r162b1269],
25	as	IN	O	as	dep	6	SENT_213	[p13l147t1272r162b1285],
26	.	.	O	.	_	0	SENT_213	[p13l139t1288r162b1301],

1	:	:	O	:	_	0	SENT_214	[p13l139t1288r162b1301],
2	U	NNP	O	U	_	0	SENT_214	[p13l141t1304r162b1321],

1	Day	NN	DURATION	day	nn	3	SENT_215	[p13l339t1333r387b1361],
2	wk	NN	DURATION	wk	nn	3	SENT_215	[p13l423t1330r464b1354],
3	wk	NN	DURATION	wk	dep	15	SENT_215	[p13l533t1330r574b1354],
4	wk	NN	DURATION	wk	nn	11	SENT_215	[p13l642t1330r684b1354],
5	wk	NN	DURATION	wk	nn	11	SENT_215	[p13l752t1330r793b1354],
6	Wk	NN	DURATION	wk	nn	11	SENT_215	[p13l862t1330r903b1354],
7	wk	NN	DURATION	wk	nn	11	SENT_215	[p13l971t1330r1013b1354],
8	_	CD	NUMBER	_	num	11	SENT_215	[p13l1236t1313r1249b1315],
9	wk	NN	DURATION	wk	nn	11	SENT_215	[p13l1628t1330r1670b1354],
10	Wk	NN	ORGANIZATION	wk	nn	11	SENT_215	[p13l1738t1330r1779b1354],
11	Wk	NN	ORGANIZATION	wk	dep	3	SENT_215	[p13l1848t1330r1889b1354],
12	wk	NN	DURATION	wk	dep	15	SENT_215	[p13l1957t1330r1998b1354],
13	15	CD	NUMBER	15	num	12	SENT_215	[p13l348t1368r376b1389],
14	3	CD	DATE	3	num	15	SENT_215	[p13l437t1367r451b1390],
15	16	CD	DATE	16	dep	23	SENT_215	[p13l540t1368r569b1389],
16	24	CD	DATE	24	number	17	SENT_215	[p13l648t1368r679b1389],
17	32	CD	DATE	32	num	19	SENT_215	[p13l758t1368r787b1389],
18	40	CD	DATE	40	number	19	SENT_215	[p13l867t1367r898b1389],
19	43	CD	DATE	43	dep	15	SENT_215	[p13l977t1367r1007b1390],
20	24	CD	DATE	24	number	21	SENT_215	[p13l1634t1368r1665b1389],
21	32	CD	DATE	32	amod	19	SENT_215	[p13l1744t1368r1774b1389],
22	40	CD	DATE	40	num	23	SENT_215	[p13l1853t1367r1884b1389],
23	43	CD	DATE	43	_	0	SENT_215	[p13l1963t1367r1993b1390],

1	Figure	NNP	O	Figure	_	0	SENT_216	[p13l122t1456r206b1488],
2	1	CD	NUMBER	1	dep	1	SENT_216	[p13l218t1458r240b1480],
3	.	.	O	.	_	0	SENT_216	[p13l218t1458r240b1480],

1	Changes	NNS	O	change	nsubj	7	SENT_217	[p13l251t1455r370b1488],
2	from	IN	O	from	_	0	SENT_217	[p13l380t1455r445b1480],
3	Baseline	NN	O	baseline	prep_from	1	SENT_217	[p13l458t1455r573b1480],
4	in	IN	O	in	_	0	SENT_217	[p13l584t1456r607b1480],
5	Percent	NN	O	percent	prep_in	3	SENT_217	[p13l621t1458r724b1480],
6	of	IN	O	of	prep	5	SENT_217	[p13l734t1455r766b1480],
7	Predicted	VBN	O	predict	_	0	SENT_217	[p13l772t1455r901b1480],
8	FEV1	NN	O	fev1	dobj	7	SENT_217	[p13l915t1458r986b1486],
9	,	,	O	,	_	0	SENT_217	[p13l915t1458r986b1486],
10	Respiratory	JJ	O	respiratory	amod	11	SENT_217	[p13l999t1456r1156b1488],
11	Symptoms	NNS	O	symptom	conj_and	8	SENT_217	[p13l1166t1457r1321b1488],
12	,	,	O	,	_	0	SENT_217	[p13l1166t1457r1321b1488],
13	and	CC	O	and	_	0	SENT_217	[p13l1332t1455r1382b1480],
14	Weight	NNP	O	Weight	dobj	7	SENT_217	[p13l1393t1455r1499b1488],
15	,	,	O	,	_	0	SENT_217	[p13l1393t1455r1499b1488],
16	and	CC	O	and	_	0	SENT_217	[p13l1510t1455r1559b1480],
17	Time	NNP	O	Time	conj_and	8	SENT_217	[p13l1570t1456r1640b1480],
18	to	TO	O	to	_	0	SENT_217	[p13l1649t1459r1677b1480],
19	the	DT	O	the	det	22	SENT_217	[p13l1686t1455r1731b1480],
20	First	NNP	ORDINAL	First	nn	22	SENT_217	[p13l1743t1456r1804b1480],
21	Pulmonary	NNP	O	Pulmonary	nn	22	SENT_217	[p13l1815t1455r1964b1488],
22	Exacerbation	NNP	O	Exacerbation	prep_to	17	SENT_217	[p13l121t1497r307b1527],
23	,	,	O	,	_	0	SENT_217	[p13l121t1497r307b1527],
24	According	VBG	O	accord	_	0	SENT_217	[p13l317t1497r457b1530],
25	to	TO	O	to	prepc_according_to	7	SENT_217	[p13l466t1501r494b1522],
26	Study	NNP	O	Study	nn	27	SENT_217	[p13l504t1497r583b1530],
27	Group	NNP	O	Group	pobj	7	SENT_217	[p13l592t1499r687b1530],
28	.	.	O	.	_	0	SENT_217	[p13l592t1499r687b1530],

1	Panel	NN	O	panel	nn	2	SENT_218	[p13l122t1547r193b1572],
2	A	NN	O	a	nsubj	3	SENT_218	[p13l205t1549r224b1572],
3	shows	VBZ	O	show	_	0	SENT_218	[p13l236t1547r321b1572],
4	the	DT	O	the	det	7	SENT_218	[p13l332t1547r375b1572],
5	absolute	JJ	O	absolute	amod	7	SENT_218	[p13l387t1547r503b1572],
6	mean	JJ	O	mean	amod	7	SENT_218	[p13l516t1556r589b1572],
7	change	NN	O	change	dobj	3	SENT_218	[p13l602t1547r700b1580],
8	from	IN	O	from	_	0	SENT_218	[p13l711t1547r775b1572],
9	baseline	NN	O	baseline	prep_from	3	SENT_218	[p13l789t1547r901b1572],
10	in	IN	O	in	_	0	SENT_218	[p13l913t1549r934b1572],
11	the	DT	O	the	det	12	SENT_218	[p13l946t1547r990b1572],
12	percent	NN	O	percent	prep_in	9	SENT_218	[p13l1002t1552r1105b1580],
13	of	IN	O	of	_	0	SENT_218	[p13l1116t1547r1145b1572],
14	predicted	VBN	O	predict	prepc_of	12	SENT_218	[p13l1153t1547r1282b1580],
15	forced	JJ	O	forced	amod	17	SENT_218	[p13l1294t1547r1379b1572],
16	expiratory	JJ	O	expiratory	amod	17	SENT_218	[p13l1391t1549r1529b1580],
17	volume	NN	O	volume	dobj	14	SENT_218	[p13l1539t1547r1640b1572],
18	in	IN	O	in	_	0	SENT_218	[p13l1653t1549r1674b1572],
19	1	CD	DURATION	1	num	21	SENT_218	[p13l1689t1549r1700b1572],
20	second	JJ	NUMBER	second	amod	21	SENT_218	[p13l1713t1547r1809b1572],
21	(	NN	O	(	prep_in	17	SENT_218	[p13l1825t1549r1917b1580],
22	FEV1	NN	O	fev1	nn	23	SENT_218	[p13l1825t1549r1917b1580],
23	)	NN	O	)	dep	21	SENT_218	[p13l1825t1549r1917b1580],
24	,	,	O	,	_	0	SENT_218	[p13l1825t1549r1917b1580],
25	through	IN	O	through	_	0	SENT_218	[p13l1928t1547r2037b1580],
26	week	NN	DURATION	week	prep_through	14	SENT_218	[p13l119t1589r189b1614],
27	48	CD	NUMBER	48	num	26	SENT_218	[p13l199t1590r239b1614],
28	.	.	O	.	_	0	SENT_218	[p13l199t1590r239b1614],

1	Panel	NN	O	panel	nn	2	SENT_219	[p13l254t1589r325b1614],
2	B	NN	O	b	nsubj	3	SENT_219	[p13l340t1591r355b1613],
3	shows	VBZ	O	show	_	0	SENT_219	[p13l368t1589r453b1614],
4	the	DT	O	the	det	5	SENT_219	[p13l464t1589r508b1614],
5	time	NN	O	time	dobj	3	SENT_219	[p13l518t1591r580b1614],
6	to	TO	O	to	_	0	SENT_219	[p13l590t1593r617b1614],
7	the	DT	O	the	det	10	SENT_219	[p13l628t1589r671b1614],
8	first	JJ	ORDINAL	first	amod	10	SENT_219	[p13l682t1588r738b1614],
9	pulmonary	JJ	O	pulmonary	amod	10	SENT_219	[p13l750t1589r899b1622],
10	exacerbation	NN	O	exacerbation	prep_to	3	SENT_219	[p13l910t1589r1094b1618],
11	,	,	O	,	_	0	SENT_219	[p13l910t1589r1094b1618],
12	expressed	VBN	O	express	partmod	10	SENT_219	[p13l1106t1589r1243b1621],
13	as	IN	O	as	mark	15	SENT_219	[p13l1256t1597r1284b1614],
14	estimates	NNS	O	estimate	nsubj	15	SENT_219	[p13l1296t1591r1429b1614],
15	ofthe	VBP	O	ofthe	advcl	12	SENT_219	[p13l1441t1588r1520b1614],
16	pr	NN	O	pr	nn	17	SENT_219	[p13l1533t1597r1560b1621],
17	rtion	NN	O	rtion	dobj	15	SENT_219	[p13l1618t1591r1681b1614],
18	of	IN	O	of	_	0	SENT_219	[p13l1694t1588r1724b1614],
19	subjects	NNS	O	subject	prep_of	17	SENT_219	[p13l1731t1589r1845b1622],
20	free	JJ	O	free	amod	10	SENT_219	[p13l1856t1588r1908b1614],
21	from	IN	O	from	_	0	SENT_219	[p13l1919t1588r1983b1614],
22	events	NNS	O	event	prep_from	20	SENT_219	[p13l120t1635r217b1655],
23	.	.	O	.	_	0	SENT_219	[p13l120t1635r217b1655],

1	Panel	NN	O	panel	nn	2	SENT_220	[p13l231t1630r303b1655],
2	C	NN	O	c	nsubj	3	SENT_220	[p13l316t1632r334b1655],
3	shows	VBZ	O	show	_	0	SENT_220	[p13l346t1630r431b1655],
4	the	DT	O	the	det	7	SENT_220	[p13l443t1630r486b1655],
5	absolute	JJ	O	absolute	amod	7	SENT_220	[p13l498t1630r615b1655],
6	mean	JJ	O	mean	amod	7	SENT_220	[p13l627t1639r701b1655],
7	change	NN	O	change	dobj	3	SENT_220	[p13l714t1630r812b1663],
8	from	IN	O	from	_	0	SENT_220	[p13l823t1630r888b1655],
9	baseline	NN	O	baseline	prep_from	3	SENT_220	[p13l902t1630r1014b1655],
10	in	IN	O	in	_	0	SENT_220	[p13l1026t1633r1048b1655],
11	the	DT	O	the	det	12	SENT_220	[p13l1060t1630r1103b1655],
12	score	NN	NUMBER	score	prep_in	3	SENT_220	[p13l1115t1639r1188b1655],
13	on	IN	O	on	_	0	SENT_220	[p13l1199t1639r1231b1655],
14	the	DT	O	the	det	16	SENT_220	[p13l1243t1630r1287b1655],
15	respiratory	JJ	O	respiratory	amod	16	SENT_220	[p13l1299t1633r1448b1663],
16	domai	NN	O	domaus	prep_on	12	SENT_220	[p13l1459t1630r1544b1655],
17	the	DT	O	the	det	20	SENT_220	[p13l1611t1630r1654b1655],
18	Cystic	JJ	MISC	cystic	amod	20	SENT_220	[p13l1666t1632r1746b1663],
19	Fibrosis	NNP	MISC	Fibrosis	nn	20	SENT_220	[p13l1759t1630r1865b1655],
20	Questionnaire	NNP	MISC	Questionnaire	dobj	3	SENT_220	[p13l1877t1632r2016b1662, p13l121t1672r306b1697],
21	—	CD	NUMBER	—	num	20	SENT_220	[p13l1877t1632r2016b1662, p13l121t1672r306b1697],
22	revised	VBN	O	revise	partmod	20	SENT_220	[p13l1877t1632r2016b1662, p13l121t1672r306b1697],
23	Q-R	NN	O	q-r	nn	24	SENT_220	[p13l369t1674r440b1705],
24	)	NN	O	)	dobj	22	SENT_220	[p13l369t1674r440b1705],
25	,	,	O	,	_	0	SENT_220	[p13l369t1674r440b1705],
26	a	DT	O	a	det	28	SENT_220	[p13l454t1681r466b1697],
27	quality-of-life	JJ	O	quality-of-life	amod	28	SENT_220	[p13l478t1672r660b1705],
28	questionnaire	NN	O	questionnaire	appos	24	SENT_220	[p13l672t1674r862b1705],
29	that	WDT	O	that	nsubjpass	31	SENT_220	[p13l872t1672r927b1697],
30	is	VBZ	O	be	auxpass	31	SENT_220	[p13l939t1674r958b1697],
31	scored	VBN	O	score	rcmod	28	SENT_220	[p13l971t1672r1060b1697],
32	on	IN	O	on	_	0	SENT_220	[p13l1073t1681r1106b1697],
33	a	DT	O	a	det	35	SENT_220	[p13l1119t1681r1131b1697],
34	100-point	JJ	O	100-point	amod	35	SENT_220	[p13l1145t1674r1278b1705],
35	scale	NN	O	scale	prep_on	31	SENT_220	[p13l1290t1672r1365b1702],
36	,	,	O	,	_	0	SENT_220	[p13l1290t1672r1365b1702],
37	with	IN	O	with	_	0	SENT_220	[p13l1377t1672r1434b1697],
38	higher	JJR	O	higher	amod	39	SENT_220	[p13l1448t1672r1535b1705],
39	numbers	NNS	O	number	prep_with	31	SENT_220	[p13l1546t1672r1668b1697],
40	indicating	VBG	O	indicate	partmod	39	SENT_220	[p13l1681t1672r1818b1705],
41	a	DT	O	a	det	43	SENT_220	[p13l1829t1681r1841b1697],
42	lower	JJR	O	lower	amod	43	SENT_220	[p13l1855t1672r1929b1697],
43	effect	NN	O	effect	dobj	40	SENT_220	[p13l1939t1672r2017b1697],
44	of	IN	O	of	_	0	SENT_220	[p13l120t1713r150b1739],
45	symptoms	NNS	O	symptom	prep_of	43	SENT_220	[p13l157t1718r301b1747],
46	he	PRP	O	he	dep	45	SENT_220	[p13l371t1714r402b1739],
47	patient	NN	O	patient	poss	50	SENT_220	[p13l414t1716r532b1746],
48	’s	POS	O	’s	_	0	SENT_220	[p13l414t1716r532b1746],
49	quality	NN	O	quality	nn	50	SENT_220	[p13l544t1714r637b1747],
50	oflife	NN	O	oflife	dep	46	SENT_220	[p13l647t1713r731b1739],
51	.	.	O	.	_	0	SENT_220	[p13l647t1713r731b1739],

1	The	DT	O	the	det	3	SENT_221	[p13l742t1714r794b1739],
2	established	VBN	O	establish	amod	3	SENT_221	[p13l805t1714r962b1739],
3	minimum	NN	O	minimum	_	0	SENT_221	[p13l976t1716r1109b1739],
4	clinically	RB	O	clinically	advmod	5	SENT_221	[p13l1122t1714r1240b1747],
5	important	JJ	O	important	amod	3	SENT_221	[p13l1252t1716r1391b1746],
6	difference	NN	O	difference	dep	3	SENT_221	[p13l1402t1713r1540b1739],
7	for	IN	O	for	_	0	SENT_221	[p13l1551t1713r1589b1739],
8	the	DT	O	the	det	9	SENT_221	[p13l1599t1714r1642b1739],
9	CF	NN	O	cf	prep_for	6	SENT_221	[p13l1654t1716r1689b1739],
10	-	:	O	-	_	0	SENT_221	[p13l1718t1716r1745b1738],
11	R	NN	O	r	nn	13	SENT_221	[p13l1718t1716r1745b1738],
12	respiratory	JJ	O	respiratory	amod	13	SENT_221	[p13l1758t1716r1907b1747],
13	domain	NN	O	domain	dep	3	SENT_221	[p13l1917t1714r2021b1739],
14	is	VBZ	O	be	cop	16	SENT_221	[p13l121t1758r140b1780],
15	4	CD	NUMBER	4	num	16	SENT_221	[p13l152t1758r166b1780],
16	points	NNS	O	point	rcmod	13	SENT_221	[p13l179t1758r273b1788],
17	.	.	O	.	_	0	SENT_221	[p13l179t1758r273b1788],

1	Panel	NN	O	panel	nn	2	SENT_222	[p13l287t1755r359b1780],
2	D	NN	O	d	nsubj	3	SENT_222	[p13l374t1758r393b1780],
3	shows	VBZ	O	show	_	0	SENT_222	[p13l405t1755r491b1780],
4	the	DT	O	the	det	7	SENT_222	[p13l502t1755r545b1780],
5	absolute	JJ	O	absolute	amod	7	SENT_222	[p13l557t1755r674b1780],
6	mean	NN	O	mean	nn	7	SENT_222	[p13l687t1764r761b1780],
7	ch	NN	O	ch	dobj	3	SENT_222	[p13l773t1755r803b1780],
8	from	IN	O	from	_	0	SENT_222	[p13l882t1755r947b1780],
9	baseline	NN	O	baseline	prep_from	3	SENT_222	[p13l961t1755r1073b1780],
10	in	IN	O	in	_	0	SENT_222	[p13l1086t1758r1107b1780],
11	weight	NN	O	weight	prep_in	9	SENT_222	[p13l1119t1755r1219b1788],
12	,	,	O	,	_	0	SENT_222	[p13l1119t1755r1219b1788],
13	through	IN	O	through	_	0	SENT_222	[p13l1231t1755r1339b1788],
14	week	NN	DURATION	week	prep_through	3	SENT_222	[p13l1351t1755r1421b1780],
15	48	CD	NUMBER	48	num	14	SENT_222	[p13l1431t1757r1472b1781],
16	.	.	O	.	_	0	SENT_222	[p13l1431t1757r1472b1781],

1	The	DT	O	the	det	2	SENT_223	[p13l1483t1755r1534b1780],
2	values	NNS	O	value	nsubj	9	SENT_223	[p13l1545t1755r1631b1780],
3	a	DT	O	a	det	7	SENT_223	[p13l1644t1764r1657b1780],
4	he	PRP	O	he	amod	7	SENT_223	[p13l1717t1755r1748b1780],
5	95	CD	PERCENT	95	num	6	SENT_223	[p13l1759t1756r1818b1782],
6	%	NN	PERCENT	%	dep	4	SENT_223	[p13l1759t1756r1818b1782],
7	confidence	NN	O	confidence	dep	2	SENT_223	[p13l1830t1755r1982b1780],
8	intervals	NNS	O	interval	dep	2	SENT_223	[p13l121t1797r237b1822],
9	(	VBP	O	(	_	0	SENT_223	[p13l252t1797r388b1830],
10	indicated	VBN	O	indicate	dep	9	SENT_223	[p13l252t1797r388b1830],
11	by	IN	O	by	_	0	SENT_223	[p13l402t1797r431b1830],
12	I	PRP	O	I	dep	13	SENT_223	[p13l441t1800r450b1822],
13	bars	NNS	O	bar	prep_by	10	SENT_223	[p13l462t1797r527b1830],
14	)	RB	O	)	advmod	10	SENT_223	[p13l462t1797r527b1830],
15	in	IN	O	in	_	0	SENT_223	[p13l543t1799r564b1822],
16	Panels	NNP	O	Panels	nn	17	SENT_223	[p13l579t1797r667b1822],
17	A	NNP	O	A	prep_in	10	SENT_223	[p13l678t1799r705b1827],
18	,	,	O	,	_	0	SENT_223	[p13l678t1799r705b1827],
19	C	NNP	O	C	appos	17	SENT_223	[p13l718t1799r744b1827],
20	,	,	O	,	_	0	SENT_223	[p13l718t1799r744b1827],
21	and	CC	O	and	_	0	SENT_223	[p13l757t1797r805b1822],
22	re	VB	O	re	conj_and	10	SENT_223	[p13l868t1806r892b1822],
23	unadjusted	JJ	O	unadjusted	dobj	22	SENT_223	[p13l904t1797r1066b1830],
24	.	.	O	.	_	0	SENT_223	[p13l904t1797r1066b1830],

1	The	DT	O	the	det	4	SENT_224	[p13l1077t1797r1129b1822],
2	first	JJ	ORDINAL	first	amod	4	SENT_224	[p13l1139t1797r1195b1822],
3	data	NN	O	datum	nn	4	SENT_224	[p13l1206t1797r1265b1822],
4	points	NNS	O	point	nsubj	15	SENT_224	[p13l1278t1799r1363b1830],
5	in	IN	O	in	_	0	SENT_224	[p13l1376t1799r1398b1822],
6	Panels	NNP	O	Panels	nn	7	SENT_224	[p13l1413t1797r1500b1822],
7	A	NNP	O	A	prep_in	4	SENT_224	[p13l1511t1799r1539b1827],
8	,	,	O	,	_	0	SENT_224	[p13l1511t1799r1539b1827],
9	C	NNP	O	C	prep_in	4	SENT_224	[p13l1552t1799r1577b1827],
10	,	,	O	,	_	0	SENT_224	[p13l1552t1799r1577b1827],
11	and	CC	O	and	_	0	SENT_224	[p13l1591t1797r1639b1822],
12	D	NN	O	d	prep_in	4	SENT_224	[p13l1654t1799r1673b1822],
13	are	VBP	O	be	cop	15	SENT_224	[p13l1685t1806r1725b1822],
14	baseline	NN	O	baseline	nn	15	SENT_224	[p13l1738t1797r1850b1822],
15	data	NNS	O	datum	_	0	SENT_224	[p13l1862t1797r1928b1822],
16	.	.	O	.	_	0	SENT_224	[p13l1862t1797r1928b1822],

1	A	DT	O	a	det	2	SENT_225	[p13l138t2064r205b2134],
2	total	NN	O	total	nsubjpass	9	SENT_225	[p13l247t2056r445b2135],
3	of	IN	O	of	_	0	SENT_225	[p13l491t2055r591b2135],
4	53	CD	NUMBER	53	num	7	SENT_225	[p13l620t2062r713b2135],
5	serious	JJ	O	serious	amod	7	SENT_225	[p13l764t2057r1067b2135],
6	adverse	JJ	O	adverse	amod	7	SENT_225	[p13l1114t2056r1430b2135],
7	events	NNS	O	event	prep_of	2	SENT_225	[p13l1477t2073r1742b2135],
8	were	VBD	O	be	auxpass	9	SENT_225	[p13l1784t2082r1987b2135],
9	reported	VBN	O	report	_	0	SENT_225	[p13l2033t2082r2147b2134, p13l11t2183r295b2283],

1	over	IN	O	over	_	0	SENT_226	[p13l341t2209r520b2263],
2	the	DT	O	the	det	3	SENT_226	[p13l562t2183r696b2261],
3	course	NN	O	course	pobj	1	SENT_226	[p13l742t2209r1023b2262],
4	of	IN	O	of	_	0	SENT_226	[p13l1069t2182r1169b2262],
5	the	DT	O	the	det	7	SENT_226	[p13l1196t2183r1330b2261],
6	treatment	NN	O	treatment	nn	7	SENT_226	[p13l1375t2200r1801b2261],
7	period	NN	O	period	prep_of	3	SENT_226	[p13l1840t2183r2143b2283],
8	.	.	O	.	_	0	SENT_226	[p13l1840t2183r2143b2283],

1	There	EX	O	there	expl	2	SENT_227	[p13l8t2312r254b2390],
2	was	VBD	O	be	_	0	SENT_227	[p13l290t2338r454b2391],
3	a	DT	O	a	det	5	SENT_227	[p13l495t2338r539b2390],
4	lower	JJR	O	lower	amod	5	SENT_227	[p13l577t2312r816b2391],
5	rate	NN	O	rate	nsubj	2	SENT_227	[p13l853t2329r1014b2390],
6	of	IN	O	of	_	0	SENT_227	[p13l1055t2311r1155b2391],
7	serious	JJ	O	serious	amod	9	SENT_227	[p13l1178t2313r1482b2391],
8	adverse	JJ	O	adverse	amod	9	SENT_227	[p13l1523t2312r1839b2391],
9	events	NNS	O	event	prep_of	5	SENT_227	[p13l1880t2329r2145b2391],
10	in	IN	O	in	_	0	SENT_227	[p13l11t2441r95b2518],
11	the	DT	O	the	det	13	SENT_227	[p13l131t2440r265b2519],
12	ivacaftor	NN	O	ivacaftor	nn	13	SENT_227	[p13l300t2439r679b2520],
13	group	NN	O	group	prep_in	9	SENT_227	[p13l712t2466r965b2542],
14	than	IN	O	than	prep	2	SENT_227	[p13l1004t2440r1201b2519],
15	in	IN	O	in	pcomp	14	SENT_227	[p13l1236t2441r1320b2518],
16	the	DT	O	the	det	18	SENT_227	[p13l1357t2440r1490b2519],
17	placebo	NN	O	placebo	nn	18	SENT_227	[p13l1525t2440r1856b2541],
18	group	NN	O	group	pobj	15	SENT_227	[p13l1893t2466r2147b2542],

1	(	NN	O	(	_	0	SENT_228	[p13l17t2574r227b2660],
2	24	CD	PERCENT	24	num	3	SENT_228	[p13l17t2574r227b2660],
3	%	NN	PERCENT	%	dep	1	SENT_228	[p13l17t2574r227b2660],
4	vs.	CC	O	vs.	_	0	SENT_228	[p13l264t2595r374b2648],
5	42	CD	PERCENT	42	num	6	SENT_228	[p13l420t2574r656b2660],
6	%	NN	PERCENT	%	dep	1	SENT_228	[p13l420t2574r656b2660],
7	)	CD	NUMBER	)	dep	6	SENT_228	[p13l420t2574r656b2660],
8	.	.	O	.	_	0	SENT_228	[p13l420t2574r656b2660],

1	Pulmonary	JJ	O	pulmonary	amod	2	SENT_229	[p13l703t2569r1185b2669],
2	exacerbation	NN	O	exacerbation	_	0	SENT_229	[p13l1223t2569r1772b2648],
3	and	CC	O	and	_	0	SENT_229	[p13l1813t2569r1972b2648],
4	hemoptysis	NN	O	hemoptysis	conj_and	2	SENT_229	[p13l2014t2569r2147b2647, p13l12t2698r397b2797],

1	occurred	VBD	O	occur	_	0	SENT_230	[p13l441t2697r819b2776],
2	more	RBR	O	more	advmod	3	SENT_230	[p13l860t2723r1080b2776],
3	frequently	RB	O	frequently	advmod	1	SENT_230	[p13l1121t2696r1560b2797],
4	in	IN	O	in	_	0	SENT_230	[p13l1596t2698r1679b2775],
5	the	DT	O	the	det	6	SENT_230	[p13l1721t2697r1853b2775],
6	placebo	NN	O	placebo	prep_in	1	SENT_230	[p13l1893t2697r2147b2797, p13l12t2826r116b2906],

1	group	NN	O	group	_	0	SENT_231	[p13l150t2852r404b2928],
2	than	IN	O	than	dep	1	SENT_231	[p13l438t2826r636b2905],
3	in	IN	O	in	_	0	SENT_231	[p13l668t2827r752b2904],
4	the	DT	O	the	det	6	SENT_231	[p13l785t2826r919b2905],
5	ivacaftor	NN	O	ivacaftor	nn	6	SENT_231	[p13l951t2825r1329b2906],
6	group	NN	O	group	prep_in	2	SENT_231	[p13l1358t2852r1635b2928],
7	.	.	O	.	_	0	SENT_231	[p13l1358t2852r1635b2928],

1	There	EX	O	there	expl	2	SENT_232	[p13l1670t2826r1916b2905],
2	were	VBD	O	be	_	0	SENT_232	[p13l1945t2852r2148b2906],
3	no	DT	O	no	det	4	SENT_232	[p13l12t2981r118b3035],
4	cases	NNS	O	case	nsubj	2	SENT_232	[p13l161t2982r385b3034],
5	of	IN	O	of	_	0	SENT_232	[p13l429t2954r530b3035],
6	hypoglycemia	NN	O	hypoglycemia	prep_of	4	SENT_232	[p13l552t2955r1154b3057],
7	in	IN	O	in	_	0	SENT_232	[p13l1193t2956r1277b3033],
8	the	DT	O	the	det	10	SENT_232	[p13l1318t2955r1452b3034],
9	placebo	NN	O	placebo	nn	10	SENT_232	[p13l1492t2955r1823b3056],
10	group	NN	O	group	prep_in	6	SENT_232	[p13l1866t2981r2143b3057],
11	,	,	O	,	_	0	SENT_232	[p13l1866t2981r2143b3057],

1	Whereas	IN	O	whereas	mark	3	SENT_233	[p13l7t3084r361b3163],
2	there	EX	O	there	expl	3	SENT_233	[p13l420t3084r637b3162],
3	were	VBD	O	be	_	0	SENT_233	[p13l688t3110r891b3163],
4	two	CD	NUMBER	two	num	5	SENT_233	[p13l948t3101r1106b3163],
5	cases	NNS	O	case	nsubj	3	SENT_233	[p13l1164t3110r1387b3162],
6	in	IN	O	in	_	0	SENT_233	[p13l1444t3085r1528b3162],
7	the	DT	O	the	det	9	SENT_233	[p13l1584t3084r1717b3162],
8	ivacaftor	NN	O	ivacaftor	nn	9	SENT_233	[p13l1772t3083r2151b3163],
9	group	NN	O	group	prep_in	5	SENT_233	[p13l12t3238r290b3314],
10	:	:	O	:	_	0	SENT_233	[p13l12t3238r290b3314],
11	one	CD	NUMBER	one	nsubj	24	SENT_233	[p13l342t3238r494b3292],
12	of	IN	O	of	_	0	SENT_233	[p13l542t3211r642b3292],
13	the	DT	O	the	det	14	SENT_233	[p13l672t3212r806b3291],
14	subjects	NNS	O	subject	prep_of	11	SENT_233	[p13l854t3212r1195b3313],
15	had	VBD	O	have	rcmod	9	SENT_233	[p13l1244t3212r1402b3292],
16	diabetes	NN	O	diabetes	dobj	15	SENT_233	[p13l1449t3212r1805b3292],
17	related	JJ	O	related	amod	16	SENT_233	[p13l1855t3212r2148b3292],
18	to	TO	O	to	_	0	SENT_233	[p13l12t3358r94b3421],
19	the	DT	O	the	det	21	SENT_233	[p13l141t3341r274b3420],
20	cystic	JJ	O	cystic	amod	21	SENT_233	[p13l320t3342r559b3442],
21	fibrosis	NN	O	fibrosis	prep_to	17	SENT_233	[p13l602t3340r928b3421],
22	and	CC	O	and	_	0	SENT_233	[p13l974t3341r1133b3421],
23	was	VBD	O	be	aux	24	SENT_233	[p13l1173t3368r1336b3421],
24	receiving	VBG	O	receive	rcmod	9	SENT_233	[p13l1382t3342r1775b3443],
25	insulin	NN	O	insulin	dobj	24	SENT_233	[p13l1815t3341r2142b3438],
26	,	,	O	,	_	0	SENT_233	[p13l1815t3341r2142b3438],

1	and	CC	O	and	dep	3	SENT_234	[p13l11t3469r168b3548],
2	the	DT	O	the	det	3	SENT_234	[p13l199t3469r331b3547],
3	other	JJ	O	other	_	0	SENT_234	[p13l363t3469r588b3548],
4	had	VBD	O	have	aux	5	SENT_234	[p13l616t3469r771b3548],
5	had	VBN	O	have	rcmod	3	SENT_234	[p13l801t3469r957b3548],
6	previous	JJ	O	previous	amod	7	SENT_234	[p13l986t3470r1344b3569],
7	episodes	NNS	O	episode	dobj	5	SENT_234	[p13l1378t3469r1742b3569],
8	of	IN	O	of	_	0	SENT_234	[p13l1775t3468r1875b3548],
9	symptoms	NNS	O	symptom	prep_of	7	SENT_234	[p13l1888t3495r2147b3569, p13l12t3615r223b3678],

1	suggestive	JJ	O	suggestive	_	0	SENT_235	[p13l268t3599r707b3700],
2	of	IN	O	of	_	0	SENT_235	[p13l749t3597r849b3678],
3	hypoglycemia	NN	O	hypoglycemia	prep_of	1	SENT_235	[p13l873t3598r1486b3700],
4	.	.	O	.	_	0	SENT_235	[p13l873t3598r1486b3700],

1	No	DT	O	no	det	2	SENT_236	[p13l1531t3606r1655b3678],
2	deaths	NNS	O	death	nsubj	3	SENT_236	[p13l1699t3598r1975b3678],
3	occurred	VBD	O	occur	_	0	SENT_236	[p13l2020t3624r2147b3678, p14l12t20r288b99],

1	during	IN	O	during	_	0	SENT_237	[p14l331t20r618b121],
2	the	DT	O	the	det	3	SENT_237	[p14l658t20r790b98],
3	study	NN	O	study	pobj	1	SENT_237	[p14l835t20r1075b120],
4	.	.	O	.	_	0	SENT_237	[p14l835t20r1075b120],

1	No	DT	O	no	det	4	SENT_238	[p14l1122t28r1247b99],
2	clinically	RB	O	clinically	advmod	3	SENT_238	[p14l1292t20r1678b120],
3	important	JJ	O	important	amod	4	SENT_238	[p14l1716t21r2153b120],
4	trends	NNS	O	trend	nsubjpass	9	SENT_238	[p14l12t148r276b227],
5	attributable	JJ	O	attributable	amod	4	SENT_238	[p14l316t148r807b227],
6	to	TO	O	to	_	0	SENT_238	[p14l846t165r927b227],
7	ivacaftor	NN	O	ivacaftor	prep_to	5	SENT_238	[p14l966t147r1336b227],
8	were	VBD	O	be	auxpass	9	SENT_238	[p14l1367t174r1566b227],
9	identiﬁed	VBN	O	identiﬁed	_	0	SENT_238	[p14l1605t147r2014b227],
10	in	IN	O	in	_	0	SENT_238	[p14l2052t149r2134b226],
11	clinical	JJ	O	clinical	amod	13	SENT_238	[p14l12t276r317b353],
12	laboratory	NN	O	laboratory	nn	13	SENT_238	[p14l345t276r780b375],
13	tests	NNS	O	test	prep_in	9	SENT_238	[p14l806t292r994b354],
14	(	JJ	O	(	amod	16	SENT_238	[p14l1031t282r1319b366],
15	serum	NN	O	serum	nn	16	SENT_238	[p14l1031t282r1319b366],
16	chemical	NN	O	chemical	dep	13	SENT_238	[p14l1350t276r1748b371],
17	,	,	O	,	_	0	SENT_238	[p14l1350t276r1748b371],
18	hematologic	JJ	O	hematologic	prep_in	9	SENT_238	[p14l1783t276r2132b354, p14l11t404r242b505],
19	,	,	O	,	_	0	SENT_238	[p14l1783t276r2132b354, p14l11t404r242b505],
20	and	CC	O	and	_	0	SENT_238	[p14l282t404r439b483],
21	coagulation	NN	O	coagulation	nn	22	SENT_238	[p14l474t404r985b505],
22	tests	NNS	O	test	conj_and	18	SENT_238	[p14l1020t421r1214b482],
23	and	CC	O	and	_	0	SENT_238	[p14l1250t404r1408b483],
24	urinalysis	NN	O	urinalysis	nn	25	SENT_238	[p14l1442t404r1911b504],
25	)	NN	O	)	prep_in	9	SENT_238	[p14l1442t404r1911b504],
26	,	,	O	,	_	0	SENT_238	[p14l1442t404r1911b504],
27	vital	JJ	O	vital	amod	28	SENT_238	[p14l1947t404r2134b483],
28	signs	NNS	O	sign	conj_or	25	SENT_238	[p14l13t533r259b633],
29	,	,	O	,	_	0	SENT_238	[p14l13t533r259b633],
30	digital	JJ	O	digital	amod	33	SENT_238	[p14l300t532r577b633],
31	or	CC	O	or	_	0	SENT_238	[p14l612t558r700b611],
32	ambulatory	JJ	O	ambulatory	amod	33	SENT_238	[p14l732t532r1231b632],
33	electrocardiograms	NNS	O	electrocardiogram	conj_or	25	SENT_238	[p14l1262t532r2129b633],
34	,	,	O	,	_	0	SENT_238	[p14l1262t532r2129b633],
35	or	CC	O	or	_	0	SENT_238	[p14l12t685r100b738],
36	physical	JJ	O	physical	amod	37	SENT_238	[p14l133t660r477b759],
37	examinations	NNS	O	examination	conj_and	13	SENT_238	[p14l515t661r1112b738],
38	.	.	O	.	_	0	SENT_238	[p14l515t661r1112b738],

1	DISCUSSION	NN	O	discussion	_	0	SENT_239	[p14l734t956r1412b1015],

1	In	IN	O	in	_	0	SENT_240	[p14l11t1180r99b1250],
2	this	DT	O	this	prep_in	20	SENT_240	[p14l136t1173r295b1250],
3	randomized	VBN	O	randomize	partmod	2	SENT_240	[p14l333t1173r877b1268],
4	,	,	O	,	_	0	SENT_240	[p14l333t1173r877b1268],
5	placebo	NN	O	placebo	nn	6	SENT_240	[p14l917t1173r1726b1272],
6	—	NN	O	—	nsubjpass	20	SENT_240	[p14l917t1173r1726b1272],
7	controlled	VBN	O	control	partmod	6	SENT_240	[p14l917t1173r1726b1272],
8	trial	NN	O	trial	dobj	7	SENT_240	[p14l1762t1173r1963b1268],
9	,	,	O	,	_	0	SENT_240	[p14l1762t1173r1963b1268],
10	administration	NN	O	administration	appos	6	SENT_240	[p14l2003t1173r2133b1251, p14l12t1301r553b1379],
11	of	IN	O	of	_	0	SENT_240	[p14l588t1299r688b1379],
12	ivacaftor	NN	O	ivacaftor	prep_of	10	SENT_240	[p14l703t1299r1097b1396],
13	,	,	O	,	_	0	SENT_240	[p14l703t1299r1097b1396],
14	an	DT	O	a	det	17	SENT_240	[p14l1136t1326r1239b1378],
15	oral	JJ	O	oral	amod	17	SENT_240	[p14l1273t1300r1439b1379],
16	CFTR	NN	ORGANIZATION	cftr	nn	17	SENT_240	[p14l1472t1306r1724b1384],
17	potentiator	NN	O	potentiator	appos	6	SENT_240	[p14l1746t1301r2133b1400, p14l12t1446r149b1525],
18	,	,	O	,	_	0	SENT_240	[p14l1746t1301r2133b1400, p14l12t1446r149b1525],
19	was	VBD	O	be	auxpass	20	SENT_240	[p14l179t1455r340b1508],
20	associated	VBN	O	associate	_	0	SENT_240	[p14l369t1429r804b1508],
21	with	IN	O	with	_	0	SENT_240	[p14l828t1429r1021b1508],
22	significant	JJ	O	significant	amod	23	SENT_240	[p14l1050t1428r1508b1530],
23	improvements	NNS	O	improvement	prep_with	20	SENT_240	[p14l1530t1430r2132b1529],
24	in	IN	O	in	_	0	SENT_240	[p14l11t1558r95b1634],
25	primary	JJ	O	primary	amod	29	SENT_240	[p14l131t1558r481b1656],
26	and	CC	O	and	_	0	SENT_240	[p14l513t1557r670b1635],
27	secondary	JJ	O	secondary	conj_and	25	SENT_240	[p14l709t1557r1147b1656],
28	end	NN	O	end	nn	29	SENT_240	[p14l1181t1557r1333b1635],
29	points	NNS	O	point	prep_in	23	SENT_240	[p14l1369t1558r1639b1656],
30	in	IN	O	in	_	0	SENT_240	[p14l1677t1558r1761b1634],
31	persons	NNS	O	person	prep_in	29	SENT_240	[p14l1797t1583r2132b1656],
32	with	IN	O	with	_	0	SENT_240	[p14l7t1684r203b1763],
33	cystic	JJ	O	cystic	amod	34	SENT_240	[p14l241t1685r478b1784],
34	fibrosis	NN	O	fibrosis	prep_with	20	SENT_240	[p14l515t1683r839b1763],
35	who	WP	O	who	nsubj	36	SENT_240	[p14l875t1684r1057b1764],
36	had	VBD	O	have	rcmod	34	SENT_240	[p14l1097t1684r1253b1763],
37	at	IN	O	at	quantmod	39	SENT_240	[p14l1289t1701r1368b1762],
38	least	JJS	O	least	mwe	37	SENT_240	[p14l1400t1684r1599b1762],
39	one	CD	NUMBER	one	num	40	SENT_240	[p14l1632t1710r1783b1763],
40	copy	NN	O	copy	dobj	36	SENT_240	[p14l1822t1710r2019b1784],
41	of	IN	O	of	_	0	SENT_240	[p14l2053t1683r2152b1763],
42	the	DT	O	the	det	43	SENT_240	[p14l12t1813r143b1891],
43	G551D	NN	O	g551d	prep_of	40	SENT_240	[p14l173t1820r672b1893],
44	.	.	O	.	_	0	SENT_240	[p14l173t1820r672b1893],

1	—	NN	O	—	_	0	SENT_241	[p14l173t1820r672b1893],
2	.	.	O	.	_	0	SENT_241	[p14l173t1820r672b1893],

1	CFTR	NN	ORGANIZATION	cftr	_	0	SENT_242	[p14l173t1820r672b1893],
2	mutation	NN	O	mutation	dep	1	SENT_242	[p14l694t1814r1103b1892],
3	.	.	O	.	_	0	SENT_242	[p14l694t1814r1103b1892],

1	Progressive	JJ	O	progressive	amod	2	SENT_243	[p14l1137t1814r1616b1914],
2	loss	NN	O	loss	_	0	SENT_243	[p14l1645t1813r1806b1892],
3	of	IN	O	of	_	0	SENT_243	[p14l1838t1812r1937b1892],
4	lung	NN	O	lung	prep_of	2	SENT_243	[p14l1947t1813r2137b1914],

1	1668	CD	DATE	1668	_	0	SENT_244	[p14l149t1989r224b2012],
2	MBER	NNP	O	MBER	dep	1	SENT_244	[p14l1463t2000r1527b2015],
3	3	CD	NUMBER	3	num	2	SENT_244	[p14l1537t2000r1555b2022],
4	,	,	O	,	_	0	SENT_244	[p14l1537t2000r1555b2022],
5	2011	CD	DATE	2011	num	2	SENT_244	[p14l1567t2000r1618b2016],

1	N	NN	O	n	nn	3	SENT_245	[p14l937t2000r951b2015],
2	ENGLJ	NN	O	englj	nn	3	SENT_245	[p14l965t2000r1043b2022],
3	MED	NN	O	med	_	0	SENT_245	[p14l1058t2000r1110b2015],
4	365	CD	NUMBER	365	dep	3	SENT_245	[p14l1120t1994r1196b2022],
5	;	:	O	;	_	0	SENT_245	[p14l1120t1994r1196b2022],
6	18	CD	NUMBER	18	num	8	SENT_245	[p14l1120t1994r1196b2022],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_245	[p14l1231t2000r1355b2022],
8	NOVE	NNP	O	NOVE	dep	3	SENT_245	[p14l1392t2000r1458b2016],
9	The	DT	O	the	det	12	SENT_245	[p14l935t2033r986b2057],
10	New	NNP	O	New	nn	12	SENT_245	[p14l995t2034r1057b2057],
11	England	NNP	O	England	nn	12	SENT_245	[p14l1066t2033r1177b2064],
12	Journal	NNP	O	Journal	dep	8	SENT_245	[p14l1186t2033r1283b2057],
13	of	IN	O	of	_	0	SENT_245	[p14l1293t2033r1322b2057],
14	Medicine	NNP	O	Medicine	prep_of	8	SENT_245	[p14l1329t2033r1454b2057],

1	Downloaded	VBN	O	download	_	0	SENT_246	[p14l377t2074r547b2097],
2	from	IN	O	from	_	0	SENT_246	[p14l556t2074r621b2097],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_246	[p14l629t2074r748b2104],
4	at	IN	O	at	_	0	SENT_246	[p14l758t2078r781b2097],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_246	[p14l789t2074r972b2097],
6	on	IN	O	on	_	0	SENT_246	[p14l981t2081r1014b2097],
7	Januaiy	NNP	DATE	Januaiy	prep_on	1	SENT_246	[p14l1022t2074r1125b2104],
8	5	CD	DATE	5	num	7	SENT_246	[p14l1135t2074r1158b2101],
9	,	,	DATE	,	_	0	SENT_246	[p14l1135t2074r1158b2101],
10	2014	CD	DATE	2014	num	7	SENT_246	[p14l1168t2074r1241b2097],
11	.	.	O	.	_	0	SENT_246	[p14l1168t2074r1241b2097],

1	For	IN	O	for	_	0	SENT_247	[p14l1251t2074r1298b2097],
2	personal	JJ	O	personal	amod	3	SENT_247	[p14l1306t2074r1418b2104],
3	use	NN	O	use	pobj	1	SENT_247	[p14l1427t2081r1471b2097],
4	only	RB	O	only	advmod	3	SENT_247	[p14l1480t2074r1545b2104],
5	.	.	O	.	_	0	SENT_247	[p14l1480t2074r1545b2104],

1	No	DT	O	no	det	3	SENT_248	[p14l1556t2074r1595b2097],
2	other	JJ	O	other	amod	3	SENT_248	[p14l1605t2074r1673b2097],
3	uses	NNS	O	use	_	0	SENT_248	[p14l1682t2081r1738b2097],
4	without	IN	O	without	_	0	SENT_248	[p14l1748t2074r1849b2097],
5	permission	NN	O	permission	prep_without	3	SENT_248	[p14l1857t2074r2010b2104],
6	.	.	O	.	_	0	SENT_248	[p14l1857t2074r2010b2104],

1	Copyright	NN	O	copyright	_	0	SENT_249	[p14l728t2115r862b2146],
2	©	CD	NUMBER	©	num	6	SENT_249	[p14l871t2115r895b2139],
3	2011	CD	DATE	2011	num	6	SENT_249	[p14l905t2115r967b2139],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_249	[p14l979t2115r1170b2139],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_249	[p14l1180t2115r1288b2139],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_249	[p14l1299t2115r1404b2146],
7	.	.	O	.	_	0	SENT_249	[p14l1299t2115r1404b2146],

1	All	DT	O	all	det	2	SENT_250	[p14l1415t2115r1456b2139],
2	rights	NNS	O	rights	nsubj	3	SENT_250	[p14l1465t2115r1540b2146],
3	reserved	VBN	O	reserve	_	0	SENT_250	[p14l1550t2115r1668b2139],
4	.	.	O	.	_	0	SENT_250	[p14l1550t2115r1668b2139],

1	A	DT	O	a	det	3	SENT_251	[p14l715t2221r734b2240],
2	CFTR	NNP	O	CFTR	nn	3	SENT_251	[p14l747t2221r831b2240],
3	POTENTIATOR	NNP	O	POTENTIATOR	_	0	SENT_251	[p14l844t2221r1082b2240],
4	FOR	IN	O	for	_	0	SENT_251	[p14l1095t2221r1159b2240],
5	CYSTIC	NNP	O	CYSTIC	nn	6	SENT_251	[p14l1171t2221r1282b2240],
6	FIBROSIS	NNP	O	FIBROSIS	prep_for	3	SENT_251	[p14l1297t2221r1445b2240],

1	function	NN	O	function	nsubj	15	SENT_252	[p14l10t2435r379b2516],
2	is	VBZ	O	be	cop	5	SENT_252	[p14l422t2437r487b2514],
3	a	DT	O	a	det	5	SENT_252	[p14l531t2462r576b2514],
4	major	JJ	O	major	amod	5	SENT_252	[p14l617t2437r869b2536],
5	source	NN	O	source	ccomp	34	SENT_252	[p14l909t2462r1189b2516],
6	of	IN	O	of	_	0	SENT_252	[p14l1232t2435r1334b2515],
7	illness	NN	O	illness	prep_of	5	SENT_252	[p14l1357t2436r1634b2514],
8	in	IN	O	in	_	0	SENT_252	[p14l1678t2437r1762b2514],
9	patients	NNS	O	patient	prep_in	7	SENT_252	[p14l1803t2437r2147b2536],
10	with	IN	O	with	_	0	SENT_252	[p14l6t2565r196b2645],
11	cystic	JJ	O	cystic	amod	12	SENT_252	[p14l237t2566r465b2665],
12	fibrosis	NN	O	fibrosis	prep_with	9	SENT_252	[p14l506t2564r840b2661],
13	,	,	O	,	_	0	SENT_252	[p14l506t2564r840b2661],
14	and	CC	O	and	_	0	SENT_252	[p14l885t2565r1040b2644],
15	decreased	VBD	O	decrease	conj_and	5	SENT_252	[p14l1081t2565r1489b2644],
16	FEV1	NN	O	fev1	nsubjpass	18	SENT_252	[p14l1528t2573r1720b2669],
17	is	VBZ	O	be	auxpass	18	SENT_252	[p14l1761t2566r1825b2643],
18	associated	VBN	O	associate	ccomp	15	SENT_252	[p14l1867t2566r2148b2644, p14l10t2693r183b2772],
19	with	IN	O	with	_	0	SENT_252	[p14l203t2693r394b2773],
20	an	DT	O	a	det	22	SENT_252	[p14l418t2719r520b2771],
21	increased	VBN	O	increase	amod	22	SENT_252	[p14l544t2693r939b2772],
22	risk	NN	O	risk	prep_with	18	SENT_252	[p14l964t2693r1123b2773],
23	of	IN	O	of	_	0	SENT_252	[p14l1145t2692r1243b2772],
24	death	NN	O	death	prep_of	22	SENT_252	[p14l1250t2693r1537b2772],
25	.5	CD	NUMBER	.5	num	24	SENT_252	[p14l1250t2693r1537b2772],
26	Consequently	RB	O	consequently	advmod	22	SENT_252	[p14l1566t2693r2144b2793],
27	,	,	O	,	_	0	SENT_252	[p14l1566t2693r2144b2793],
28	FEV1	NN	O	fev1	nsubj	34	SENT_252	[p14l9t2830r207b2926],
29	has	VBZ	O	have	aux	34	SENT_252	[p14l244t2822r388b2900],
30	been	VBN	O	be	cop	34	SENT_252	[p14l428t2822r630b2901],
31	a	DT	O	a	det	34	SENT_252	[p14l666t2848r711b2900],
32	key	JJ	O	key	amod	34	SENT_252	[p14l746t2822r892b2922],
33	end	NN	O	end	nn	34	SENT_252	[p14l924t2822r1078b2901],
34	point	NN	O	point	_	0	SENT_252	[p14l1113t2823r1345b2923],
35	for	IN	O	for	_	0	SENT_252	[p14l1376t2821r1500b2901],
36	the	DT	O	the	det	37	SENT_252	[p14l1534t2822r1668b2901],
37	evaluation	NN	O	evaluation	prep_for	34	SENT_252	[p14l1705t2822r2150b2902],
38	of	IN	O	of	_	0	SENT_252	[p14l11t2949r110b3029],
39	new	JJ	O	new	amod	40	SENT_252	[p14l123t2976r300b3030],
40	therapies	NNS	O	therapy	prep_of	37	SENT_252	[p14l327t2950r712b3050],
41	for	IN	O	for	_	0	SENT_252	[p14l745t2949r867b3029],
42	cystic	JJ	O	cystic	amod	43	SENT_252	[p14l895t2951r1130b3050],
43	fibrosis	NN	O	fibrosis	prep_for	34	SENT_252	[p14l1160t2949r1504b3029],
44	.	.	O	.	_	0	SENT_252	[p14l1160t2949r1504b3029],

1	Inhaled	VBN	O	inhale	_	0	SENT_253	[p14l1539t2950r1866b3029],
2	tobra	NN	O	tobra	nn	4	SENT_253	[p14l1896t2950r2148b3029],
3	—	NN	O	—	nn	4	SENT_253	[p14l1896t2950r2148b3029],
4	mycin	NN	O	mycin	dobj	1	SENT_253	[p14l10t3080r293b3179],
5	,	,	O	,	_	0	SENT_253	[p14l10t3080r293b3179],
6	as	IN	O	as	mark	12	SENT_253	[p14l327t3105r413b3157],
7	compared	VBN	O	compare	prep	12	SENT_253	[p14l444t3079r875b3179],
8	with	IN	O	with	pcomp	7	SENT_253	[p14l899t3079r1096b3159],
9	placebo	NN	O	placebo	pobj	8	SENT_253	[p14l1123t3079r1477b3179],
10	,	,	O	,	_	0	SENT_253	[p14l1123t3079r1477b3179],
11	was	VBD	O	be	auxpass	12	SENT_253	[p14l1507t3105r1671b3158],
12	associated	VBN	O	associate	dep	4	SENT_253	[p14l1701t3079r2149b3158],
13	with	IN	O	with	_	0	SENT_253	[p14l6t3207r205b3287],
14	a	DT	O	a	det	17	SENT_253	[p14l252t3233r297b3285],
15	12	CD	PERCENT	12	number	16	SENT_253	[p14l345t3212r534b3286],
16	%	NN	PERCENT	%	amod	17	SENT_253	[p14l345t3212r534b3286],
17	increase	NN	O	increase	prep_with	12	SENT_253	[p14l579t3208r942b3285],
18	in	IN	O	in	_	0	SENT_253	[p14l989t3208r1074b3285],
19	the	DT	O	the	det	20	SENT_253	[p14l1121t3207r1257b3285],
20	improvement	NN	O	improvement	prep_in	17	SENT_253	[p14l1303t3208r1893b3307],
21	from	IN	O	from	_	0	SENT_253	[p14l1934t3206r2150b3286],
22	baseline	NN	O	baseline	prep_from	12	SENT_253	[p14l11t3336r373b3415],
23	in	IN	O	in	_	0	SENT_253	[p14l412t3337r497b3414],
24	FEV1	NN	O	fev1	prep_in	22	SENT_253	[p14l535t3344r737b3440],
25	at	IN	O	at	_	0	SENT_253	[p14l774t3353r855b3414],
26	20	CD	NUMBER	20	num	27	SENT_253	[p14l889t3342r991b3415],
27	W	NN	O	w	prep_at	1	SENT_253	[p14l1026t3336r1396b3431],
28	€	CD	MONEY	€	num	30	SENT_253	[p14l1026t3336r1396b3431],
29	€	NN	MONEY	€	nn	30	SENT_253	[p14l1026t3336r1396b3431],
30	l	NN	O	l	npadvmod	31	SENT_253	[p14l1026t3336r1396b3431],
31	<	JJR	O	<	amod	27	SENT_253	[p14l1026t3336r1396b3431],
32	S17	CD	NUMBER	s17	tmod	1	SENT_253	[p14l1026t3336r1396b3431],
33	;	:	O	;	_	0	SENT_253	[p14l1026t3336r1396b3431],
34	dornase	NN	O	dornase	nn	35	SENT_253	[p14l1440t3336r1790b3415],
35	alfa	NN	O	alfa	nsubjpass	43	SENT_253	[p14l1829t3335r2016b3432],
36	,	,	O	,	_	0	SENT_253	[p14l1829t3335r2016b3432],
37	as	IN	O	as	mark	35	SENT_253	[p14l2060t3362r2147b3414],
38	compared	VBN	O	compare	_	0	SENT_253	[p14l11t3465r440b3565],
39	with	IN	O	with	_	0	SENT_253	[p14l488t3465r685b3544],
40	placebo	NN	O	placebo	prep_compared_with	35	SENT_253	[p14l736t3465r1090b3565],
41	,	,	O	,	_	0	SENT_253	[p14l736t3465r1090b3565],
42	was	VBD	O	be	auxpass	43	SENT_253	[p14l1144t3491r1308b3544],
43	associated	VBN	O	associate	conj_and	1	SENT_253	[p14l1362t3465r1810b3544],
44	with	IN	O	with	_	0	SENT_253	[p14l1857t3465r2054b3545],
45	a	DT	O	a	det	48	SENT_253	[p14l2106t3491r2151b3543],
46	5.8	CD	PERCENT	5.8	num	48	SENT_253	[p14l12t3599r226b3674],
47	%	NN	PERCENT	%	nn	48	SENT_253	[p14l12t3599r226b3674],
48	improvement	NN	O	improvement	prep_with	43	SENT_253	[p14l260t3595r838b3694],
49	in	IN	O	in	_	0	SENT_253	[p14l869t3595r953b3672],
50	FEV1	NN	O	fev1	prep_in	48	SENT_253	[p14l987t3602r1186b3698],
51	after	IN	O	after	_	0	SENT_253	[p14l1221t3593r1425b3673],
52	24	CD	DURATION	24	num	53	SENT_253	[p14l1458t3600r1556b3673],
53	weeks	NNS	NUMBER	week	prep_after	43	SENT_253	[p14l1588t3594r1951b3689],
54	“	CD	NUMBER	“	dep	53	SENT_253	[p14l1588t3594r1951b3689],
55	;	:	O	;	_	0	SENT_253	[p14l1588t3594r1951b3689],
56	and	CC	O	and	_	0	SENT_253	[p14l1990t3594r2149b3673],
57	hypertonic	JJ	O	hypertonic	amod	58	SENT_253	[p15l10t19r477b119],
58	saline	NN	O	saline	nsubjpass	60	SENT_253	[p15l508t19r761b97],
59	was	VBD	O	be	auxpass	60	SENT_253	[p15l787t45r951b99],
60	associated	VBN	O	associate	conj_and	1	SENT_253	[p15l983t19r1431b98],
61	with	IN	O	with	_	0	SENT_253	[p15l1457t19r1654b98],
62	a	DT	O	a	det	65	SENT_253	[p15l1684t45r1729b97],
63	3.2	CD	PERCENT	3.2	num	65	SENT_253	[p15l1759t24r1973b98],
64	%	NN	PERCENT	%	nn	65	SENT_253	[p15l1759t24r1973b98],
65	improvement	NN	O	improvement	prep_with	60	SENT_253	[p15l2003t20r2148b97, p15l8t165r462b249],
66	in	IN	O	in	_	0	SENT_253	[p15l483t149r566b226],
67	FEV1	NN	O	fev1	prep_in	65	SENT_253	[p15l592t156r787b252],
68	after	IN	O	after	_	0	SENT_253	[p15l814t147r1013b226],
69	48	CD	NUMBER	48	num	70	SENT_253	[p15l1036t154r1136b227],
70	W	NN	O	w	prep_after	67	SENT_253	[p15l1161t148r1519b228],
71	€	CD	MONEY	€	num	73	SENT_253	[p15l1161t148r1519b228],
72	€	NN	MONEY	€	nn	73	SENT_253	[p15l1161t148r1519b228],
73	l	NN	O	l	npadvmod	74	SENT_253	[p15l1161t148r1519b228],
74	<	JJR	O	<	amod	70	SENT_253	[p15l1161t148r1519b228],
75	S.	NNP	O	S.	tmod	60	SENT_253	[p15l1161t148r1519b228],
76	18	CD	NUMBER	18	num	75	SENT_253	[p15l1161t148r1519b228],
77	The	DT	O	the	det	78	SENT_253	[p15l1544t148r1703b227],
78	standards	NNS	O	standard	nsubj	84	SENT_253	[p15l1732t148r2147b227],
79	for	IN	O	for	_	0	SENT_253	[p15l10t276r134b357],
80	managing	VBG	O	manage	amod	82	SENT_253	[p15l175t278r620b379],
81	cystic	JJ	O	cystic	amod	82	SENT_253	[p15l661t278r901b378],
82	fibrosis	NN	O	fibrosis	prep_for	78	SENT_253	[p15l944t276r1271b357],
83	have	VBP	O	have	aux	84	SENT_253	[p15l1318t277r1509b357],
84	changed	VBN	O	change	rcmod	75	SENT_253	[p15l1554t277r1919b379],
85	considerably	RB	O	considerably	advmod	84	SENT_253	[p15l1964t303r2148b357, p15l11t406r389b506],
86	over	IN	O	over	_	0	SENT_253	[p15l414t432r590b485],
87	the	DT	DURATION	the	det	90	SENT_253	[p15l616t406r748b484],
88	past	JJ	DURATION	past	amod	90	SENT_253	[p15l775t423r955b506],
89	two	CD	DURATION	two	num	90	SENT_253	[p15l978t423r1135b485],
90	decades	NNS	DURATION	decade	prep_over	84	SENT_253	[p15l1166t406r1595b485],
91	.	.	O	.	_	0	SENT_253	[p15l1166t406r1595b485],

1	”	NN	O	”	nsubj	8	SENT_254	[p15l1166t406r1595b485],
2	The	DT	O	the	det	3	SENT_254	[p15l1621t406r1781b484],
3	subjects	NNS	O	subject	dep	1	SENT_254	[p15l1812t406r2147b506],
4	in	IN	O	in	_	0	SENT_254	[p15l10t535r93b612],
5	the	DT	O	the	det	7	SENT_254	[p15l123t534r256b612],
6	current	JJ	DATE	current	amod	7	SENT_254	[p15l287t551r602b614],
7	study	NN	O	study	prep_in	1	SENT_254	[p15l627t534r858b634],
8	received	VBD	O	receive	_	0	SENT_254	[p15l882t534r1229b614],
9	the	DT	O	the	det	10	SENT_254	[p15l1258t534r1392b612],
10	standard	NN	O	standard	dobj	8	SENT_254	[p15l1423t534r1803b613],
11	of	IN	O	of	_	0	SENT_254	[p15l1833t533r1933b613],
12	care	NN	O	care	prep_of	10	SENT_254	[p15l1945t560r2144b630],
13	,	,	O	,	_	0	SENT_254	[p15l1945t560r2144b630],
14	with	IN	O	with	_	0	SENT_254	[p15l6t662r202b742],
15	the	DT	O	the	det	16	SENT_254	[p15l245t662r378b740],
16	exception	NN	O	exception	prep_with	8	SENT_254	[p15l421t663r835b762],
17	of	IN	O	of	_	0	SENT_254	[p15l878t661r979b741],
18	hypertonic	JJ	O	hypertonic	amod	20	SENT_254	[p15l1002t662r1469b762],
19	saline	NN	O	saline	nn	20	SENT_254	[p15l1511t662r1764b740],
20	therapy	NN	O	therapy	prep_of	16	SENT_254	[p15l1807t662r2144b762],
21	.	.	O	.	_	0	SENT_254	[p15l1807t662r2144b762],

1	In	IN	O	in	_	0	SENT_255	[p15l8t799r98b869],
2	the	DT	DATE	the	det	3	SENT_255	[p15l126t791r260b870],
3	year	NN	DATE	year	prep_in	16	SENT_255	[p15l283t817r464b892],
4	before	IN	DATE	before	_	0	SENT_255	[p15l489t790r759b871],
5	the	DT	O	the	det	6	SENT_255	[p15l787t791r921b870],
6	study	NN	O	study	prep_before	3	SENT_255	[p15l950t791r1182b892],
7	and	CC	O	and	_	0	SENT_255	[p15l1203t791r1363b871],
8	during	IN	O	during	_	0	SENT_255	[p15l1391t791r1682b893],
9	the	DT	O	the	det	10	SENT_255	[p15l1706t791r1840b870],
10	course	NN	O	course	prep_during	3	SENT_255	[p15l1868t817r2149b871],
11	of	IN	O	of	_	0	SENT_255	[p15l11t918r111b998],
12	the	DT	O	the	det	13	SENT_255	[p15l122t919r256b997],
13	study	NN	O	study	prep_of	10	SENT_255	[p15l287t919r531b1019],
14	,	,	O	,	_	0	SENT_255	[p15l287t919r531b1019],
15	subjects	NNS	O	subject	nsubj	16	SENT_255	[p15l567t919r909b1019],
16	received	VBD	O	receive	_	0	SENT_255	[p15l940t919r1288b998],
17	dornase	NN	O	dornase	nn	18	SENT_255	[p15l1318t919r1661b998],
18	alfa	NN	O	alfa	nsubj	21	SENT_255	[p15l1689t918r1850b997],
19	(	CD	PERCENT	(	number	20	SENT_255	[p15l1882t924r2144b1015],
20	69	CD	PERCENT	69	num	21	SENT_255	[p15l1882t924r2144b1015],
21	%	NN	PERCENT	%	xcomp	16	SENT_255	[p15l1882t924r2144b1015],
22	)	CD	NUMBER	)	dep	21	SENT_255	[p15l1882t924r2144b1015],
23	,	,	O	,	_	0	SENT_255	[p15l1882t924r2144b1015],
24	oral	JJ	O	oral	amod	26	SENT_255	[p15l11t1048r178b1127],
25	azithromycin	NN	O	azithromycin	nn	26	SENT_255	[p15l207t1048r781b1148],
26	(	NN	O	(	appos	21	SENT_255	[p15l817t1053r1076b1144],
27	63	CD	PERCENT	63	number	28	SENT_255	[p15l817t1053r1076b1144],
28	%	NN	PERCENT	%	amod	26	SENT_255	[p15l817t1053r1076b1144],
29	)	CD	NUMBER	)	dep	26	SENT_255	[p15l817t1053r1076b1144],
30	,	,	O	,	_	0	SENT_255	[p15l817t1053r1076b1144],
31	and	CC	O	and	_	0	SENT_255	[p15l1111t1048r1270b1127],
32	inhaled	VBD	O	inhale	conj_and	16	SENT_255	[p15l1301t1048r1626b1127],
33	tobramycin	NN	O	tobramycin	dobj	32	SENT_255	[p15l1657t1048r2149b1148],
34	(	CD	PERCENT	(	num	33	SENT_255	[p15l15t1181r279b1267],
35	39	CD	PERCENT	39	number	36	SENT_255	[p15l15t1181r279b1267],
36	%	NN	PERCENT	%	amod	33	SENT_255	[p15l15t1181r279b1267],
37	)	CD	NUMBER	)	dobj	16	SENT_255	[p15l15t1181r279b1267],
38	.	.	O	.	_	0	SENT_255	[p15l15t1181r279b1267],

1	When	WRB	O	when	advmod	2	SENT_256	[p15l318t1176r574b1254],
2	added	VBN	O	add	advcl	15	SENT_256	[p15l611t1176r867b1255],
3	to	TO	O	to	_	0	SENT_256	[p15l904t1193r987b1255],
4	these	DT	O	these	det	5	SENT_256	[p15l1025t1176r1250b1254],
5	therapies	NNS	O	therapy	prep_to	2	SENT_256	[p15l1288t1176r1705b1276],
6	,	,	O	,	_	0	SENT_256	[p15l1288t1176r1705b1276],
7	ivacaftor	NN	O	ivacaftor	nsubjpass	15	SENT_256	[p15l1747t1175r2144b1272],
8	,	,	O	,	_	0	SENT_256	[p15l1747t1175r2144b1272],
9	as	IN	O	as	mark	7	SENT_256	[p15l10t1331r96b1383],
10	compared	VBN	O	compare	_	0	SENT_256	[p15l131t1305r560b1405],
11	with	IN	O	with	_	0	SENT_256	[p15l588t1305r785b1385],
12	placebo	NN	O	placebo	prep_compared_with	7	SENT_256	[p15l816t1305r1170b1405],
13	,	,	O	,	_	0	SENT_256	[p15l816t1305r1170b1405],
14	was	VBD	O	be	auxpass	15	SENT_256	[p15l1204t1331r1368b1384],
15	associated	VBN	O	associate	_	0	SENT_256	[p15l1402t1305r1850b1384],
16	with	IN	O	with	_	0	SENT_256	[p15l1878t1305r2075b1384],
17	a	DT	O	a	det	19	SENT_256	[p15l2106t1331r2151b1383],
18	relative	JJ	O	relative	amod	19	SENT_256	[p15l10t1434r321b1514],
19	improvement	NN	O	improvement	prep_with	15	SENT_256	[p15l354t1435r932b1534],
20	of	IN	O	of	_	0	SENT_256	[p15l962t1433r1062b1513],
21	17.2	CD	PERCENT	17.2	num	22	SENT_256	[p15l1080t1440r1333b1514],
22	%	NN	PERCENT	%	prep_of	19	SENT_256	[p15l1080t1440r1333b1514],
23	in	IN	O	in	_	0	SENT_256	[p15l1365t1435r1449b1512],
24	FEV1	NN	O	fev1	prep_in	22	SENT_256	[p15l1481t1442r1680b1538],
25	over	IN	O	over	_	0	SENT_256	[p15l1713t1460r1893b1514],
26	baseline	NN	O	baseline	nn	27	SENT_256	[p15l1924t1434r2148b1513, p15l9t1563r169b1641],
27	values	NNS	O	value	prep_over	24	SENT_256	[p15l210t1563r474b1642],
28	at	IN	O	at	_	0	SENT_256	[p15l521t1580r600b1641],
29	24	CD	DURATION	24	num	30	SENT_256	[p15l639t1569r738b1642],
30	weeks	NNS	NUMBER	week	prep_at	15	SENT_256	[p15l778t1563r1066b1659],
31	,	,	O	,	_	0	SENT_256	[p15l778t1563r1066b1659],
32	a	DT	O	a	det	33	SENT_256	[p15l1116t1589r1161b1641],
33	change	NN	O	change	appos	30	SENT_256	[p15l1205t1563r1512b1664],
34	that	WDT	O	that	nsubjpass	36	SENT_256	[p15l1557t1563r1732b1641],
35	was	VBD	O	be	auxpass	36	SENT_256	[p15l1767t1589r1930b1642],
36	sustained	VBN	O	sustain	rcmod	33	SENT_256	[p15l1979t1589r2148b1642, p15l11t1690r282b1769],
37	to	TO	O	to	_	0	SENT_256	[p15l328t1707r411b1769],
38	48	CD	DURATION	48	num	39	SENT_256	[p15l456t1696r559b1769],
39	Weeks	NNS	DURATION	week	prep_to	36	SENT_256	[p15l601t1690r890b1770],
40	.	.	O	.	_	0	SENT_256	[p15l601t1690r890b1770],

1	Nearly	RB	O	nearly	quantmod	2	SENT_257	[p15l939t1690r1224b1790],
2	75	CD	PERCENT	75	num	3	SENT_257	[p15l1266t1696r1450b1769],
3	%	NN	PERCENT	%	nsubj	12	SENT_257	[p15l1266t1696r1450b1769],
4	of	IN	O	of	_	0	SENT_257	[p15l1496t1689r1596b1769],
5	the	DT	O	the	det	6	SENT_257	[p15l1625t1690r1758b1768],
6	subjects	NNS	O	subject	prep_of	3	SENT_257	[p15l1805t1690r2147b1790],
7	who	WP	O	who	nsubjpass	9	SENT_257	[p15l6t1820r190b1900],
8	were	VBD	O	be	auxpass	9	SENT_257	[p15l225t1846r429b1900],
9	treated	VBN	O	treat	rcmod	6	SENT_257	[p15l467t1820r768b1900],
10	with	IN	O	with	_	0	SENT_257	[p15l801t1820r998b1900],
11	ivacaftor	NN	O	ivacaftor	prep_with	9	SENT_257	[p15l1036t1819r1414b1900],
12	had	VBD	O	have	_	0	SENT_257	[p15l1449t1820r1607b1900],
13	a	DT	O	a	det	15	SENT_257	[p15l1644t1847r1689b1899],
14	mean	JJ	O	mean	amod	15	SENT_257	[p15l1726t1846r1964b1899],
15	improvement	NN	O	improvement	dobj	12	SENT_257	[p15l2002t1821r2148b1899, p15l9t1966r463b2050],

1	through	IN	O	through	_	0	SENT_258	[p15l483t1949r828b2051],
2	Week	NN	DATE	week	prep_through	6	SENT_258	[p15l848t1949r1071b2029],
3	24	CD	DATE	24	num	2	SENT_258	[p15l1091t1956r1188b2029],
4	of	IN	DATE	of	_	0	SENT_258	[p15l1215t1948r1314b2029],
5	5	CD	PERCENT	5	prep_of	2	SENT_258	[p15l1323t1957r1366b2029],
6	percentage	NN	PERCENT	percentage	amod	7	SENT_258	[p15l1393t1966r1856b2051],
7	points	NNS	PERCENT	point	_	0	SENT_258	[p15l1881t1950r2147b2050],
8	or	CC	O	or	cc	9	SENT_258	[p15l11t2104r100b2157],
9	more	JJR	O	more	dep	7	SENT_258	[p15l127t2104r348b2157],
10	in	IN	O	in	_	0	SENT_258	[p15l378t2079r461b2156],
11	the	DT	O	the	det	12	SENT_258	[p15l492t2078r625b2157],
12	percent	NN	O	percent	prep_in	9	SENT_258	[p15l654t2095r979b2179],
13	of	IN	O	of	_	0	SENT_258	[p15l1004t2077r1105b2157],
14	predicted	VBN	O	predict	amod	15	SENT_258	[p15l1115t2078r1521b2178],
15	FEV1	NN	O	fev1	prep_of	12	SENT_258	[p15l1549t2086r1771b2182],
16	.	.	O	.	_	0	SENT_258	[p15l1549t2086r1771b2182],

1	The	DT	O	the	det	2	SENT_259	[p15l1803t2078r1964b2157],
2	fact	NN	O	fact	nsubj	19	SENT_259	[p15l1994t2077r2154b2156],
3	that	IN	O	that	complm	11	SENT_259	[p15l11t2207r184b2286],
4	lung	NN	O	lung	nn	5	SENT_259	[p15l221t2207r416b2309],
5	function	NN	O	function	nsubj	11	SENT_259	[p15l456t2206r825b2287],
6	in	IN	O	in	_	0	SENT_259	[p15l868t2208r952b2285],
7	some	DT	O	some	det	8	SENT_259	[p15l997t2233r1222b2287],
8	subjects	NNS	O	subject	prep_in	5	SENT_259	[p15l1267t2207r1608b2308],
9	did	VBD	O	do	aux	11	SENT_259	[p15l1655t2207r1790b2287],
10	not	RB	O	not	neg	11	SENT_259	[p15l1833t2224r1977b2287],
11	appear	VB	O	appear	dep	2	SENT_259	[p15l2015t2233r2148b2308, p15l8t2361r201b2435],
12	to	TO	O	to	aux	13	SENT_259	[p15l233t2352r315b2414],
13	have	VB	O	have	xcomp	11	SENT_259	[p15l350t2335r541b2415],
14	a	DT	O	a	det	15	SENT_259	[p15l574t2361r619b2413],
15	response	NN	O	response	dobj	13	SENT_259	[p15l652t2361r1036b2435],
16	to	TO	O	to	_	0	SENT_259	[p15l1070t2352r1152b2414],
17	ivacaftor	NN	O	ivacaftor	prep_to	15	SENT_259	[p15l1186t2334r1565b2415],
18	may	MD	O	may	aux	19	SENT_259	[p15l1596t2361r1776b2435],
19	indicate	VB	O	indicate	_	0	SENT_259	[p15l1805t2335r2149b2414],
20	that	IN	O	that	complm	37	SENT_259	[p15l11t2463r184b2541],
21	other	JJ	O	other	amod	22	SENT_259	[p15l222t2463r451b2542],
22	factors	NNS	O	factor	nsubj	37	SENT_259	[p15l490t2462r807b2559],
23	,	,	O	,	_	0	SENT_259	[p15l490t2462r807b2559],
24	such	JJ	O	such	_	0	SENT_259	[p15l856t2463r1052b2543],
25	as	IN	O	as	_	0	SENT_259	[p15l1093t2489r1179b2541],
26	pulmonary	JJ	O	pulmonary	amod	27	SENT_259	[p15l1222t2463r1705b2563],
27	exacerbation	NN	O	exacerbation	prep_such_as	22	SENT_259	[p15l1743t2463r2148b2542, p15l11t2593r182b2672],
28	during	IN	O	during	_	0	SENT_259	[p15l225t2592r516b2694],
29	the	DT	O	the	det	30	SENT_259	[p15l556t2592r690b2671],
30	course	NN	O	course	prep_during	27	SENT_259	[p15l734t2618r1015b2672],
31	of	IN	O	of	_	0	SENT_259	[p15l1060t2591r1161b2672],
32	the	DT	O	the	det	33	SENT_259	[p15l1185t2592r1319b2671],
33	study	NN	O	study	prep_of	30	SENT_259	[p15l1364t2592r1608b2693],
34	,	,	O	,	_	0	SENT_259	[p15l1364t2592r1608b2693],
35	might	MD	O	might	aux	37	SENT_259	[p15l1657t2592r1919b2694],
36	have	VB	O	have	aux	37	SENT_259	[p15l1957t2592r2149b2672],
37	occurred	VBN	O	occur	ccomp	19	SENT_259	[p15l11t2721r400b2800],
38	in	IN	O	in	_	0	SENT_259	[p15l444t2722r529b2799],
39	these	DT	O	these	det	40	SENT_259	[p15l575t2721r805b2799],
40	subjects	NNS	O	subject	prep_in	37	SENT_259	[p15l852t2721r1227b2821],
41	.	.	O	.	_	0	SENT_259	[p15l852t2721r1227b2821],

1	The	DT	O	the	det	2	SENT_260	[p15l1275t2721r1439b2799],
2	subjects	NNS	O	subject	nsubj	9	SENT_260	[p15l1486t2721r1835b2821],
3	in	IN	O	in	_	0	SENT_260	[p15l1882t2722r1967b2799],
4	the	DT	O	the	det	6	SENT_260	[p15l2012t2721r2149b2799],
5	ivacaftor	NN	O	ivacaftor	nn	6	SENT_260	[p15l10t2849r388b2930],
6	trial	NN	O	trial	prep_in	2	SENT_260	[p15l426t2850r606b2929],
7	were	VBD	O	be	cop	9	SENT_260	[p15l640t2876r844b2930],
8	slightly	RB	O	slightly	advmod	9	SENT_260	[p15l886t2850r1206b2952],
9	older	JJR	O	older	_	0	SENT_260	[p15l1242t2850r1461b2930],
10	than	IN	O	than	mark	12	SENT_260	[p15l1499t2850r1697b2929],
11	were	VBD	O	be	cop	12	SENT_260	[p15l1733t2876r1936b2930],
12	participants	NNS	O	participant	ccomp	9	SENT_260	[p15l1975t2876r2148b2951, p15l11t2979r382b3078],
13	in	IN	O	in	_	0	SENT_260	[p15l425t2979r508b3056],
14	studies	NNS	O	study	prep_in	12	SENT_260	[p15l552t2978r854b3057],
15	of	IN	O	of	_	0	SENT_260	[p15l898t2977r998b3057],
16	other	JJ	O	other	amod	17	SENT_260	[p15l1022t2978r1252b3057],
17	therapies	NNS	O	therapy	prep_of	14	SENT_260	[p15l1290t2978r1972b3078],
18	,14	CD	NUMBER	,14	num	19	SENT_260	[p15l1290t2978r1972b3078],
19	v16	NN	O	v16	dep	17	SENT_260	[p15l1290t2978r1972b3078],
20	»	CD	NUMBER	»	number	21	SENT_260	[p15l1290t2978r1972b3078],
21	17	CD	NUMBER	17	dep	19	SENT_260	[p15l1290t2978r1972b3078],
22	but	CC	O	but	_	0	SENT_260	[p15l2013t2978r2154b3058],
23	the	DT	O	the	det	24	SENT_260	[p15l11t3106r144b3184],
24	severity	NN	O	severity	nsubj	35	SENT_260	[p15l188t3107r516b3206],
25	of	IN	O	of	_	0	SENT_260	[p15l555t3105r655b3185],
26	disease	NN	O	disease	prep_of	24	SENT_260	[p15l680t3106r1015b3202],
27	,	,	O	,	_	0	SENT_260	[p15l680t3106r1015b3202],
28	as	IN	O	as	mark	29	SENT_260	[p15l1063t3132r1149b3184],
29	measured	VBN	O	measure	dep	24	SENT_260	[p15l1193t3106r1615b3185],
30	by	IN	O	by	_	0	SENT_260	[p15l1658t3106r1756b3206],
31	baseline	NN	O	baseline	nn	32	SENT_260	[p15l1794t3106r2149b3185],
32	FEV1	NN	O	fev1	prep_by	29	SENT_260	[p15l9t3243r230b3339],
33	,	,	O	,	_	0	SENT_260	[p15l9t3243r230b3339],
34	Was	VBD	O	be	cop	35	SENT_260	[p15l273t3261r437b3315],
35	similar	JJ	O	similar	conj_but	9	SENT_260	[p15l483t3235r809b3314],
36	.	.	O	.	_	0	SENT_260	[p15l483t3235r809b3314],

1	Subgroup	NN	O	subgroup	nn	2	SENT_261	[p15l859t3235r1273b3337],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_261	[p15l1315t3235r1677b3335],
3	were	VBD	O	be	auxpass	4	SENT_261	[p15l1717t3261r1920b3315],
4	conducted	VBN	O	conduct	_	0	SENT_261	[p15l1964t3261r2148b3314, p15l11t3364r297b3443],
5	to	TO	O	to	aux	6	SENT_261	[p15l329t3381r412b3443],
6	ascertain	VB	O	ascertain	xcomp	4	SENT_261	[p15l443t3365r840b3442],
7	Whether	IN	O	whether	complm	12	SENT_261	[p15l867t3364r1224b3443],
8	the	DT	O	the	det	10	SENT_261	[p15l1253t3364r1387b3442],
9	clinical	JJ	O	clinical	amod	10	SENT_261	[p15l1419t3364r1734b3442],
10	response	NN	O	response	nsubjpass	12	SENT_261	[p15l1765t3390r2149b3464],
11	Was	VBD	O	be	auxpass	12	SENT_261	[p15l6t3520r169b3573],
12	affected	VBN	O	affect	dep	4	SENT_261	[p15l210t3492r559b3573],
13	by	IN	O	by	_	0	SENT_261	[p15l599t3493r696b3594],
14	age	NN	O	age	agent	12	SENT_261	[p15l730t3520r898b3595],
15	,	,	O	,	_	0	SENT_261	[p15l730t3520r898b3595],
16	sex	NN	O	sex	conj_or	14	SENT_261	[p15l945t3520r1102b3590],
17	,	,	O	,	_	0	SENT_261	[p15l945t3520r1102b3590],
18	or	CC	O	or	_	0	SENT_261	[p15l1147t3519r1236b3573],
19	severity	NN	O	severity	conj_or	14	SENT_261	[p15l1275t3494r1603b3594],
20	of	IN	O	of	_	0	SENT_261	[p15l1638t3492r1738b3573],
21	lung	NN	O	lung	nn	22	SENT_261	[p15l1758t3493r1953b3595],
22	disease	NN	O	disease	prep_of	14	SENT_261	[p15l1990t3493r2148b3573, p15l11t3648r216b3702],
23	.	.	O	.	_	0	SENT_261	[p15l1990t3493r2148b3573, p15l11t3648r216b3702],

1	Although	IN	O	although	mark	6	SENT_262	[p15l260t3622r671b3724],
2	the	DT	O	the	det	3	SENT_262	[p15l713t3622r846b3701],
3	number	NN	O	number	nsubj	6	SENT_262	[p15l889t3622r1229b3702],
4	of	IN	O	of	_	0	SENT_262	[p15l1270t3621r1370b3702],
5	subjects	NNS	O	subject	prep_of	3	SENT_262	[p15l1395t3622r1737b3723],
6	included	VBD	O	include	advcl	26	SENT_262	[p15l1780t3622r2150b3702],
7	in	IN	O	in	mark	13	SENT_262	[p16l10t22r93b99],
8	some	DT	O	some	nsubj	13	SENT_262	[p16l133t47r359b101],
9	of	IN	O	of	_	0	SENT_262	[p16l397t20r498b101],
10	these	DT	O	these	det	11	SENT_262	[p16l518t21r743b100],
11	subgroups	NNS	O	subgroup	prep_of	8	SENT_262	[p16l782t21r1232b123],
12	was	VBD	O	be	cop	13	SENT_262	[p16l1267t48r1431b101],
13	small	JJ	O	small	advcl	6	SENT_262	[p16l1473t21r1732b118],
14	,	,	O	,	_	0	SENT_262	[p16l1473t21r1732b118],
15	and	CC	O	and	_	0	SENT_262	[p16l1774t21r1934b101],
16	caution	NN	O	caution	nsubjpass	19	SENT_262	[p16l1972t48r2148b101, p16l11t151r182b230],
17	is	VBZ	O	be	auxpass	19	SENT_262	[p16l215t151r282b229],
18	therefore	RB	O	therefore	advmod	19	SENT_262	[p16l319t149r711b230],
19	advised	VBN	O	advise	advcl	6	SENT_262	[p16l746t150r1066b230],
20	in	IN	O	in	_	0	SENT_262	[p16l1101t151r1184b228],
21	drawing	VBG	O	draw	amod	22	SENT_262	[p16l1220t150r1581b252],
22	conclusions	NNS	O	conclusion	prep_in	19	SENT_262	[p16l1613t150r2144b247],
23	,	,	O	,	_	0	SENT_262	[p16l1613t150r2144b247],
24	the	DT	O	the	det	25	SENT_262	[p16l11t279r144b357],
25	analyses	NNS	O	analysis	nsubj	26	SENT_262	[p16l174t279r536b379],
26	revealed	VBD	O	reveal	_	0	SENT_262	[p16l568t279r923b358],
27	consistent	JJ	O	consistent	amod	28	SENT_262	[p16l953t280r1396b358],
28	responses	NNS	O	response	dobj	26	SENT_262	[p16l1421t305r1847b379],
29	across	IN	O	across	_	0	SENT_262	[p16l1879t305r2146b358],
30	subgroups	NNS	O	subgroup	prep_across	26	SENT_262	[p16l11t408r486b509],
31	.	.	O	.	_	0	SENT_262	[p16l11t408r486b509],

1	Pulmonary	JJ	O	pulmonary	amod	2	SENT_263	[p16l139t536r621b636],
2	exacerbations	NNS	O	exacerbation	nsubj	8	SENT_263	[p16l681t536r1273b615],
3	are	VBP	O	be	cop	8	SENT_263	[p16l1336t562r1466b614],
4	another	DT	O	another	det	8	SENT_263	[p16l1529t536r1867b615],
5	clinically	RB	O	clinically	advmod	6	SENT_263	[p16l1927t536r2148b614, p16l11t664r210b764],
6	important	JJ	O	important	amod	8	SENT_263	[p16l248t665r693b764],
7	end	NN	O	end	nn	8	SENT_263	[p16l731t664r885b743],
8	point	NN	O	point	_	0	SENT_263	[p16l926t665r1179b764],
9	,	,	O	,	_	0	SENT_263	[p16l926t665r1179b764],
10	since	IN	O	since	mark	13	SENT_263	[p16l1229t665r1446b742],
11	they	PRP	O	they	nsubj	13	SENT_263	[p16l1488t664r1673b764],
12	frequently	RB	O	frequently	advmod	13	SENT_263	[p16l1711t663r2154b764],
13	lead	VBP	O	lead	advcl	8	SENT_263	[p16l9t792r184b871],
14	to	TO	O	to	_	0	SENT_263	[p16l223t809r305b871],
15	hospitalization	NN	O	hospitalization	prep_to	13	SENT_263	[p16l347t792r1024b892],
16	,	,	O	,	_	0	SENT_263	[p16l347t792r1024b892],
17	and	CC	O	and	_	0	SENT_263	[p16l1069t792r1228b871],
18	25	CD	PERCENT	25	num	19	SENT_263	[p16l1267t797r1455b871],
19	%	NN	PERCENT	%	nsubj	23	SENT_263	[p16l1267t797r1455b871],
20	of	IN	O	of	_	0	SENT_263	[p16l1494t791r1595b871],
21	hospitalized	VBN	O	hospitalize	amod	22	SENT_263	[p16l1616t792r2150b892],
22	patients	NNS	O	patient	prep_of	19	SENT_263	[p16l9t922r352b1022],
23	have	VBP	O	have	conj_and	8	SENT_263	[p16l391t921r582b1001],
24	permanent	JJ	O	permanent	amod	25	SENT_263	[p16l618t938r1096b1022],
25	loss	NN	O	loss	dobj	23	SENT_263	[p16l1127t921r1292b1001],
26	of	IN	O	of	_	0	SENT_263	[p16l1331t920r1431b1001],
27	lung	NN	O	lung	nn	28	SENT_263	[p16l1449t921r1643b1023],
28	function	NN	O	function	prep_of	25	SENT_263	[p16l1677t920r2150b1001],
29	?	.	O	?	_	0	SENT_263	[p16l1677t920r2150b1001],

1	“	NN	O	“	npadvmod	14	SENT_264	[p16l1677t920r2150b1001],
2	At	IN	O	at	_	0	SENT_264	[p16l6t1057r105b1127],
3	24	CD	DURATION	24	num	4	SENT_264	[p16l137t1055r234b1128],
4	weeks	NNS	NUMBER	week	prep_at	14	SENT_264	[p16l266t1049r548b1145],
5	,	,	O	,	_	0	SENT_264	[p16l266t1049r548b1145],
6	dornase	NN	O	dornase	nn	7	SENT_264	[p16l591t1049r928b1128],
7	alfa	NN	O	alfa	nsubj	14	SENT_264	[p16l964t1048r1142b1145],
8	,	,	O	,	_	0	SENT_264	[p16l964t1048r1142b1145],
9	as	IN	O	as	mark	7	SENT_264	[p16l1184t1075r1268b1127],
10	compared	VBN	O	compare	_	0	SENT_264	[p16l1308t1049r1730b1149],
11	with	IN	O	with	_	0	SENT_264	[p16l1761t1049r1955b1129],
12	placebo	NN	O	placebo	prep_compared_with	7	SENT_264	[p16l1990t1049r2148b1149, p16l11t1177r226b1273],
13	,	,	O	,	_	0	SENT_264	[p16l1990t1049r2148b1149, p16l11t1177r226b1273],
14	reduced	VBD	O	reduce	_	0	SENT_264	[p16l267t1177r600b1256],
15	the	DT	O	the	det	16	SENT_264	[p16l637t1177r768b1255],
16	risk	NN	O	risk	dobj	14	SENT_264	[p16l805t1177r967b1257],
17	of	IN	O	of	_	0	SENT_264	[p16l999t1176r1099b1256],
18	exacerbations	NNS	O	exacerbation	prep_of	16	SENT_264	[p16l1118t1177r1696b1256],
19	by	IN	O	by	_	0	SENT_264	[p16l1735t1177r1832b1277],
20	22	CD	PERCENT	22	num	21	SENT_264	[p16l1864t1182r2150b1256],
21	%	NN	PERCENT	%	prep_by	14	SENT_264	[p16l1864t1182r2150b1256],
22	.	.	O	.	_	0	SENT_264	[p16l1864t1182r2150b1256],

1	“	NN	O	“	_	0	SENT_265	[p16l1864t1182r2150b1256],
2	At	IN	O	at	dep	1	SENT_265	[p16l6t1314r106b1384],
3	48	CD	DURATION	48	num	4	SENT_265	[p16l131t1312r232b1385],
4	weeks	NNS	NUMBER	week	pobj	2	SENT_265	[p16l262t1306r546b1402],
5	,	,	O	,	_	0	SENT_265	[p16l262t1306r546b1402],
6	hypertonic	JJ	O	hypertonic	amod	7	SENT_265	[p16l583t1306r1042b1406],
7	saline	NN	O	saline	appos	4	SENT_265	[p16l1076t1306r1347b1402],
8	,	,	O	,	_	0	SENT_265	[p16l1076t1306r1347b1402],
9	as	IN	O	as	mark	14	SENT_265	[p16l1384t1332r1469b1384],
10	compared	VBN	O	compare	_	0	SENT_265	[p16l1504t1306r1928b1406],
11	with	IN	O	with	prepc_compared_with	14	SENT_265	[p16l1955t1306r2149b1385],
12	placebo	NN	O	placebo	pobj	14	SENT_265	[p16l8t1435r362b1535],
13	,	,	O	,	_	0	SENT_265	[p16l8t1435r362b1535],
14	reduced	VBD	O	reduce	dep	4	SENT_265	[p16l403t1435r742b1514],
15	the	DT	O	the	det	16	SENT_265	[p16l777t1435r911b1513],
16	risk	NN	O	risk	dobj	14	SENT_265	[p16l946t1435r1110b1515],
17	by	IN	O	by	_	0	SENT_265	[p16l1141t1435r1239b1535],
18	66	CD	NUMBER	66	number	19	SENT_265	[p16l1270t1440r1557b1514],
19	°	CD	NUMBER	°	prep_by	14	SENT_265	[p16l1270t1440r1557b1514],
20	/	:	O	/	punct	22	SENT_265	[p16l1270t1440r1557b1514],
21	o.	SYM	O	o.	dep	22	SENT_265	[p16l1270t1440r1557b1514],
22	13	CD	NUMBER	13	dep	19	SENT_265	[p16l1270t1440r1557b1514],
23	With	IN	O	with	_	0	SENT_265	[p16l1590t1435r1804b1513],
24	the	DT	O	the	det	25	SENT_265	[p16l1839t1435r1973b1513],
25	use	NN	O	use	prep_with	14	SENT_265	[p16l2008t1461r2149b1514],
26	of	IN	O	of	_	0	SENT_265	[p16l11t1564r111b1645],
27	a	DT	O	a	det	29	SENT_265	[p16l128t1592r172b1644],
28	similar	JJ	O	similar	amod	29	SENT_265	[p16l207t1565r516b1644],
29	deﬁnition	NN	O	deﬁnition	prep_of	25	SENT_265	[p16l548t1564r980b1645],
30	of	IN	O	of	_	0	SENT_265	[p16l1016t1564r1117b1645],
31	exacerbation	NN	O	exacerbation	prep_of	29	SENT_265	[p16l1134t1565r1707b1662],
32	,	,	O	,	_	0	SENT_265	[p16l1134t1565r1707b1662],
33	ivacaftor	NN	O	ivacaftor	appos	31	SENT_265	[p16l1747t1564r2144b1662],
34	,	,	O	,	_	0	SENT_265	[p16l1747t1564r2144b1662],

1	Table	NNP	O	Table	_	0	SENT_266	[p17l77t173r269b237],
2	2	CD	NUMBER	2	dep	1	SENT_266	[p17l291t179r350b237],
3	.	.	O	.	_	0	SENT_266	[p17l291t179r350b237],

1	Treatment	NN	O	treatment	nn	2	SENT_267	[p17l374t179r744b238],
2	Effect	NN	O	effect	_	0	SENT_267	[p17l771t171r966b238],
3	of	IN	O	of	_	0	SENT_267	[p17l987t171r1068b238],
4	lvacaftor	NN	O	lvacaftor	prep_of	2	SENT_267	[p17l1082t171r1388b238],
5	with	IN	O	with	_	0	SENT_267	[p17l1407t173r1557b238],
6	Respect	NN	O	respect	prep_with	2	SENT_267	[p17l1589t179r1864b257],
7	to	TO	O	to	_	0	SENT_267	[p17l76t291r146b345],
8	the	DT	O	the	det	9	SENT_267	[p17l167t280r281b345],
9	Change	NNP	O	Change	prep_to	2	SENT_267	[p17l304t280r573b365],
10	from	IN	O	from	_	0	SENT_267	[p17l594t280r758b345],
11	Baseline	NNP	O	Baseline	prep_from	2	SENT_267	[p17l791t280r1083b345],
12	through	IN	O	through	_	0	SENT_267	[p17l1105t280r1384b365],
13	Week	NNP	DURATION	Week	prep_through	2	SENT_267	[p17l1410t280r1605b345],
14	48	CD	NUMBER	48	num	13	SENT_267	[p17l1627t285r1710b346],
15	in	IN	O	in	_	0	SENT_267	[p17l1737t282r1795b344],
16	the	DT	O	the	det	17	SENT_267	[p17l1820t280r1933b345],
17	Percent	NN	O	percent	prep_in	2	SENT_267	[p17l83t394r347b454],
18	of	IN	O	of	prep	2	SENT_267	[p17l368t387r449b454],
19	Predicted	VBN	O	predict	partmod	2	SENT_267	[p17l463t389r787b454],
20	FEV1	NN	O	fev1	dobj	19	SENT_267	[p17l819t394r1004b468],
21	,	,	O	,	_	0	SENT_267	[p17l819t394r1004b468],
22	According	VBG	O	accord	_	0	SENT_267	[p17l1028t389r1388b473],
23	to	TO	O	to	prepc_according_to	19	SENT_267	[p17l1408t399r1477b454],
24	Subgroups	NNS	O	subgroup	pobj	19	SENT_267	[p17l1500t389r1950b473],
25	.	.	O	.	_	0	SENT_267	[p17l1500t389r1950b473],

1	*	NN	O	*	_	0	SENT_268	[p17l1500t389r1950b473],

1	Treatment	NN	O	treatment	_	0	SENT_269	[p17l1252t587r1621b646],

1	Effect	NN	O	effect	_	0	SENT_270	[p17l1343t677r1538b743],
2	P	NN	O	p	nn	3	SENT_270	[p17l1792t636r1832b693],
3	Value	NN	O	value	dep	1	SENT_270	[p17l1856t630r2055b695],

1	Subgroup	NN	O	subgroup	_	0	SENT_271	[p17l78t630r423b714],

1	Baseline	NN	O	baseline	nn	2	SENT_272	[p17l86t849r375b914],
2	%	NN	O	%	_	0	SENT_272	[p17l403t852r472b916],
3	of	IN	O	of	_	0	SENT_272	[p17l502t848r578b914],
4	predicted	VBN	O	predict	amod	5	SENT_272	[p17l600t849r922b933],
5	FEV1	NN	O	fev1	prep_of	2	SENT_272	[p17l961t855r1122b929],

1	Geographic	JJ	O	geographic	amod	2	SENT_273	[p17l81t1297r490b1382],
2	region	NN	O	region	_	0	SENT_273	[p17l518t1303r732b1382],
3	North	NNP	LOCATION	North	nn	6	SENT_273	[p17l215t1446r413b1511],
4	America	NNP	LOCATION	America	nn	6	SENT_273	[p17l440t1451r730b1511],
5	Europe	NNP	LOCATION	Europe	nn	6	SENT_273	[p17l215t1601r459b1680],
6	Australia	NNP	LOCATION	Australia	dep	2	SENT_273	[p17l206t1745r519b1810],

1	Sex	NN	O	sex	_	0	SENT_274	[p17l81t1899r198b1959],

1	Male	JJ	O	male	_	0	SENT_275	[p17l215t2043r381b2108],
2	Female	JJ	O	female	dep	1	SENT_275	[p17l215t2193r464b2257],

1	Age	NN	O	age	_	0	SENT_276	[p17l77t2346r209b2427],

1	<	JJR	O	<	_	0	SENT_277	[p17l209t2495r336b2556],
2	18	CD	DURATION	18	num	3	SENT_277	[p17l209t2495r336b2556],
3	yr	NN	DURATION	yr	dep	1	SENT_277	[p17l360t2514r424b2576],
4	218	CD	DURATION	218	num	5	SENT_277	[p17l209t2645r336b2706],
5	yr	NN	DURATION	yr	dep	1	SENT_277	[p17l360t2663r424b2725],

1	7	CD	NUMBER	7	dep	7	SENT_278	[p17l9t2866r49b2904],
2	'	''	O	'	_	0	SENT_278	[p17l9t2866r49b2904],
3	‘	CD	NUMBER	‘	nsubj	7	SENT_278	[p17l9t2866r49b2904],
4	The	DT	O	the	det	6	SENT_278	[p17l73t2860r202b2925],
5	treatment	NN	O	treatment	nn	6	SENT_278	[p17l228t2873r573b2925],
6	effect	NN	O	effect	nsubj	7	SENT_278	[p17l601t2860r788b2925],
7	represents	VBZ	O	represent	_	0	SENT_278	[p17l819t2873r1180b2944],
8	the	DT	O	the	det	9	SENT_278	[p17l1209t2860r1317b2925],
9	difference	NN	O	difference	dobj	7	SENT_278	[p17l1346t2860r1688b2925],
10	between	IN	O	between	_	0	SENT_278	[p17l1720t2860r2002b2925],
11	the	DT	O	the	det	13	SENT_278	[p17l2032t2860r2141b2925],
12	ivacaftor	NN	O	ivacaftor	nn	13	SENT_278	[p17l79t2957r379b3022],
13	group	NN	O	group	prep_between	9	SENT_278	[p17l407t2980r612b3042],
14	and	CC	O	and	_	0	SENT_278	[p17l643t2957r767b3022],
15	the	DT	O	the	det	17	SENT_278	[p17l798t2957r908b3022],
16	placebo	NN	O	placebo	nn	17	SENT_278	[p17l942t2957r1210b3041],
17	group	NN	O	group	conj_and	9	SENT_278	[p17l1241t2980r1446b3042],
18	with	IN	O	with	_	0	SENT_278	[p17l1474t2957r1619b3022],
19	respect	NN	O	respect	_	0	SENT_278	[p17l1656t2970r1908b3041],
20	to	TO	O	to	_	0	SENT_278	[p17l1934t2970r2003b3022],
21	the	DT	O	the	det	23	SENT_278	[p17l73t3053r183b3118],
22	absolute	JJ	O	absolute	amod	23	SENT_278	[p17l214t3053r512b3118],
23	change	NN	O	change	prep_with_respect_to	17	SENT_278	[p17l542t3053r793b3138],
24	from	IN	O	from	_	0	SENT_278	[p17l821t3053r986b3118],
25	baseline	NN	O	baseline	prep_from	23	SENT_278	[p17l1023t3053r1309b3118],
26	through	IN	DATE	through	_	0	SENT_278	[p17l1336t3053r1613b3138],
27	week	NN	DATE	week	prep_through	7	SENT_278	[p17l1644t3053r1820b3118],
28	48	CD	DATE	48	num	27	SENT_278	[p17l1847t3058r1928b3119],
29	in	IN	O	in	_	0	SENT_278	[p17l79t3155r134b3213],
30	the	DT	O	the	det	31	SENT_278	[p17l165t3149r275b3214],
31	percent	NN	O	percent	prep_in	27	SENT_278	[p17l309t3162r569b3233],
32	of	IN	O	of	_	0	SENT_278	[p17l598t3149r674b3214],
33	predicted	VBN	O	predict	amod	34	SENT_278	[p17l696t3149r1019b3233],
34	FEV1	NN	O	fev1	prep_of	31	SENT_278	[p17l1058t3155r1239b3229],
35	.	.	O	.	_	0	SENT_278	[p17l1058t3155r1239b3229],

1	as	IN	O	as	mark	14	SENT_279	[p17l11t3485r95b3537],
2	compared	VBN	O	compare	_	0	SENT_279	[p17l127t3459r546b3559],
3	with	IN	O	with	prepc_compared_with	14	SENT_279	[p17l571t3459r764b3538],
4	placebo	NN	O	placebo	pobj	14	SENT_279	[p17l792t3459r1135b3559],
5	,	,	O	,	_	0	SENT_279	[p17l792t3459r1135b3559],
6	in	IN	O	in	_	0	SENT_279	[p17l1170t3460r1252b3536],
7	addition	NN	O	addition	_	0	SENT_279	[p17l1281t3459r1630b3537],
8	to	TO	O	to	_	0	SENT_279	[p17l1661t3475r1740b3537],
9	the	DT	O	the	det	10	SENT_279	[p17l1772t3459r1902b3537],
10	standard	NN	O	standard	pobj	14	SENT_279	[p17l1934t3475r2140b3537, p17l12t3587r204b3665],
11	of	IN	O	of	_	0	SENT_279	[p17l235t3586r334b3665],
12	care	NN	O	care	prep_of	10	SENT_279	[p17l347t3613r542b3683],
13	,	,	O	,	_	0	SENT_279	[p17l347t3613r542b3683],
14	resulted	VBD	O	result	_	0	SENT_279	[p17l578t3587r915b3666],
15	in	IN	O	in	_	0	SENT_279	[p17l944t3588r1028b3664],
16	a	DT	O	a	det	18	SENT_279	[p17l1057t3613r1102b3665],
17	relative	JJ	O	relative	amod	18	SENT_279	[p17l1131t3587r1433b3666],
18	reduction	NN	O	reduction	prep_in	14	SENT_279	[p17l1464t3587r1866b3666],
19	in	IN	O	in	_	0	SENT_279	[p17l1896t3588r1979b3664],
20	the	DT	O	the	det	21	SENT_279	[p17l2010t3587r2141b3665],
21	risk	NN	O	risk	prep_in	18	SENT_279	[p17l11t3715r176b3794],
22	of	IN	O	of	_	0	SENT_279	[p17l205t3714r305b3793],
23	exacerbation	NN	O	exacerbation	prep_of	21	SENT_279	[p17l320t3715r867b3793],
24	of	IN	O	of	_	0	SENT_279	[p17l902t3714r1002b3793],
25	60	CD	PERCENT	60	num	26	SENT_279	[p17l1017t3720r1205b3794],
26	%	NN	PERCENT	%	prep_of	23	SENT_279	[p17l1017t3720r1205b3794],
27	at	IN	O	at	_	0	SENT_279	[p17l1237t3731r1317b3793],
28	24	CD	DURATION	24	num	29	SENT_279	[p17l1345t3720r1442b3793],
29	Weeks	NNS	DURATION	week	prep_at	14	SENT_279	[p17l1471t3715r1733b3794],
30	and	CC	O	and	_	0	SENT_279	[p17l1768t3715r1926b3793],
31	55	CD	PERCENT	55	num	32	SENT_279	[p17l1961t3720r2143b3794],
32	%	NN	PERCENT	%	prep_at	14	SENT_279	[p17l1961t3720r2143b3794],

1	at	IN	O	at	_	0	SENT_280	[p18l11t53r88b114],
2	48	CD	DURATION	48	num	3	SENT_280	[p18l110t41r210b114],
3	weeks	NNS	NUMBER	week	pobj	1	SENT_280	[p18l237t36r516b115],
4	.	.	O	.	_	0	SENT_280	[p18l237t36r516b115],

1	Treatment	NN	O	treatment	nsubj	5	SENT_281	[p18l547t41r986b114],
2	with	IN	O	with	_	0	SENT_281	[p18l1005t36r1197b115],
3	ivacaftor	NN	O	ivacaftor	prep_with	1	SENT_281	[p18l1225t35r1591b115],
4	also	RB	O	also	advmod	5	SENT_281	[p18l1616t36r1783b114],
5	reduced	VBD	O	reduce	_	0	SENT_281	[p18l1813t36r2143b115],
6	the	DT	O	the	det	7	SENT_281	[p18l12t164r144b242],
7	number	NN	O	number	dobj	5	SENT_281	[p18l187t164r526b243],
8	of	IN	O	of	_	0	SENT_281	[p18l566t163r666b242],
9	days	NNS	DURATION	day	prep_of	7	SENT_281	[p18l691t164r876b264],
10	of	IN	O	of	_	0	SENT_281	[p18l921t163r1021b242],
11	hospitalization	NN	O	hospitalization	prep_of	9	SENT_281	[p18l1045t164r1720b264],
12	,	,	O	,	_	0	SENT_281	[p18l1045t164r1720b264],
13	the	DT	O	the	det	15	SENT_281	[p18l1768t164r1902b242],
14	total	JJ	O	total	amod	15	SENT_281	[p18l1944t164r2143b242],
15	number	NN	O	number	conj_and	7	SENT_281	[p18l11t292r350b371],
16	and	CC	O	and	_	0	SENT_281	[p18l393t292r551b370],
17	duration	NN	O	duration	conj_and	7	SENT_281	[p18l597t292r964b371],
18	of	IN	O	of	_	0	SENT_281	[p18l1011t291r1112b370],
19	exacerbations	NNS	O	exacerbation	prep_of	15	SENT_281	[p18l1140t292r1753b388],
20	,	,	O	,	_	0	SENT_281	[p18l1140t292r1753b388],
21	and	CC	O	and	_	0	SENT_281	[p18l1804t292r1963b370],
22	the	DT	O	the	det	23	SENT_281	[p18l2009t292r2142b370],
23	number	NN	O	number	dobj	5	SENT_281	[p18l11t420r356b499],
24	of	IN	O	of	_	0	SENT_281	[p18l404t419r506b498],
25	pulmonary	JJ	O	pulmonary	amod	26	SENT_281	[p18l538t420r1027b520],
26	exacerbations	NNS	O	exacerbation	prep_of	23	SENT_281	[p18l1074t420r1677b498],
27	requiring	VBG	O	require	xcomp	5	SENT_281	[p18l1730t421r2145b521],
28	intravenous	JJ	O	intravenous	amod	29	SENT_281	[p18l11t549r511b627],
29	antibiotics	NNS	O	antibiotic	dobj	27	SENT_281	[p18l540t548r1017b626],
30	.	.	O	.	_	0	SENT_281	[p18l540t548r1017b626],

1	The	DT	O	the	det	5	SENT_282	[p18l1047t548r1208b626],
2	within	IN	O	within	advmod	5	SENT_282	[p18l1232t548r1806b649],
3	—	CD	NUMBER	—	num	4	SENT_282	[p18l1232t548r1806b649],
4	group	NN	O	group	pobj	2	SENT_282	[p18l1232t548r1806b649],
5	change	NN	O	change	nsubj	17	SENT_282	[p18l1837t548r2142b649],
6	in	IN	O	in	_	0	SENT_282	[p18l11t678r95b754],
7	the	DT	O	the	det	8	SENT_282	[p18l143t677r278b755],
8	score	NN	NUMBER	score	prep_in	5	SENT_282	[p18l328t702r554b755],
9	on	IN	O	on	_	0	SENT_282	[p18l603t702r709b755],
10	the	DT	O	the	det	13	SENT_282	[p18l758t677r893b755],
11	CFQ-R	NN	MISC	cfq-r	nn	13	SENT_282	[p18l941t682r1241b775],
12	respiratory	JJ	O	respiratory	amod	13	SENT_282	[p18l1278t678r1761b777],
13	domain	NN	O	domain	prep_on	8	SENT_282	[p18l1806t677r2142b755],
14	through	IN	O	through	_	0	SENT_282	[p18l12t805r368b906],
15	48	CD	DURATION	48	num	16	SENT_282	[p18l411t810r514b883],
16	weeks	NNS	NUMBER	week	prep_through	13	SENT_282	[p18l556t805r823b884],
17	exceeded	VBD	O	exceed	_	0	SENT_282	[p18l871t805r1265b883],
18	the	DT	O	the	det	22	SENT_282	[p18l1310t805r1445b883],
19	minimal	JJ	O	minimal	amod	22	SENT_282	[p18l1490t805r1870b883],
20	clinically	RB	O	clinically	advmod	21	SENT_282	[p18l1915t805r2140b883, p18l12t933r208b1033],
21	important	JJ	O	important	amod	22	SENT_282	[p18l236t934r674b1033],
22	difference	NN	O	difference	dobj	17	SENT_282	[p18l703t932r1130b1011],
23	of	IN	O	of	_	0	SENT_282	[p18l1165t932r1265b1011],
24	4	CD	NUMBER	4	num	25	SENT_282	[p18l1278t939r1328b1011],
25	points	NNS	O	point	prep_of	22	SENT_282	[p18l1360t934r1627b1033],
26	established	VBN	O	establish	partmod	25	SENT_282	[p18l1663t933r2142b1011],
27	for	IN	O	for	_	0	SENT_282	[p18l11t1060r134b1139],
28	this	DT	O	this	det	29	SENT_282	[p18l165t1061r326b1139],
29	domain	NN	O	domain	prep_for	26	SENT_282	[p18l362t1061r693b1139],
30	in	IN	O	in	_	0	SENT_282	[p18l726t1062r809b1138],
31	patients	NNS	O	patient	prep_in	29	SENT_282	[p18l841t1062r1183b1161],
32	with	IN	O	with	_	0	SENT_282	[p18l1214t1061r1410b1140],
33	stable	JJ	O	stable	amod	34	SENT_282	[p18l1445t1061r1693b1139],
34	disease	NN	O	disease	prep_with	31	SENT_282	[p18l1728t1061r2143b1139],
35	.	.	O	.	_	0	SENT_282	[p18l1728t1061r2143b1139],

1	-	:	O	-	_	0	SENT_283	[p18l1728t1061r2143b1139],
2	’	NN	O	’	nsubj	53	SENT_283	[p18l1728t1061r2143b1139],
3	-1	CD	NUMBER	-1	num	4	SENT_283	[p18l1728t1061r2143b1139],
4	Patients	NNS	O	patient	nsubj	9	SENT_283	[p18l139t1190r480b1267],
5	with	IN	O	with	_	0	SENT_283	[p18l512t1189r708b1268],
6	cystic	JJ	O	cystic	amod	7	SENT_283	[p18l742t1190r981b1289],
7	fibrosis	NN	O	fibrosis	prep_with	4	SENT_283	[p18l1013t1188r1339b1267],
8	typically	RB	O	typically	advmod	9	SENT_283	[p18l1376t1189r1741b1289],
9	have	VBP	O	have	rcmod	2	SENT_283	[p18l1771t1189r1961b1268],
10	difficulty	NN	O	difficulty	dobj	9	SENT_283	[p18l1996t1188r2140b1267, p18l11t1316r291b1417],
11	gaining	VBG	O	gain	partmod	10	SENT_283	[p18l321t1318r656b1418],
12	and	CC	O	and	_	0	SENT_283	[p18l688t1317r846b1395],
13	maintaining	VBG	O	maintain	conj_and	11	SENT_283	[p18l880t1318r1423b1418],
14	weight	NN	O	weight	dobj	11	SENT_283	[p18l1449t1317r1806b1418],
15	}	CD	NUMBER	}	num	17	SENT_283	[p18l1449t1317r1806b1418],
16	Weight	NNP	O	Weight	nn	17	SENT_283	[p18l1837t1317r2147b1418],
17	gain	NN	O	gain	nsubjpass	19	SENT_283	[p18l11t1446r198b1546],
18	was	VBD	O	be	auxpass	19	SENT_283	[p18l224t1471r385b1524],
19	measured	VBN	O	measure	rcmod	14	SENT_283	[p18l419t1445r832b1524],
20	in	IN	O	in	_	0	SENT_283	[p18l863t1446r945b1522],
21	two	CD	NUMBER	two	num	22	SENT_283	[p18l977t1462r1133b1524],
22	studies	NNS	O	study	prep_in	19	SENT_283	[p18l1167t1445r1463b1524],
23	of	IN	O	of	_	0	SENT_283	[p18l1496t1444r1596b1523],
24	oral	JJ	O	oral	amod	27	SENT_283	[p18l1609t1445r1773b1523],
25	azithro	NN	O	azithro	nn	27	SENT_283	[p18l1803t1445r2140b1523],
26	—	NN	O	—	nn	27	SENT_283	[p18l1803t1445r2140b1523],
27	mycin	NN	O	mycin	prep_of	22	SENT_283	[p18l11t1574r451b1673],
28	.22	CD	NUMBER	.22	number	29	SENT_283	[p18l11t1574r451b1673],
29	»	CD	NUMBER	»	amod	27	SENT_283	[p18l11t1574r451b1673],
30	23	CD	NUMBER	23	dep	29	SENT_283	[p18l11t1574r451b1673],
31	In	IN	O	in	dep	30	SENT_283	[p18l491t1580r578b1650],
32	those	DT	O	those	det	33	SENT_283	[p18l617t1573r841b1651],
33	trials	NNS	O	trial	pobj	31	SENT_283	[p18l881t1573r1113b1668],
34	,	,	O	,	_	0	SENT_283	[p18l881t1573r1113b1668],
35	the	DT	O	the	det	38	SENT_283	[p18l1158t1573r1287b1651],
36	mean	NN	O	mean	nn	38	SENT_283	[p18l1326t1599r1559b1651],
37	treatment	NN	O	treatment	nn	38	SENT_283	[p18l1597t1589r2007b1651],
38	effect	NN	O	effect	appos	33	SENT_283	[p18l2041t1572r2140b1651, p18l11t1700r167b1779],
39	with	IN	O	with	_	0	SENT_283	[p18l192t1701r385b1780],
40	azithromycin	NN	O	azithromycin	prep_with	38	SENT_283	[p18l419t1701r981b1801],
41	as	IN	O	as	_	0	SENT_283	[p18l1015t1727r1100b1779],
42	compared	VBN	O	compare	prepc_as	19	SENT_283	[p18l1137t1701r1559b1801],
43	with	IN	O	with	pcomp	42	SENT_283	[p18l1589t1701r1783b1780],
44	placebo	NN	O	placebo	pobj	43	SENT_283	[p18l1815t1701r2140b1801],
45	during	IN	O	during	_	0	SENT_283	[p18l12t1829r295b1930],
46	the	DT	O	the	det	49	SENT_283	[p18l323t1829r453b1907],
47	24-week	JJ	DURATION	24-week	amod	49	SENT_283	[p18l483t1829r834b1908],
48	treatment	NN	O	treatment	nn	49	SENT_283	[p18l860t1845r1275b1907],
49	period	NN	O	period	prep_during	44	SENT_283	[p18l1299t1829r1572b1929],
50	was	VBD	O	be	cop	53	SENT_283	[p18l1597t1855r1758b1908],
51	a	DT	O	a	det	53	SENT_283	[p18l1790t1855r1834b1907],
52	weight	NN	O	weight	nn	53	SENT_283	[p18l1859t1829r2147b1930],
53	gain	NN	O	gain	_	0	SENT_283	[p18l11t1958r194b2058],
54	of	IN	O	of	_	0	SENT_283	[p18l225t1956r323b2035],
55	0.7	CD	NUMBER	0.7	num	56	SENT_283	[p18l335t1962r455b2035],
56	kg	NN	O	kg	prep_of	53	SENT_283	[p18l485t1957r591b2058],
57	in	IN	O	in	_	0	SENT_283	[p18l617t1958r699b2034],
58	subjects	NNS	O	subject	prep_in	56	SENT_283	[p18l730t1957r1056b2057],
59	with	IN	O	with	_	0	SENT_283	[p18l1084t1957r1275b2036],
60	endobronchial	JJ	O	endobronchial	amod	61	SENT_283	[p18l1305t1957r1907b2035],
61	colonization	NN	O	colonization	prep_with	58	SENT_283	[p18l1937t1957r2140b2035, p18l11t2086r362b2163],
62	with	IN	O	with	_	0	SENT_283	[p18l390t2085r583b2164],
63	Pseudomonas	FW	PERSON	pseudomonas	nn	64	SENT_283	[p18l612t2085r1120b2163],
64	aeruginosazz	FW	O	aeruginosazz	prep_with	61	SENT_283	[p18l1139t2087r1612b2185],
65	and	CC	O	and	_	0	SENT_283	[p18l1644t2085r1801b2163],
66	0.58	CD	NUMBER	0.58	num	67	SENT_283	[p18l1832t2090r2005b2163],
67	kg	NN	O	kg	prep_with	58	SENT_283	[p18l2039t2085r2145b2186],
68	in	IN	O	in	_	0	SENT_283	[p18l11t2215r95b2291],
69	subjects	NNS	O	subject	prep_in	67	SENT_283	[p18l146t2214r494b2314],
70	without	IN	O	without	_	0	SENT_283	[p18l542t2214r888b2293],
71	P.	FW	PERSON	p.	nn	74	SENT_283	[p18l930t2221r994b2292],
72	aeruginosa	FW	PERSON	aeruginosa	nn	74	SENT_283	[p18l1037t2215r1453b2314],
73	endobronchial	JJ	O	endobronchial	amod	74	SENT_283	[p18l1504t2214r2143b2292],
74	colonization	NN	O	colonization	prep_without	53	SENT_283	[p18l12t2342r652b2437],
75	,23	CD	NUMBER	,23	nsubjpass	81	SENT_283	[p18l12t2342r652b2437],
76	and	CC	O	and	_	0	SENT_283	[p18l694t2342r853b2420],
77	these	DT	O	these	det	79	SENT_283	[p18l893t2342r1117b2420],
78	treatment	NN	O	treatment	nn	79	SENT_283	[p18l1158t2358r1583b2420],
79	effects	NNS	O	effect	nsubjpass	81	SENT_283	[p18l1619t2341r1901b2420],
80	were	VBD	O	be	auxpass	81	SENT_283	[p18l1939t2368r2141b2421],
81	associated	VBN	O	associate	rcmod	74	SENT_283	[p18l11t2471r445b2549],
82	with	IN	O	with	_	0	SENT_283	[p18l472t2471r664b2550],
83	improved	VBN	O	improve	amod	85	SENT_283	[p18l694t2471r1091b2571],
84	pulmonary	JJ	O	pulmonary	amod	85	SENT_283	[p18l1121t2471r1591b2571],
85	status	NN	O	status	prep_with	81	SENT_283	[p18l1619t2487r1864b2550],
86	in	IN	O	in	_	0	SENT_283	[p18l1897t2472r1980b2548],
87	the	DT	O	the	det	88	SENT_283	[p18l2011t2471r2142b2549],
88	subjects	NNS	O	subject	prep_in	85	SENT_283	[p18l12t2599r353b2699],
89	receiving	VBG	O	receive	partmod	88	SENT_283	[p18l408t2600r800b2700],
90	azithromycin	NN	O	azithromycin	dobj	89	SENT_283	[p18l849t2599r1444b2699],
91	.	.	O	.	_	0	SENT_283	[p18l849t2599r1444b2699],

1	In	IN	O	in	_	0	SENT_284	[p18l1501t2606r1591b2676],
2	the	DT	O	the	det	4	SENT_284	[p18l1644t2599r1778b2677],
3	current	JJ	DATE	current	amod	4	SENT_284	[p18l1832t2615r2147b2678],
4	study	NN	O	study	prep_in	14	SENT_284	[p18l12t2727r256b2827],
5	,	,	O	,	_	0	SENT_284	[p18l12t2727r256b2827],
6	the	DT	O	the	det	8	SENT_284	[p18l298t2727r432b2805],
7	weight	NN	O	weight	nn	8	SENT_284	[p18l464t2727r758b2828],
8	gain	NN	O	gain	nsubj	14	SENT_284	[p18l789t2728r979b2828],
9	at	IN	O	at	_	0	SENT_284	[p18l1015t2743r1094b2805],
10	48	CD	DURATION	48	num	11	SENT_284	[p18l1123t2732r1225b2805],
11	weeks	NNS	NUMBER	week	prep_at	8	SENT_284	[p18l1259t2727r1521b2806],
12	was	VBD	O	be	cop	14	SENT_284	[p18l1556t2753r1718b2806],
13	3.1	CD	NUMBER	3.1	num	14	SENT_284	[p18l1758t2732r1882b2806],
14	kg	NN	O	kg	_	0	SENT_284	[p18l1918t2727r2026b2828],
15	in	IN	O	in	_	0	SENT_284	[p18l2058t2728r2142b2804],
16	subjects	NNS	O	subject	prep_in	14	SENT_284	[p18l12t2855r353b2955],
17	receiving	VBG	O	receive	partmod	16	SENT_284	[p18l413t2856r805b2956],
18	ivacaftor	NN	O	ivacaftor	dobj	17	SENT_284	[p18l859t2854r1254b2951],
19	,	,	O	,	_	0	SENT_284	[p18l859t2854r1254b2951],
20	as	IN	O	as	_	0	SENT_284	[p18l1318t2881r1403b2933],
21	compared	VBN	O	compare	prepc_as	14	SENT_284	[p18l1464t2855r1893b2955],
22	with	IN	O	with	pcomp	21	SENT_284	[p18l1946t2855r2142b2934],

1	N	NN	O	n	nn	3	SENT_285	[p18l545t3042r559b3057],
2	ENGLJ	NN	O	englj	nn	3	SENT_285	[p18l573t3042r651b3064],
3	MED	NN	O	med	_	0	SENT_285	[p18l666t3042r718b3057],
4	5	CD	NUMBER	5	dep	3	SENT_285	[p18l759t3036r804b3064],
5	;	:	O	;	_	0	SENT_285	[p18l759t3036r804b3064],
6	18	CD	NUMBER	18	num	8	SENT_285	[p18l759t3036r804b3064],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_285	[p18l839t3042r963b3064],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_285	[p18l1000t3042r1135b3058],
9	3,2011	CD	DATE	3,2011	number	10	SENT_285	[p18l1145t3042r1226b3064],
10	1669	CD	DATE	1669	dep	8	SENT_285	[p18l1940t3031r2016b3055],

1	e	LS	O	e	dep	4	SENT_286	[p18l739t3083r753b3099],
2	New	NNP	O	New	nn	4	SENT_286	[p18l762t3076r824b3099],
3	England	NNP	O	England	nn	4	SENT_286	[p18l833t3075r944b3106],
4	Journal	NNP	O	Journal	_	0	SENT_286	[p18l952t3075r1050b3099],
5	of	IN	O	of	prep	4	SENT_286	[p18l1059t3075r1088b3099],
6	Medicine	NNP	O	Medicine	dep	4	SENT_286	[p18l1095t3075r1220b3099],

1	Downloaded	VBN	O	download	_	0	SENT_287	[p18l144t3116r314b3139],
2	from	IN	O	from	_	0	SENT_287	[p18l323t3116r387b3139],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_287	[p18l396t3116r514b3146],
4	at	IN	O	at	_	0	SENT_287	[p18l524t3120r547b3139],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_287	[p18l556t3116r738b3139],
6	on	IN	O	on	_	0	SENT_287	[p18l748t3123r780b3139],
7	January	NNP	DATE	January	prep_on	1	SENT_287	[p18l789t3116r892b3146],
8	5	CD	DATE	5	num	7	SENT_287	[p18l902t3116r924b3144],
9	,	,	DATE	,	_	0	SENT_287	[p18l902t3116r924b3144],
10	2014	CD	DATE	2014	num	7	SENT_287	[p18l935t3116r1007b3139],
11	.	.	O	.	_	0	SENT_287	[p18l935t3116r1007b3139],

1	For	IN	O	for	_	0	SENT_288	[p18l1018t3116r1064b3139],
2	personal	JJ	O	personal	amod	3	SENT_288	[p18l1072t3116r1184b3146],
3	use	NN	O	use	pobj	1	SENT_288	[p18l1194t3123r1237b3139],
4	only	RB	O	only	advmod	3	SENT_288	[p18l1247t3116r1312b3146],
5	.	.	O	.	_	0	SENT_288	[p18l1247t3116r1312b3146],

1	No	DT	O	no	det	3	SENT_289	[p18l1322t3116r1362b3139],
2	other	JJ	O	other	amod	3	SENT_289	[p18l1372t3116r1440b3139],
3	uses	NNS	O	use	_	0	SENT_289	[p18l1448t3123r1504b3139],
4	without	IN	O	without	_	0	SENT_289	[p18l1515t3116r1616b3139],
5	permission	NN	O	permission	prep_without	3	SENT_289	[p18l1624t3116r1776b3146],
6	.	.	O	.	_	0	SENT_289	[p18l1624t3116r1776b3146],

1	Copyright	NN	O	copyright	_	0	SENT_290	[p18l494t3157r629b3188],
2	©	CD	NUMBER	©	num	6	SENT_290	[p18l638t3157r661b3181],
3	2011	CD	DATE	2011	num	6	SENT_290	[p18l671t3157r734b3181],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_290	[p18l746t3157r937b3181],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_290	[p18l947t3157r1055b3181],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_290	[p18l1065t3157r1170b3188],
7	.	.	O	.	_	0	SENT_290	[p18l1065t3157r1170b3188],

1	All	DT	O	all	det	2	SENT_291	[p18l1181t3157r1223b3181],
2	rights	NNS	O	rights	nsubj	3	SENT_291	[p18l1232t3157r1306b3188],
3	reserved	VBN	O	reserve	_	0	SENT_291	[p18l1316t3157r1435b3181],
4	.	.	O	.	_	0	SENT_291	[p18l1316t3157r1435b3181],

1	The	DT	O	the	det	4	SENT_292	[p18l673t3263r718b3284],
2	NEW	NNP	O	NEW	nn	4	SENT_292	[p18l737t3265r822b3284],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_292	[p18l841t3265r1029b3284],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_292	[p18l1048t3265r1227b3291],
5	of	IN	O	of	_	0	SENT_292	[p18l1247t3263r1275b3290],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_292	[p18l1287t3265r1486b3284],

1	L	NN	O	l	_	0	SENT_293	[p19l191t638r220b656],
2	-5	CD	NUMBER	-5	dep	1	SENT_293	[p19l108t596r235b660],
3	.	.	O	.	_	0	SENT_293	[p19l108t596r235b660],

1	.	.	O	.	_	0	SENT_294	[p19l108t596r235b660],

1	513	CD	NUMBER	513	_	0	SENT_295	[p19l115t660r221b750],
2	$	$	MONEY	$	dep	1	SENT_295	[p19l180t736r235b759],
3	33	CD	MONEY	33	number	2	SENT_295	[p19l124t752r221b804],
4	‘	CD	MONEY	‘	number	2	SENT_295	[p19l112t795r221b851],
5	"	``	O	"	punct	7	SENT_295	[p19l112t795r221b851],
6	5	CD	NUMBER	5	num	7	SENT_295	[p19l112t795r221b851],
7	C	NN	O	c	dep	2	SENT_295	[p19l123t844r152b869],
8	--	:	O	--	_	0	SENT_295	[p19l109t859r221b901],
9	5	CD	PERCENT	5	number	10	SENT_295	[p19l109t859r221b901],
10	m	NN	PERCENT	m	num	11	SENT_295	[p19l123t904r235b930],
11	%	NN	PERCENT	%	dep	1	SENT_295	[p19l123t904r235b930],
12	no	DT	O	no	det	15	SENT_295	[p19l123t932r167b961],
13	S	NN	O	s	nn	15	SENT_295	[p19l123t965r152b991],
14	(	NN	O	(	nn	15	SENT_295	[p19l123t996r153b1021],
15	B	NN	O	b	dep	11	SENT_295	[p19l123t996r153b1021],
16	.	.	O	.	_	0	SENT_295	[p19l108t1027r152b1052],

1	C	NN	O	c	nn	2	SENT_296	[p19l108t1027r152b1052],
2	U	NN	O	u	_	0	SENT_296	[p19l112t1057r153b1091],

1	(	NN	O	(	nn	3	SENT_297	[p19l180t2228r235b2288],
2	m	NN	O	m	nn	3	SENT_297	[p19l180t2228r235b2288],
3	mol	NN	O	mol	_	0	SENT_297	[p19l176t2132r221b2220],
4	/	:	O	/	punct	6	SENT_297	[p19l176t1994r235b2128],
5	liter	NN	O	liter	nn	6	SENT_297	[p19l176t1994r235b2128],
6	)	NN	O	)	dep	3	SENT_297	[p19l176t1994r235b2128],

1	N	NN	O	n	_	0	SENT_298	[p19l1664t2232r1795b2270],
2	=	JJ	O	=	amod	4	SENT_298	[p19l1664t2232r1795b2270],
3	76	CD	NUMBER	76	tmod	2	SENT_298	[p19l1664t2232r1795b2270],
4	N	NN	O	n	dep	1	SENT_298	[p19l1917t2230r2045b2268],
5	=	JJ	O	=	amod	4	SENT_298	[p19l1917t2230r2045b2268],
6	75	CD	NUMBER	75	tmod	5	SENT_298	[p19l1917t2230r2045b2268],

1	Sweat	NN	O	sweat	nn	2	SENT_299	[p19l112t2179r153b2327],
2	Chloride	NN	O	chloride	_	0	SENT_299	[p19l108t1955r153b2162],

1	Ivacaftor	NNP	O	Ivacaftor	_	0	SENT_300	[p19l1759t2322r1955b2364],

1	Figure	NN	O	figure	_	0	SENT_301	[p19l64t2921r226b2983],
2	2	CD	NUMBER	2	dep	1	SENT_301	[p19l246t2924r292b2968],
3	.	.	O	.	_	0	SENT_301	[p19l246t2924r292b2968],

1	Changes	NNS	O	change	_	0	SENT_302	[p19l314t2920r542b2983],
2	from	IN	O	from	_	0	SENT_302	[p19l562t2919r686b2968],
3	Baseline	NN	O	baseline	prep_from	1	SENT_302	[p19l713t2920r933b2968],
4	through	IN	O	through	_	0	SENT_302	[p19l952t2920r1161b2983],
5	Week	NN	DURATION	week	prep_through	1	SENT_302	[p19l1183t2920r1329b2968],
6	48	CD	NUMBER	48	num	5	SENT_302	[p19l1348t2923r1411b2968],
7	in	IN	O	in	_	0	SENT_302	[p19l1434t2921r1477b2967],
8	Sweat	NNP	O	Sweat	nn	9	SENT_302	[p19l1500t2924r1659b2968],
9	Chloride	NNP	O	Chloride	prep_in	1	SENT_302	[p19l1678t2920r1917b2978],
10	,	,	O	,	_	0	SENT_302	[p19l1678t2920r1917b2978],
11	According	VBG	O	accord	_	0	SENT_302	[p19l58t3000r328b3063],
12	to	TO	O	to	prepc_according_to	9	SENT_302	[p19l345t3008r397b3048],
13	Study	NNP	O	Study	nn	14	SENT_302	[p19l418t3000r568b3063],
14	Group	NNP	O	Group	pobj	9	SENT_302	[p19l588t3004r770b3062],
15	.	.	O	.	_	0	SENT_302	[p19l588t3004r770b3062],

1	Panel	NN	O	panel	nn	2	SENT_303	[p19l65t3096r202b3144],
2	A	NN	O	a	nsubj	3	SENT_303	[p19l225t3099r263b3143],
3	shows	VBZ	O	show	_	0	SENT_303	[p19l284t3096r448b3144],
4	the	DT	O	the	det	6	SENT_303	[p19l470t3096r553b3144],
5	mean	JJ	O	mean	amod	6	SENT_303	[p19l578t3113r719b3144],
6	change	NN	O	change	dobj	3	SENT_303	[p19l744t3096r933b3160],
7	from	IN	O	from	_	0	SENT_303	[p19l954t3096r1078b3144],
8	baseline	NN	O	baseline	prep_from	3	SENT_303	[p19l1105t3096r1321b3144],
9	in	IN	O	in	_	0	SENT_303	[p19l1345t3101r1386b3143],
10	the	DT	O	the	det	11	SENT_303	[p19l1409t3096r1492b3144],
11	concentration	NN	O	concentration	prep_in	8	SENT_303	[p19l1514t3101r1881b3144],
12	of	IN	O	of	_	0	SENT_303	[p19l1906t3096r1964b3144],
13	sweat	NN	O	sweat	nn	14	SENT_303	[p19l62t3185r213b3224],
14	chloride	NN	O	chloride	prep_of	11	SENT_303	[p19l234t3176r463b3224],
15	.	.	O	.	_	0	SENT_303	[p19l234t3176r463b3224],

1	Panel	NN	O	panel	nn	2	SENT_304	[p19l491t3176r629b3224],
2	B	NN	O	b	nsubj	3	SENT_304	[p19l658t3180r686b3224],
3	shows	VBZ	O	show	_	0	SENT_304	[p19l711t3176r874b3224],
4	the	DT	O	the	det	7	SENT_304	[p19l896t3176r979b3224],
5	actual	JJ	O	actual	amod	7	SENT_304	[p19l1002t3176r1158b3224],
6	mean	JJ	O	mean	amod	7	SENT_304	[p19l1185t3193r1327b3224],
7	concentrations	NNS	O	concentration	dobj	3	SENT_304	[p19l1352t3181r1749b3224],
8	of	IN	O	of	_	0	SENT_304	[p19l1772t3176r1830b3224],
9	sweat	NN	O	sweat	nn	10	SENT_304	[p19l1844t3185r1994b3224],
10	chloride	NN	O	chloride	prep_of	7	SENT_304	[p19l61t3256r275b3304],
11	over	IN	O	over	_	0	SENT_304	[p19l298t3273r411b3305],
12	time	NN	O	time	prep_over	10	SENT_304	[p19l429t3261r562b3313],
13	;	:	O	;	_	0	SENT_304	[p19l429t3261r562b3313],
14	the	DT	O	the	det	16	SENT_304	[p19l585t3256r668b3304],
15	dashed	VBN	O	dash	amod	16	SENT_304	[p19l690t3256r878b3304],
16	line	NN	O	line	nsubj	22	SENT_304	[p19l906t3256r996b3304],
17	at	IN	O	at	_	0	SENT_304	[p19l1019t3265r1065b3304],
18	60	CD	NUMBER	60	num	19	SENT_304	[p19l1087t3259r1148b3305],
19	mmol	NN	O	mmol	prep_at	16	SENT_304	[p19l1172t3256r1322b3304],
20	per	IN	O	per	_	0	SENT_304	[p19l1350t3273r1434b3319],
21	liter	NN	O	liter	prep_per	19	SENT_304	[p19l1456t3256r1556b3304],
22	represents	VBZ	O	represent	parataxis	3	SENT_304	[p19l1579t3265r1857b3319],
23	the	DT	O	the	det	25	SENT_304	[p19l1879t3256r1962b3304],
24	cutoff	NN	O	cutoff	nn	25	SENT_304	[p19l1984t3265r2080b3305, p19l61t3336r139b3385],
25	point	NN	O	point	dobj	22	SENT_304	[p19l155t3341r290b3399],
26	for	IN	O	for	_	0	SENT_304	[p19l310t3336r384b3385],
27	the	DT	O	the	det	28	SENT_304	[p19l402t3336r486b3385],
28	diagnosis	NN	O	diagnosis	prep_for	25	SENT_304	[p19l508t3336r759b3400],
29	of	IN	O	of	_	0	SENT_304	[p19l783t3336r840b3385],
30	cystic	JJ	O	cystic	amod	31	SENT_304	[p19l853t3341r1002b3400],
31	fibrosis	NN	O	fibrosis	prep_of	28	SENT_304	[p19l1022t3336r1234b3385],
32	.	.	O	.	_	0	SENT_304	[p19l1022t3336r1234b3385],

1	The	DT	O	the	det	2	SENT_305	[p19l1256t3336r1355b3385],
2	values	NNS	O	value	nsubj	8	SENT_305	[p19l1376t3336r1542b3385],
3	and	CC	O	and	_	0	SENT_305	[p19l1565t3336r1659b3385],
4	95	CD	PERCENT	95	number	5	SENT_305	[p19l1684t3339r1797b3387],
5	%	NN	PERCENT	%	amod	7	SENT_305	[p19l1684t3339r1797b3387],
6	confidence	NN	O	confidence	nn	7	SENT_305	[p19l1819t3336r1969b3385, p19l61t3417r217b3465],
7	intervals	NNS	O	interval	conj_and	2	SENT_305	[p19l241t3417r464b3465],
8	(	VBP	O	(	_	0	SENT_305	[p19l493t3417r754b3480],
9	indicated	VBN	O	indicate	csubj	18	SENT_305	[p19l493t3417r754b3480],
10	by	IN	O	by	_	0	SENT_305	[p19l782t3417r836b3480],
11	I	PRP	O	I	dep	12	SENT_305	[p19l856t3422r874b3464],
12	bars	NNS	O	bar	prep_by	9	SENT_305	[p19l897t3417r1022b3480],
13	)	RB	O	)	advmod	9	SENT_305	[p19l897t3417r1022b3480],
14	in	IN	O	in	prep	9	SENT_305	[p19l1052t3421r1094b3464],
15	both	CC	O	both	dep	14	SENT_305	[p19l1121t3417r1236b3465],
16	panels	NNS	O	panel	conj	14	SENT_305	[p19l1263t3417r1431b3479],
17	are	VBP	O	be	cop	18	SENT_305	[p19l1456t3433r1533b3465],
18	unadjusted	JJ	O	unadjusted	ccomp	8	SENT_305	[p19l1558t3417r1868b3480],
19	.	.	O	.	_	0	SENT_305	[p19l1558t3417r1868b3480],

1	The	DT	O	the	det	4	SENT_306	[p19l1890t3417r1989b3465],
2	first	JJ	ORDINAL	first	amod	4	SENT_306	[p19l60t3496r167b3545],
3	data	NN	O	datum	nn	4	SENT_306	[p19l188t3497r300b3545],
4	points	NNS	O	point	nsubj	10	SENT_306	[p19l326t3501r489b3559],
5	in	IN	O	in	_	0	SENT_306	[p19l515t3501r556b3544],
6	both	DT	O	both	det	7	SENT_306	[p19l583t3497r698b3545],
7	panels	NNS	O	panel	prep_in	4	SENT_306	[p19l726t3497r894b3559],
8	are	VBP	O	be	cop	10	SENT_306	[p19l918t3513r996b3545],
9	baseline	JJ	O	baseline	amod	10	SENT_306	[p19l1020t3497r1236b3545],
10	data	NNS	O	datum	_	0	SENT_306	[p19l1258t3497r1386b3545],
11	.	.	O	.	_	0	SENT_306	[p19l1258t3497r1386b3545],

1	0.4	CD	NUMBER	0.4	num	2	SENT_307	[p20l563t83r658b137],
2	kg	NN	O	kg	_	0	SENT_307	[p20l706t79r787b154],
3	in	IN	O	in	_	0	SENT_307	[p20l832t80r896b136],
4	subjects	NNS	O	subject	prep_in	2	SENT_307	[p20l945t79r1204b153],
5	receiving	VBG	O	receive	partmod	2	SENT_307	[p20l1255t80r1553b154],
6	placebo	NN	O	placebo	dobj	5	SENT_307	[p20l1598t79r1867b153],
7	,	,	O	,	_	0	SENT_307	[p20l1598t79r1867b153],
8	with	IN	O	with	_	0	SENT_307	[p20l1916t79r2064b138],
9	a	DT	O	a	det	12	SENT_307	[p20l2112t98r2146b137],
10	similar	JJ	O	similar	amod	12	SENT_307	[p20l564t174r796b232],
11	between-group	NN	O	between-group	nn	12	SENT_307	[p20l831t174r1322b249],
12	difference	NN	O	difference	prep_with	5	SENT_307	[p20l1360t173r1689b232],
13	at	IN	O	at	_	0	SENT_307	[p20l1725t186r1785b232],
14	24	CD	DURATION	24	num	15	SENT_307	[p20l1817t178r1891b232],
15	Weeks	NNS	DURATION	week	prep_at	12	SENT_307	[p20l1923t174r2140b233],
16	.	.	O	.	_	0	SENT_307	[p20l1923t174r2140b233],

1	In	IN	O	in	_	0	SENT_308	[p20l562t274r628b326],
2	patients	NNS	O	patient	prep_in	9	SENT_308	[p20l657t270r912b343],
3	with	IN	O	with	_	0	SENT_308	[p20l941t269r1086b328],
4	cystic	JJ	O	cystic	amod	5	SENT_308	[p20l1117t270r1294b343],
5	fibrosis	NN	O	fibrosis	prep_with	2	SENT_308	[p20l1325t268r1585b340],
6	,	,	O	,	_	0	SENT_308	[p20l1325t268r1585b340],
7	Weight	NNP	O	Weight	nsubjpass	9	SENT_308	[p20l1616t269r1835b344],
8	is	VBZ	O	be	auxpass	9	SENT_308	[p20l1861t270r1910b327],
9	affected	VBN	O	affect	ccomp	20	SENT_308	[p20l1942t268r2144b327, p20l563t364r635b422],
10	by	IN	O	by	_	0	SENT_308	[p20l666t364r739b438],
11	multiple	JJ	O	multiple	amod	12	SENT_308	[p20l767t364r1038b438],
12	factors	NNS	O	factor	agent	9	SENT_308	[p20l1070t363r1310b435],
13	,	,	O	,	_	0	SENT_308	[p20l1070t363r1310b435],
14	including	VBG	O	include	_	0	SENT_308	[p20l1345t364r1658b439],
15	pancreatic	JJ	O	pancreatic	amod	16	SENT_308	[p20l1686t365r2026b438],
16	insufficiency	NN	O	insufficiency	prep_including	9	SENT_308	[p20l2057t365r2144b421, p20l564t458r922b533],
17	with	IN	O	with	_	0	SENT_308	[p20l941t459r1089b518],
18	maldigestion	NN	O	maldigestion	prep_with	16	SENT_308	[p20l1114t459r1562b534],
19	,	,	O	,	_	0	SENT_308	[p20l1114t459r1562b534],
20	increased	VBD	O	increase	_	0	SENT_308	[p20l1591t459r1901b517],
21	caloric	JJ	O	caloric	amod	22	SENT_308	[p20l1927t459r2145b517],
22	needs	NNS	O	need	iobj	20	SENT_308	[p20l562t554r756b625],
23	,	,	O	,	_	0	SENT_308	[p20l562t554r756b625],
24	diabetes	NN	O	diabetes	conj_and	22	SENT_308	[p20l782t554r1054b625],
25	,	,	O	,	_	0	SENT_308	[p20l782t554r1054b625],
26	and	CC	O	and	_	0	SENT_308	[p20l1079t554r1194b612],
27	anoreXia	NN	O	anorexia	iobj	20	SENT_308	[p20l1215t555r1595b612],
28	.5	CD	NUMBER	.5	num	29	SENT_308	[p20l1215t555r1595b612],
29	>	JJR	O	>	dobj	20	SENT_308	[p20l1215t555r1595b612],
30	24	CD	NUMBER	24	nsubj	20	SENT_308	[p20l1215t555r1595b612],
31	A	DT	O	a	det	34	SENT_308	[p20l1613t559r1663b611],
32	systemic	JJ	O	systemic	amod	34	SENT_308	[p20l1683t555r1948b628],
33	CFTR	NNP	ORGANIZATION	CFTR	nn	34	SENT_308	[p20l1969t558r2152b616],
34	modulator	NN	O	modulator	nsubj	42	SENT_308	[p20l562t649r902b720],
35	,	,	O	,	_	0	SENT_308	[p20l562t649r902b720],
36	such	JJ	O	such	_	0	SENT_308	[p20l929t649r1069b708],
37	as	IN	O	as	_	0	SENT_308	[p20l1090t668r1152b707],
38	ivacaftor	NN	O	ivacaftor	prep_such_as	34	SENT_308	[p20l1174t648r1456b720],
39	,	,	O	,	_	0	SENT_308	[p20l1174t648r1456b720],
40	may	MD	O	may	aux	42	SENT_308	[p20l1482t668r1612b723],
41	also	RB	O	also	advmod	42	SENT_308	[p20l1630t649r1753b707],
42	affect	VB	O	affect	rcmod	30	SENT_308	[p20l1775t648r1952b707],
43	CFTR	NN	ORGANIZATION	cftr	nn	44	SENT_308	[p20l1969t653r2152b711],
44	function	NN	O	function	dobj	42	SENT_308	[p20l562t743r828b803],
45	in	IN	O	in	_	0	SENT_308	[p20l859t745r920b801],
46	gastrointestinal	JJ	O	gastrointestinal	amod	47	SENT_308	[p20l951t744r1443b819],
47	epithelia	NN	O	epithelium	prep_in	42	SENT_308	[p20l1474t744r1756b818],
48	,	,	O	,	_	0	SENT_308	[p20l1474t744r1756b818],
49	Which	WDT	O	which	nsubj	51	SENT_308	[p20l1788t744r1980b803],
50	may	MD	O	may	aux	51	SENT_308	[p20l2013t763r2148b818],
51	contribute	VB	O	contribute	rcmod	47	SENT_308	[p20l563t839r899b898],
52	to	TO	O	to	_	0	SENT_308	[p20l933t851r994b897],
53	improved	VBN	O	improve	amod	54	SENT_308	[p20l1027t839r1334b913],
54	absorption	NN	O	absorption	prep_to	51	SENT_308	[p20l1366t839r1722b913],
55	of	IN	O	of	_	0	SENT_308	[p20l1755t838r1830b897],
56	nutrients	NNS	O	nutrient	prep_of	54	SENT_308	[p20l1849t840r2143b898],
57	in	IN	O	in	_	0	SENT_308	[p20l562t935r623b991],
58	patients	NNS	O	patient	prep_in	56	SENT_308	[p20l648t935r897b1008],
59	with	IN	O	with	_	0	SENT_308	[p20l921t934r1065b993],
60	cystic	JJ	O	cystic	amod	61	SENT_308	[p20l1091t935r1264b1008],
61	fibrosis	NN	O	fibrosis	prep_with	58	SENT_308	[p20l1290t933r1544b1004],
62	;	:	O	;	_	0	SENT_308	[p20l1290t933r1544b1004],
63	however	RB	O	however	advmod	69	SENT_308	[p20l1573t934r1846b1005],
64	,	,	O	,	_	0	SENT_308	[p20l1573t934r1846b1005],
65	no	DT	O	no	det	67	SENT_308	[p20l1876t953r1954b992],
66	causal	JJ	O	causal	amod	67	SENT_308	[p20l1982t953r2144b993, p20l562t1029r618b1087],
67	relationship	NN	O	relationship	nsubjpass	71	SENT_308	[p20l661t1029r1053b1103],
68	Was	VBD	O	be	auxpass	69	SENT_308	[p20l1094t1048r1217b1088],
69	studied	VBN	O	study	parataxis	42	SENT_308	[p20l1263t1029r1501b1088],
70	or	CC	O	or	_	0	SENT_308	[p20l1545t1048r1612b1087],
71	proven	VBN	O	prove	conj_or	69	SENT_308	[p20l1652t1048r1872b1103],
72	in	IN	O	in	_	0	SENT_308	[p20l1915t1030r1978b1086],
73	this	DT	O	this	det	74	SENT_308	[p20l2022t1029r2143b1087],
74	trial	NN	O	trial	prep_in	69	SENT_308	[p20l563t1125r716b1183],
75	.	.	O	.	_	0	SENT_308	[p20l563t1125r716b1183],

1	Table	NNP	O	Table	_	0	SENT_309	[p20l77t1447r268b1512],
2	3	CD	NUMBER	3	dep	1	SENT_309	[p20l292t1453r350b1511],
3	.	.	O	.	_	0	SENT_309	[p20l292t1453r350b1511],

1	Adverse	JJ	O	adverse	amod	2	SENT_310	[p20l374t1447r659b1512],
2	Events	NNS	O	event	_	0	SENT_310	[p20l687t1453r937b1512],
3	.	.	O	.	_	0	SENT_310	[p20l687t1453r937b1512],

1	Placebo	NN	O	placebo	nn	2	SENT_311	[p20l1305t1642r1573b1707],
2	lvacaftor	NN	O	lvacaftor	_	0	SENT_311	[p20l1760t1641r2065b1707],
3	Adverse	JJ	O	adverse	amod	6	SENT_311	[p20l77t1739r361b1804],
4	Event	NN	O	event	nn	6	SENT_311	[p20l393t1745r587b1804],
5	(	NN	O	(	nn	6	SENT_311	[p20l1306t1745r1383b1825],
6	N	NN	O	n	dep	2	SENT_311	[p20l1306t1745r1383b1825],
7	=	JJ	O	=	quantmod	9	SENT_311	[p20l1403t1771r1448b1793],
8	78	CD	NUMBER	78	number	9	SENT_311	[p20l1465t1743r1567b1824],
9	)	CD	NUMBER	)	num	14	SENT_311	[p20l1465t1743r1567b1824],
10	(	NN	O	(	nn	14	SENT_311	[p20l1779t1745r1856b1824],
11	N	NN	O	n	nn	14	SENT_311	[p20l1779t1745r1856b1824],
12	=	JJ	O	=	amod	14	SENT_311	[p20l1876t1771r1920b1793],
13	83	CD	NUMBER	83	num	14	SENT_311	[p20l1935t1743r2040b1825],
14	)	NN	O	)	dep	6	SENT_311	[p20l1935t1743r2040b1825],

1	no.	NN	O	no.	_	0	SENT_312	[p20l1360t1955r1455b1997],
2	of	IN	O	of	_	0	SENT_312	[p20l1487t1931r1565b2018],
3	subjects	NNS	O	subject	prep_of	1	SENT_312	[p20l1569t1931r1829b2018],
4	(	CD	PERCENT	(	num	5	SENT_312	[p20l1860t1935r1976b2017],
5	%	NN	PERCENT	%	dep	1	SENT_312	[p20l1860t1935r1976b2017],
6	)	CD	NUMBER	)	dep	5	SENT_312	[p20l1860t1935r1976b2017],

1	Any	DT	O	any	det	3	SENT_313	[p20l77t2085r208b2166],
2	adverse	JJ	O	adverse	amod	3	SENT_313	[p20l234t2081r502b2146],
3	event	NN	O	event	_	0	SENT_313	[p20l528t2094r717b2146],
4	78	CD	NUMBER	78	num	5	SENT_313	[p20l1293t2085r1369b2146],
5	(	NN	O	(	dep	3	SENT_313	[p20l1404t2085r1574b2166],
6	100	CD	NUMBER	100	number	7	SENT_313	[p20l1404t2085r1574b2166],
7	)	CD	NUMBER	)	num	9	SENT_313	[p20l1404t2085r1574b2166],
8	82	CD	NUMBER	82	number	9	SENT_313	[p20l1786t2085r1864b2146],
9	(	CD	NUMBER	(	dep	5	SENT_313	[p20l1900t2086r2028b2166],
10	99	CD	NUMBER	99	num	11	SENT_313	[p20l1900t2086r2028b2166],
11	)	NN	O	)	dep	3	SENT_313	[p20l1900t2086r2028b2166],

1	Serious	JJ	O	serious	amod	3	SENT_314	[p20l81t2235r340b2295],
2	adverse	JJ	O	adverse	amod	3	SENT_314	[p20l369t2230r637b2295],
3	event	NN	O	event	_	0	SENT_314	[p20l663t2236r894b2295],
4	*	NN	O	*	dep	3	SENT_314	[p20l663t2236r894b2295],

1	33	CD	NUMBER	33	num	2	SENT_315	[p20l1291t2236r1365b2295],
2	<	JJR	O	<	_	0	SENT_315	[p20l1404t2236r1423b2316],
3	<	JJR	O	<	amod	5	SENT_315	[p20l1900t2236r1919b2316],
4	Pulmonary	JJ	O	pulmonary	amod	5	SENT_315	[p20l214t2380r592b2465],
5	exacerbation	NN	O	exacerbation	dep	2	SENT_315	[p20l616t2380r1058b2444],
6	26	CD	NUMBER	26	number	7	SENT_315	[p20l1290t2385r1370b2445],
7	(	CD	NUMBER	(	dep	5	SENT_315	[p20l1404t2385r1532b2465],
8	33	CD	NUMBER	33	num	10	SENT_315	[p20l1404t2385r1532b2465],
9	)	NN	O	)	nn	10	SENT_315	[p20l1404t2385r1532b2465],
10	(	NN	O	(	dep	2	SENT_315	[p20l1900t2385r1919b2465],

1	Hemoptysis	NNP	O	Hemoptysis	nn	2	SENT_316	[p20l214t2534r634b2614],
2	Hypoglycemia	NNP	O	Hypoglycemia	_	0	SENT_316	[p20l214t2678r709b2764],
3	O	NN	O	o	dep	2	SENT_316	[p20l1331t2682r1370b2743],

1	Adverse	JJ	O	adverse	amod	2	SENT_317	[p20l77t2827r358b2892],
2	event	NN	O	event	_	0	SENT_317	[p20l385t2840r573b2892],
3	leading	VBG	O	lead	partmod	2	SENT_317	[p20l601t2827r854b2913],
4	to	TO	O	to	aux	5	SENT_317	[p20l876t2840r945b2892],
5	study	VB	O	study	xcomp	3	SENT_317	[p20l973t2827r1182b2913],
6	-	:	O	-	_	0	SENT_317	[p20l973t2827r1182b2913],
7	5	CD	NUMBER	5	number	8	SENT_317	[p20l1334t2833r1366b2892],
8	(	CD	NUMBER	(	dep	2	SENT_317	[p20l1404t2833r1489b2912],
9	6	CD	NUMBER	6	num	10	SENT_317	[p20l1404t2833r1489b2912],
10	)	NN	O	)	dep	8	SENT_317	[p20l1404t2833r1489b2912],

1	drug	NN	O	drug	nn	2	SENT_318	[p20l339t2924r500b3010],
2	interruption	NN	O	interruption	_	0	SENT_318	[p20l528t2930r943b3009],

1	Adverse	JJ	O	adverse	amod	2	SENT_319	[p20l77t3074r358b3138],
2	event	NN	O	event	_	0	SENT_319	[p20l385t3086r573b3138],
3	leading	VBG	O	lead	amod	2	SENT_319	[p20l601t3074r854b3159],
4	to	TO	O	to	_	0	SENT_319	[p20l876t3086r945b3138],
5	studydrug	NN	O	studydrug	prep_to	2	SENT_319	[p20l973t3074r1182b3159, p20l339t3171r500b3256],

1	discontinuation	NN	O	discontinuation	_	0	SENT_320	[p20l525t3171r1076b3235],

1	7	CD	NUMBER	7	nsubj	7	SENT_321	[p20l10t3397r49b3434],
2	"	``	O	"	punct	1	SENT_321	[p20l10t3397r49b3434],
3	Included	VBN	O	include	partmod	1	SENT_321	[p20l81t3390r378b3455],
4	are	VBP	O	be	cop	7	SENT_321	[p20l412t3413r516b3455],
5	serious	JJ	O	serious	amod	7	SENT_321	[p20l547t3397r799b3455],
6	adverse	JJ	O	adverse	amod	7	SENT_321	[p20l831t3390r1099b3455],
7	events	NNS	O	event	_	0	SENT_321	[p20l1129t3403r1353b3455],
8	that	WDT	O	that	nsubj	9	SENT_321	[p20l1382t3390r1521b3455],
9	occurred	VBD	O	occur	rcmod	7	SENT_321	[p20l1549t3390r1854b3455],
10	in	IN	O	in	_	0	SENT_321	[p20l1890t3397r1946b3454],
11	more	JJR	O	more	mwe	12	SENT_321	[p20l80t3510r258b3552],
12	than	IN	O	than	quantmod	13	SENT_321	[p20l286t3487r439b3552],
13	one	CD	NUMBER	one	prep_in	9	SENT_321	[p20l473t3510r600b3552],
14	subject	JJ	O	subject	acomp	9	SENT_321	[p20l631t3487r883b3572],
15	per	IN	O	per	_	0	SENT_321	[p20l915t3510r1024b3571],
16	group	NN	O	group	prep_per	9	SENT_321	[p20l1052t3510r1277b3572],
17	.	.	O	.	_	0	SENT_321	[p20l1052t3510r1277b3572],

1	CFT	NNP	O	CFT	nn	2	SENT_322	[p21l140t104r316b177],
2	R	NN	O	r	nsubj	3	SENT_322	[p21l317t105r390b182],
3	plays	VBZ	O	play	_	0	SENT_322	[p21l412t98r624b199],
4	an	DT	O	a	det	6	SENT_322	[p21l659t124r761b177],
5	important	JJ	O	important	amod	6	SENT_322	[p21l794t99r1231b199],
6	role	NN	O	role	iobj	3	SENT_322	[p21l1259t98r1416b177],
7	in	IN	O	in	_	0	SENT_322	[p21l1450t99r1533b176],
8	the	DT	O	the	det	11	SENT_322	[p21l1567t98r1699b177],
9	reabsorp	NN	O	reabsorp	nn	11	SENT_322	[p21l1733t98r2140b199],
10	—	NN	O	—	nn	11	SENT_322	[p21l1733t98r2140b199],
11	tion	NN	O	tion	prep_in	6	SENT_322	[p21l11t228r181b306],
12	of	IN	O	of	_	0	SENT_322	[p21l216t227r316b306],
13	chloride	NN	O	chloride	prep_of	11	SENT_322	[p21l332t227r682b306],
14	in	IN	O	in	_	0	SENT_322	[p21l715t228r799b305],
15	the	DT	O	the	det	17	SENT_322	[p21l833t227r966b306],
16	sweat	NN	O	sweat	nn	17	SENT_322	[p21l1002t244r1245b306],
17	duct	NN	O	duct	prep_in	13	SENT_322	[p21l1274t227r1558b306],
18	.25	CD	NUMBER	.25	dobj	3	SENT_322	[p21l1274t227r1558b306],
19	We	PRP	O	we	nsubj	20	SENT_322	[p21l1591t235r1725b306],
20	observed	VBD	O	observe	rcmod	18	SENT_322	[p21l1759t227r2142b306],
21	a	DT	O	a	det	23	SENT_322	[p21l10t382r55b434],
22	large	JJ	O	large	amod	23	SENT_322	[p21l84t355r296b456],
23	correction	NN	O	correction	dobj	20	SENT_322	[p21l330t356r765b434],
24	of	IN	O	of	_	0	SENT_322	[p21l797t355r897b434],
25	elevated	JJ	O	elevated	amod	26	SENT_322	[p21l911t355r1250b434],
26	levels	NNS	O	level	prep_of	23	SENT_322	[p21l1281t355r1509b434],
27	of	IN	O	of	_	0	SENT_322	[p21l1544t355r1643b434],
28	sweat	NN	O	sweat	nn	29	SENT_322	[p21l1658t372r1899b434],
29	chloride	NN	O	chloride	prep_of	26	SENT_322	[p21l1926t355r2140b434, p21l11t483r174b562],
30	in	IN	O	in	_	0	SENT_322	[p21l205t484r289b561],
31	the	DT	O	the	det	33	SENT_322	[p21l322t483r454b562],
32	ivacaftor	NN	O	ivacaftor	nn	33	SENT_322	[p21l486t483r863b562],
33	group	NN	O	group	prep_in	20	SENT_322	[p21l892t509r1168b584],
34	,	,	O	,	_	0	SENT_322	[p21l892t509r1168b584],
35	as	IN	O	as	mark	36	SENT_322	[p21l1205t510r1290b562],
36	compared	VBN	O	compare	advcl	20	SENT_322	[p21l1325t483r1753b584],
37	with	IN	O	with	_	0	SENT_322	[p21l1780t483r1976b562],
38	the	DT	O	the	det	40	SENT_322	[p21l2008t483r2141b562],
39	placebo	NN	O	placebo	nn	40	SENT_322	[p21l10t611r340b712],
40	group	NN	O	group	prep_with	36	SENT_322	[p21l380t637r656b712],
41	,	,	O	,	_	0	SENT_322	[p21l380t637r656b712],
42	as	RB	O	as	advmod	40	SENT_322	[p21l700t638r786b690],
43	early	RB	O	early	advmod	40	SENT_322	[p21l828t611r1034b712],
44	as	IN	O	as	amod	40	SENT_322	[p21l1069t638r1155b690],
45	2	CD	DURATION	2	num	46	SENT_322	[p21l1196t617r1243b689],
46	weeks	NNS	NUMBER	week	dep	40	SENT_322	[p21l1280t611r1542b691],
47	after	IN	O	after	_	0	SENT_322	[p21l1583t611r1785b690],
48	the	DT	O	the	det	49	SENT_322	[p21l1823t611r1955b690],
49	initiation	NN	O	initiation	prep_after	36	SENT_322	[p21l1995t612r2140b689, p21l11t740r300b818],
50	of	IN	O	of	_	0	SENT_322	[p21l349t739r450b818],
51	the	DT	O	the	det	53	SENT_322	[p21l480t739r615b818],
52	study	NN	O	study	nn	53	SENT_322	[p21l665t739r900b840],
53	drug	NN	O	drug	prep_of	49	SENT_322	[p21l943t739r1172b840],
54	.	.	O	.	_	0	SENT_322	[p21l943t739r1172b840],

1	Ivacaftor	NNP	O	Ivacaftor	nsubj	5	SENT_323	[p21l1223t739r1613b818],
2	is	VBZ	O	be	cop	5	SENT_323	[p21l1657t740r1724b818],
3	the	DT	O	the	det	5	SENT_323	[p21l1775t739r1910b818],
4	first	JJ	ORDINAL	first	amod	5	SENT_323	[p21l1958t739r2147b818],
5	agent	NN	O	agent	_	0	SENT_323	[p21l10t884r248b968],
6	to	TO	O	to	aux	7	SENT_323	[p21l284t884r366b946],
7	show	VB	O	show	infmod	5	SENT_323	[p21l411t867r637b946],
8	a	DT	O	a	det	9	SENT_323	[p21l674t894r718b946],
9	reduction	NN	O	reduction	dobj	7	SENT_323	[p21l758t867r1169b946],
10	in	IN	O	in	_	0	SENT_323	[p21l1209t868r1293b945],
11	the	DT	O	the	det	14	SENT_323	[p21l1335t867r1468b946],
12	sweat	NN	O	sweat	nn	14	SENT_323	[p21l1512t884r1754b946],
13	chloride	NN	O	chloride	nn	14	SENT_323	[p21l1792t867r2141b946],
14	level	NN	O	level	prep_in	9	SENT_323	[p21l10t995r199b1074],
15	to	TO	O	to	_	0	SENT_323	[p21l231t1012r313b1074],
16	values	NNS	O	value	prep_to	7	SENT_323	[p21l343t995r606b1074],
17	below	IN	O	below	_	0	SENT_323	[p21l641t995r898b1074],
18	the	DT	O	the	det	20	SENT_323	[p21l928t995r1061b1074],
19	diagnostic	JJ	O	diagnostic	amod	20	SENT_323	[p21l1094t995r1546b1096],
20	threshold	NN	O	threshold	prep_below	7	SENT_323	[p21l1578t995r1989b1074],
21	for	IN	O	for	_	0	SENT_323	[p21l2021t995r2144b1074],
22	cystic	JJ	O	cystic	amod	26	SENT_323	[p21l11t1124r250b1224],
23	fibrosis	NN	O	fibrosis	nn	26	SENT_323	[p21l293t1123r619b1202],
24	(	NN	O	(	nn	26	SENT_323	[p21l669t1129r796b1215],
25	60	CD	NUMBER	60	num	26	SENT_323	[p21l669t1129r796b1215],
26	mmol	NN	O	mmol	prep_for	20	SENT_323	[p21l841t1123r1095b1202],
27	per	IN	O	per	_	0	SENT_323	[p21l1138t1149r1278b1224],
28	liter	NN	O	liter	nn	29	SENT_323	[p21l1318t1123r1539b1214],
29	)	NN	O	)	prep_per	20	SENT_323	[p21l1318t1123r1539b1214],
30	.	.	O	.	_	0	SENT_323	[p21l1318t1123r1539b1214],

1	This	DT	O	this	det	2	SENT_324	[p21l1586t1123r1774b1202],
2	finding	NN	O	finding	nsubj	3	SENT_324	[p21l1820t1123r2145b1224],
3	confirms	VBZ	O	confirm	_	0	SENT_324	[p21l11t1251r414b1330],
4	the	DT	O	the	det	5	SENT_324	[p21l468t1251r604b1330],
5	observation	NN	O	observation	dobj	3	SENT_324	[p21l657t1251r1170b1330],
6	from	IN	O	from	_	0	SENT_324	[p21l1222t1251r1437b1330],
7	an	DT	O	a	det	11	SENT_324	[p21l1487t1277r1592b1330],
8	early	JJ	O	early	amod	11	SENT_324	[p21l1645t1251r2141b1352],
9	—	NN	O	—	nn	11	SENT_324	[p21l1645t1251r2141b1352],
10	phase	NN	O	phase	nn	11	SENT_324	[p21l1645t1251r2141b1352],
11	trial	NN	O	trial	prep_from	3	SENT_324	[p21l11t1379r190b1458],
12	that	WDT	O	that	dobj	14	SENT_324	[p21l223t1379r396b1458],
13	ivacaftor	NN	O	ivacaftor	nsubj	14	SENT_324	[p21l423t1379r801b1458],
14	improved	VBD	O	improve	rcmod	11	SENT_324	[p21l830t1379r1236b1480],
15	CFTR	NNP	O	CFTR	dep	17	SENT_324	[p21l1269t1379r1941b1463],
16	—	CD	NUMBER	—	num	15	SENT_324	[p21l1269t1379r1941b1463],
17	mediated	JJ	O	mediated	amod	19	SENT_324	[p21l1269t1379r1941b1463],
18	iontransport	NN	O	iontransport	nn	19	SENT_324	[p21l1973t1380r2140b1458, p21l11t1524r419b1608],
19	function	NN	O	function	dobj	14	SENT_324	[p21l454t1507r924b1586],
20	.	.	O	.	_	0	SENT_324	[p21l454t1507r924b1586],

1	“	NN	O	“	_	0	SENT_325	[p21l454t1507r924b1586],

1	The	DT	O	the	det	2	SENT_326	[p21l137t1635r298b1714],
2	mechanisms	NNS	O	mechanism	nsubj	16	SENT_326	[p21l343t1635r888b1714],
3	by	IN	O	by	_	0	SENT_326	[p21l935t1635r1033b1736],
4	which	WDT	O	which	rel	10	SENT_326	[p21l1068t1635r1331b1714],
5	changes	NNS	O	change	nsubj	10	SENT_326	[p21l1377t1635r1726b1736],
6	in	IN	O	in	_	0	SENT_326	[p21l1772t1636r1855b1713],
7	CFTR	NNP	ORGANIZATION	CFTR	nn	8	SENT_326	[p21l1900t1641r2152b1719],
8	function	NN	O	function	prep_in	5	SENT_326	[p21l11t1763r379b1842],
9	may	MD	O	may	aux	10	SENT_326	[p21l447t1789r628b1864],
10	lead	VB	O	lead	rcmod	2	SENT_326	[p21l691t1763r865b1842],
11	to	TO	O	to	_	0	SENT_326	[p21l934t1780r1016b1842],
12	pulmonary	JJ	O	pulmonary	amod	15	SENT_326	[p21l1085t1763r1565b1864],
13	and	CC	O	and	_	0	SENT_326	[p21l1629t1763r1788b1842],
14	weight	NN	O	weight	amod	15	SENT_326	[p21l1851t1763r2147b1864],
15	changes	NNS	O	change	prep_to	10	SENT_326	[p21l11t1891r361b1992],
16	are	VBP	O	be	_	0	SENT_326	[p21l405t1918r534b1970],
17	incompletely	RB	O	incompletely	advmod	18	SENT_326	[p21l577t1891r1133b1992],
18	understood	VBN	O	understand	dep	16	SENT_326	[p21l1171t1891r1665b1970],
19	and	CC	O	and	_	0	SENT_326	[p21l1707t1891r1866b1970],
20	probably	RB	O	probably	advmod	21	SENT_326	[p21l1907t1891r2140b1992, p21l10t2019r185b2120],
21	multifactorial	JJ	O	multifactorial	conj_and	18	SENT_326	[p21l221t2019r840b2098],
22	.	.	O	.	_	0	SENT_326	[p21l221t2019r840b2098],

1	In	FW	O	in	nn	3	SENT_327	[p21l885t2027r975b2097],
2	vitro	FW	O	vitro	nn	3	SENT_327	[p21l1011t2020r1210b2098],
3	studies	NNS	O	study	nsubj	23	SENT_327	[p21l1254t2019r1555b2098],
4	of	IN	O	of	_	0	SENT_327	[p21l1599t2019r1700b2098],
5	air	NN	O	air	nn	9	SENT_327	[p21l1722t2019r2142b2120],
6	—	NN	O	—	nn	9	SENT_327	[p21l1722t2019r2142b2120],
7	liquid	JJ	O	liquid	amod	9	SENT_327	[p21l1722t2019r2142b2120],
8	interface	NN	O	interface	nn	9	SENT_327	[p21l10t2147r373b2226],
9	cultures	NNS	O	culture	prep_of	3	SENT_327	[p21l403t2147r735b2226],
10	of	IN	O	of	_	0	SENT_327	[p21l769t2147r867b2226],
11	bronchial	JJ	O	bronchial	amod	13	SENT_327	[p21l879t2147r1277b2226],
12	epithelial	JJ	O	epithelial	amod	13	SENT_327	[p21l1307t2147r1694b2248],
13	cells	NNS	O	cell	prep_of	3	SENT_327	[p21l1723t2147r1904b2226],
14	from	IN	O	from	_	0	SENT_327	[p21l1935t2147r2142b2226],
15	the	DT	O	the	det	16	SENT_327	[p21l11t2275r146b2354],
16	lungs	NNS	O	lung	prep_from	13	SENT_327	[p21l197t2275r434b2376],
17	of	IN	O	of	_	0	SENT_327	[p21l489t2275r590b2354],
18	patients	NNS	O	patient	prep_of	16	SENT_327	[p21l622t2276r970b2376],
19	with	IN	O	with	_	0	SENT_327	[p21l1020t2275r1218b2355],
20	cystic	JJ	O	cystic	amod	21	SENT_327	[p21l1271t2276r1512b2376],
21	fibrosis	NN	O	fibrosis	prep_with	18	SENT_327	[p21l1564t2275r1894b2354],
22	have	VBP	O	have	aux	23	SENT_327	[p21l1948t2275r2140b2354],
23	shown	VBN	O	show	_	0	SENT_327	[p21l12t2403r287b2482],
24	that	IN	O	that	complm	30	SENT_327	[p21l315t2403r482b2482],
25	correction	NN	O	correction	nsubj	30	SENT_327	[p21l507t2404r928b2482],
26	of	IN	O	of	_	0	SENT_327	[p21l958t2403r1055b2482],
27	abnormal	JJ	O	abnormal	amod	29	SENT_327	[p21l1065t2403r1468b2482],
28	CFTR	NNP	O	CFTR	nn	29	SENT_327	[p21l1496t2403r2142b2487],
29	—	NN	O	—	prep_of	25	SENT_327	[p21l1496t2403r2142b2487],
30	mediated	VBD	O	mediate	ccomp	23	SENT_327	[p21l1496t2403r2142b2487],
31	ion	NN	O	ion	nn	32	SENT_327	[p21l10t2532r144b2610],
32	transport	NN	O	transport	nsubj	33	SENT_327	[p21l179t2548r582b2632],
33	increases	VBZ	O	increase	ccomp	30	SENT_327	[p21l612t2532r1002b2610],
34	the	DT	O	the	det	39	SENT_327	[p21l1040t2531r1172b2610],
35	air	NN	O	air	nn	39	SENT_327	[p21l1207t2531r1683b2610],
36	—	NN	O	—	nn	39	SENT_327	[p21l1207t2531r1683b2610],
37	surface	NN	O	surface	nn	39	SENT_327	[p21l1207t2531r1683b2610],
38	fluid	NN	O	fluid	nn	39	SENT_327	[p21l1718t2531r1921b2610],
39	level	NN	O	level	dobj	33	SENT_327	[p21l1955t2531r2142b2610],
40	and	CC	O	and	_	0	SENT_327	[p21l10t2659r164b2738],
41	ciliary	JJ	O	ciliary	amod	42	SENT_327	[p21l192t2659r448b2760],
42	beat	JJ	O	beat	amod	43	SENT_327	[p21l472t2659r646b2738],
43	frequency	NN	O	frequency	conj_and	39	SENT_327	[p21l669t2659r1156b2760],
44	.	.	O	.	_	0	SENT_327	[p21l669t2659r1156b2760],

1	”	NN	O	”	npadvmod	2	SENT_328	[p21l669t2659r1156b2760],
2	Thus	RB	O	thus	advmod	17	SENT_328	[p21l1181t2659r1407b2755],
3	,	,	O	,	_	0	SENT_328	[p21l1181t2659r1407b2755],
4	the	DT	O	the	det	5	SENT_328	[p21l1441t2659r1569b2738],
5	improvement	NN	O	improvement	nsubj	17	SENT_328	[p21l1596t2660r2147b2760],
6	in	IN	O	in	_	0	SENT_328	[p21l10t2789r95b2866],
7	FEV1	NN	O	fev1	prep_in	5	SENT_328	[p21l144t2796r345b2893],
8	observed	VBN	O	observe	partmod	7	SENT_328	[p21l396t2788r785b2867],
9	after	IN	O	after	_	0	SENT_328	[p21l835t2788r1042b2867],
10	2	CD	DURATION	2	num	11	SENT_328	[p21l1090t2794r1137b2866],
11	weeks	NNS	NUMBER	week	prep_after	8	SENT_328	[p21l1184t2788r1450b2868],
12	in	IN	O	in	_	0	SENT_328	[p21l1503t2789r1587b2866],
13	the	DT	O	the	det	15	SENT_328	[p21l1638t2788r1773b2867],
14	current	JJ	DATE	current	amod	15	SENT_328	[p21l1825t2805r2147b2867],
15	study	NN	O	study	prep_in	11	SENT_328	[p21l12t2916r240b3017],
16	may	MD	O	may	aux	17	SENT_328	[p21l269t2942r447b3017],
17	reflect	VB	O	reflect	_	0	SENT_328	[p21l476t2916r752b2995],
18	improved	JJ	O	improved	amod	20	SENT_328	[p21l779t2916r1179b3017],
19	airway	NN	O	airway	nn	20	SENT_328	[p21l1211t2917r1496b3017],
20	clearance	NN	O	clearance	dobj	17	SENT_328	[p21l1525t2916r1946b2995],
21	.	.	O	.	_	0	SENT_328	[p21l1525t2916r1946b2995],

1	The	DT	O	the	det	4	SENT_329	[p21l1981t2916r2141b2995],
2	limited	JJ	O	limited	amod	4	SENT_329	[p21l10t3045r320b3124],
3	additional	JJ	O	additional	amod	4	SENT_329	[p21l346t3045r785b3124],
4	improvements	NNS	O	improvement	nsubj	10	SENT_329	[p21l811t3046r1427b3146],
5	in	IN	O	in	_	0	SENT_329	[p21l1456t3046r1540b3123],
6	FEV1	NN	O	fev1	prep_in	4	SENT_329	[p21l1566t3053r1763b3150],
7	through	IN	O	through	_	0	SENT_329	[p21l1792t3045r2142b3146],
8	48	CD	DURATION	48	num	9	SENT_329	[p21l10t3179r110b3252],
9	weeks	NNS	NUMBER	week	prep_through	6	SENT_329	[p21l137t3173r393b3253],
10	suggest	VBP	O	suggest	_	0	SENT_329	[p21l427t3190r747b3274],
11	that	IN	O	that	complm	17	SENT_329	[p21l771t3173r941b3252],
12	continued	VBN	O	continue	amod	14	SENT_329	[p21l965t3173r1386b3252],
13	longitudinal	JJ	O	longitudinal	amod	14	SENT_329	[p21l1413t3173r1934b3274],
14	data	NNS	O	datum	nsubjpass	17	SENT_329	[p21l1964t3173r2143b3252],
15	will	MD	O	will	aux	17	SENT_329	[p21l6t3301r172b3380],
16	be	VB	O	be	auxpass	17	SENT_329	[p21l213t3301r309b3380],
17	required	VBN	O	require	ccomp	10	SENT_329	[p21l352t3301r714b3402],
18	to	TO	O	to	aux	19	SENT_329	[p21l756t3318r838b3380],
19	assess	VB	O	assess	xcomp	17	SENT_329	[p21l880t3328r1144b3380],
20	whether	IN	O	whether	complm	24	SENT_329	[p21l1183t3301r1540b3380],
21	CFTR	NNP	ORGANIZATION	CFTR	nn	22	SENT_329	[p21l1578t3307r1830b3385],
22	modulation	NN	O	modulation	nsubj	24	SENT_329	[p21l1861t3301r2140b3380, p21l10t3429r264b3508],
23	can	MD	O	can	aux	24	SENT_329	[p21l310t3455r462b3508],
24	effect	VB	O	effect	ccomp	19	SENT_329	[p21l508t3429r756b3508],
25	further	JJ	O	further	amod	27	SENT_329	[p21l797t3429r1112b3508],
26	physiological	JJ	O	physiological	amod	27	SENT_329	[p21l1154t3429r1738b3530],
27	changes	NNS	O	change	dobj	24	SENT_329	[p21l1784t3429r2139b3530],
28	in	IN	O	in	_	0	SENT_329	[p21l10t3558r95b3635],
29	the	DT	O	the	det	30	SENT_329	[p21l144t3557r279b3636],
30	airways	NNS	O	airway	prep_in	24	SENT_329	[p21l327t3558r660b3658],
31	of	IN	O	of	_	0	SENT_329	[p21l711t3557r813b3636],
32	patients	NNS	O	patient	prep_of	30	SENT_329	[p21l841t3558r1191b3658],
33	with	IN	O	with	_	0	SENT_329	[p21l1237t3557r1437b3637],
34	cystic	JJ	O	cystic	amod	35	SENT_329	[p21l1486t3558r1730b3658],
35	fibrosis	NN	O	fibrosis	prep_with	32	SENT_329	[p21l1777t3557r2136b3636],
36	.	.	O	.	_	0	SENT_329	[p21l1777t3557r2136b3636],

1	Weight	NNP	O	Weight	nn	2	SENT_330	[p21l7t3685r317b3786],
2	gain	NN	O	gain	nsubj	3	SENT_330	[p21l350t3686r540b3786],
3	appeared	VBD	O	appear	_	0	SENT_330	[p21l577t3685r971b3786],
4	to	TO	O	to	_	0	SENT_330	[p21l1009t3702r1091b3764],
5	plateau	NN	O	plateau	prep_to	3	SENT_330	[p21l1130t3685r1442b3786],
6	after	IN	O	after	_	0	SENT_330	[p21l1479t3685r1682b3764],
7	16	CD	DURATION	16	num	8	SENT_330	[p21l1721t3691r1814b3764],
8	weeks	NNS	NUMBER	week	prep_after	3	SENT_330	[p21l1849t3685r2136b3765],
9	.	.	O	.	_	0	SENT_330	[p21l1849t3685r2136b3765],

1	This	DT	DATE	this	nsubj	3	SENT_331	[p22l7t20r194b99],
2	may	MD	DATE	may	aux	3	SENT_331	[p22l255t46r434b121],
3	indicate	VB	O	indicate	_	0	SENT_331	[p22l486t20r826b99],
4	either	CC	O	either	advmod	3	SENT_331	[p22l885t20r1131b99],
5	that	IN	O	that	complm	7	SENT_331	[p22l1187t20r1358b99],
6	subjects	NNS	O	subject	nsubj	7	SENT_331	[p22l1413t20r1750b121],
7	reached	VBD	O	reach	ccomp	3	SENT_331	[p22l1811t20r2142b99],
8	their	PRP$	O	they	poss	11	SENT_331	[p22l11t148r214b227],
9	ideal	JJ	O	ideal	amod	11	SENT_331	[p22l252t148r456b227],
10	body	NN	O	body	nn	11	SENT_331	[p22l498t148r706b249],
11	weight	NN	O	weight	dobj	7	SENT_331	[p22l739t148r1032b249],
12	or	CC	O	or	_	0	SENT_331	[p22l1069t174r1157b227],
13	that	IN	O	that	complm	17	SENT_331	[p22l1196t148r1367b227],
14	other	JJ	O	other	amod	16	SENT_331	[p22l1405t148r1631b227],
15	physiological	JJ	O	physiological	amod	16	SENT_331	[p22l1669t148r2140b249, p22l11t276r132b355],
16	factors	NNS	O	factor	nsubj	17	SENT_331	[p22l186t276r475b355],
17	prevented	VBD	O	prevent	conj_or	7	SENT_331	[p22l531t276r948b377],
18	them	PRP	O	they	dobj	17	SENT_331	[p22l1003t276r1223b355],
19	from	IN	O	from	_	0	SENT_331	[p22l1278t276r1488b355],
20	gaining	VBG	O	gain	prepc_from	17	SENT_331	[p22l1543t277r1876b377],
21	addi1670	NN	O	addi1670	dobj	20	SENT_331	[p22l1927t276r2140b355, p22l149t452r225b475],

1	N	NN	O	n	nn	3	SENT_332	[p22l937t463r951b478],
2	ENGLJ	NN	O	englj	nn	3	SENT_332	[p22l965t463r1043b485],
3	MED	NN	O	med	_	0	SENT_332	[p22l1058t463r1110b478],
4	365	CD	NUMBER	365	dep	3	SENT_332	[p22l1120t457r1196b485],
5	;	:	O	;	_	0	SENT_332	[p22l1120t457r1196b485],
6	18	CD	NUMBER	18	num	7	SENT_332	[p22l1120t457r1196b485],
7	NEJM.ORG	NN	O	nejm.org	dep	4	SENT_332	[p22l1231t463r1355b485],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	7	SENT_332	[p22l1392t463r1527b479],
9	3	CD	DATE	3	num	8	SENT_332	[p22l1537t463r1555b485],
10	,	,	DATE	,	_	0	SENT_332	[p22l1537t463r1555b485],
11	2011	CD	DATE	2011	num	8	SENT_332	[p22l1567t463r1618b479],

1	The	DT	O	the	det	4	SENT_333	[p22l935t496r986b520],
2	New	NNP	O	New	nn	4	SENT_333	[p22l995t497r1057b520],
3	England	NNP	O	England	nn	4	SENT_333	[p22l1066t496r1177b527],
4	Journal	NNP	O	Journal	_	0	SENT_333	[p22l1186t496r1283b520],
5	of	IN	O	of	_	0	SENT_333	[p22l1293t496r1322b520],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_333	[p22l1329t496r1454b520],

1	Downloaded	VBN	O	download	_	0	SENT_334	[p22l377t537r547b560],
2	from	IN	O	from	_	0	SENT_334	[p22l556t537r621b560],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_334	[p22l629t537r748b567],
4	at	IN	O	at	_	0	SENT_334	[p22l758t541r781b560],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_334	[p22l789t537r972b560],
6	on	IN	O	on	_	0	SENT_334	[p22l981t544r1014b560],
7	January	NNP	DATE	January	prep_on	1	SENT_334	[p22l1022t537r1125b567],
8	5	CD	DATE	5	num	7	SENT_334	[p22l1135t537r1158b564],
9	,	,	DATE	,	_	0	SENT_334	[p22l1135t537r1158b564],
10	2014	CD	DATE	2014	num	7	SENT_334	[p22l1168t537r1241b560],
11	.	.	O	.	_	0	SENT_334	[p22l1168t537r1241b560],

1	For	IN	O	for	_	0	SENT_335	[p22l1251t537r1298b560],
2	personal	JJ	O	personal	amod	3	SENT_335	[p22l1306t537r1418b567],
3	use	NN	O	use	pobj	1	SENT_335	[p22l1427t544r1471b560],
4	only	RB	O	only	advmod	3	SENT_335	[p22l1480t537r1545b567],
5	.	.	O	.	_	0	SENT_335	[p22l1480t537r1545b567],

1	No	DT	O	no	det	3	SENT_336	[p22l1556t537r1595b560],
2	other	JJ	O	other	amod	3	SENT_336	[p22l1605t537r1673b560],
3	uses	NNS	O	use	_	0	SENT_336	[p22l1682t544r1738b560],
4	without	IN	O	without	_	0	SENT_336	[p22l1748t537r1849b560],
5	permission	NN	O	permission	prep_without	3	SENT_336	[p22l1857t537r2010b567],
6	.	.	O	.	_	0	SENT_336	[p22l1857t537r2010b567],

1	Copyright	NN	O	copyright	_	0	SENT_337	[p22l728t578r862b609],
2	©	CD	NUMBER	©	num	6	SENT_337	[p22l871t578r895b602],
3	2011	CD	DATE	2011	num	6	SENT_337	[p22l905t578r967b602],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_337	[p22l979t578r1170b602],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_337	[p22l1180t578r1289b602],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_337	[p22l1299t578r1404b609],
7	.	.	O	.	_	0	SENT_337	[p22l1299t578r1404b609],

1	All	DT	O	all	det	2	SENT_338	[p22l1415t578r1456b602],
2	rights	NNS	O	rights	nsubj	3	SENT_338	[p22l1465t578r1540b609],
3	reserved	VBN	O	reserve	_	0	SENT_338	[p22l1550t578r1668b602],
4	.	.	O	.	_	0	SENT_338	[p22l1550t578r1668b602],

1	A	DT	O	a	det	3	SENT_339	[p22l715t684r734b703],
2	CFTR	NNP	O	CFTR	nn	3	SENT_339	[p22l747t684r831b703],
3	POTENTIATOR	NNP	O	POTENTIATOR	_	0	SENT_339	[p22l844t684r1082b703],
4	FOR	IN	O	for	_	0	SENT_339	[p22l1095t684r1159b703],
5	CYSTIC	NNP	O	CYSTIC	nn	6	SENT_339	[p22l1171t684r1282b703],
6	FIBROSIS	NNP	O	FIBROSIS	prep_for	3	SENT_339	[p22l1297t684r1445b703],

1	tional	JJ	O	tional	amod	2	SENT_340	[p22l12t898r259b977],
2	weight	NN	O	weight	_	0	SENT_340	[p22l297t898r609b999],
3	.	.	O	.	_	0	SENT_340	[p22l297t898r609b999],

1	The	DT	O	the	det	5	SENT_341	[p22l654t898r814b976],
2	longer	JJR	O	longer	amod	5	SENT_341	[p22l857t898r1363b999],
3	—	NN	O	—	nn	5	SENT_341	[p22l857t898r1363b999],
4	term	NN	O	term	nn	5	SENT_341	[p22l857t898r1363b999],
5	effects	NNS	O	effect	nsubjpass	15	SENT_341	[p22l1406t897r1685b976],
6	of	IN	O	of	_	0	SENT_341	[p22l1731t897r1831b977],
7	modulation	NN	O	modulation	prep_of	5	SENT_341	[p22l1856t898r2132b977, p22l10t1026r255b1105],
8	of	IN	O	of	_	0	SENT_341	[p22l280t1025r380b1105],
9	CFTR	NNP	O	CFTR	prep_of	7	SENT_341	[p22l386t1032r636b1109],
10	on	IN	O	on	_	0	SENT_341	[p22l652t1052r757b1105],
11	lung	NN	O	lung	nn	12	SENT_341	[p22l781t1026r972b1127],
12	function	NN	O	function	prep_on	9	SENT_341	[p22l994t1025r1358b1105],
13	will	MD	O	will	aux	15	SENT_341	[p22l1378t1026r1541b1105],
14	be	VB	O	be	auxpass	15	SENT_341	[p22l1566t1026r1662b1105],
15	monitored	VBN	O	monitor	_	0	SENT_341	[p22l1687t1026r2133b1105],
16	in	IN	O	in	_	0	SENT_341	[p22l11t1155r93b1232],
17	the	DT	O	the	det	18	SENT_341	[p22l135t1154r267b1232],
18	participants	NNS	O	participant	nsubj	19	SENT_341	[p22l307t1155r819b1254],
19	receiving	VBG	O	receive	prepc_in	15	SENT_341	[p22l862t1155r1249b1255],
20	ivacaftor	NN	O	ivacaftor	dobj	19	SENT_341	[p22l1286t1153r1659b1233],
21	in	IN	O	in	_	0	SENT_341	[p22l1697t1155r1780b1232],
22	the	DT	O	the	det	27	SENT_341	[p22l1822t1154r1953b1232],
23	ongoing	JJ	O	ongoing	amod	27	SENT_341	[p22l1996t1180r2132b1233, p22l11t1283r256b1383],
24	open	JJ	O	open	amod	27	SENT_341	[p22l303t1282r746b1382],
25	—	NN	O	—	nn	27	SENT_341	[p22l303t1282r746b1382],
26	label	NN	O	label	nn	27	SENT_341	[p22l303t1282r746b1382],
27	folloW	NN	O	follow	prep_in	19	SENT_341	[p22l795t1281r1200b1382],
28	—	CD	NUMBER	—	dep	27	SENT_341	[p22l795t1281r1200b1382],
29	up	RP	O	up	prep	19	SENT_341	[p22l795t1281r1200b1382],
30	study	NN	O	study	dep	29	SENT_341	[p22l1253t1282r1493b1382],
31	.	.	O	.	_	0	SENT_341	[p22l1253t1282r1493b1382],

1	Although	IN	O	although	mark	24	SENT_342	[p22l1544t1282r1950b1383],
2	the	DT	O	the	det	4	SENT_342	[p22l2001t1282r2133b1360],
3	complete	JJ	O	complete	amod	4	SENT_342	[p22l12t1409r399b1509],
4	chain	NN	O	chain	nsubj	24	SENT_342	[p22l432t1409r667b1487],
5	of	IN	O	of	_	0	SENT_342	[p22l701t1408r800b1488],
6	events	NNS	O	event	prep_of	4	SENT_342	[p22l815t1426r1077b1489],
7	from	IN	O	from	_	0	SENT_342	[p22l1112t1408r1322b1488],
8	CFTR	NNP	ORGANIZATION	CFTR	nn	9	SENT_342	[p22l1354t1415r1605b1493],
9	dysfunction	NN	O	dysfunction	prep_from	6	SENT_342	[p22l1627t1408r2133b1509],
10	to	TO	O	to	_	0	SENT_342	[p22l12t1555r91b1617],
11	ion	NN	O	ion	nn	14	SENT_342	[p22l124t1539r681b1638],
12	—	NN	O	—	nn	14	SENT_342	[p22l124t1539r681b1638],
13	transport	NN	O	transport	nn	14	SENT_342	[p22l124t1539r681b1638],
14	imbalance	NN	O	imbalance	prep_to	9	SENT_342	[p22l707t1538r1140b1617],
15	to	TO	O	to	_	0	SENT_342	[p22l1173t1555r1252b1617],
16	progressive	JJ	O	progressive	nn	21	SENT_342	[p22l1284t1539r1756b1639],
17	obstructive	JJ	O	obstructive	amod	21	SENT_342	[p22l1789t1538r2132b1617, p22l12t1667r151b1745],
18	and	CC	O	and	_	0	SENT_342	[p22l176t1666r329b1744],
19	destructive	JJ	O	destructive	conj_and	17	SENT_342	[p22l355t1666r798b1745],
20	airway	NN	O	airway	nn	21	SENT_342	[p22l823t1667r1097b1765],
21	disease	NN	O	disease	prep_to	14	SENT_342	[p22l1119t1666r1414b1744],
22	is	VBZ	O	be	cop	24	SENT_342	[p22l1440t1667r1502b1743],
23	still	RB	O	still	advmod	24	SENT_342	[p22l1532t1666r1683b1744],
24	unknown	JJ	O	unknown	advcl	28	SENT_342	[p22l1708t1666r2128b1761],
25	,	,	O	,	_	0	SENT_342	[p22l1708t1666r2128b1761],
26	this	DT	O	this	det	27	SENT_342	[p22l12t1794r174b1872],
27	study	NN	O	study	nsubj	28	SENT_342	[p22l218t1794r452b1894],
28	suggests	VBZ	O	suggest	_	0	SENT_342	[p22l490t1811r862b1895],
29	that	IN	O	that	complm	36	SENT_342	[p22l906t1794r1081b1872],
30	a	DT	O	a	det	31	SENT_342	[p22l1116t1820r1161b1872],
31	drug	NN	O	drug	nsubj	36	SENT_342	[p22l1201t1794r1408b1895],
32	targeting	VBG	O	target	partmod	31	SENT_342	[p22l1446t1795r1852b1895],
33	CFTR	NNP	ORGANIZATION	CFTR	nn	34	SENT_342	[p22l1890t1800r2143b1877],
34	dysfunction	NN	O	dysfunction	dobj	32	SENT_342	[p22l12t1921r520b2022],
35	can	MD	O	can	aux	36	SENT_342	[p22l562t1948r711b2000],
36	affect	VB	O	affect	ccomp	28	SENT_342	[p22l751t1921r998b2001],
37	lung	NN	O	lung	nn	38	SENT_342	[p22l1032t1922r1226b2023],
38	function	NN	O	function	dobj	36	SENT_342	[p22l1264t1921r1630b2001],
39	and	CC	O	and	_	0	SENT_342	[p22l1671t1922r1829b2001],
40	symptoms	NNS	O	symptom	dobj	36	SENT_342	[p22l1872t1948r2132b2022, p22l12t2067r243b2146],
41	,	,	O	,	_	0	SENT_342	[p22l1872t1948r2132b2022, p22l12t2067r243b2146],
42	thus	RB	O	thus	advmod	43	SENT_342	[p22l282t2050r461b2129],
43	confirming	VBG	O	confirm	dep	36	SENT_342	[p22l498t2049r986b2151],
44	that	IN	O	that	complm	50	SENT_342	[p22l1015t2050r1185b2128],
45	CFTR	NNP	ORGANIZATION	CFTR	nsubj	50	SENT_342	[p22l1213t2056r1461b2133],
46	is	VBZ	O	be	cop	50	SENT_342	[p22l1482t2051r1547b2128],
47	a	DT	O	a	det	50	SENT_342	[p22l1581t2076r1626b2128],
48	valid	JJ	O	valid	amod	50	SENT_342	[p22l1653t2050r1853b2129],
49	therapeutic	JJ	O	therapeutic	amod	50	SENT_342	[p22l1886t2050r2132b2128, p22l9t2179r278b2278],
50	target	NN	O	target	ccomp	43	SENT_342	[p22l328t2195r590b2279],
51	and	CC	O	and	_	0	SENT_342	[p22l634t2178r794b2257],
52	providing	VBG	O	provide	conj_and	43	SENT_342	[p22l843t2178r1270b2279],
53	an	DT	O	a	det	55	SENT_342	[p22l1316t2204r1420b2256],
54	important	JJ	O	important	amod	55	SENT_342	[p22l1469t2179r1919b2278],
55	tool	NN	O	tool	dobj	52	SENT_342	[p22l1965t2178r2134b2257],
56	for	IN	O	for	_	0	SENT_342	[p22l11t2305r134b2385],
57	further	JJ	O	further	amod	58	SENT_342	[p22l163t2305r472b2385],
58	study	NN	O	study	prep_for	52	SENT_342	[p22l502t2306r732b2406],
59	of	IN	O	of	_	0	SENT_342	[p22l761t2305r861b2385],
60	the	DT	O	the	det	61	SENT_342	[p22l875t2306r1007b2385],
61	pathophysiology	NN	O	pathophysiology	prep_of	58	SENT_342	[p22l1039t2306r1754b2407],
62	of	IN	O	of	_	0	SENT_342	[p22l1782t2305r1882b2385],
63	cystic	JJ	O	cystic	amod	64	SENT_342	[p22l1897t2307r2134b2406],
64	fibrosis	NN	O	fibrosis	prep_of	61	SENT_342	[p22l11t2433r359b2513],
65	.	.	O	.	_	0	SENT_342	[p22l11t2433r359b2513],

1	Daily	NNP	SET	Daily	nn	3	SENT_343	[p22l139t2561r370b2661],
2	oral	JJ	O	oral	amod	3	SENT_343	[p22l435t2561r605b2640],
3	administration	NN	O	administration	nsubjpass	11	SENT_343	[p22l673t2561r1336b2640],
4	of	IN	O	of	_	0	SENT_343	[p22l1406t2560r1507b2640],
5	ivacaftor	NN	O	ivacaftor	prep_of	3	SENT_343	[p22l1557t2560r1944b2641],
6	for	IN	O	for	_	0	SENT_343	[p22l2011t2560r2137b2640],
7	48	CD	DURATION	48	num	8	SENT_343	[p22l9t2696r110b2769],
8	weeks	NNS	NUMBER	week	prep_for	5	SENT_343	[p22l141t2690r398b2769],
9	was	VBD	O	be	auxpass	11	SENT_343	[p22l429t2716r589b2769],
10	not	RB	O	not	neg	11	SENT_343	[p22l625t2707r765b2769],
11	associated	VBN	O	associate	_	0	SENT_343	[p22l792t2690r1230b2769],
12	with	IN	O	with	_	0	SENT_343	[p22l1258t2690r1450b2769],
13	a	DT	O	a	det	16	SENT_343	[p22l1482t2716r1527b2768],
14	greater	JJR	O	greater	amod	16	SENT_343	[p22l1558t2707r1858b2791],
15	safety	NN	O	safety	nn	16	SENT_343	[p22l1889t2689r2138b2790],
16	risk	NN	O	risk	prep_with	11	SENT_343	[p22l11t2818r171b2897],
17	than	IN	O	than	_	0	SENT_343	[p22l205t2818r398b2896],
18	that	DT	O	that	prep_than	16	SENT_343	[p22l436t2818r606b2896],
19	observed	VBN	O	observe	partmod	18	SENT_343	[p22l639t2818r1012b2897],
20	with	IN	O	with	_	0	SENT_343	[p22l1045t2818r1237b2897],
21	placebo	NN	O	placebo	prep_with	19	SENT_343	[p22l1273t2818r1618b2917],
22	.	.	O	.	_	0	SENT_343	[p22l1273t2818r1618b2917],

1	Serious	JJ	O	serious	amod	3	SENT_344	[p22l1663t2819r1965b2897],
2	adverse	JJ	O	adverse	amod	3	SENT_344	[p22l2005t2818r2132b2896, p22l7t2972r222b3025],
3	events	NNS	O	event	nsubj	13	SENT_344	[p22l269t2963r532b3025],
4	were	VBD	O	be	cop	13	SENT_344	[p22l576t2972r777b3025],
5	less	RBR	O	less	advmod	6	SENT_344	[p22l822t2946r977b3025],
6	common	JJ	O	common	acomp	13	SENT_344	[p22l1026t2972r1408b3025],
7	in	IN	O	in	_	0	SENT_344	[p22l1453t2947r1536b3024],
8	the	DT	O	the	det	10	SENT_344	[p22l1583t2946r1715b3024],
9	ivacaftor	NN	O	ivacaftor	nn	10	SENT_344	[p22l1761t2945r2137b3025],
10	group	NN	O	group	prep_in	13	SENT_344	[p22l11t3100r285b3175],
11	,	,	O	,	_	0	SENT_344	[p22l11t3100r285b3175],
12	primarily	RB	O	primarily	advmod	13	SENT_344	[p22l322t3074r728b3174],
13	owing	VBG	O	owe	_	0	SENT_344	[p22l756t3075r1025b3175],
14	to	TO	O	to	_	0	SENT_344	[p22l1055t3091r1137b3153],
15	a	DT	O	a	det	17	SENT_344	[p22l1170t3100r1214b3152],
16	reduced	VBN	O	reduce	amod	17	SENT_344	[p22l1245t3074r1582b3153],
17	incidence	NN	O	incidence	prep_to	13	SENT_344	[p22l1613t3074r2018b3153],
18	of	IN	O	of	_	0	SENT_344	[p22l2052t3073r2152b3153],
19	pulmonary	JJ	O	pulmonary	amod	20	SENT_344	[p22l9t3201r468b3301],
20	exacerbations	NNS	O	exacerbation	prep_of	17	SENT_344	[p22l498t3201r1054b3280],
21	and	CC	O	and	_	0	SENT_344	[p22l1090t3201r1243b3280],
22	hemoptysis	NN	O	hemoptysis	prep_of	17	SENT_344	[p22l1277t3201r1764b3301],
23	.	.	O	.	_	0	SENT_344	[p22l1277t3201r1764b3301],

1	The	DT	O	the	dep	104	SENT_345	[p22l1800t3201r1956b3279],
2	frequency	NN	O	frequency	dep	104	SENT_345	[p22l1991t3200r2132b3279, p22l12t3355r306b3429],
3	of	IN	O	of	dep	104	SENT_345	[p22l336t3328r434b3408],
4	liver	NN	O	liver	dep	104	SENT_345	[p22l448t3329r625b3409],
5	enzyme	NN	O	enzyme	dep	104	SENT_345	[p22l657t3355r978b3429],
6	levels	NNS	O	level	dep	104	SENT_345	[p22l1011t3329r1234b3409],
7	that	WDT	O	that	dep	104	SENT_345	[p22l1270t3329r1438b3407],
8	were	VBD	O	be	dep	104	SENT_345	[p22l1462t3355r1659b3409],
9	more	JJR	O	more	dep	104	SENT_345	[p22l1693t3355r1907b3408],
10	than	IN	O	than	dep	104	SENT_345	[p22l1942t3329r2133b3407],
11	2	CD	NUMBER	2	dep	104	SENT_345	[p22l11t3464r58b3536],
12	times	NNS	O	time	dep	104	SENT_345	[p22l100t3459r336b3536],
13	the	DT	O	the	dep	104	SENT_345	[p22l379t3458r512b3537],
14	upper	JJ	O	upper	dep	104	SENT_345	[p22l552t3484r800b3558],
15	limit	NN	O	limit	dep	104	SENT_345	[p22l837t3458r1046b3536],
16	of	IN	O	of	dep	104	SENT_345	[p22l1082t3457r1182b3537],
17	the	DT	O	the	dep	104	SENT_345	[p22l1205t3458r1337b3536],
18	normal	JJ	O	normal	dep	104	SENT_345	[p22l1378t3458r1692b3537],
19	range	NN	O	range	dep	104	SENT_345	[p22l1732t3484r1973b3559],
20	for	IN	O	for	dep	104	SENT_345	[p22l2014t3457r2137b3537],
21	age	NN	O	age	dep	104	SENT_345	[p22l10t3612r154b3687],
22	was	VBD	O	be	dep	104	SENT_345	[p22l212t3612r375b3665],
23	similar	JJ	O	similar	dep	104	SENT_345	[p22l441t3586r747b3664],
24	in	IN	O	in	dep	104	SENT_345	[p22l807t3587r890b3664],
25	the	DT	O	the	dep	104	SENT_345	[p22l954t3586r1086b3665],
26	ivacaftor	NN	O	ivacaftor	dep	104	SENT_345	[p22l1148t3585r1524b3665],
27	and	CC	O	and	dep	104	SENT_345	[p22l1584t3586r1742b3665],
28	placebo	NN	O	placebo	dep	104	SENT_345	[p22l1803t3586r2132b3686],
29	groups	NNS	O	group	dep	104	SENT_345	[p23l11t46r306b121],
30	(	VBP	O	(	dep	104	SENT_345	[p23l348t20r606b111],
31	Table	NNP	O	Table	dep	104	SENT_345	[p23l348t20r606b111],
32	5	CD	NUMBER	5	dep	104	SENT_345	[p23l644t28r686b99],
33	in	IN	O	in	dep	104	SENT_345	[p23l724t21r807b98],
34	the	DT	O	the	dep	104	SENT_345	[p23l843t20r976b98],
35	Supplementary	NNP	O	Supplementary	dep	104	SENT_345	[p23l1013t20r1660b120],
36	Appendix	NNP	O	Appendix	dep	104	SENT_345	[p23l1687t20r2128b120],
37	)	NN	O	)	dep	104	SENT_345	[p23l1687t20r2128b120],
38	and	CC	O	and	dep	104	SENT_345	[p23l10t147r168b226],
39	was	VBD	O	be	dep	104	SENT_345	[p23l213t173r376b227],
40	also	RB	O	also	dep	104	SENT_345	[p23l427t147r599b226],
41	similar	JJ	O	similar	dep	104	SENT_345	[p23l652t147r958b225],
42	to	TO	O	to	dep	104	SENT_345	[p23l1005t164r1086b226],
43	the	DT	O	the	dep	104	SENT_345	[p23l1138t147r1270b225],
44	frequency	NN	O	frequency	dep	104	SENT_345	[p23l1320t146r1744b247],
45	in	IN	O	in	dep	104	SENT_345	[p23l1788t148r1872b225],
46	adult	JJ	O	adult	dep	104	SENT_345	[p23l1921t147r2138b227],
47	and	CC	O	and	dep	104	SENT_345	[p23l10t275r167b354],
48	adolescent	JJ	O	adolescent	dep	104	SENT_345	[p23l199t275r649b354],
49	populations	NNS	O	population	dep	104	SENT_345	[p23l675t275r1185b375],
50	with	IN	O	with	dep	104	SENT_345	[p23l1215t275r1409b355],
51	cystic	JJ	O	cystic	dep	104	SENT_345	[p23l1442t276r1678b375],
52	fll	NN	O	fll	dep	104	SENT_345	[p23l1711t274r2133b354],
53	)	NN	O	)	dep	104	SENT_345	[p23l1711t274r2133b354],
54	I	PRP	O	I	dep	104	SENT_345	[p23l1711t274r2133b354],
55	'	''	O	'	_	0	SENT_345	[p23l1711t274r2133b354],
56	OSlS	NN	O	osl	dep	104	SENT_345	[p23l1711t274r2133b354],
57	.26	CD	NUMBER	.26	dep	104	SENT_345	[p23l1711t274r2133b354],
58	In	IN	O	in	dep	104	SENT_345	[p23l138t412r226b482],
59	summary	NN	O	summary	dep	104	SENT_345	[p23l267t430r692b504],
60	,	,	O	,	_	0	SENT_345	[p23l267t430r692b504],
61	these	DT	O	these	dep	104	SENT_345	[p23l738t404r961b482],
62	findings	NNS	O	finding	dep	104	SENT_345	[p23l1001t403r1365b505],
63	represent	VBP	O	represent	dep	104	SENT_345	[p23l1408t421r1810b504],
64	an	DT	O	a	dep	104	SENT_345	[p23l1845t430r1947b482],
65	important	JJ	O	important	dep	104	SENT_345	[p23l1987t405r2132b482, p23l9t548r336b631],
66	milestone	NN	O	milestone	dep	104	SENT_345	[p23l383t531r805b610],
67	in	IN	O	in	dep	104	SENT_345	[p23l857t532r940b609],
68	the	DT	O	the	dep	104	SENT_345	[p23l993t531r1126b609],
69	development	NN	O	development	dep	104	SENT_345	[p23l1179t531r1728b631],
70	of	IN	O	of	dep	104	SENT_345	[p23l1775t530r1875b610],
71	treatments	NNS	O	treatment	dep	104	SENT_345	[p23l1909t548r2132b609, p23l11t677r266b738],
72	designed	VBN	O	design	dep	104	SENT_345	[p23l298t660r671b761],
73	to	TO	O	to	dep	104	SENT_345	[p23l701t677r780b739],
74	improve	VB	O	improve	dep	104	SENT_345	[p23l810t661r1150b760],
75	CFTR	NNP	ORGANIZATION	CFTR	dep	104	SENT_345	[p23l1179t666r1426b743],
76	protein	NN	O	protein	dep	104	SENT_345	[p23l1444t661r1747b760],
77	function	NN	O	function	dep	104	SENT_345	[p23l1776t659r2133b739],
78	as	IN	O	as	dep	104	SENT_345	[p23l11t814r95b866],
79	a	DT	O	a	dep	104	SENT_345	[p23l133t814r177b866],
80	means	NN	O	means	dep	104	SENT_345	[p23l212t814r486b867],
81	of	IN	O	of	dep	104	SENT_345	[p23l525t787r624b867],
82	addressing	VBG	O	address	dep	104	SENT_345	[p23l641t788r1100b889],
83	the	DT	O	the	dep	104	SENT_345	[p23l1133t788r1263b866],
84	underlying	VBG	O	underlie	dep	104	SENT_345	[p23l1300t788r1754b889],
85	cause	NN	O	cause	dep	104	SENT_345	[p23l1788t814r2016b867],
86	of	IN	O	of	dep	104	SENT_345	[p23l2054t787r2152b867],
87	cystic	JJ	O	cystic	dep	104	SENT_345	[p23l11t917r243b1016],
88	fibrosis	NN	O	fibrosis	dep	104	SENT_345	[p23l297t915r613b995],
89	and	CC	O	and	dep	104	SENT_345	[p23l670t916r826b995],
90	begin	VB	O	begin	dep	104	SENT_345	[p23l881t916r1118b1017],
91	to	TO	O	to	dep	104	SENT_345	[p23l1174t933r1254b995],
92	fulfill	VB	O	fulfill	dep	104	SENT_345	[p23l1311t915r1553b995],
93	the	DT	O	the	dep	104	SENT_345	[p23l1609t916r1739b994],
94	promise	NN	O	promise	dep	104	SENT_345	[p23l1793t917r2138b1016],
95	ushered	VBD	O	usher	dep	104	SENT_345	[p23l10t1044r340b1123],
96	in	RP	O	in	dep	104	SENT_345	[p23l376t1045r458b1122],
97	with	IN	O	with	dep	104	SENT_345	[p23l491t1044r683b1123],
98	the	DT	O	the	dep	104	SENT_345	[p23l720t1044r851b1123],
99	discovery	NN	O	discovery	dep	104	SENT_345	[p23l888t1044r1283b1144],
100	of	IN	O	of	dep	104	SENT_345	[p23l1316t1043r1415b1123],
101	the	DT	O	the	dep	104	SENT_345	[p23l1434t1044r1564b1123],
102	CFT	NNP	O	CFT	dep	104	SENT_345	[p23l1601t1051r1756b1122],
103	R	NN	O	r	dep	104	SENT_345	[p23l1750t1052r1813b1124],
104	gene	NN	O	gene	_	0	SENT_345	[p23l1844t1070r2061b1145],
105	.	.	O	.	_	0	SENT_345	[p23l1844t1070r2061b1145],

1	Supported	VBN	O	support	dep	124	SENT_346	[p23l97t1257r425b1332],
2	by	IN	O	by	dep	124	SENT_346	[p23l448t1257r521b1332],
3	Vertex	NNP	ORGANIZATION	Vertex	dep	124	SENT_346	[p23l537t1262r740b1316],
4	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	124	SENT_346	[p23l759t1257r1307b1328],
5	;	:	O	;	_	0	SENT_346	[p23l759t1257r1307b1328],
6	grants	NNS	O	grant	dep	124	SENT_346	[p23l1333t1270r1536b1332],
7	from	IN	O	from	dep	124	SENT_346	[p23l1560t1256r1718b1316],
8	the	DT	O	the	dep	124	SENT_346	[p23l1740t1257r1840b1315],
9	National	NNP	ORGANIZATION	National	dep	124	SENT_346	[p23l1860t1257r2139b1316],
10	Institute	NNP	ORGANIZATION	Institute	dep	124	SENT_346	[p23l8t1354r279b1413],
11	for	IN	ORGANIZATION	for	dep	124	SENT_346	[p23l306t1352r398b1412],
12	Health	NNP	ORGANIZATION	Health	dep	124	SENT_346	[p23l422t1353r639b1412],
13	Research	NNP	ORGANIZATION	Research	dep	124	SENT_346	[p23l663t1353r956b1415],
14	Respiratory	NNP	ORGANIZATION	Respiratory	dep	124	SENT_346	[p23l981t1354r1355b1428],
15	Disease	NNP	ORGANIZATION	Disease	dep	124	SENT_346	[p23l1376t1354r1620b1412],
16	Biomedical	NNP	ORGANIZATION	Biomedical	dep	124	SENT_346	[p23l1646t1353r2007b1412],
17	Research	NNP	ORGANIZATION	Research	dep	124	SENT_346	[p23l2031t1358r2138b1415, p23l11t1449r216b1507],
18	Unit	NNP	ORGANIZATION	Unit	dep	124	SENT_346	[p23l240t1450r381b1508],
19	at	IN	O	at	dep	124	SENT_346	[p23l400t1462r460b1507],
20	the	DT	O	the	dep	124	SENT_346	[p23l480t1449r579b1507],
21	Royal	NNP	LOCATION	Royal	dep	124	SENT_346	[p23l602t1449r782b1524],
22	Brompton	NNP	LOCATION	Brompton	dep	124	SENT_346	[p23l804t1454r1129b1524],
23	and	CC	O	and	dep	124	SENT_346	[p23l1153t1449r1271b1508],
24	Harefield	NNP	ORGANIZATION	Harefield	dep	124	SENT_346	[p23l1294t1448r1598b1508],
25	National	NNP	ORGANIZATION	National	dep	124	SENT_346	[p23l1620t1449r1899b1508],
26	Health	NNP	ORGANIZATION	Health	dep	124	SENT_346	[p23l1922t1449r2139b1507],
27	Service	NNP	ORGANIZATION	Service	dep	124	SENT_346	[p23l11t1546r233b1605],
28	Foundation	NNP	ORGANIZATION	Foundation	dep	124	SENT_346	[p23l271t1545r641b1605],
29	Trust	NNP	ORGANIZATION	Trust	dep	124	SENT_346	[p23l677t1549r849b1604],
30	and	CC	ORGANIZATION	and	dep	124	SENT_346	[p23l884t1545r1002b1604],
31	Imperial	NNP	ORGANIZATION	Imperial	dep	124	SENT_346	[p23l1039t1545r1314b1620],
32	College	NNP	ORGANIZATION	College	dep	124	SENT_346	[p23l1352t1545r1590b1620],
33	London	NNP	ORGANIZATION	London	dep	124	SENT_346	[p23l1628t1545r1892b1616],
34	;	:	O	;	_	0	SENT_346	[p23l1628t1545r1892b1616],
35	grants	NNS	O	grant	dep	124	SENT_346	[p23l1933t1558r2137b1620],
36	from	IN	O	from	dep	124	SENT_346	[p23l9t1640r172b1700],
37	the	DT	O	the	dep	124	SENT_346	[p23l203t1641r305b1699],
38	Cystic	JJ	ORGANIZATION	cystic	dep	124	SENT_346	[p23l337t1642r536b1716],
39	Fibrosis	NNP	ORGANIZATION	Fibrosis	dep	124	SENT_346	[p23l566t1641r828b1700],
40	Foundation	NNP	ORGANIZATION	Foundation	dep	124	SENT_346	[p23l859t1641r1244b1701],
41	Therapeutic	JJ	ORGANIZATION	therapeutic	dep	124	SENT_346	[p23l1272t1641r1672b1716],
42	Development	NNP	ORGANIZATION	Development	dep	124	SENT_346	[p23l1701t1641r2143b1716],
43	Center	NNP	ORGANIZATION	Center	dep	124	SENT_346	[p23l9t1740r241b1807],
44	;	:	O	;	_	0	SENT_346	[p23l9t1740r241b1807],
45	the	DT	O	the	dep	124	SENT_346	[p23l277t1736r377b1794],
46	Institute	NNP	ORGANIZATION	Institute	dep	124	SENT_346	[p23l409t1737r687b1795],
47	for	IN	ORGANIZATION	for	dep	124	SENT_346	[p23l720t1735r813b1795],
48	Translational	JJ	ORGANIZATION	translational	dep	124	SENT_346	[p23l841t1736r1280b1795],
49	Health	NNP	ORGANIZATION	Health	dep	124	SENT_346	[p23l1312t1736r1532b1794],
50	Sciences	NNPS	ORGANIZATION	Sciences	dep	124	SENT_346	[p23l1567t1737r1856b1807],
51	;	:	O	;	_	0	SENT_346	[p23l1567t1737r1856b1807],
52	the	DT	O	the	dep	124	SENT_346	[p23l1892t1736r1993b1794],
53	National	NNP	ORGANIZATION	National	dep	124	SENT_346	[p23l2024t1741r2138b1795, p23l10t1831r196b1890],
54	Center	NNP	ORGANIZATION	Center	dep	124	SENT_346	[p23l220t1835r432b1890],
55	for	IN	ORGANIZATION	for	dep	124	SENT_346	[p23l455t1830r547b1890],
56	Research	NNP	ORGANIZATION	Research	dep	124	SENT_346	[p23l568t1831r861b1893],
57	Resources	NNPS	ORGANIZATION	Resources	dep	124	SENT_346	[p23l884t1836r1209b1893],
58	of	IN	ORGANIZATION	of	dep	124	SENT_346	[p23l1237t1830r1311b1890],
59	the	DT	ORGANIZATION	the	dep	124	SENT_346	[p23l1323t1831r1422b1889],
60	National	NNP	ORGANIZATION	National	dep	124	SENT_346	[p23l1445t1831r1725b1890],
61	Institutes	NNPS	ORGANIZATION	Institutes	dep	124	SENT_346	[p23l1748t1832r2051b1891],
62	of	IN	ORGANIZATION	of	dep	124	SENT_346	[p23l2078t1830r2153b1890],
63	Health	NNP	ORGANIZATION	Health	dep	124	SENT_346	[p23l8t1927r231b1985],
64	(	CD	NUMBER	(	dep	124	SENT_346	[p23l263t1932r453b1995],
65	NIH	NNP	ORGANIZATION	NIH	dep	124	SENT_346	[p23l263t1932r453b1995],
66	)	CD	NUMBER	)	dep	124	SENT_346	[p23l263t1932r453b1995],
67	(	CD	NUMBER	(	dep	124	SENT_346	[p23l490t1931r645b1995],
68	UL1	NN	O	ul1	dep	124	SENT_346	[p23l490t1931r645b1995],
69	RR025014	NN	O	rr025014	dep	124	SENT_346	[p23l674t1931r1009b1989],
70	to	TO	O	to	dep	124	SENT_346	[p23l1039t1939r1100b1986],
71	the	DT	O	the	dep	124	SENT_346	[p23l1131t1927r1233b1985],
72	University	NNP	ORGANIZATION	University	dep	124	SENT_346	[p23l1262t1928r1597b2002],
73	of	IN	ORGANIZATION	of	dep	124	SENT_346	[p23l1624t1926r1699b1986],
74	Washington	NNP	ORGANIZATION	Washington	dep	124	SENT_346	[p23l1712t1927r2134b2002],
75	,	,	O	,	_	0	SENT_346	[p23l1712t1927r2134b2002],
76	UL1	NN	O	ul1	dep	124	SENT_346	[p23l9t2027r138b2082],
77	RR024153	NN	O	rr024153	dep	124	SENT_346	[p23l162t2027r485b2085],
78	to	TO	O	to	dep	124	SENT_346	[p23l513t2035r573b2082],
79	Children	NNP	O	Children	dep	124	SENT_346	[p23l598t2023r924b2082],
80	’s	POS	O	’s	dep	124	SENT_346	[p23l598t2023r924b2082],
81	Hospital	NN	O	hospital	dep	124	SENT_346	[p23l950t2023r1223b2098],
82	of	IN	O	of	dep	124	SENT_346	[p23l1248t2022r1323b2082],
83	Pittsburgh	NNP	LOCATION	Pittsburgh	dep	124	SENT_346	[p23l1333t2023r1671b2098],
84	of	IN	O	of	dep	124	SENT_346	[p23l1696t2022r1771b2082],
85	the	DT	O	the	dep	124	SENT_346	[p23l1782t2023r1881b2081],
86	University	NNP	ORGANIZATION	University	dep	124	SENT_346	[p23l1906t2024r2138b2083, p23l11t2120r121b2194],
87	of	IN	ORGANIZATION	of	dep	124	SENT_346	[p23l150t2118r225b2178],
88	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	dep	124	SENT_346	[p23l242t2119r581b2194],
89	Medical	NNP	ORGANIZATION	Medical	dep	124	SENT_346	[p23l611t2119r867b2178],
90	Center	NNP	ORGANIZATION	Center	dep	124	SENT_346	[p23l899t2123r1124b2190],
91	,	,	O	,	_	0	SENT_346	[p23l899t2123r1124b2190],
92	and	CC	O	and	dep	124	SENT_346	[p23l1160t2119r1278b2178],
93	UL1	NN	O	ul1	dep	124	SENT_346	[p23l1310t2123r1439b2178],
94	RR	NN	O	rr	dep	124	SENT_346	[p23l1470t2124r1578b2181],
95	025005	CD	NUMBER	025005	dep	124	SENT_346	[p23l1603t2123r1831b2178],
96	to	TO	O	to	dep	124	SENT_346	[p23l1866t2131r1927b2178],
97	Johns	NNP	ORGANIZATION	Johns	dep	124	SENT_346	[p23l1952t2119r2137b2188],
98	Hopkins	NNP	ORGANIZATION	Hopkins	dep	124	SENT_346	[p23l8t2215r283b2290],
99	University	NNP	ORGANIZATION	University	dep	124	SENT_346	[p23l312t2216r672b2290],
100	)	NN	O	)	dep	124	SENT_346	[p23l312t2216r672b2290],
101	;	:	O	;	_	0	SENT_346	[p23l312t2216r672b2290],
102	the	DT	O	the	dep	124	SENT_346	[p23l703t2215r803b2273],
103	Cystic	JJ	ORGANIZATION	cystic	dep	124	SENT_346	[p23l831t2215r1023b2290],
104	Fibrosis	NNP	ORGANIZATION	Fibrosis	dep	124	SENT_346	[p23l1049t2215r1300b2274],
105	Foundation	NNP	ORGANIZATION	Foundation	dep	124	SENT_346	[p23l1328t2215r1698b2275],
106	Therapeutics	NNP	ORGANIZATION	Therapeutics	dep	124	SENT_346	[p23l1723t2215r2138b2290],
107	Development	NNP	ORGANIZATION	Development	dep	124	SENT_346	[p23l8t2311r434b2386],
108	Network	NNP	ORGANIZATION	Network	dep	124	SENT_346	[p23l456t2311r738b2371],
109	Coordinating	NNP	ORGANIZATION	Coordinating	dep	124	SENT_346	[p23l763t2311r1196b2386],
110	Center	NNP	ORGANIZATION	Center	dep	124	SENT_346	[p23l1222t2315r1433b2370],
111	(	CD	NUMBER	(	dep	124	SENT_346	[p23l1462t2316r1541b2379],
112	to	TO	O	to	dep	124	SENT_346	[p23l1462t2316r1541b2379],
113	Seattle	NNP	LOCATION	Seattle	dep	124	SENT_346	[p23l1572t2311r1783b2370],
114	Children	NNP	O	Children	dep	124	SENT_346	[p23l1812t2311r2138b2370],
115	’s	POS	O	’s	dep	124	SENT_346	[p23l1812t2311r2138b2370],
116	Hospital	NNP	O	Hospital	dep	124	SENT_346	[p23l8t2407r322b2482],
117	)	NN	O	)	dep	124	SENT_346	[p23l8t2407r322b2482],
118	;	:	O	;	_	0	SENT_346	[p23l8t2407r322b2482],
119	Clinical	JJ	ORGANIZATION	clinical	dep	124	SENT_346	[p23l347t2407r595b2466],
120	Translational	JJ	ORGANIZATION	translational	dep	124	SENT_346	[p23l614t2407r1044b2466],
121	Research	NN	ORGANIZATION	research	dep	124	SENT_346	[p23l1064t2407r1356b2469],
122	Center	NNP	ORGANIZATION	Center	dep	124	SENT_346	[p23l1378t2411r1590b2466],
123	(	CD	NUMBER	(	dep	124	SENT_346	[p23l1613t2411r2139b2475],
124	UL1	NN	O	ul1	_	0	SENT_346	[p23l1613t2411r2139b2475],
125	.	.	O	.	_	0	SENT_346	[p23l1613t2411r2139b2475],

1	—	NN	O	—	_	0	SENT_347	[p23l1613t2411r2139b2475],
2	.	.	O	.	_	0	SENT_347	[p23l1613t2411r2139b2475],

1	RR	NN	O	rr	_	0	SENT_348	[p23l1613t2411r2139b2475],
2	.	.	O	.	_	0	SENT_348	[p23l1613t2411r2139b2475],

1	—	NN	O	—	_	0	SENT_349	[p23l1613t2411r2139b2475],
2	.	.	O	.	_	0	SENT_349	[p23l1613t2411r2139b2475],

1	024134	CD	NUMBER	024134	_	0	SENT_350	[p23l1613t2411r2139b2475],
2	to	TO	O	to	_	0	SENT_350	[p23l10t2516r72b2562],
3	the	DT	O	the	det	11	SENT_350	[p23l105t2503r208b2562],
4	University	NNP	ORGANIZATION	University	dep	11	SENT_350	[p23l239t2504r578b2578],
5	of	IN	ORGANIZATION	of	_	0	SENT_350	[p23l606t2502r683b2562],
6	Pennsylvania/Children	NNP	ORGANIZATION	Pennsylvania/Children	poss	8	SENT_350	[p23l699t2503r1503b2578],
7	’s	POS	O	’s	_	0	SENT_350	[p23l699t2503r1503b2578],
8	Hospital	NN	O	hospital	prep_of	4	SENT_350	[p23l1536t2503r1821b2578],
9	of	IN	O	of	_	0	SENT_350	[p23l1852t2502r1928b2562],
10	Philadelphia	NNP	LOCATION	Philadelphia	prep_of	8	SENT_350	[p23l1945t2503r2138b2561, p23l10t2599r293b2674],
11	)	NN	O	)	prep_to	1	SENT_350	[p23l1945t2503r2138b2561, p23l10t2599r293b2674],
12	;	:	O	;	_	0	SENT_350	[p23l1945t2503r2138b2561, p23l10t2599r293b2674],
13	and	CC	O	and	_	0	SENT_350	[p23l319t2599r439b2658],
14	the	DT	O	the	det	18	SENT_350	[p23l463t2599r565b2657],
15	NIH	NNP	O	NIH	nn	18	SENT_350	[p23l587t2604r729b2658],
16	(	NN	O	(	nn	18	SENT_350	[p23l757t2603r912b2668],
17	UL1	NN	O	ul1	nn	18	SENT_350	[p23l757t2603r912b2668],
18	RR024989	NN	O	rr024989	prep_to	1	SENT_350	[p23l935t2603r1271b2661],
19	and	CC	O	and	_	0	SENT_350	[p23l1295t2599r1416b2658],
20	P30	NN	O	p30	nn	21	SENT_350	[p23l1438t2603r1556b2658],
21	DK27651	NN	O	dk27651	conj_and	18	SENT_350	[p23l1579t2603r1876b2660],
22	to	TO	O	to	_	0	SENT_350	[p23l1900t2611r1963b2658],
23	Case	NNP	ORGANIZATION	Case	nn	26	SENT_350	[p23l1987t2603r2138b2658],
24	Western	NNP	ORGANIZATION	Western	nn	26	SENT_350	[p23l6t2700r271b2753],
25	Reserve	NNP	ORGANIZATION	Reserve	nn	26	SENT_350	[p23l291t2700r537b2757],
26	University	NNP	ORGANIZATION	University	prep_to	18	SENT_350	[p23l557t2695r892b2770],
27	,	,	O	,	_	0	SENT_350	[p23l557t2695r892b2770],
28	UL1	NNP	O	UL1	nn	29	SENT_350	[p23l916t2699r1046b2754],
29	RR	NNP	O	RR	appos	1	SENT_350	[p23l1065t2700r1173b2757],
30	025758	CD	NUMBER	025758	num	29	SENT_350	[p23l1186t2699r1412b2754],
31	to	TO	O	to	_	0	SENT_350	[p23l1435t2708r1496b2754],
32	Children	NNP	O	Children	poss	35	SENT_350	[p23l1518t2695r1843b2754],
33	’s	POS	O	’s	_	0	SENT_350	[p23l1518t2695r1843b2754],
34	Hospital	NNP	LOCATION	Hospital	nn	35	SENT_350	[p23l1865t2695r2139b2770],
35	Boston	NNP	LOCATION	Boston	prep_to	29	SENT_350	[p23l8t2796r250b2862],
36	,	,	O	,	_	0	SENT_350	[p23l8t2796r250b2862],
37	K23	NN	O	k23	nn	38	SENT_350	[p23l283t2795r410b2852],
38	DK075788	NN	O	dk075788	appos	1	SENT_350	[p23l440t2795r769b2852],
39	and	CC	O	and	_	0	SENT_350	[p23l799t2791r918b2850],
40	5UL1	NN	O	5ul1	nn	41	SENT_350	[p23l948t2795r1115b2850],
41	RR025777	NN	O	rr025777	conj_and	38	SENT_350	[p23l1144t2795r1476b2853],
42	to	TO	O	to	_	0	SENT_350	[p23l1506t2804r1567b2850],
43	the	DT	O	the	det	71	SENT_350	[p23l1598t2791r1698b2849],
44	University	NNP	ORGANIZATION	University	dep	71	SENT_350	[p23l1726t2792r2051b2866],
45	of	IN	ORGANIZATION	of	_	0	SENT_350	[p23l2078t2790r2152b2850],
46	Alabama	NNP	ORGANIZATION	Alabama	prep_of	44	SENT_350	[p23l6t2887r296b2946],
47	at	IN	O	at	_	0	SENT_350	[p23l315t2900r375b2945],
48	Birmingham	NNP	LOCATION	Birmingham	prep_at	46	SENT_350	[p23l391t2887r822b2962],
49	,	,	O	,	_	0	SENT_350	[p23l391t2887r822b2962],
50	and	CC	O	and	_	0	SENT_350	[p23l848t2887r966b2946],
51	1UL1	NN	O	1ul1	nn	52	SENT_350	[p23l990t2891r1151b2946],
52	RR025744	NN	O	rr025744	conj_and	46	SENT_350	[p23l1172t2891r1501b2949],
53	to	TO	O	to	_	0	SENT_350	[p23l1523t2900r1584b2946],
54	Stanford	NNP	ORGANIZATION	Stanford	nn	56	SENT_350	[p23l1608t2886r1884b2946],
55	University	NNP	ORGANIZATION	University	nn	56	SENT_350	[p23l1906t2888r2138b2946, p23l11t2984r156b3058],
56	)	NN	O	)	prep_to	52	SENT_350	[p23l1906t2888r2138b2946, p23l11t2984r156b3058],
57	;	:	O	;	_	0	SENT_350	[p23l1906t2888r2138b2946, p23l11t2984r156b3058],
58	and	CC	O	and	_	0	SENT_350	[p23l188t2983r306b3042],
59	an	DT	O	a	det	61	SENT_350	[p23l335t3002r412b3041],
60	infrastructure	NN	O	infrastructure	nn	61	SENT_350	[p23l441t2982r891b3043],
61	grant	NN	O	grant	conj_and	46	SENT_350	[p23l920t2996r1095b3058],
62	from	IN	O	from	_	0	SENT_350	[p23l1119t2982r1277b3042],
63	Northern	JJ	ORGANIZATION	northern	amod	64	SENT_350	[p23l1304t2983r1605b3042],
64	Ireland	NNP	ORGANIZATION	Ireland	prep_from	61	SENT_350	[p23l1633t2983r1862b3042],
65	Clinical	JJ	ORGANIZATION	clinical	amod	71	SENT_350	[p23l1891t2983r2139b3042],
66	Research	NN	ORGANIZATION	research	nn	71	SENT_350	[p23l8t3079r301b3141],
67	Network	NNP	ORGANIZATION	Network	nn	71	SENT_350	[p23l322t3079r604b3139],
68	(	CD	NUMBER	(	npadvmod	69	SENT_350	[p23l627t3079r1022b3154],
69	Respiratory	JJ	O	respiratory	amod	71	SENT_350	[p23l627t3079r1022b3154],
70	Medicine	NN	O	medicine	nn	71	SENT_350	[p23l1039t3079r1372b3147],
71	)	NN	O	)	prep_to	38	SENT_350	[p23l1039t3079r1372b3147],
72	.	.	O	.	_	0	SENT_350	[p23l1039t3079r1372b3147],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_351	[p23l94t3175r442b3235],
2	forms	VBZ	O	form	_	0	SENT_351	[p23l475t3174r668b3234],
3	provided	VBN	O	provide	csubj	8	SENT_351	[p23l702t3175r989b3250],
4	by	IN	O	by	_	0	SENT_351	[p23l1023t3175r1097b3250],
5	the	DT	O	the	det	6	SENT_351	[p23l1127t3175r1228b3233],
6	authors	NNS	O	author	prep_by	3	SENT_351	[p23l1261t3175r1508b3235],
7	are	VBP	O	be	cop	8	SENT_351	[p23l1542t3194r1641b3233],
8	available	JJ	O	available	ccomp	2	SENT_351	[p23l1674t3175r1960b3234],
9	With	IN	O	with	_	0	SENT_351	[p23l1990t3175r2139b3235],
10	the	DT	O	the	det	12	SENT_351	[p23l10t3271r111b3329],
11	full	JJ	O	full	amod	12	SENT_351	[p23l136t3270r251b3331],
12	text	NN	O	text	prep_with	8	SENT_351	[p23l276t3283r399b3329],
13	of	IN	O	of	_	0	SENT_351	[p23l421t3270r498b3330],
14	this	DT	O	this	det	15	SENT_351	[p23l509t3271r632b3329],
15	article	NN	O	article	prep_of	12	SENT_351	[p23l659t3271r865b3329],
16	at	IN	O	at	_	0	SENT_351	[p23l890t3284r950b3329],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_351	[p23l970t3276r1310b3346],
18	.	.	O	.	_	0	SENT_351	[p23l970t3276r1310b3346],

1	We	PRP	O	we	nsubj	2	SENT_352	[p23l93t3372r194b3426],
2	thank	VBP	O	thank	_	0	SENT_352	[p23l216t3367r414b3427],
3	Nicole	NNP	PERSON	Nicole	nn	4	SENT_352	[p23l430t3367r641b3426],
4	Mayer	NNP	PERSON	Mayer	dobj	2	SENT_352	[p23l661t3367r1223b3442],
5	.	.	O	.	_	0	SENT_352	[p23l661t3367r1223b3442],

1	—	NN	O	—	_	0	SENT_353	[p23l661t3367r1223b3442],
2	.	.	O	.	_	0	SENT_353	[p23l661t3367r1223b3442],

1	Hamblett	NNP	PERSON	Hamblett	nn	3	SENT_354	[p23l661t3367r1223b3442],
2	,	,	O	,	_	0	SENT_354	[p23l661t3367r1223b3442],
3	Ph.D.	NNP	O	Ph.D.	_	0	SENT_354	[p23l1248t3367r1444b3438],
4	,	,	O	,	_	0	SENT_354	[p23l1248t3367r1444b3438],
5	of	IN	O	of	_	0	SENT_354	[p23l1471t3366r1548b3426],
6	Seattle	NNP	LOCATION	Seattle	nn	7	SENT_354	[p23l1557t3367r1777b3426],
7	Children	NNP	O	Children	prep_of	3	SENT_354	[p23l1799t3367r2138b3426],
8	’s	POS	O	’s	possessive	7	SENT_354	[p23l1799t3367r2138b3426],

1	Hospital	NN	O	hospital	_	0	SENT_355	[p24l8t17r315b92],
2	;	:	O	;	_	0	SENT_355	[p24l8t17r315b92],
3	all	PDT	O	all	predet	5	SENT_355	[p24l345t17r427b75],
4	the	DT	O	the	det	5	SENT_355	[p24l454t17r557b75],
5	patients	NNS	O	patient	dep	1	SENT_355	[p24l583t18r852b92],
6	involved	VBN	O	involve	partmod	5	SENT_355	[p24l880t17r1156b77],
7	in	IN	O	in	_	0	SENT_355	[p24l1183t17r1247b75],
8	the	DT	O	the	det	9	SENT_355	[p24l1275t17r1378b75],
9	study	NN	O	study	prep_in	6	SENT_355	[p24l1407t17r1601b92],
10	;	:	O	;	_	0	SENT_355	[p24l1407t17r1601b92],
11	the	DT	O	the	det	12	SENT_355	[p24l1632t17r1734b75],
12	study	NN	O	study	conj_and	5	SENT_355	[p24l1763t17r1943b92],
13	coordinators	NNS	O	coordinator	nsubj	14	SENT_355	[p24l1967t36r2138b76, p24l10t113r288b172],
14	(	VBP	O	(	rcmod	12	SENT_355	[p24l320t118r443b181],
15	see	VB	O	see	xcomp	14	SENT_355	[p24l320t118r443b181],
16	the	DT	O	the	det	18	SENT_355	[p24l471t113r574b171],
17	Supplementary	NNP	O	Supplementary	nn	18	SENT_355	[p24l603t113r1109b188],
18	Appendix	NNP	O	Appendix	dobj	15	SENT_355	[p24l1130t113r1455b188],
19	for	IN	O	for	_	0	SENT_355	[p24l1479t112r1576b172],
20	a	DT	O	a	det	23	SENT_355	[p24l1600t132r1633b171],
21	complete	JJ	O	complete	amod	23	SENT_355	[p24l1660t113r1963b188],
22	list	NN	O	list	nn	23	SENT_355	[p24l1990t113r2136b184],
23	)	NN	O	)	prep_for	18	SENT_355	[p24l1990t113r2136b184],
24	;	:	O	;	_	0	SENT_355	[p24l1990t113r2136b184],
25	and	CC	O	and	_	0	SENT_355	[p24l9t209r128b268],
26	the	DT	O	the	det	28	SENT_355	[p24l167t209r268b268],
27	following	VBG	O	follow	amod	28	SENT_355	[p24l307t208r622b284],
28	employees	NNS	O	employee	dep	1	SENT_355	[p24l659t209r994b284],
29	of	IN	O	of	_	0	SENT_355	[p24l1035t208r1111b268],
30	Vertex	NNP	ORGANIZATION	Vertex	nn	31	SENT_355	[p24l1133t214r1339b268],
31	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	prep_of	28	SENT_355	[p24l1374t209r1932b269],
32	:	:	O	:	_	0	SENT_355	[p24l1374t209r1932b269],
33	Adrienne	NNP	PERSON	Adrienne	nn	34	SENT_355	[p24l1972t209r2138b268, p24l10t324r163b364],
34	Aiello	NNP	PERSON	Aiello	dep	1	SENT_355	[p24l182t305r395b376],
35	,	,	O	,	_	0	SENT_355	[p24l182t305r395b376],
36	Pharm	NNP	O	Pharm	appos	34	SENT_355	[p24l422t305r757b376],
37	.	.	O	.	_	0	SENT_355	[p24l422t305r757b376],

1	D.	NNP	O	D.	_	0	SENT_356	[p24l422t305r757b376],
2	,	,	O	,	_	0	SENT_356	[p24l422t305r757b376],
3	and	CC	O	and	_	0	SENT_356	[p24l784t305r905b364],
4	Barry	NNP	PERSON	Barry	nn	5	SENT_356	[p24l927t310r1112b380],
5	Lubarsky	NNP	PERSON	Lubarsky	conj_and	1	SENT_356	[p24l1130t305r1450b380],
6	,	,	O	,	_	0	SENT_356	[p24l1130t305r1450b380],
7	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_356	[p24l1476t305r1673b376],
8	,	,	O	,	_	0	SENT_356	[p24l1476t305r1673b376],
9	for	IN	O	for	_	0	SENT_356	[p24l1700t304r1795b364],
10	providing	VBG	O	provide	prepc_for	1	SENT_356	[p24l1815t305r2141b380],
11	medical-writing	JJ	O	medical-writing	dobj	10	SENT_356	[p24l9t401r569b476],
12	,	,	O	,	_	0	SENT_356	[p24l9t401r569b476],
13	editorial	NN	O	editorial	dobj	10	SENT_356	[p24l601t401r905b472],
14	,	,	O	,	_	0	SENT_356	[p24l601t401r905b472],
15	and	CC	O	and	_	0	SENT_356	[p24l936t401r1058b460],
16	coordination	NN	O	coordination	nn	17	SENT_356	[p24l1086t401r1522b460],
17	support	NN	O	support	dobj	10	SENT_356	[p24l1550t413r1828b476],
18	;	:	O	;	_	0	SENT_356	[p24l1550t413r1828b476],
19	Lily	NNP	PERSON	Lily	nn	20	SENT_356	[p24l1858t401r1981b476],
20	Lee	NNP	PERSON	Lee	dep	11	SENT_356	[p24l2004t406r2135b472],
21	,	,	O	,	_	0	SENT_356	[p24l2004t406r2135b472],
22	Ph.D.	NNP	O	Ph.D.	appos	20	SENT_356	[p24l8t497r207b568],
23	,	,	O	,	_	0	SENT_356	[p24l8t497r207b568],
24	for	IN	O	for	_	0	SENT_356	[p24l250t496r346b556],
25	preparing	VBG	O	prepare	prepc_for	20	SENT_356	[p24l382t498r716b572],
26	the	DT	O	the	det	28	SENT_356	[p24l753t497r856b555],
27	study	NN	O	study	nn	28	SENT_356	[p24l897t497r1076b572],
28	document	NN	O	document	dobj	25	SENT_356	[p24l1112t497r1468b568],
29	;	:	O	;	_	0	SENT_356	[p24l1112t497r1468b568],
30	Robert	NNP	PERSON	Robert	nn	35	SENT_356	[p24l1509t497r1739b559],
31	Kauffman	NNP	PERSON	Kauffman	nn	35	SENT_356	[p24l1774t496r2134b568],
32	,	,	O	,	_	0	SENT_356	[p24l1774t496r2134b568],
33	M.D.	NNP	O	M.D.	appos	35	SENT_356	[p24l7t598r188b664],
34	,	,	O	,	_	0	SENT_356	[p24l7t598r188b664],
35	Ph.D.	NNP	O	Ph.D.	dep	28	SENT_356	[p24l218t593r417b664],
36	,	,	O	,	_	0	SENT_356	[p24l218t593r417b664],
37	for	IN	O	for	_	0	SENT_356	[p24l449t592r545b652],
38	providing	VBG	O	provide	prepc_for	35	SENT_356	[p24l569t593r897b668],
39	advice	NN	O	advice	dobj	38	SENT_356	[p24l922t593r1128b653],
40	on	IN	O	on	_	0	SENT_356	[p24l1156t612r1237b652],
41	the	DT	O	the	det	43	SENT_356	[p24l1265t593r1368b651],
42	study	NN	O	study	nn	43	SENT_356	[p24l1397t593r1576b668],
43	design	NN	O	design	prep_on	38	SENT_356	[p24l1601t593r1821b668],
44	and	CC	O	and	_	0	SENT_356	[p24l1848t593r1969b652],
45	data	NNS	O	datum	nn	46	SENT_356	[p24l1998t593r2140b652],
46	interpretation	NN	O	interpretation	conj_and	43	SENT_356	[p24l8t690r500b764],
47	;	:	O	;	_	0	SENT_356	[p24l8t690r500b764],
48	Christopher	NNP	PERSON	Christopher	nn	49	SENT_356	[p24l537t689r941b764],
49	Simard	NNP	PERSON	Simard	dep	11	SENT_356	[p24l975t689r1231b760],
50	,	,	O	,	_	0	SENT_356	[p24l975t689r1231b760],
51	M.D.	NNP	O	M.D.	appos	49	SENT_356	[p24l1267t694r1448b760],
52	,	,	O	,	_	0	SENT_356	[p24l1267t694r1448b760],
53	for	IN	O	for	_	0	SENT_356	[p24l1486t688r1582b748],
54	performing	VBG	O	perform	prepc_for	11	SENT_356	[p24l1612t688r2004b764],
55	the	DT	O	the	det	57	SENT_356	[p24l2036t689r2139b747],
56	patient-safety	NN	O	patient-safety	nn	57	SENT_356	[p24l8t784r470b860],
57	analysis	NN	O	analysis	dobj	54	SENT_356	[p24l501t785r788b860],
58	;	:	O	;	_	0	SENT_356	[p24l501t785r788b860],
59	Sorana	NNP	PERSON	Sorana	nn	60	SENT_356	[p24l828t789r1058b844],
60	Ailinca	NNP	PERSON	Ailinca	dep	1	SENT_356	[p24l1089t785r1350b857],
61	,	,	O	,	_	0	SENT_356	[p24l1089t785r1350b857],
62	Nikki	NNP	PERSON	Nikki	nn	63	SENT_356	[p24l1387t785r1578b845],
63	Shannon	NNP	PERSON	Shannon	appos	60	SENT_356	[p24l1614t785r1928b857],
64	,	,	O	,	_	0	SENT_356	[p24l1614t785r1928b857],
65	R.N.	NNP	O	R.N.	appos	60	SENT_356	[p24l1966t790r2135b856],
66	,	,	O	,	_	0	SENT_356	[p24l1966t790r2135b856],
67	B.H.	NNP	O	B.H.	nn	68	SENT_356	[p24l8t885r348b952],
68	Sc	NNP	O	Sc	appos	60	SENT_356	[p24l8t885r348b952],
69	.	.	O	.	_	0	SENT_356	[p24l8t885r348b952],

1	A.	NN	O	a.	_	0	SENT_357	[p24l8t885r348b952],
2	,	,	O	,	_	0	SENT_357	[p24l8t885r348b952],
3	and	CC	O	and	_	0	SENT_357	[p24l375t881r497b940],
4	Jennifer	NNP	PERSON	Jennifer	nn	5	SENT_357	[p24l513t880r788b949],
5	Webster	NNP	PERSON	Webster	conj_and	1	SENT_357	[p24l806t881r1096b952],
6	,	,	O	,	_	0	SENT_357	[p24l806t881r1096b952],
7	M.B.A.	NNP	O	M.B.A.	appos	1	SENT_357	[p24l1122t886r1372b952],
8	,	,	O	,	_	0	SENT_357	[p24l1122t886r1372b952],
9	for	IN	O	for	_	0	SENT_357	[p24l1399t880r1495b940],
10	providing	VBG	O	provide	prepc_for	7	SENT_357	[p24l1516t881r1844b956],
11	clinicaloperations	NNS	O	clinicaloperation	iobj	10	SENT_357	[p24l1866t881r2138b939, p24l10t978r366b1052],
12	support	NN	O	support	dobj	10	SENT_357	[p24l408t989r686b1052],
13	;	:	O	;	_	0	SENT_357	[p24l408t989r686b1052],
14	and	CC	O	and	_	0	SENT_357	[p24l729t977r851b1036],
15	Jiuhong	NNP	PERSON	Jiuhong	nn	16	SENT_357	[p24l883t977r1152b1052],
16	Zha	NNP	PERSON	Zha	appos	1	SENT_357	[p24l1188t977r1331b1048],
17	,	,	O	,	_	0	SENT_357	[p24l1188t977r1331b1048],
18	Ph.D.	NNP	O	Ph.D.	appos	16	SENT_357	[p24l1374t977r1573b1048],
19	,	,	O	,	_	0	SENT_357	[p24l1374t977r1573b1048],
20	for	IN	O	for	_	0	SENT_357	[p24l1617t976r1713b1036],
21	performing	VBG	O	perform	prepc_for	16	SENT_357	[p24l1750t976r2141b1052],
22	the	DT	O	the	det	24	SENT_357	[p24l10t1073r112b1131],
23	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_357	[p24l139t1073r715b1148],
24	analysis	NN	O	analysis	dobj	21	SENT_357	[p24l741t1073r1028b1148],
25	.	.	O	.	_	0	SENT_357	[p24l741t1073r1028b1148],

1	REFERENCES	NNS	O	reference	_	0	SENT_358	[p24l13t1255r336b1287],

1	1	LS	NUMBER	1	_	0	SENT_359	[p24l11t1364r47b1403],
2	.	.	O	.	_	0	SENT_359	[p24l11t1364r47b1403],

1	Patient	NN	O	patient	nn	2	SENT_360	[p24l105t1359r272b1403],
2	registry	NN	O	registry	_	0	SENT_360	[p24l295t1359r491b1415],
3	:	:	O	:	_	0	SENT_360	[p24l295t1359r491b1415],
4	2008	CD	DATE	2008	num	6	SENT_360	[p24l518t1362r634b1403],
5	annual	JJ	SET	annual	amod	6	SENT_360	[p24l660t1359r826b1403],
6	data	NNS	O	datum	nsubj	7	SENT_360	[p24l851t1359r953b1403],
7	report	VBP	O	report	dep	2	SENT_360	[p24l978t1373r1041b1403, p24l9t1439r111b1486],
8	to	TO	O	to	_	0	SENT_360	[p24l124t1439r169b1474],
9	the	DT	O	the	det	11	SENT_360	[p24l185t1430r259b1474],
10	Center	NNP	O	Center	nn	11	SENT_360	[p24l274t1433r432b1474],
11	directors	NNS	O	director	prep_to	7	SENT_360	[p24l446t1430r672b1474],
12	.	.	O	.	_	0	SENT_360	[p24l446t1430r672b1474],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_361	[p24l689t1430r921b1483],
2	,	,	O	,	_	0	SENT_361	[p24l689t1430r921b1483],
3	MD	NNP	O	MD	_	0	SENT_361	[p24l937t1434r1039b1474],
4	:	:	O	:	_	0	SENT_361	[p24l937t1434r1039b1474],
5	Cystic	JJ	MISC	cystic	amod	7	SENT_361	[p24l9t1502r156b1557],
6	Fibrosis	NNP	MISC	Fibrosis	nn	7	SENT_361	[p24l175t1501r367b1545],
7	Foundation	NNP	MISC	Foundation	dep	3	SENT_361	[p24l387t1501r683b1554],
8	,	,	O	,	_	0	SENT_361	[p24l387t1501r683b1554],
9	2009	CD	DATE	2009	appos	7	SENT_361	[p24l705t1504r836b1545],
10	.	.	O	.	_	0	SENT_361	[p24l705t1504r836b1545],

1	2	LS	NUMBER	2	_	0	SENT_362	[p24l9t1577r49b1616],
2	.	.	O	.	_	0	SENT_362	[p24l9t1577r49b1616],

1	Farrell	NNP	PERSON	Farrell	nn	2	SENT_363	[p24l105t1572r266b1616],
2	PM	NNP	O	PM	_	0	SENT_363	[p24l295t1576r385b1616],
3	.	.	O	.	_	0	SENT_363	[p24l295t1576r385b1616],

1	The	DT	O	the	det	2	SENT_364	[p24l417t1572r508b1616],
2	prevalence	NN	O	prevalence	_	0	SENT_364	[p24l538t1572r798b1628],
3	of	IN	O	of	_	0	SENT_364	[p24l828t1571r885b1616],
4	cystic	JJ	O	cystic	amod	5	SENT_364	[p24l906t1573r1042b1628],
5	fibrosis	NN	O	fibrosis	prep_of	2	SENT_364	[p24l10t1642r195b1687],
6	in	IN	O	in	_	0	SENT_364	[p24l217t1643r264b1686],
7	the	DT	O	the	det	9	SENT_364	[p24l284t1643r360b1687],
8	European	NNP	ORGANIZATION	European	nn	9	SENT_364	[p24l380t1647r616b1699],
9	Union	NNP	ORGANIZATION	Union	prep_in	2	SENT_364	[p24l636t1643r800b1687],
10	.	.	O	.	_	0	SENT_364	[p24l636t1643r800b1687],

1	I	PRP	O	I	nsubj	2	SENT_365	[p24l818t1647r838b1694],
2	Cyst	VBP	O	cyst	_	0	SENT_365	[p24l857t1646r963b1699],
3	Fibros	NNP	O	Fibros	dobj	2	SENT_365	[p24l980t1643r1041b1686, p24l10t1714r114b1758],
4	2008	CD	DATE	2008	num	3	SENT_365	[p24l135t1717r459b1767],
5	;	:	O	;	_	0	SENT_365	[p24l135t1717r459b1767],
6	7:450	CD	NUMBER	7:450	num	7	SENT_365	[p24l135t1717r459b1767],
7	-3	CD	NUMBER	-3	dep	3	SENT_365	[p24l135t1717r459b1767],
8	.	.	O	.	_	0	SENT_365	[p24l135t1717r459b1767],

1	3	LS	NUMBER	3	_	0	SENT_366	[p24l10t1790r47b1829],
2	.	.	O	.	_	0	SENT_366	[p24l10t1790r47b1829],

1	Gibson	NNP	ORGANIZATION	Gibson	nn	2	SENT_367	[p24l106t1785r282b1829],
2	RL	NNP	ORGANIZATION	RL	_	0	SENT_367	[p24l317t1789r398b1838],
3	,	,	O	,	_	0	SENT_367	[p24l317t1789r398b1838],
4	Burns	NNP	PERSON	Burns	nn	5	SENT_367	[p24l437t1789r581b1829],
5	JL	NNP	O	JL	appos	2	SENT_367	[p24l613t1789r679b1838],
6	,	,	O	,	_	0	SENT_367	[p24l613t1789r679b1838],
7	Ramsey	NNP	PERSON	Ramsey	nn	8	SENT_367	[p24l718t1789r912b1841],
8	BW	NN	O	bw	appos	5	SENT_367	[p24l946t1789r1038b1829],
9	.	.	O	.	_	0	SENT_367	[p24l946t1789r1038b1829],

1	Pathophysiology	NN	O	pathophysiology	_	0	SENT_368	[p24l9t1856r417b1912],
2	and	CC	O	and	_	0	SENT_368	[p24l433t1856r522b1900],
3	management	NN	O	management	conj_and	1	SENT_368	[p24l541t1865r864b1912],
4	of	IN	O	of	_	0	SENT_368	[p24l880t1855r937b1900],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_368	[p24l944t1856r1041b1912, p24l10t1941r200b1983],
6	infections	NNS	O	infection	prep_of	1	SENT_368	[p24l216t1926r461b1971],
7	in	IN	O	in	_	0	SENT_368	[p24l481t1927r528b1970],
8	cystic	JJ	O	cystic	amod	9	SENT_368	[p24l547t1927r684b1983],
9	fibrosis	NN	O	fibrosis	prep_in	1	SENT_368	[p24l702t1926r903b1971],
10	.	.	O	.	_	0	SENT_368	[p24l702t1926r903b1971],

1	Am	VBP	O	be	cop	2	SENT_369	[p24l922t1931r1043b1978],
2	]	CD	NUMBER	]	dep	6	SENT_369	[p24l922t1931r1043b1978],
3	Respir	NNP	O	Respir	nn	5	SENT_369	[p24l9t1998r167b2054],
4	Crit	NNP	O	Crit	nn	5	SENT_369	[p24l185t1998r277b2042],
5	Care	NNP	O	Care	nsubj	6	SENT_369	[p24l294t2001r404b2042],
6	Med	VBD	O	med	_	0	SENT_369	[p24l422t1998r527b2042],
7	2003	CD	DATE	2003	dobj	6	SENT_369	[p24l547t2001r959b2051],
8	;	:	O	;	_	0	SENT_369	[p24l547t2001r959b2051],
9	168:918	CD	NUMBER	168:918	num	10	SENT_369	[p24l547t2001r959b2051],
10	-51	CD	NUMBER	-51	dep	7	SENT_369	[p24l547t2001r959b2051],
11	.	.	O	.	_	0	SENT_369	[p24l547t2001r959b2051],

1	4	LS	NUMBER	4	_	0	SENT_370	[p24l8t2074r48b2113],
2	.	.	O	.	_	0	SENT_370	[p24l8t2074r48b2113],

1	Rowe	NNP	PERSON	Rowe	nn	2	SENT_371	[p24l105t2073r237b2116],
2	SM	NNP	O	SM	_	0	SENT_371	[p24l258t2072r344b2122],
3	,	,	O	,	_	0	SENT_371	[p24l258t2072r344b2122],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_371	[p24l365t2069r512b2113],
5	S	NNP	O	S	appos	2	SENT_371	[p24l531t2072r569b2122],
6	,	,	O	,	_	0	SENT_371	[p24l531t2072r569b2122],
7	Sorscher	NNP	PERSON	Sorscher	nn	9	SENT_371	[p24l592t2069r800b2113],
8	E	NNP	O	E	nn	9	SENT_371	[p24l817t2073r876b2120],
9	]	NN	O	]	appos	5	SENT_371	[p24l817t2073r876b2120],
10	.	.	O	.	_	0	SENT_371	[p24l817t2073r876b2120],

1	Cystic	JJ	O	cystic	amod	2	SENT_372	[p24l898t2069r1042b2125],
2	fibrosis	NN	O	fibrosis	_	0	SENT_372	[p24l10t2139r205b2184],
3	.	.	O	.	_	0	SENT_372	[p24l10t2139r205b2184],

1	N	NN	O	n	nn	3	SENT_373	[p24l222t2144r264b2184],
2	Engl	NNP	O	Engl	nn	3	SENT_373	[p24l278t2140r417b2196],
3	]	NNP	O	]	nsubj	4	SENT_373	[p24l278t2140r417b2196],
4	Med	VBD	O	med	_	0	SENT_373	[p24l430t2140r535b2184],
5	2005	CD	DATE	2005	dobj	4	SENT_373	[p24l550t2143r1038b2193],
6	;	:	O	;	_	0	SENT_373	[p24l550t2143r1038b2193],
7	352:1992	CD	DURATION	352:1992	num	8	SENT_373	[p24l550t2143r1038b2193],
8	-2001	CD	DURATION	-2001	dep	5	SENT_373	[p24l550t2143r1038b2193],
9	.	.	O	.	_	0	SENT_373	[p24l550t2143r1038b2193],

1	5	CD	NUMBER	5	_	0	SENT_374	[p24l10t2216r47b2255],
2	.	.	O	.	_	0	SENT_374	[p24l10t2216r47b2255],

1	Welsh	NNP	MISC	Welsh	nn	3	SENT_375	[p24l104t2211r253b2255],
2	M	NNP	MISC	M	nn	3	SENT_375	[p24l284t2215r363b2264],
3	]	NN	O	]	_	0	SENT_375	[p24l284t2215r363b2264],
4	,	,	O	,	_	0	SENT_375	[p24l284t2215r363b2264],
5	Ramsey	NNP	PERSON	Ramsey	nn	6	SENT_375	[p24l398t2215r593b2267],
6	BW	NN	O	bw	appos	3	SENT_375	[p24l622t2215r715b2264],
7	,	,	O	,	_	0	SENT_375	[p24l622t2215r715b2264],
8	Accurso	NNP	PERSON	Accurso	nn	10	SENT_375	[p24l749t2215r947b2255],
9	F	NN	O	f	nn	10	SENT_375	[p24l980t2215r1038b2264],
10	)	NN	O	)	appos	3	SENT_375	[p24l980t2215r1038b2264],
11	,	,	O	,	_	0	SENT_375	[p24l980t2215r1038b2264],
12	Cutting	VBG	O	cut	partmod	3	SENT_375	[p24l9t2283r195b2338],
13	GR	NN	O	gr	dobj	12	SENT_375	[p24l208t2285r299b2329],
14	.	.	O	.	_	0	SENT_375	[p24l208t2285r299b2329],

1	Cystic	JJ	O	cystic	amod	2	SENT_376	[p24l318t2282r463b2338],
2	fibrosis	NN	O	fibrosis	_	0	SENT_376	[p24l479t2281r676b2326],
3	.	.	O	.	_	0	SENT_376	[p24l479t2281r676b2326],

1	In	IN	O	in	dep	4	SENT_377	[p24l694t2286r758b2326],
2	:	:	O	:	_	0	SENT_377	[p24l694t2286r758b2326],
3	Scriver	NNP	PERSON	Scriver	nn	4	SENT_377	[p24l777t2282r940b2326],
4	CR	NN	O	cr	_	0	SENT_377	[p24l954t2285r1038b2335],
5	,	,	O	,	_	0	SENT_377	[p24l954t2285r1038b2335],
6	Beaudet	NNP	PERSON	Beaudet	nn	7	SENT_377	[p24l9t2353r206b2397],
7	AR	NNS	O	ar	appos	4	SENT_377	[p24l220t2357r309b2406],
8	,	,	O	,	_	0	SENT_377	[p24l220t2357r309b2406],
9	Sly	NNP	O	Sly	nn	10	SENT_377	[p24l332t2353r400b2409],
10	W	NNP	O	W	appos	4	SENT_377	[p24l415t2357r476b2406],
11	,	,	O	,	_	0	SENT_377	[p24l415t2357r476b2406],
12	Valle	NNP	ORGANIZATION	Valle	nn	13	SENT_377	[p24l497t2353r616b2397],
13	D	NNP	ORGANIZATION	D	appos	4	SENT_377	[p24l635t2357r685b2406],
14	,	,	O	,	_	0	SENT_377	[p24l635t2357r685b2406],
15	eds	NNS	O	ed	appos	4	SENT_377	[p24l708t2353r801b2397],
16	.	.	O	.	_	0	SENT_377	[p24l708t2353r801b2397],

1	The	DT	O	the	det	5	SENT_378	[p24l822t2353r913b2397],
2	metabolic	JJ	O	metabolic	amod	5	SENT_378	[p24l933t2362r1041b2397, p24l9t2424r156b2468],
3	and	CC	O	and	_	0	SENT_378	[p24l184t2424r274b2468],
4	molecular	JJ	O	molecular	amod	5	SENT_378	[p24l304t2424r551b2468],
5	bases	NNS	O	basis	_	0	SENT_378	[p24l580t2424r711b2468],
6	of	IN	O	of	_	0	SENT_378	[p24l742t2423r799b2468],
7	inherited	VBN	O	inherit	amod	8	SENT_378	[p24l818t2424r1042b2468],
8	disease	NN	O	disease	prep_of	5	SENT_378	[p24l10t2495r201b2539],
9	.	.	O	.	_	0	SENT_378	[p24l10t2495r201b2539],

1	8th	JJ	ORDINAL	8th	nsubj	2	SENT_379	[p24l228t2495r307b2539],
2	ed	VBN	O	ed	_	0	SENT_379	[p24l331t2495r399b2539],
3	.	.	O	.	_	0	SENT_379	[p24l331t2495r399b2539],

1	New	NNP	LOCATION	New	nn	2	SENT_380	[p24l425t2499r536b2539],
2	York	NNP	LOCATION	York	_	0	SENT_380	[p24l556t2495r680b2539],
3	:	:	O	:	_	0	SENT_380	[p24l556t2495r680b2539],
4	McGraw-Hill	NNP	ORGANIZATION	McGraw-Hill	dep	2	SENT_380	[p24l704t2495r1039b2548],
5	,	,	O	,	_	0	SENT_380	[p24l704t2495r1039b2548],
6	2001:521	CD	NUMBER	2001:521	number	7	SENT_380	[p24l10t2569r320b2610],
7	—	CD	NUMBER	—	appos	4	SENT_380	[p24l10t2569r320b2610],
8	88	CD	NUMBER	88	dep	7	SENT_380	[p24l10t2569r320b2610],
9	.	.	O	.	_	0	SENT_380	[p24l10t2569r320b2610],

1	6	CD	NUMBER	6	_	0	SENT_381	[p24l10t2642r49b2681],
2	.	.	O	.	_	0	SENT_381	[p24l10t2642r49b2681],

1	Kerem	NNP	PERSON	Kerem	nn	2	SENT_382	[p24l105t2641r264b2682],
2	B	NNP	PERSON	B	_	0	SENT_382	[p24l281t2641r327b2690],
3	,	,	O	,	_	0	SENT_382	[p24l281t2641r327b2690],
4	Rommens	NNP	O	Rommens	nn	5	SENT_382	[p24l346t2641r596b2684],
5	JM	NN	O	jm	appos	2	SENT_382	[p24l609t2641r691b2690],
6	,	,	O	,	_	0	SENT_382	[p24l609t2641r691b2690],
7	Buchanan	NNP	PERSON	Buchanan	nn	8	SENT_382	[p24l711t2637r957b2681],
8	JA	NNP	O	JA	appos	2	SENT_382	[p24l968t2641r1038b2690],
9	,	,	O	,	_	0	SENT_382	[p24l968t2641r1038b2690],
10	et	FW	O	et	nn	11	SENT_382	[p24l10t2717r54b2752],
11	al.	FW	O	al.	appos	2	SENT_382	[p24l75t2708r131b2752],
12	.	.	O	.	_	0	SENT_382	[p24l75t2708r131b2752],

1	Identification	NN	O	identification	_	0	SENT_383	[p24l158t2707r496b2752],
2	of	IN	O	of	_	0	SENT_383	[p24l521t2707r578b2752],
3	the	DT	O	the	det	6	SENT_383	[p24l593t2708r668b2752],
4	cystic	JJ	O	cystic	amod	6	SENT_383	[p24l694t2709r830b2764],
5	fibrosis	NN	O	fibrosis	nn	6	SENT_383	[p24l855t2707r1041b2752],
6	gene	NN	O	gene	prep_of	1	SENT_383	[p24l9t2793r137b2835],
7	:	:	O	:	_	0	SENT_383	[p24l9t2793r137b2835],
8	genetic	JJ	O	genetic	amod	9	SENT_383	[p24l164t2780r340b2835],
9	analysis	NN	O	analysis	dep	1	SENT_383	[p24l364t2779r574b2835],
10	.	.	O	.	_	0	SENT_383	[p24l364t2779r574b2835],

1	Science	NN	O	science	_	0	SENT_384	[p24l603t2779r782b2823],
2	1989	CD	DATE	1989	num	1	SENT_384	[p24l808t2782r1039b2832],
3	;	:	O	;	_	0	SENT_384	[p24l808t2782r1039b2832],
4	245	CD	NUMBER	245	num	6	SENT_384	[p24l808t2782r1039b2832],
5	:	:	O	:	_	0	SENT_384	[p24l808t2782r1039b2832],
6	1073-80	CD	NUMBER	1073-80	dep	1	SENT_384	[p24l11t2853r216b2894],
7	.	.	O	.	_	0	SENT_384	[p24l11t2853r216b2894],

1	7	CD	NUMBER	7	_	0	SENT_385	[p24l11t2926r44b2965],
2	.	.	O	.	_	0	SENT_385	[p24l11t2926r44b2965],

1	Riordan	NNP	PERSON	Riordan	nn	2	SENT_386	[p24l105t2921r304b2968],
2	JR	NNP	O	JR	_	0	SENT_386	[p24l324t2925r397b2974],
3	,	,	O	,	_	0	SENT_386	[p24l324t2925r397b2974],
4	Rommens	NNP	O	Rommens	nn	5	SENT_386	[p24l426t2925r675b2968],
5	IM	NNP	O	IM	appos	2	SENT_386	[p24l697t2925r779b2974],
6	,	,	O	,	_	0	SENT_386	[p24l697t2925r779b2974],
7	Kerem	NNP	PERSON	Kerem	nn	8	SENT_386	[p24l808t2925r967b2966],
8	B	NNP	PERSON	B	appos	2	SENT_386	[p24l993t2925r1038b2974],
9	,	,	O	,	_	0	SENT_386	[p24l993t2925r1038b2974],
10	et	FW	O	et	nn	11	SENT_386	[p24l10t3001r54b3036],
11	al.	FW	O	al.	appos	2	SENT_386	[p24l75t2992r131b3036],
12	.	.	O	.	_	0	SENT_386	[p24l75t2992r131b3036],

1	Identification	NN	O	identification	_	0	SENT_387	[p24l158t2991r496b3036],
2	of	IN	O	of	_	0	SENT_387	[p24l521t2991r578b3036],
3	the	DT	O	the	det	6	SENT_387	[p24l593t2992r668b3036],
4	cystic	JJ	O	cystic	amod	6	SENT_387	[p24l694t2993r830b3048],
5	fibrosis	NN	O	fibrosis	nn	6	SENT_387	[p24l855t2991r1041b3036],
6	gene	NN	O	gene	prep_of	1	SENT_387	[p24l9t3077r139b3119],
7	:	:	O	:	_	0	SENT_387	[p24l9t3077r139b3119],
8	cloning	NN	O	cloning	dep	1	SENT_387	[p24l183t3063r372b3119],
9	and	CC	O	and	_	0	SENT_387	[p24l411t3063r502b3107],
10	characterization	NN	O	characterization	conj_and	8	SENT_387	[p24l543t3063r953b3107],
11	of	IN	O	of	_	0	SENT_387	[p24l995t3062r1052b3107],
12	complementary	JJ	O	complementary	amod	13	SENT_387	[p24l10t3134r395b3190],
13	DNA	NN	O	dna	prep_of	8	SENT_387	[p24l425t3138r556b3178],
14	.	.	O	.	_	0	SENT_387	[p24l425t3138r556b3178],

1	Science	NN	O	science	_	0	SENT_388	[p24l594t3134r773b3178],
2	1989	CD	DATE	1989	num	1	SENT_388	[p24l808t3137r1039b3187],
3	;	:	O	;	_	0	SENT_388	[p24l808t3137r1039b3187],
4	245	CD	NUMBER	245	num	6	SENT_388	[p24l808t3137r1039b3187],
5	:	:	O	:	_	0	SENT_388	[p24l808t3137r1039b3187],
6	1066-73	CD	NUMBER	1066-73	dep	1	SENT_388	[p24l11t3208r212b3249],
7	.	.	O	.	_	0	SENT_388	[p24l11t3208r212b3249],

1	[	NN	O	[	_	0	SENT_389	[p24l233t3209r464b3258],
2	Erratum	NN	O	erratum	dep	1	SENT_389	[p24l233t3209r464b3258],
3	,	,	O	,	_	0	SENT_389	[p24l233t3209r464b3258],
4	Science	NN	O	science	appos	2	SENT_389	[p24l482t3206r658b3249],
5	1989	CD	DATE	1989	rcmod	4	SENT_389	[p24l674t3208r1036b3258],
6	;	:	O	;	_	0	SENT_389	[p24l674t3208r1036b3258],
7	245:1437	CD	NUMBER	245:1437	dep	5	SENT_389	[p24l674t3208r1036b3258],
8	.	.	O	.	_	0	SENT_389	[p24l674t3208r1036b3258],
9	]	SYM	O	]	dep	5	SENT_389	[p24l674t3208r1036b3258],

1	8	CD	NUMBER	8	_	0	SENT_390	[p24l1116t1363r1156b1403],
2	.	.	O	.	_	0	SENT_390	[p24l1116t1363r1156b1403],

1	LeGrys	NNP	O	LeGrys	nn	2	SENT_391	[p24l1213t1362r1384b1415],
2	VA.	NNP	O	VA.	_	0	SENT_391	[p24l1402t1363r1481b1403],
3	.	.	O	.	_	0	SENT_391	[p24l1402t1363r1481b1403],

1	Sweat	NN	O	sweat	nn	4	SENT_392	[p24l1504t1362r1646b1403],
2	analysis	NN	O	analysis	nn	4	SENT_392	[p24l1662t1359r1856b1415],
3	proficiency	NN	O	proficiency	nn	4	SENT_392	[p24l1875t1358r2152b1415],
4	testing	NN	O	testing	_	0	SENT_392	[p24l1117t1430r1288b1486],
5	for	IN	O	for	_	0	SENT_392	[p24l1306t1429r1376b1474],
6	cystic	JJ	O	cystic	amod	7	SENT_392	[p24l1396t1430r1532b1486],
7	fibrosis	NN	O	fibrosis	prep_for	4	SENT_392	[p24l1552t1429r1752b1474],
8	.	.	O	.	_	0	SENT_392	[p24l1552t1429r1752b1474],

1	Pediatr	NNP	O	Pediatr	nn	2	SENT_393	[p24l1775t1430r1951b1474],
2	Pulmonol	NNP	O	Pulmonol	_	0	SENT_393	[p24l1969t1430r2148b1474, p24l1117t1501r1194b1545],
3	2000	CD	DATE	2000	num	2	SENT_393	[p24l1213t1504r1605b1554],
4	;	:	O	;	_	0	SENT_393	[p24l1213t1504r1605b1554],
5	30:476	CD	NUMBER	30:476	number	6	SENT_393	[p24l1213t1504r1605b1554],
6	—	CD	NUMBER	—	dep	2	SENT_393	[p24l1213t1504r1605b1554],
7	80	CD	NUMBER	80	dep	6	SENT_393	[p24l1213t1504r1605b1554],
8	.	.	O	.	_	0	SENT_393	[p24l1213t1504r1605b1554],

1	9	CD	NUMBER	9	_	0	SENT_394	[p24l1117t1577r1154b1616],
2	.	.	O	.	_	0	SENT_394	[p24l1117t1577r1154b1616],

1	McKone	NNP	PERSON	McKone	nn	2	SENT_395	[p24l1212t1576r1412b1617],
2	EF	NNP	O	EF	_	0	SENT_395	[p24l1428t1576r1498b1625],
3	,	,	O	,	_	0	SENT_395	[p24l1428t1576r1498b1625],
4	Emerson	NNP	ORGANIZATION	Emerson	nn	5	SENT_395	[p24l1517t1576r1733b1616],
5	SS	NNP	ORGANIZATION	SS	appos	2	SENT_395	[p24l1751t1575r1819b1625],
6	,	,	O	,	_	0	SENT_395	[p24l1751t1575r1819b1625],
7	Edwards	NNP	ORGANIZATION	Edwards	nn	8	SENT_395	[p24l1837t1572r2047b1616],
8	KL	NNP	ORGANIZATION	KL	appos	2	SENT_395	[p24l2064t1576r2146b1625],
9	,	,	O	,	_	0	SENT_395	[p24l2064t1576r2146b1625],
10	Aitken	NNP	PERSON	Aitken	nn	11	SENT_395	[p24l1115t1643r1278b1687],
11	ML	NNP	O	ML	appos	2	SENT_395	[p24l1298t1647r1392b1687],
12	.	.	O	.	_	0	SENT_395	[p24l1298t1647r1392b1687],

1	Effect	NN	O	effect	_	0	SENT_396	[p24l1416t1642r1561b1687],
2	of	IN	O	of	_	0	SENT_396	[p24l1581t1642r1637b1687],
3	genotype	NN	O	genotype	prep_of	1	SENT_396	[p24l1649t1652r1874b1699],
4	on	IN	O	on	_	0	SENT_396	[p24l1896t1657r1956b1687],
5	phenotype	NN	O	phenotype	prep_on	3	SENT_396	[p24l1977t1643r2148b1699, p24l1117t1723r1219b1770],
6	and	CC	O	and	_	0	SENT_396	[p24l1238t1714r1327b1758],
7	mortality	NN	O	mortality	conj_and	5	SENT_396	[p24l1345t1714r1574b1770],
8	in	IN	O	in	_	0	SENT_396	[p24l1589t1714r1636b1757],
9	cystic	JJ	O	cystic	amod	10	SENT_396	[p24l1656t1714r1790b1770],
10	fibrosis	NN	O	fibrosis	prep_in	1	SENT_396	[p24l1808t1713r2006b1758],
11	:	:	O	:	_	0	SENT_396	[p24l1808t1713r2006b1758],
12	a	DT	O	a	det	14	SENT_396	[p24l2027t1728r2051b1758],
13	retrospective	JJ	O	retrospective	amod	14	SENT_396	[p24l2069t1723r2148b1758, p24l1117t1786r1361b1841],
14	cohort	NN	O	cohort	dep	1	SENT_396	[p24l1387t1785r1546b1829],
15	study	NN	O	study	dep	14	SENT_396	[p24l1568t1785r1706b1841],
16	.	.	O	.	_	0	SENT_396	[p24l1568t1785r1706b1841],

1	Lancet	NNP	O	Lancet	_	0	SENT_397	[p24l1733t1789r1895b1829],
2	2003	CD	DATE	2003	num	1	SENT_397	[p24l1917t1788r2147b1838],
3	;	:	O	;	_	0	SENT_397	[p24l1917t1788r2147b1838],
4	361	CD	NUMBER	361	num	6	SENT_397	[p24l1917t1788r2147b1838],
5	:	:	O	:	_	0	SENT_397	[p24l1917t1788r2147b1838],
6	1671-6	CD	NUMBER	1671-6	dep	1	SENT_397	[p24l1119t1859r1292b1900],
7	.	.	O	.	_	0	SENT_397	[p24l1119t1859r1292b1900],

1	10	CD	NUMBER	10	_	0	SENT_398	[p24l1119t1931r1182b1971],
2	.	.	O	.	_	0	SENT_398	[p24l1119t1931r1182b1971],

1	Van	NNP	O	Van	nn	3	SENT_399	[p24l1211t1931r1303b1971],
2	Goor	NNP	O	Goor	nn	3	SENT_399	[p24l1333t1930r1459b1971],
3	F	NN	O	f	_	0	SENT_399	[p24l1487t1931r1525b1980],
4	,	,	O	,	_	0	SENT_399	[p24l1487t1931r1525b1980],
5	Hadida	NNP	PERSON	Hadida	nn	6	SENT_399	[p24l1559t1927r1737b1971],
6	S	NNP	O	S	appos	3	SENT_399	[p24l1767t1930r1806b1980],
7	,	,	O	,	_	0	SENT_399	[p24l1767t1930r1806b1980],
8	Grootenhuis	NNP	O	Grootenhuis	nn	9	SENT_399	[p24l1840t1927r2148b1971],
9	PD	NN	O	pd	appos	3	SENT_399	[p24l1116t2002r1196b2051],
10	,	,	O	,	_	0	SENT_399	[p24l1116t2002r1196b2051],
11	et	FW	O	et	nn	12	SENT_399	[p24l1225t2007r1269b2042],
12	al.	FW	O	al.	appos	3	SENT_399	[p24l1292t1998r1347b2042],
13	.	.	O	.	_	0	SENT_399	[p24l1292t1998r1347b2042],

1	Rescue	NN	O	rescue	nsubj	7	SENT_400	[p24l1375t2002r1546b2045],
2	of	IN	O	of	_	0	SENT_400	[p24l1572t1997r1629b2042],
3	CF	NN	O	cf	nn	6	SENT_400	[p24l1644t2001r1707b2042],
4	airway	NN	O	airway	nn	6	SENT_400	[p24l1733t1998r1896b2054],
5	epithelial	JJ	O	epithelial	amod	6	SENT_400	[p24l1920t1998r2149b2054],
6	cell	NN	O	cell	prep_of	1	SENT_400	[p24l1117t2069r1200b2113],
7	function	NN	O	function	_	0	SENT_400	[p24l1221t2068r1430b2113],
8	in	FW	O	in	nn	9	SENT_400	[p24l1451t2070r1498b2112],
9	vitro	FW	O	vitro	advmod	7	SENT_400	[p24l1517t2069r1629b2113],
10	by	IN	O	by	_	0	SENT_400	[p24l1652t2069r1707b2125],
11	a	DT	O	a	det	13	SENT_400	[p24l1726t2083r1750b2113],
12	CFTR	NNP	O	CFTR	nn	13	SENT_400	[p24l1771t2072r1913b2116],
13	potentiator	NN	O	potentiator	prep_by	7	SENT_400	[p24l1928t2069r2148b2125, p24l1117t2149r1197b2193],
14	,	,	O	,	_	0	SENT_400	[p24l1928t2069r2148b2125, p24l1117t2149r1197b2193],
15	VX-770	NN	O	vx-770	appos	13	SENT_400	[p24l1214t2143r1396b2184],
16	.	.	O	.	_	0	SENT_400	[p24l1214t2143r1396b2184],

1	Proc	NNP	O	Proc	nn	7	SENT_401	[p24l1414t2144r1522b2184],
2	Natl	NNP	O	Natl	nn	7	SENT_401	[p24l1536t2140r1639b2184],
3	Acad	NNP	O	Acad	nn	7	SENT_401	[p24l1652t2140r1772b2184],
4	Sci	NNP	O	Sci	nn	7	SENT_401	[p24l1789t2141r1856b2184],
5	U	NNP	O	U	nn	7	SENT_401	[p24l1871t2144r1910b2184],
6	S	NNP	O	S	nn	7	SENT_401	[p24l1926t2143r1950b2184],
7	A	NNP	O	A	_	0	SENT_401	[p24l1965t2144r2002b2183],
8	2009	CD	DATE	2009	num	7	SENT_401	[p24l2016t2143r2147b2193],
9	;	:	O	;	_	0	SENT_401	[p24l2016t2143r2147b2193],
10	106:18825	CD	NUMBER	106:18825	number	11	SENT_401	[p24l1119t2214r1458b2255],
11	-30	CD	NUMBER	-30	dep	7	SENT_401	[p24l1119t2214r1458b2255],
12	.	.	O	.	_	0	SENT_401	[p24l1119t2214r1458b2255],

1	11	CD	NUMBER	11	_	0	SENT_402	[p24l1119t2287r1182b2326],
2	.	.	O	.	_	0	SENT_402	[p24l1119t2287r1182b2326],

1	Accurso	NNP	PERSON	Accurso	nn	3	SENT_403	[p24l1211t2286r1410b2326],
2	F	NN	O	f	nn	3	SENT_403	[p24l1428t2286r1487b2335],
3	]	NN	O	]	_	0	SENT_403	[p24l1428t2286r1487b2335],
4	,	,	O	,	_	0	SENT_403	[p24l1428t2286r1487b2335],
5	Rowe	NNP	PERSON	Rowe	nn	6	SENT_403	[p24l1508t2286r1642b2329],
6	SM	NNP	O	SM	appos	3	SENT_403	[p24l1662t2285r1750b2335],
7	,	,	O	,	_	0	SENT_403	[p24l1662t2285r1750b2335],
8	Clancy	NNP	PERSON	Clancy	nn	9	SENT_403	[p24l1771t2282r1937b2338],
9	JP	NNP	O	JP	appos	3	SENT_403	[p24l1948t2286r2009b2335],
10	,	,	O	,	_	0	SENT_403	[p24l1948t2286r2009b2335],
11	et	FW	O	et	nn	12	SENT_403	[p24l2030t2291r2074b2326],
12	al.	FW	O	al.	appos	3	SENT_403	[p24l2090t2282r2146b2326],
13	.	.	O	.	_	0	SENT_403	[p24l2090t2282r2146b2326],

1	Effect	NN	O	effect	_	0	SENT_404	[p24l1116t2352r1254b2397],
2	of	IN	O	of	_	0	SENT_404	[p24l1265t2352r1321b2397],
3	VX-770	NN	O	vx-770	prep_of	1	SENT_404	[p24l1322t2356r1485b2397],
4	in	IN	O	in	_	0	SENT_404	[p24l1499t2354r1544b2396],
5	persons	NNS	O	person	prep_in	1	SENT_404	[p24l1557t2367r1740b2409],
6	with	IN	O	with	_	0	SENT_404	[p24l1753t2353r1859b2397],
7	cystic	JJ	O	cystic	amod	8	SENT_404	[p24l1873t2353r2002b2409],
8	fibrosis	NN	O	fibrosis	prep_with	5	SENT_404	[p24l2016t2352r2148b2397, p24l1118t2424r1177b2468],
9	and	CC	O	and	_	0	SENT_404	[p24l1198t2424r1287b2468],
10	the	DT	O	the	det	12	SENT_404	[p24l1306t2424r1381b2468],
11	G551D-CFTR	NN	O	g551d-cftr	nn	12	SENT_404	[p24l1401t2427r1710b2469],
12	mutation	NN	O	mutation	prep_with	5	SENT_404	[p24l1726t2424r1959b2468],
13	.	.	O	.	_	0	SENT_404	[p24l1726t2424r1959b2468],

1	N	NN	O	n	nn	3	SENT_405	[p24l1981t2428r2022b2468],
2	Engl	NNP	O	Engl	nn	3	SENT_405	[p24l2041t2424r2149b2480],
3	J	NNP	O	J	nsubj	4	SENT_405	[p24l1111t2499r1132b2546],
4	Med	VBD	O	med	_	0	SENT_405	[p24l1149t2495r1255b2539],
5	2010	CD	DATE	2010	dobj	4	SENT_405	[p24l1274t2498r1772b2548],
6	;	:	O	;	_	0	SENT_405	[p24l1274t2498r1772b2548],
7	363:1991	CD	DURATION	363:1991	num	8	SENT_405	[p24l1274t2498r1772b2548],
8	-2003	CD	DURATION	-2003	dep	5	SENT_405	[p24l1274t2498r1772b2548],
9	.	.	O	.	_	0	SENT_405	[p24l1274t2498r1772b2548],

1	12	CD	NUMBER	12	_	0	SENT_406	[p24l1119t2571r1183b2610],
2	.	.	O	.	_	0	SENT_406	[p24l1119t2571r1183b2610],

1	Farrell	NNP	ORGANIZATION	Farrell	nn	2	SENT_407	[p24l1213t2566r1373b2610],
2	PM	NNP	ORGANIZATION	PM	_	0	SENT_407	[p24l1397t2570r1486b2619],
3	,	,	O	,	_	0	SENT_407	[p24l1397t2570r1486b2619],
4	Rosenstein	NNP	PERSON	Rosenstein	nn	6	SENT_407	[p24l1513t2567r1785b2613],
5	B	NNP	O	B	nn	6	SENT_407	[p24l1808t2570r1870b2619],
6	]	NN	O	]	appos	2	SENT_407	[p24l1808t2570r1870b2619],
7	,	,	O	,	_	0	SENT_407	[p24l1808t2570r1870b2619],
8	White	NNP	O	White	nn	9	SENT_407	[p24l1895t2566r2042b2610],
9	TB	NN	O	tb	appos	2	SENT_407	[p24l2065t2569r2146b2619],
10	,	,	O	,	_	0	SENT_407	[p24l2065t2569r2146b2619],
11	et	FW	O	et	nn	12	SENT_407	[p24l1117t2646r1161b2681],
12	al.	FW	O	al.	appos	2	SENT_407	[p24l1188t2637r1244b2681],
13	.	.	O	.	_	0	SENT_407	[p24l1188t2637r1244b2681],

1	Guidelines	NNS	O	guideline	_	0	SENT_408	[p24l1276t2637r1541b2681],
2	for	IN	O	for	_	0	SENT_408	[p24l1571t2636r1642b2681],
3	diagnosis	NN	O	diagnosis	prep_for	1	SENT_408	[p24l1670t2637r1905b2693],
4	of	IN	O	of	_	0	SENT_408	[p24l1937t2636r1993b2681],
5	cystic	JJ	O	cystic	amod	6	SENT_408	[p24l2013t2637r2149b2693],
6	fibrosis	NN	O	fibrosis	prep_of	3	SENT_408	[p24l1117t2707r1303b2752],
7	in	IN	O	in	_	0	SENT_408	[p24l1362t2708r1409b2751],
8	newborns	NNS	O	newborn	prep_in	6	SENT_408	[p24l1468t2708r1709b2752],
9	through	IN	O	through	_	0	SENT_408	[p24l1769t2708r1968b2764],
10	older	JJR	O	older	amod	11	SENT_408	[p24l2027t2708r2151b2752],
11	adults	NNS	O	adult	prep_through	8	SENT_408	[p24l1117t2779r1278b2823],
12	:	:	O	:	_	0	SENT_408	[p24l1117t2779r1278b2823],
13	Cystic	JJ	MISC	cystic	amod	17	SENT_408	[p24l1316t2780r1463b2835],
14	Fibrosis	NNP	MISC	Fibrosis	nn	17	SENT_408	[p24l1497t2779r1690b2823],
15	Foundation	NNP	MISC	Foundation	nn	17	SENT_408	[p24l1725t2779r2008b2823],
16	consensus	NN	O	consensus	nn	17	SENT_408	[p24l2044t2793r2148b2823, p24l1118t2864r1279b2894],
17	report	NN	O	report	dep	1	SENT_408	[p24l1299t2859r1464b2906],
18	.	.	O	.	_	0	SENT_408	[p24l1299t2859r1464b2906],

1	J	NNP	O	J	nn	2	SENT_409	[p24l1481t2854r1502b2901],
2	Pediatr	NNP	O	Pediatr	_	0	SENT_409	[p24l1519t2850r1695b2894],
3	2008	CD	DATE	2008	num	5	SENT_409	[p24l1712t2853r2128b2903],
4	;	:	O	;	_	0	SENT_409	[p24l1712t2853r2128b2903],
5	153	CD	NUMBER	153	dep	2	SENT_409	[p24l1712t2853r2128b2903],
6	:	:	O	:	_	0	SENT_409	[p24l1712t2853r2128b2903],
7	S4-S14	NN	O	s4-s14	dep	2	SENT_409	[p24l1712t2853r2128b2903],
8	.	.	O	.	_	0	SENT_409	[p24l1712t2853r2128b2903],

1	13	CD	NUMBER	13	_	0	SENT_410	[p24l1119t2926r1182b2965],
2	.	.	O	.	_	0	SENT_410	[p24l1119t2926r1182b2965],

1	Knudson	NNP	PERSON	Knudson	nn	3	SENT_411	[p24l1213t2921r1434b2966],
2	R	NNP	O	R	nn	3	SENT_411	[p24l1463t2925r1532b2974],
3	]	NN	O	]	_	0	SENT_411	[p24l1463t2925r1532b2974],
4	,	,	O	,	_	0	SENT_411	[p24l1463t2925r1532b2974],
5	Lebowitz	NNP	PERSON	Lebowitz	nn	6	SENT_411	[p24l1563t2921r1789b2965],
6	MD	NNP	O	MD	appos	3	SENT_411	[p24l1817t2925r1918b2974],
7	,	,	O	,	_	0	SENT_411	[p24l1817t2925r1918b2974],
8	Holberg	NNP	PERSON	Holberg	nn	10	SENT_411	[p24l1950t2921r2151b2977],
9	C	NNP	O	C	nn	10	SENT_411	[p24l1117t2995r1181b3045],
10	]	NN	O	]	appos	3	SENT_411	[p24l1117t2995r1181b3045],
11	,	,	O	,	_	0	SENT_411	[p24l1117t2995r1181b3045],
12	Burrows	NNP	O	Burrows	nn	14	SENT_411	[p24l1216t2996r1422b3036],
13	B.	NNP	O	B.	nn	14	SENT_411	[p24l1456t2996r1502b3036],
14	Changes	NNS	O	change	appos	3	SENT_411	[p24l1538t2992r1747b3048],
15	in	IN	O	in	_	0	SENT_411	[p24l1781t2992r1828b3035],
16	the	DT	O	the	det	21	SENT_411	[p24l1862t2992r1937b3036],
17	normal	JJ	O	normal	amod	21	SENT_411	[p24l1971t2992r2149b3036],
18	maximal	JJ	O	maximal	amod	21	SENT_411	[p24l1117t3063r1335b3107],
19	expiratory	JJ	O	expiratory	amod	21	SENT_411	[p24l1378t3063r1629b3119],
20	flow-volume	NN	O	flow-volume	nn	21	SENT_411	[p24l1669t3062r1976b3107],
21	curve	NN	O	curve	prep_in	14	SENT_411	[p24l2019t3077r2149b3107],
22	with	IN	O	with	_	0	SENT_411	[p24l1115t3134r1226b3178],
23	growth	NN	O	growth	prep_with	21	SENT_411	[p24l1255t3134r1434b3190],
24	and	CC	O	and	_	0	SENT_411	[p24l1463t3134r1553b3178],
25	aging	NN	O	aging	prep_with	21	SENT_411	[p24l1581t3135r1731b3190],
26	.	.	O	.	_	0	SENT_411	[p24l1581t3135r1731b3190],

1	Am	VBP	O	be	dep	4	SENT_412	[p24l1762t3138r1848b3177],
2	Rev	NN	O	rev	nn	4	SENT_412	[p24l1877t3138r1966b3181],
3	Respir	NNP	O	Respir	nn	4	SENT_412	[p24l1992t3134r2151b3190],
4	Dis	NNP	O	Dis	_	0	SENT_412	[p24l1116t3206r1195b3249],
5	1983	CD	DATE	1983	num	4	SENT_412	[p24l1218t3208r1627b3258],
6	;	:	O	;	_	0	SENT_412	[p24l1218t3208r1627b3258],
7	127:725	CD	NUMBER	127:725	num	8	SENT_412	[p24l1218t3208r1627b3258],
8	-34	CD	NUMBER	-34	dep	4	SENT_412	[p24l1218t3208r1627b3258],
9	.	.	O	.	_	0	SENT_412	[p24l1218t3208r1627b3258],

1	14	CD	NUMBER	14	_	0	SENT_413	[p24l17t3567r146b3644],
2	.	.	O	.	_	0	SENT_413	[p24l17t3567r146b3644],

1	Fuchs	NNP	PERSON	Fuchs	nn	2	SENT_414	[p24l209t3555r500b3646],
2	H	NNP	O	H	_	0	SENT_414	[p24l551t3563r700b3664],
3	]	NN	O	]	dep	2	SENT_414	[p24l551t3563r700b3664],
4	,	,	O	,	_	0	SENT_414	[p24l551t3563r700b3664],
5	Borowitz	NNP	PERSON	Borowitz	nn	6	SENT_414	[p24l755t3557r1215b3646],
6	DS	NN	O	d	appos	3	SENT_414	[p24l1264t3561r1429b3664],
7	,	,	O	,	_	0	SENT_414	[p24l1264t3561r1429b3664],
8	Christiansen	NNP	PERSON	Christiansen	appos	3	SENT_414	[p24l1486t3555r2133b3646],

1	DH	NN	O	dh	_	0	SENT_415	[p24l11t3712r205b3813],
2	,	,	O	,	_	0	SENT_415	[p24l11t3712r205b3813],
3	et	FW	O	et	nn	4	SENT_415	[p24l262t3722r354b3793],
4	al.	FW	O	al.	appos	1	SENT_415	[p24l397t3704r512b3794],
5	.	.	O	.	_	0	SENT_415	[p24l397t3704r512b3794],

1	Effect	NN	O	effect	_	0	SENT_416	[p24l567t3702r866b3793],
2	of	IN	O	of	_	0	SENT_416	[p24l911t3702r1027b3794],
3	aerosolized	JJ	O	aerosolized	amod	4	SENT_416	[p24l1056t3704r1635b3795],
4	recombinant	JJ	O	recombinant	prep_of	1	SENT_416	[p24l1686t3704r2131b3795, p25l11t53r243b124],

1	human	JJ	O	human	amod	2	SENT_417	[p25l296t35r653b126],
2	DNase	NN	MISC	dnase	_	0	SENT_417	[p25l710t43r1037b126],
3	on	IN	O	on	_	0	SENT_417	[p25l1099t64r1223b124],
4	exacerbations	NNS	O	exacerbation	prep_on	2	SENT_417	[p25l1284t35r1975b124],
5	of	IN	O	of	_	0	SENT_417	[p25l2038t33r2153b124],
6	respiratory	JJ	O	respiratory	amod	7	SENT_417	[p25l13t186r567b299],
7	symptoms	NNS	O	symptom	prep_of	4	SENT_417	[p25l609t202r1128b299],
8	and	CC	O	and	_	0	SENT_417	[p25l1177t184r1361b274],
9	on	IN	O	on	_	0	SENT_417	[p25l1408t213r1532b274],
10	pulmonary	JJ	O	pulmonary	amod	11	SENT_417	[p25l1577t184r2139b299],
11	function	NN	O	function	prep_on	2	SENT_417	[p25l11t331r443b424],
12	in	IN	O	in	_	0	SENT_417	[p25l496t335r593b422],
13	patients	NNS	O	patient	prep_in	2	SENT_417	[p25l646t335r1048b448],
14	with	IN	O	with	_	0	SENT_417	[p25l1098t333r1328b424],
15	cystic	JJ	O	cystic	amod	16	SENT_417	[p25l1383t335r1662b448],
16	fibrosis	NN	O	fibrosis	prep_with	13	SENT_417	[p25l1715t331r2127b423],
17	.	.	O	.	_	0	SENT_417	[p25l1715t331r2127b423],

1	N	NN	O	n	nn	2	SENT_418	[p25l9t490r96b573],
2	EnglJ	NN	O	englj	nsubj	3	SENT_418	[p25l132t482r430b597],
3	Med	VBD	O	med	_	0	SENT_418	[p25l464t482r682b572],
4	1994	CD	DATE	1994	dobj	3	SENT_418	[p25l725t488r1571b591],
5	;	:	O	;	_	0	SENT_418	[p25l725t488r1571b591],
6	331:637	CD	NUMBER	331:637	number	7	SENT_418	[p25l725t488r1571b591],
7	—	CD	NUMBER	—	dep	4	SENT_418	[p25l725t488r1571b591],
8	42	CD	NUMBER	42	dep	7	SENT_418	[p25l725t488r1571b591],
9	.	.	O	.	_	0	SENT_418	[p25l725t488r1571b591],

1	15	CD	NUMBER	15	_	0	SENT_419	[p25l17t643r144b721],
2	.	.	O	.	_	0	SENT_419	[p25l17t643r144b721],

1	Quittner	NNP	PERSON	Quittner	nn	2	SENT_420	[p25l211t633r642b744],
2	AL	NNP	PERSON	AL	_	0	SENT_420	[p25l668t639r838b740],
3	,	,	O	,	_	0	SENT_420	[p25l668t639r838b740],
4	Buu	NNP	MISC	Buu	nn	5	SENT_420	[p25l878t639r1070b722],
5	A	NNP	MISC	A	conj_and	2	SENT_420	[p25l1101t639r1203b740],
6	,	,	O	,	_	0	SENT_420	[p25l1101t639r1203b740],
7	Messer	NNP	PERSON	Messer	nn	8	SENT_420	[p25l1240t639r1599b720],
8	MA	NNP	PERSON	MA	conj_and	2	SENT_420	[p25l1626t639r1832b740],
9	,	,	O	,	_	0	SENT_420	[p25l1626t639r1832b740],
10	Modi	NNP	PERSON	Modi	nn	11	SENT_420	[p25l1870t631r2133b721],
11	AC	NN	O	ac	conj_and	2	SENT_420	[p25l7t786r179b889],
12	,	,	O	,	_	0	SENT_420	[p25l7t786r179b889],
13	Watrous	NNP	PERSON	Watrous	nn	15	SENT_420	[p25l227t788r647b871],
14	M.	NNP	O	M.	nn	15	SENT_420	[p25l690t788r817b870],
15	Development	NNP	O	Development	conj_and	2	SENT_420	[p25l866t780r1535b895],
16	and	CC	O	and	_	0	SENT_420	[p25l1573t780r1757b870],
17	Validation	NNP	O	Validation	conj_and	2	SENT_420	[p25l1795t780r2131b871, p25l13t929r211b1019],
18	of	IN	O	of	_	0	SENT_420	[p25l256t927r373b1019],
19	The	DT	O	the	det	22	SENT_420	[p25l393t929r581b1018],
20	Cystic	JJ	O	cystic	amod	22	SENT_420	[p25l625t931r927b1044],
21	Fibrosis	NNP	O	Fibrosis	nn	22	SENT_420	[p25l969t929r1365b1019],
22	Questionnaire	NNP	O	Questionnaire	prep_of	17	SENT_420	[p25l1412t931r2133b1042],
23	in	IN	O	in	_	0	SENT_420	[p25l11t1079r110b1166],
24	the	DT	O	the	det	26	SENT_420	[p25l193t1077r352b1166],
25	United	NNP	LOCATION	United	nn	26	SENT_420	[p25l434t1077r777b1166],
26	States	NNPS	LOCATION	States	prep_in	22	SENT_420	[p25l864t1083r1193b1166],
27	:	:	O	:	_	0	SENT_420	[p25l864t1083r1193b1166],
28	a	DT	O	a	det	33	SENT_420	[p25l1280t1107r1332b1166],
29	health-related	JJ	O	health-related	amod	33	SENT_420	[p25l1413t1077r2133b1166],
30	quality	NN	O	quality	nn	33	SENT_420	[p25l13t1224r702b1341],
31	—	CD	NUMBER	—	num	33	SENT_420	[p25l13t1224r702b1341],
32	of-life	NN	O	of-life	nn	33	SENT_420	[p25l13t1224r702b1341],
33	measure	NN	O	measure	dep	2	SENT_420	[p25l743t1256r1169b1317],
34	for	IN	O	for	_	0	SENT_420	[p25l1210t1224r1355b1316],
35	cystic	JJ	O	cystic	amod	36	SENT_420	[p25l1395t1228r1674b1341],
36	fibrosis	NN	O	fibrosis	prep_for	33	SENT_420	[p25l1715t1224r2127b1316],
37	.	.	O	.	_	0	SENT_420	[p25l1715t1224r2127b1316],

1	Chest	NN	O	chest	_	0	SENT_421	[p25l11t1375r296b1465],
2	2005	CD	DATE	2005	num	1	SENT_421	[p25l330t1381r1243b1484],
3	;	:	O	;	_	0	SENT_421	[p25l330t1381r1243b1484],
4	128:2347	CD	NUMBER	128:2347	number	5	SENT_421	[p25l330t1381r1243b1484],
5	-54	CD	NUMBER	-54	dep	1	SENT_421	[p25l330t1381r1243b1484],
6	.	.	O	.	_	0	SENT_421	[p25l330t1381r1243b1484],

1	16	CD	NUMBER	16	_	0	SENT_422	[p25l17t1534r146b1615],
2	.	.	O	.	_	0	SENT_422	[p25l17t1534r146b1615],

1	Welsh	NNP	MISC	Welsh	nn	3	SENT_423	[p25l205t1524r514b1613],
2	M	NNP	MISC	M	nn	3	SENT_423	[p25l543t1532r704b1633],
3	]	NN	O	]	_	0	SENT_423	[p25l543t1532r704b1633],
4	,	,	O	,	_	0	SENT_423	[p25l543t1532r704b1633],
5	Smith	NNP	PERSON	Smith	nn	6	SENT_423	[p25l747t1524r1043b1615],
6	AE	NNP	O	AE	appos	3	SENT_423	[p25l1072t1532r1244b1614],
7	.	.	O	.	_	0	SENT_423	[p25l1072t1532r1244b1614],

1	Molecular	JJ	O	molecular	amod	2	SENT_424	[p25l1282t1524r1793b1615],
2	mechanisms	NNS	O	mechanism	_	0	SENT_424	[p25l1824t1524r2131b1613, p25l11t1675r369b1762],
3	of	IN	O	of	_	0	SENT_424	[p25l447t1671r563b1763],
4	CFTR	NNP	O	CFTR	nn	7	SENT_424	[p25l617t1679r910b1768],
5	chloride	NN	O	chloride	nn	7	SENT_424	[p25l973t1673r1383b1763],
6	channel	NN	O	channel	nn	7	SENT_424	[p25l1458t1673r1858b1762],
7	dysfunction	NN	O	dysfunction	prep_of	2	SENT_424	[p25l1933t1673r2131b1788, p25l13t1820r443b1913],
8	in	IN	O	in	_	0	SENT_424	[p25l498t1824r595b1911],
9	cystic	JJ	O	cystic	amod	10	SENT_424	[p25l654t1824r934b1937],
10	fibrosis	NN	O	fibrosis	prep_in	7	SENT_424	[p25l989t1820r1401b1912],
11	.	.	O	.	_	0	SENT_424	[p25l989t1820r1401b1912],

1	Cell	NN	O	cell	_	0	SENT_425	[p25l1464t1822r1658b1912],
2	1993	CD	DATE	1993	num	1	SENT_425	[p25l1717t1828r2129b1931],
3	;	:	O	;	_	0	SENT_425	[p25l1717t1828r2129b1931],
4	73	CD	NUMBER	73	num	6	SENT_425	[p25l1717t1828r2129b1931],
5	:	:	O	:	_	0	SENT_425	[p25l1717t1828r2129b1931],
6	1251-4	CD	NUMBER	1251-4	dep	1	SENT_425	[p25l15t1976r375b2059],
7	.	.	O	.	_	0	SENT_425	[p25l15t1976r375b2059],

1	17	CD	NUMBER	17	_	0	SENT_426	[p25l17t2131r136b2208],
2	.	.	O	.	_	0	SENT_426	[p25l17t2131r136b2208],

1	Ramsey	NNP	PERSON	Ramsey	nn	2	SENT_427	[p25l209t2127r609b2234],
2	BW	NN	O	bw	_	0	SENT_427	[p25l640t2127r831b2228],
3	,	,	O	,	_	0	SENT_427	[p25l640t2127r831b2228],
4	Pepe	NNP	PERSON	Pepe	nn	5	SENT_427	[p25l876t2127r1108b2234],
5	MS	NN	PERSON	m	appos	2	SENT_427	[p25l1143t2125r1330b2228],
6	,	,	O	,	_	0	SENT_427	[p25l1143t2125r1330b2228],
7	Quan	NNP	O	Quan	nn	8	SENT_427	[p25l1375t2125r1648b2232],
8	JM	NN	O	jm	appos	2	SENT_427	[p25l1674t2127r1844b2228],
9	,	,	O	,	_	0	SENT_427	[p25l1674t2127r1844b2228],
10	et	FW	O	et	nn	11	SENT_427	[p25l1890t2137r1981b2208],
11	al.	FW	O	al.	appos	2	SENT_427	[p25l2012t2119r2127b2209],
12	.	.	O	.	_	0	SENT_427	[p25l2012t2119r2127b2209],

1	Intermittent	JJ	O	intermittent	amod	2	SENT_428	[p25l11t2267r636b2356],
2	administration	NN	O	administration	nsubj	4	SENT_428	[p25l719t2267r1478b2356],
3	of	IN	O	of	prep	2	SENT_428	[p25l1569t2265r1686b2356],
4	inhaled	VBN	O	inhale	_	0	SENT_428	[p25l1753t2267r2133b2356],
5	tobramycin	NN	O	tobramycin	dobj	4	SENT_428	[p25l13t2416r585b2531],
6	in	IN	O	in	_	0	SENT_428	[p25l636t2418r734b2505],
7	patients	NNS	O	patient	prep_in	4	SENT_428	[p25l783t2418r1185b2531],
8	with	IN	O	with	_	0	SENT_428	[p25l1232t2416r1462b2507],
9	cystic	JJ	O	cystic	amod	10	SENT_428	[p25l1513t2418r1793b2531],
10	fibrosis	NN	O	fibrosis	prep_with	4	SENT_428	[p25l1844t2414r2131b2506, p25l13t2565r168b2655],
11	.	.	O	.	_	0	SENT_428	[p25l1844t2414r2131b2506, p25l13t2565r168b2655],

1	N	NN	O	n	nn	3	SENT_429	[p25l213t2573r298b2656],
2	Engll	NNP	O	Engll	nn	3	SENT_429	[p25l335t2565r633b2680],
3	Med	NNP	O	Med	_	0	SENT_429	[p25l666t2565r884b2655],
4	1999	CD	DATE	1999	num	3	SENT_429	[p25l927t2571r1729b2674],
5	;	:	O	;	_	0	SENT_429	[p25l927t2571r1729b2674],
6	340:233	CD	NUMBER	340:233	number	7	SENT_429	[p25l927t2571r1729b2674],
7	-30	CD	NUMBER	-30	dep	3	SENT_429	[p25l927t2571r1729b2674],
8	.	.	O	.	_	0	SENT_429	[p25l927t2571r1729b2674],

1	18	CD	NUMBER	18	_	0	SENT_430	[p25l17t2722r148b2805],
2	.	.	O	.	_	0	SENT_430	[p25l17t2722r148b2805],

1	Elkins	NNP	PERSON	Elkins	nn	2	SENT_431	[p25l209t2714r524b2805],
2	MR	NN	PERSON	mr	_	0	SENT_431	[p25l571t2722r777b2823],
3	,	,	O	,	_	0	SENT_431	[p25l571t2722r777b2823],
4	Robinson	NNP	PERSON	Robinson	nn	5	SENT_431	[p25l828t2714r1314b2809],
5	M	NNP	O	M	appos	2	SENT_431	[p25l1359t2722r1484b2823],
6	,	,	O	,	_	0	SENT_431	[p25l1359t2722r1484b2823],
7	Rose	NNP	PERSON	Rose	nn	8	SENT_431	[p25l1537t2722r1779b2809],
8	BR	NNP	O	BR	appos	2	SENT_431	[p25l1824t2722r1995b2823],
9	,	,	O	,	_	0	SENT_431	[p25l1824t2722r1995b2823],
10	et	FW	O	et	nn	11	SENT_431	[p25l2050t2732r2139b2803],
11	al.	FW	O	al.	appos	2	SENT_431	[p25l11t2863r126b2953],
12	.	.	O	.	_	0	SENT_431	[p25l11t2863r126b2953],

1	A	DT	O	a	det	3	SENT_432	[p25l165t2871r243b2952],
2	controlled	JJ	O	controlled	amod	3	SENT_432	[p25l278t2863r793b2953],
3	trial	NN	O	trial	nsubj	8	SENT_432	[p25l832t2863r1042b2952],
4	of	IN	O	of	_	0	SENT_432	[p25l1082t2861r1197b2953],
5	long	JJ	O	long	amod	7	SENT_432	[p25l1213t2863r1716b2978],
6	—	JJ	O	—	amod	7	SENT_432	[p25l1213t2863r1716b2978],
7	term	NN	O	term	prep_of	3	SENT_432	[p25l1213t2863r1716b2978],
8	inhaled	VBD	O	inhale	_	0	SENT_432	[p25l1753t2863r2133b2953],
9	hypertonic	JJ	O	hypertonic	amod	10	SENT_432	[p25l13t3012r556b3127],
10	saline	NN	O	saline	dobj	8	SENT_432	[p25l613t3012r908b3101],
11	in	IN	O	in	_	0	SENT_432	[p25l963t3014r1060b3101],
12	patients	NNS	O	patient	prep_in	8	SENT_432	[p25l1114t3014r1516b3127],
13	with	IN	O	with	_	0	SENT_432	[p25l1569t3012r1798b3103],
14	cystic	JJ	O	cystic	amod	15	SENT_432	[p25l1854t3014r2134b3127],
15	fibrosis	NN	O	fibrosis	prep_with	8	SENT_432	[p25l11t3159r423b3251],
16	.	.	O	.	_	0	SENT_432	[p25l11t3159r423b3251],

1	N	NN	O	n	nn	3	SENT_433	[p25l468t3169r554b3252],
2	Engll	NNP	O	Engll	nn	3	SENT_433	[p25l591t3161r888b3276],
3	Med	NNP	O	Med	_	0	SENT_433	[p25l922t3161r1140b3251],
4	2006	CD	DATE	2006	num	3	SENT_433	[p25l1179t3167r2052b3270],
5	;	:	O	;	_	0	SENT_433	[p25l1179t3167r2052b3270],
6	354:229	CD	NUMBER	354:229	number	7	SENT_433	[p25l1179t3167r2052b3270],
7	—	CD	NUMBER	—	dep	3	SENT_433	[p25l1179t3167r2052b3270],
8	40	CD	NUMBER	40	dep	7	SENT_433	[p25l1179t3167r2052b3270],
9	.	.	O	.	_	0	SENT_433	[p25l1179t3167r2052b3270],

1	19	CD	NUMBER	19	_	0	SENT_434	[p25l17t3320r142b3399],
2	.	.	O	.	_	0	SENT_434	[p25l17t3320r142b3399],

1	Flume	NNP	O	Flume	nn	2	SENT_435	[p25l209t3310r512b3401],
2	PA	NN	O	pa	_	0	SENT_435	[p25l593t3318r747b3419],
3	,	,	O	,	_	0	SENT_435	[p25l593t3318r747b3419],
4	O’Sullivan	NNP	O	O’Sullivan	nn	5	SENT_435	[p25l834t3310r1345b3401],
5	BP	NNP	O	BP	appos	2	SENT_435	[p25l1424t3318r1569b3419],
6	,	,	O	,	_	0	SENT_435	[p25l1424t3318r1569b3419],
7	Robinson	NNP	PERSON	Robinson	nn	8	SENT_435	[p25l1654t3310r2133b3405],
8	KA	NN	O	ka	appos	2	SENT_435	[p25l11t3467r191b3568],
9	,	,	O	,	_	0	SENT_435	[p25l11t3467r191b3568],
10	et	FW	O	et	nn	11	SENT_435	[p25l232t3477r322b3548],
11	al.	FW	O	al.	appos	2	SENT_435	[p25l347t3459r460b3549],
12	.	.	O	.	_	0	SENT_435	[p25l347t3459r460b3549],

1	Cystic	JJ	O	cystic	amod	2	SENT_436	[p25l500t3461r795b3574],
2	fibrosis	NN	O	fibrosis	_	0	SENT_436	[p25l827t3457r1203b3549],
3	pulmonary	JJ	O	pulmonary	amod	4	SENT_436	[p25l1236t3459r1791b3574],
4	guidelines	NNS	O	guideline	dep	2	SENT_436	[p25l1816t3459r2132b3574, p25l11t3607r282b3696],
5	:	:	O	:	_	0	SENT_436	[p25l1816t3459r2132b3574, p25l11t3607r282b3696],
6	chronic	JJ	O	chronic	amod	7	SENT_436	[p25l361t3607r746b3696],
7	medications	NNS	O	medication	dep	2	SENT_436	[p25l818t3607r1443b3696],
8	for	IN	O	for	_	0	SENT_436	[p25l1519t3605r1664b3696],
9	mainteENGLJ	NN	O	mainteenglj	prep_for	7	SENT_436	[p25l1735t3607r2131b3696, p26l573t55r651b77],

1	MED	NN	O	med	_	0	SENT_437	[p26l666t55r718b70],
2	;	:	O	;	_	0	SENT_437	[p26l772t49r804b75],
3	18	CD	NUMBER	18	num	4	SENT_437	[p26l772t49r804b75],
4	NEJM.ORG	NN	O	nejm.org	dep	1	SENT_437	[p26l839t55r963b77],
5	NOVEMBER	NNP	DATE	NOVEMBER	dep	4	SENT_437	[p26l1000t55r1156b77],
6	}	CD	DATE	}	num	5	SENT_437	[p26l1000t55r1156b77],
7	2011	CD	DATE	2011	num	8	SENT_437	[p26l1175t55r1226b71],
8	1671	CD	DATE	1671	dep	4	SENT_437	[p26l1940t44r2016b67],

1	T	NN	O	t	_	0	SENT_438	[p26l702t89r721b112],
2	e	SYM	O	e	dep	3	SENT_438	[p26l739t96r753b112],
3	ew	FW	O	ew	rcmod	1	SENT_438	[p26l786t96r824b112],
4	England	NNP	O	England	nn	5	SENT_438	[p26l833t88r944b119],
5	Journal	NNP	O	Journal	dep	1	SENT_438	[p26l952t88r1050b112],
6	of	IN	O	of	_	0	SENT_438	[p26l1059t88r1088b112],
7	Medicine	NNP	O	Medicine	prep_of	5	SENT_438	[p26l1095t88r1220b112],

1	Downloaded	VBN	O	download	_	0	SENT_439	[p26l144t129r314b152],
2	from	IN	O	from	_	0	SENT_439	[p26l323t129r387b152],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_439	[p26l396t129r514b159],
4	at	IN	O	at	_	0	SENT_439	[p26l524t133r547b152],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_439	[p26l556t129r738b152],
6	on	IN	O	on	_	0	SENT_439	[p26l748t136r780b152],
7	J	NN	O	j	nn	8	SENT_439	[p26l789t129r801b152],
8	anu	NN	O	anu	prep_on	1	SENT_439	[p26l803t136r849b152],
9	,	,	O	,	_	0	SENT_439	[p26l919t148r924b157],
10	2014	CD	DATE	2014	appos	8	SENT_439	[p26l935t129r1007b152],
11	.	.	O	.	_	0	SENT_439	[p26l935t129r1007b152],

1	For	IN	O	for	_	0	SENT_440	[p26l1018t129r1064b152],
2	personal	JJ	O	personal	amod	3	SENT_440	[p26l1072t129r1185b159],
3	use	NN	O	use	pobj	1	SENT_440	[p26l1194t136r1237b152],
4	only	RB	O	only	advmod	3	SENT_440	[p26l1247t129r1312b159],
5	.	.	O	.	_	0	SENT_440	[p26l1247t129r1312b159],

1	No	DT	O	no	det	3	SENT_441	[p26l1322t129r1362b152],
2	other	JJ	O	other	amod	3	SENT_441	[p26l1372t129r1440b152],
3	uses	NNS	O	use	_	0	SENT_441	[p26l1448t136r1504b152],
4	without	IN	O	without	_	0	SENT_441	[p26l1514t129r1616b152],
5	permission	NN	O	permission	prep_without	3	SENT_441	[p26l1624t129r1776b159],
6	.	.	O	.	_	0	SENT_441	[p26l1624t129r1776b159],

1	Copyright	NN	O	copyright	nn	5	SENT_442	[p26l494t170r629b201],
2	©	CD	NUMBER	©	num	5	SENT_442	[p26l638t170r661b194],
3	2011	CD	DATE	2011	num	5	SENT_442	[p26l671t170r734b194],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_442	[p26l746t171r844b194],
5	usetts	NNP	O	usetts	_	0	SENT_442	[p26l862t174r937b194],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_442	[p26l947t170r1055b194],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_442	[p26l1065t170r1170b201],
8	.	.	O	.	_	0	SENT_442	[p26l1065t170r1170b201],

1	All	DT	O	all	det	2	SENT_443	[p26l1181t170r1223b194],
2	rights	NNS	O	rights	nsubj	3	SENT_443	[p26l1232t170r1306b201],
3	reserved	VBN	O	reserve	_	0	SENT_443	[p26l1316t170r1435b194],
4	.	.	O	.	_	0	SENT_443	[p26l1316t170r1435b194],

1	A	DT	O	a	det	3	SENT_444	[p26l715t276r734b295],
2	CFTR	NNP	O	CFTR	nn	3	SENT_444	[p26l747t276r830b295],
3	POTENTIATOR	NNP	O	POTENTIATOR	_	0	SENT_444	[p26l844t276r1082b295],
4	FOR	IN	O	for	_	0	SENT_444	[p26l1095t276r1159b295],
5	CYSTIC	NNP	O	CYSTIC	nn	6	SENT_444	[p26l1171t276r1282b295],
6	FIBROSIS	NNP	O	FIBROSIS	prep_for	3	SENT_444	[p26l1296t276r1445b295],

1	nance	NN	O	nance	_	0	SENT_445	[p26l10t624r304b684],
2	of	IN	O	of	_	0	SENT_445	[p26l337t594r453b686],
3	lung	NN	O	lung	nn	4	SENT_445	[p26l461t594r687b712],
4	health	NN	O	health	prep_of	1	SENT_445	[p26l714t594r1056b686],
5	.	.	O	.	_	0	SENT_445	[p26l714t594r1056b686],

1	Aml	NNP	O	Aml	nn	4	SENT_446	[p26l1090t602r1331b700],
2	Respir	NNP	O	Respir	nn	4	SENT_446	[p26l1359t596r1682b710],
3	Crit	NNP	O	Crit	nn	4	SENT_446	[p26l1710t596r1898b686],
4	Care	NNP	O	Care	nsubj	5	SENT_446	[p26l1923t600r2147b686],
5	Med	VBD	O	med	_	0	SENT_446	[p26l6t744r224b836],
6	2007	CD	DATE	2007	dobj	5	SENT_446	[p26l261t752r1090b854],
7	;	:	O	;	_	0	SENT_446	[p26l261t752r1090b854],
8	176:957	CD	NUMBER	176:957	num	9	SENT_446	[p26l261t752r1090b854],
9	-69	CD	NUMBER	-69	dep	6	SENT_446	[p26l261t752r1090b854],
10	.	.	O	.	_	0	SENT_446	[p26l261t752r1090b854],

1	20	CD	NUMBER	20	_	0	SENT_447	[p26l8t904r148b986],
2	.	.	O	.	_	0	SENT_447	[p26l8t904r148b986],

1	Sanders	NNP	PERSON	Sanders	nn	2	SENT_448	[p26l213t894r607b986],
2	DB	NNP	O	DB	_	0	SENT_448	[p26l646t902r824b1006],
3	,	,	O	,	_	0	SENT_448	[p26l646t902r824b1006],
4	Bittner	NNP	PERSON	Bittner	nn	5	SENT_448	[p26l868t896r1221b986],
5	RC	NNP	O	RC	appos	2	SENT_448	[p26l1253t902r1427b1004],
6	,	,	O	,	_	0	SENT_448	[p26l1253t902r1427b1004],
7	Rosenfeld	NNP	PERSON	Rosenfeld	nn	8	SENT_448	[p26l1470t894r1980b990],
8	M	NNP	O	M	appos	5	SENT_448	[p26l2015t902r2141b1004],
9	,	,	O	,	_	0	SENT_448	[p26l2015t902r2141b1004],
10	Hoffman	NNP	ORGANIZATION	Hoffman	nn	11	SENT_448	[p26l10t1044r477b1136],
11	LR	NNP	ORGANIZATION	LR	appos	5	SENT_448	[p26l517t1052r685b1154],
12	,	,	O	,	_	0	SENT_448	[p26l517t1052r685b1154],
13	Redding	NNP	O	Redding	nn	14	SENT_448	[p26l732t1044r1164b1162],
14	Gl	NNP	O	Gl	appos	5	SENT_448	[p26l1203t1052r1345b1154],
15	,	,	O	,	_	0	SENT_448	[p26l1203t1052r1345b1154],
16	Goss	NNP	PERSON	Goss	nn	17	SENT_448	[p26l1395t1050r1644b1136],
17	CH	NN	O	ch	appos	5	SENT_448	[p26l1690t1050r1876b1136],
18	.	.	O	.	_	0	SENT_448	[p26l1690t1050r1876b1136],

1	Failure	NN	O	failure	_	0	SENT_449	[p26l1924t1044r2147b1134, p26l10t1224r168b1286],
2	to	TO	O	to	aux	3	SENT_449	[p26l203t1214r298b1286],
3	recover	VB	O	recover	dep	1	SENT_449	[p26l333t1224r694b1286],
4	to	TO	O	to	_	0	SENT_449	[p26l726t1214r820b1286],
5	baseline	NN	O	baseline	nn	7	SENT_449	[p26l856t1194r1267b1286],
6	pulmonary	JJ	O	pulmonary	amod	7	SENT_449	[p26l1299t1194r1858b1310],
7	function	NN	O	function	prep_to	3	SENT_449	[p26l1885t1194r2147b1286, p26l10t1346r208b1436],
8	after	IN	O	after	_	0	SENT_449	[p26l251t1344r489b1436],
9	cystic	JJ	O	cystic	amod	12	SENT_449	[p26l531t1346r814b1460],
10	fibrosis	NN	O	fibrosis	nn	12	SENT_449	[p26l856t1344r1241b1436],
11	pulmonary	JJ	O	pulmonary	amod	12	SENT_449	[p26l1287t1344r1852b1460],
12	exacerbation	NN	O	exacerbation	prep_after	7	SENT_449	[p26l1892t1374r2147b1434, p26l12t1494r461b1586],
13	.	.	O	.	_	0	SENT_449	[p26l1892t1374r2147b1434, p26l12t1494r461b1586],

1	AmJ	NN	O	amj	nn	4	SENT_450	[p26l499t1502r746b1600],
2	Respir	NN	O	respir	nn	4	SENT_450	[p26l778t1496r1107b1610],
3	Crit	NNP	O	Crit	nn	4	SENT_450	[p26l1139t1496r1331b1586],
4	Care	NNP	O	Care	nsubj	5	SENT_450	[p26l1361t1500r1590b1586],
5	Med	VBD	O	med	_	0	SENT_450	[p26l1622t1494r1842b1586],
6	2010	CD	DATE	2010	dobj	5	SENT_450	[p26l1877t1500r2143b1604],
7	;	:	O	;	_	0	SENT_450	[p26l1877t1500r2143b1604],
8	182:627	CD	NUMBER	182:627	num	9	SENT_450	[p26l14t1650r583b1736],
9	-32	CD	NUMBER	-32	dep	6	SENT_450	[p26l14t1650r583b1736],
10	.	.	O	.	_	0	SENT_450	[p26l14t1650r583b1736],

1	21	CD	NUMBER	21	_	0	SENT_451	[p26l8t1806r146b1884],
2	.	.	O	.	_	0	SENT_451	[p26l8t1806r146b1884],

1	Quittner	NNP	PERSON	Quittner	nn	2	SENT_452	[p26l209t1796r645b1908],
2	AL	NNP	PERSON	AL	_	0	SENT_452	[p26l676t1802r846b1906],
3	,	,	O	,	_	0	SENT_452	[p26l676t1802r846b1906],
4	Modi	NNP	PERSON	Modi	nn	5	SENT_452	[p26l888t1794r1154b1886],
5	AC	NN	O	ac	appos	2	SENT_452	[p26l1187t1802r1361b1904],
6	,	,	O	,	_	0	SENT_452	[p26l1187t1802r1361b1904],
7	Wainwright	NN	PERSON	wainwright	nn	8	SENT_452	[p26l1401t1794r2012b1912],
8	C	NN	PERSON	c	appos	5	SENT_452	[p26l2045t1802r2141b1904],
9	,	,	O	,	_	0	SENT_452	[p26l2045t1802r2141b1904],
10	Otto	NNP	PERSON	Otto	nn	11	SENT_452	[p26l10t1950r236b2036],
11	K	NNP	PERSON	K	appos	5	SENT_452	[p26l287t1952r389b2054],
12	,	,	O	,	_	0	SENT_452	[p26l287t1952r389b2054],
13	Kirihara	NNP	PERSON	Kirihara	nn	14	SENT_452	[p26l447t1944r876b2038],
14	J	NNP	PERSON	J	appos	5	SENT_452	[p26l914t1952r980b2054],
15	,	,	O	,	_	0	SENT_452	[p26l914t1952r980b2054],
16	Montgomery	NNP	ORGANIZATION	Montgomery	nn	17	SENT_452	[p26l1035t1952r1696b2062],
17	AB	NNP	ORGANIZATION	AB	appos	5	SENT_452	[p26l1738t1952r1914b2036],
18	.	.	O	.	_	0	SENT_452	[p26l1738t1952r1914b2036],

1	Determination	NN	O	determination	_	0	SENT_453	[p26l1971t1952r2147b2034, p26l10t2096r621b2186],
2	of	IN	O	of	_	0	SENT_453	[p26l662t2094r779b2186],
3	the	DT	O	the	det	8	SENT_453	[p26l798t2094r956b2186],
4	minimal	JJ	O	minimal	amod	8	SENT_453	[p26l996t2094r1435b2184],
5	clinically	RB	O	clinically	advmod	6	SENT_453	[p26l1477t2094r1942b2210],
6	important	JJ	O	important	amod	8	SENT_453	[p26l1977t2096r2147b2184, p26l8t2264r395b2360],
7	difference	NN	O	difference	nn	8	SENT_453	[p26l455t2244r968b2336],
8	scores	NNS	O	score	prep_of	1	SENT_453	[p26l1035t2274r1347b2336],
9	for	IN	O	for	_	0	SENT_453	[p26l1415t2244r1561b2336],
10	the	DT	O	the	det	13	SENT_453	[p26l1624t2244r1780b2336],
11	Cystic	JJ	O	cystic	amod	13	SENT_453	[p26l1846t2246r2149b2360],
12	Fibrosis	NNP	O	Fibrosis	nn	13	SENT_453	[p26l8t2394r399b2486],
13	Questionnaire	NNP	O	Questionnaire	prep_for	1	SENT_453	[p26l435t2394r1573b2508],
14	.	.	O	.	_	0	SENT_453	[p26l435t2394r1573b2508],

1	—	NN	O	—	_	0	SENT_454	[p26l435t2394r1573b2508],
2	.	.	O	.	_	0	SENT_454	[p26l435t2394r1573b2508],

1	Revised	VBN	O	revise	_	0	SENT_455	[p26l435t2394r1573b2508],
2	respiratory	JJ	O	respiratory	amod	4	SENT_455	[p26l1606t2396r2153b2510],
3	symptom	NN	O	symptom	nn	4	SENT_455	[p26l12t2564r491b2660],
4	scale	NN	O	scale	dobj	1	SENT_455	[p26l533t2544r784b2636],
5	in	IN	O	in	_	0	SENT_455	[p26l824t2546r922b2634],
6	two	CD	NUMBER	two	num	7	SENT_455	[p26l964t2564r1151b2636],
7	populations	NNS	O	population	prep_in	4	SENT_455	[p26l1191t2544r1810b2660],
8	of	IN	O	of	_	0	SENT_455	[p26l1854t2544r1972b2636],
9	patients	NNS	O	patient	prep_of	7	SENT_455	[p26l1989t2574r2147b2660, p26l10t2696r296b2786],
10	with	IN	O	with	_	0	SENT_455	[p26l367t2694r600b2786],
11	cystic	JJ	O	cystic	amod	12	SENT_455	[p26l673t2696r960b2808],
12	fibrosis	NN	O	fibrosis	prep_with	1	SENT_455	[p26l1032t2694r1425b2786],
13	and	CC	O	and	_	0	SENT_455	[p26l1498t2694r1686b2786],
14	chronic	JJ	O	chronic	conj_and	1	SENT_455	[p26l1760t2694r2149b2786],

1	Pseudomonas	FW	PERSON	pseudomonas	nn	3	SENT_456	[p26l8t2953r341b2998],
2	aeruginosa	FW	O	aeruginosa	nn	3	SENT_456	[p26l358t2954r624b3010],
3	airway	NN	O	airway	_	0	SENT_456	[p26l638t2954r798b3009],
4	infection	NN	O	infection	dep	3	SENT_456	[p26l811t2953r1040b2997],
5	.	.	O	.	_	0	SENT_456	[p26l811t2953r1040b2997],

1	Chest	NN	O	chest	_	0	SENT_457	[p26l9t3025r144b3069],
2	2009	CD	DATE	2009	num	1	SENT_457	[p26l159t3028r564b3078],
3	;	:	O	;	_	0	SENT_457	[p26l159t3028r564b3078],
4	135:1610	CD	NUMBER	135:1610	number	5	SENT_457	[p26l159t3028r564b3078],
5	-8	CD	NUMBER	-8	dep	1	SENT_457	[p26l159t3028r564b3078],
6	.	.	O	.	_	0	SENT_457	[p26l159t3028r564b3078],

1	22	CD	NUMBER	22	_	0	SENT_458	[p26l8t3102r77b3140],
2	.	.	O	.	_	0	SENT_458	[p26l8t3102r77b3140],

1	Saiman	NNP	PERSON	Saiman	nn	2	SENT_459	[p26l107t3097r290b3140],
2	L	NNP	PERSON	L	_	0	SENT_459	[p26l314t3100r357b3149],
3	,	,	O	,	_	0	SENT_459	[p26l314t3100r357b3149],
4	Marshall	NNP	PERSON	Marshall	nn	5	SENT_459	[p26l383t3096r603b3140],
5	BC	NNP	O	BC	appos	2	SENT_459	[p26l627t3099r710b3149],
6	,	,	O	,	_	0	SENT_459	[p26l627t3099r710b3149],
7	MayerHamblett	NNP	O	MayerHamblett	nn	8	SENT_459	[p26l735t3100r1042b3152, p26l9t3166r121b3210],
8	N	NNP	O	N	appos	2	SENT_459	[p26l149t3170r202b3220],
9	,	,	O	,	_	0	SENT_459	[p26l149t3170r202b3220],
10	et	FW	O	et	nn	11	SENT_459	[p26l237t3175r281b3210],
11	al.	FW	O	al.	appos	2	SENT_459	[p26l310t3166r365b3210],
12	.	.	O	.	_	0	SENT_459	[p26l310t3166r365b3210],

1	Azithromycin	NNP	O	Azithromycin	nsubj	8	SENT_460	[p26l398t3166r736b3222],
2	in	IN	O	in	_	0	SENT_460	[p26l767t3167r815b3210],
3	patients	NNS	O	patient	prep_in	1	SENT_460	[p26l845t3167r1042b3222],
4	with	IN	O	with	_	0	SENT_460	[p26l7t3238r117b3283],
5	cystic	JJ	O	cystic	amod	6	SENT_460	[p26l151t3239r287b3294],
6	fibrosis	NN	O	fibrosis	prep_with	3	SENT_460	[p26l320t3238r505b3282],
7	chronically	RB	O	chronically	advmod	6	SENT_460	[p26l540t3238r814b3294],
8	infected	VBN	O	infect	_	0	SENT_460	[p26l845t3238r1043b3282],
9	with	IN	O	with	_	0	SENT_460	[p26l7t3308r117b3353],
10	Pseudomonas	FW	PERSON	pseudomonas	nn	11	SENT_460	[p26l134t3308r471b3353],
11	aeruginosa	FW	O	aeruginosa	prep_with	8	SENT_460	[p26l489t3309r773b3365],
12	:	:	O	:	_	0	SENT_460	[p26l489t3309r773b3365],
13	a	DT	O	a	nsubj	14	SENT_460	[p26l792t3323r817b3352],
14	randomized	VBN	O	randomize	parataxis	8	SENT_460	[p26l833t3308r1042b3352, p26l9t3379r110b3423],
15	controlled	JJ	O	controlled	amod	16	SENT_460	[p26l122t3379r374b3423],
16	trial	NN	O	trial	dobj	14	SENT_460	[p26l386t3379r502b3423],
17	.	.	O	.	_	0	SENT_460	[p26l386t3379r502b3423],

1	JAMA	NNP	O	JAMA	_	0	SENT_461	[p26l512t3383r659b3430],
2	2003	CD	DATE	2003	num	1	SENT_461	[p26l670t3382r1042b3432, p26l10t3454r80b3495],
3	;	:	O	;	_	0	SENT_461	[p26l670t3382r1042b3432, p26l10t3454r80b3495],
4	290:174956	CD	NUMBER	290:174956	dep	1	SENT_461	[p26l670t3382r1042b3432, p26l10t3454r80b3495],
5	.	.	O	.	_	0	SENT_461	[p26l670t3382r1042b3432, p26l10t3454r80b3495],

1	23	CD	NUMBER	23	_	0	SENT_462	[p26l8t3527r75b3566],
2	.	.	O	.	_	0	SENT_462	[p26l8t3527r75b3566],

1	Saiman	NNP	PERSON	Saiman	nn	2	SENT_463	[p26l107t3523r290b3566],
2	L	NNP	PERSON	L	_	0	SENT_463	[p26l324t3526r367b3576],
3	,	,	O	,	_	0	SENT_463	[p26l324t3526r367b3576],
4	Anstead	NNP	O	Anstead	nn	5	SENT_463	[p26l403t3522r604b3566],
5	M	NNP	O	M	appos	2	SENT_463	[p26l637t3526r699b3576],
6	,	,	O	,	_	0	SENT_463	[p26l637t3526r699b3576],
7	MayerHamblett	NNP	O	MayerHamblett	nn	8	SENT_463	[p26l735t3526r1042b3578, p26l9t3593r121b3637],
8	N	NNP	O	N	appos	2	SENT_463	[p26l145t3597r198b3647],
9	,	,	O	,	_	0	SENT_463	[p26l145t3597r198b3647],
10	et	FW	O	et	nn	11	SENT_463	[p26l229t3602r273b3637],
11	al.	FW	O	al.	appos	2	SENT_463	[p26l298t3593r354b3637],
12	.	.	O	.	_	0	SENT_463	[p26l298t3593r354b3637],

1	Effect	NN	O	effect	nsubj	12	SENT_464	[p26l383t3593r529b3637],
2	of	IN	O	of	_	0	SENT_464	[p26l555t3593r611b3637],
3	azithromycin	NN	O	azithromycin	prep_of	1	SENT_464	[p26l628t3593r955b3649],
4	on	IN	O	on	_	0	SENT_464	[p26l983t3607r1043b3637],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_464	[p26l8t3664r282b3720],
6	function	NN	O	function	prep_on	3	SENT_464	[p26l301t3664r511b3709],
7	in	IN	O	in	_	0	SENT_464	[p26l532t3665r579b3708],
8	patients	NNS	O	patient	prep_in	6	SENT_464	[p26l600t3665r796b3720],
9	with	IN	O	with	_	0	SENT_464	[p26l816t3664r928b3708],
10	cystic	JJ	O	cystic	amod	11	SENT_464	[p26l950t3679r1042b3720, p26l9t3736r69b3779],
11	fibrosis	NN	O	fibrosis	prep_with	8	SENT_464	[p26l86t3735r273b3779],
12	uninfected	JJ	O	uninfected	_	0	SENT_464	[p26l292t3735r557b3780],
13	with	IN	O	with	_	0	SENT_464	[p26l573t3735r685b3780],
14	Pseudomonas	FW	PERSON	pseudomonas	nn	15	SENT_464	[p26l702t3735r1042b3780],
15	proach	FW	O	proach	prep_with	12	SENT_464	[p26l1118t2953r1286b3009],
16	to	TO	O	to	_	0	SENT_464	[p26l1309t2962r1355b2997],
17	the	DT	O	the	det	19	SENT_464	[p26l1378t2953r1454b2997],
18	nutritional	JJ	O	nutritional	amod	19	SENT_464	[p26l1476t2953r1742b2998],
19	care	NN	O	care	prep_to	12	SENT_464	[p26l1765t2967r1865b2997],
20	of	IN	O	of	_	0	SENT_464	[p26l1887t2953r1945b2997],
21	patients	NNS	O	patient	prep_of	19	SENT_464	[p26l1955t2954r2151b3009],
22	with	IN	O	with	_	0	SENT_464	[p26l1116t3025r1228b3070],
23	cystic	JJ	O	cystic	amod	24	SENT_464	[p26l1258t3026r1395b3081],
24	fibrosis	NN	O	fibrosis	prep_with	21	SENT_464	[p26l1425t3025r1626b3069],
25	.	.	O	.	_	0	SENT_464	[p26l1425t3025r1626b3069],

1	J	NNP	O	J	nn	3	SENT_465	[p26l1654t3029r1676b3076],
2	R	NNP	O	R	nn	3	SENT_465	[p26l1704t3029r1745b3072],
3	Soc	NNP	O	Soc	nsubj	4	SENT_465	[p26l1771t3028r1854b3069],
4	Med	VBD	O	med	_	0	SENT_465	[p26l1883t3025r1989b3069],
5	1989	CD	DATE	1989	num	7	SENT_465	[p26l2021t3028r2150b3078],
6	;	:	O	;	_	0	SENT_465	[p26l2021t3028r2150b3078],
7	82	CD	NUMBER	82	dobj	4	SENT_465	[p26l1119t3096r1330b3152],
8	:	:	O	:	_	0	SENT_465	[p26l1119t3096r1330b3152],
9	Suppl	NNP	O	Suppl	dep	7	SENT_465	[p26l1119t3096r1330b3152],
10	16:11	CD	TIME	16:11	num	9	SENT_465	[p26l1351t3099r1565b3140],
11	-20	CD	NUMBER	-20	dep	9	SENT_465	[p26l1351t3099r1565b3140],
12	.	.	O	.	_	0	SENT_465	[p26l1351t3099r1565b3140],

1	25	CD	NUMBER	25	_	0	SENT_466	[p26l1118t3172r1184b3210],
2	.	.	O	.	_	0	SENT_466	[p26l1118t3172r1184b3210],

1	Rich	NNP	O	Rich	nn	2	SENT_467	[p26l1214t3166r1326b3213],
2	DP	NN	O	dp	_	0	SENT_467	[p26l1355t3170r1433b3219],
3	,	,	O	,	_	0	SENT_467	[p26l1355t3170r1433b3219],
4	Anderson	NNP	PERSON	Anderson	nn	5	SENT_467	[p26l1464t3166r1703b3210],
5	MP	NNP	O	MP	appos	2	SENT_467	[p26l1731t3170r1820b3220],
6	,	,	O	,	_	0	SENT_467	[p26l1731t3170r1820b3220],
7	Gregory	NNP	PERSON	Gregory	nn	9	SENT_467	[p26l1853t3169r2054b3223],
8	R	NNP	PERSON	R	nn	9	SENT_467	[p26l2081t3170r2149b3217],
9	]	NN	O	]	appos	5	SENT_467	[p26l2081t3170r2149b3217],
10	.	.	O	.	_	0	SENT_467	[p26l2081t3170r2149b3217],

1	Expression	NN	O	expression	nsubj	8	SENT_468	[p26l1118t3239r1387b3294],
2	of	IN	O	of	_	0	SENT_468	[p26l1419t3238r1476b3282],
3	cystic	JJ	O	cystic	amod	7	SENT_468	[p26l1497t3239r1633b3294],
4	fibrosis	NN	O	fibrosis	nn	7	SENT_468	[p26l1664t3238r1850b3282],
5	transmembrane	NN	O	transmembrane	nn	7	SENT_468	[p26l1883t3247r2152b3282, p26l1119t3308r1256b3352],
6	conductance	NN	O	conductance	nn	7	SENT_468	[p26l1279t3308r1588b3353],
7	regulator	NN	O	regulator	prep_of	1	SENT_468	[p26l1610t3308r1838b3365],
8	corrects	VBZ	O	correct	_	0	SENT_468	[p26l1859t3317r2054b3352],
9	defective	JJ	O	defective	amod	12	SENT_468	[p26l2078t3308r2152b3352, p26l1118t3379r1276b3424],
10	chloride	NN	O	chloride	nn	12	SENT_468	[p26l1294t3379r1493b3423],
11	channel	NN	O	channel	nn	12	SENT_468	[p26l1511t3379r1705b3423],
12	regulation	NN	O	regulation	dobj	8	SENT_468	[p26l1723t3379r1977b3436],
13	in	IN	O	in	_	0	SENT_468	[p26l1995t3380r2042b3423],
14	cystic	JJ	O	cystic	amod	18	SENT_468	[p26l2060t3394r2152b3435, p26l1119t3452r1178b3495],
15	fibrosis	NN	O	fibrosis	nn	18	SENT_468	[p26l1199t3451r1384b3495],
16	airway	NN	O	airway	nn	18	SENT_468	[p26l1407t3452r1570b3507],
17	epithelial	JJ	O	epithelial	amod	18	SENT_468	[p26l1589t3451r1818b3507],
18	cells	NNS	O	cell	prep_in	12	SENT_468	[p26l1840t3451r1961b3495],
19	.	.	O	.	_	0	SENT_468	[p26l1840t3451r1961b3495],

1	Nature	NNP	O	Nature	_	0	SENT_469	[p26l1985t3455r2152b3496],
2	1990	CD	DATE	1990	num	1	SENT_469	[p26l1120t3525r1535b3575],
3	;	:	O	;	_	0	SENT_469	[p26l1120t3525r1535b3575],
4	347:358	CD	NUMBER	347:358	number	5	SENT_469	[p26l1120t3525r1535b3575],
5	-63	CD	NUMBER	-63	dep	1	SENT_469	[p26l1120t3525r1535b3575],
6	.	.	O	.	_	0	SENT_469	[p26l1120t3525r1535b3575],

1	26	CD	NUMBER	26	_	0	SENT_470	[p26l1118t3598r1186b3637],
2	.	.	O	.	_	0	SENT_470	[p26l1118t3598r1186b3637],

1	Goss	NNP	PERSON	Goss	nn	2	SENT_471	[p26l1215t3596r1336b3637],
2	CH	NN	O	ch	_	0	SENT_471	[p26l1368t3596r1459b3646],
3	,	,	O	,	_	0	SENT_471	[p26l1368t3596r1459b3646],
4	Mayer-Hamblett	JJ	PERSON	mayer-hamblett	amod	5	SENT_471	[p26l1492t3593r1895b3649],
5	N	NN	O	n	appos	2	SENT_471	[p26l1923t3597r1977b3646],
6	,	,	O	,	_	0	SENT_471	[p26l1923t3597r1977b3646],
7	Kronmal	JJ	PERSON	kronmal	amod	8	SENT_471	[p26l2011t3597r2152b3638, p26l1119t3664r1211b3708],
8	RA	NN	O	ra	appos	2	SENT_471	[p26l1231t3668r1319b3717],
9	,	,	O	,	_	0	SENT_471	[p26l1231t3668r1319b3717],
10	Williams	NNP	PERSON	Williams	nn	11	SENT_471	[p26l1340t3664r1565b3708],
11	J	NNP	O	J	appos	2	SENT_471	[p26l1581t3668r1613b3717],
12	,	,	O	,	_	0	SENT_471	[p26l1581t3668r1613b3717],
13	Ramsey	NNP	PERSON	Ramsey	nn	14	SENT_471	[p26l1636t3668r1832b3720],
14	BW	NN	O	bw	appos	2	SENT_471	[p26l1849t3668r1942b3708],
15	.	.	O	.	_	0	SENT_471	[p26l1849t3668r1942b3708],

1	Laboratory	NNP	O	Laboratory	nn	3	SENT_472	[p26l1965t3664r2152b3708, p26l1119t3744r1217b3791],
2	parameter	NN	O	parameter	nn	3	SENT_472	[p26l1247t3744r1501b3791],
3	profiles	NNS	O	profile	_	0	SENT_472	[p26l1531t3735r1721b3791],
4	among	IN	O	among	_	0	SENT_472	[p26l1755t3749r1926b3792],
5	patients	NNS	O	patient	prep_among	3	SENT_472	[p26l1955t3736r2151b3791],
6	aeruginosa	FW	O	aeruginosa	dep	3	SENT_472	[p27l9t15r295b71],
7	:	:	O	:	_	0	SENT_472	[p27l9t15r295b71],
8	a	DT	O	a	dep	3	SENT_472	[p27l321t29r346b58],
9	randomized	VBN	O	randomize	partmod	8	SENT_472	[p27l370t14r668b58],
10	controlled	JJ	O	controlled	amod	12	SENT_472	[p27l693t14r944b58],
11	tri	FW	O	tri	nn	12	SENT_472	[p27l968t15r1042b58],
12	—	FW	O	—	dobj	9	SENT_472	[p27l968t15r1042b58],
13	with	IN	O	with	_	0	SENT_472	[p27l1116t14r1228b59],
14	cystic	JJ	O	cystic	amod	15	SENT_472	[p27l1251t15r1388b70],
15	fibrosis	NN	O	fibrosis	prep_with	9	SENT_472	[p27l1411t14r1611b58],
16	.	.	O	.	_	0	SENT_472	[p27l1411t14r1611b58],

1	J	NNP	O	J	nn	3	SENT_473	[p27l1633t18r1653b65],
2	Cyst	NNP	O	Cyst	nn	3	SENT_473	[p27l1675t17r1781b70],
3	Fibros	NNP	O	Fibros	_	0	SENT_473	[p27l1801t14r1952b58],
4	2007	CD	DATE	2007	num	3	SENT_473	[p27l1976t17r2150b67],
5	;	:	O	;	_	0	SENT_473	[p27l1976t17r2150b67],
6	6	CD	NUMBER	6	dep	3	SENT_473	[p27l1976t17r2150b67],
7	:	:	O	:	_	0	SENT_473	[p27l1976t17r2150b67],
8	al.	FW	O	al.	dep	6	SENT_473	[p27l9t86r64b130],
9	.	.	O	.	_	0	SENT_473	[p27l9t86r64b130],

1	JAMA	NNP	O	JAMA	_	0	SENT_474	[p27l81t90r228b137],
2	2010	CD	DATE	2010	num	1	SENT_474	[p27l246t89r680b139],
3	;	:	O	;	_	0	SENT_474	[p27l246t89r680b139],
4	303:1707	CD	NUMBER	303:1707	number	5	SENT_474	[p27l246t89r680b139],
5	—	CD	NUMBER	—	dep	1	SENT_474	[p27l246t89r680b139],
6	15	CD	NUMBER	15	dep	5	SENT_474	[p27l246t89r680b139],
7	.	.	O	.	_	0	SENT_474	[p27l246t89r680b139],

1	117-23	CD	NUMBER	117-23	_	0	SENT_475	[p27l1120t89r1290b130],
2	.	.	O	.	_	0	SENT_475	[p27l1120t89r1290b130],

1	24	CD	NUMBER	24	_	0	SENT_476	[p27l8t163r76b201],
2	.	.	O	.	_	0	SENT_476	[p27l8t163r76b201],

1	Durie	NNP	PERSON	Durie	nn	2	SENT_477	[p27l105t158r241b202],
2	PR	NNP	O	PR	_	0	SENT_477	[p27l260t161r339b211],
3	,	,	O	,	_	0	SENT_477	[p27l260t161r339b211],
4	Pencharz	NNP	O	Pencharz	nn	5	SENT_477	[p27l361t157r586b201],
5	PB	NN	O	pb	appos	2	SENT_477	[p27l605t161r680b201],
6	.	.	O	.	_	0	SENT_477	[p27l605t161r680b201],

1	A	DT	O	a	det	3	SENT_478	[p27l701t161r738b201],
2	rational	JJ	O	rational	amod	3	SENT_478	[p27l756t157r948b201],
3	ap	NN	O	ap	_	0	SENT_478	[p27l967t171r1042b213],
4	-	:	O	-	_	0	SENT_478	[p27l967t171r1042b213],
5	Copyright	NN	O	copyright	nn	10	SENT_478	[p27l1120t164r1300b213],
6	©	CD	NUMBER	©	num	10	SENT_478	[p27l1318t168r1358b208],
7	2011	CD	DATE	2011	num	10	SENT_478	[p27l1378t167r1468b201],
8	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	10	SENT_478	[p27l1489t164r1760b201],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_478	[p27l1777t164r1926b201],
10	Society	NNP	ORGANIZATION	Society	dep	3	SENT_478	[p27l1941t166r2080b212],
11	.	.	O	.	_	0	SENT_478	[p27l1941t166r2080b212],

1	1672	CD	DATE	1672	num	4	SENT_479	[p27l149t288r225b311],
2	N	NN	O	n	nn	4	SENT_479	[p27l937t299r951b314],
3	ENGLJ	NN	O	englj	nn	4	SENT_479	[p27l965t299r1043b321],
4	MED	NN	O	med	_	0	SENT_479	[p27l1058t299r1110b314],
5	365	CD	NUMBER	365	dep	4	SENT_479	[p27l1120t293r1196b321],
6	;	:	O	;	_	0	SENT_479	[p27l1120t293r1196b321],
7	18	CD	NUMBER	18	num	8	SENT_479	[p27l1120t293r1196b321],
8	NEJM.ORG	NN	O	nejm.org	dep	5	SENT_479	[p27l1231t299r1355b321],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_479	[p27l1392t299r1527b315],
10	3	CD	DATE	3	num	9	SENT_479	[p27l1537t299r1555b321],
11	,	,	DATE	,	_	0	SENT_479	[p27l1537t299r1555b321],
12	2011	CD	DATE	2011	num	9	SENT_479	[p27l1567t299r1618b315],

1	The	DT	O	the	det	4	SENT_480	[p27l935t332r986b356],
2	New	NNP	O	New	nn	4	SENT_480	[p27l995t333r1057b356],
3	England	NNP	O	England	nn	4	SENT_480	[p27l1066t332r1177b363],
4	Journal	NNP	O	Journal	_	0	SENT_480	[p27l1186t332r1283b356],
5	of	IN	O	of	_	0	SENT_480	[p27l1293t332r1322b356],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_480	[p27l1329t332r1454b356],

1	Downloaded	VBN	O	download	_	0	SENT_481	[p27l377t373r547b396],
2	from	IN	O	from	_	0	SENT_481	[p27l556t373r621b396],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_481	[p27l629t373r748b403],
4	at	IN	O	at	_	0	SENT_481	[p27l758t377r781b396],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_481	[p27l789t373r972b396],
6	on	IN	O	on	_	0	SENT_481	[p27l981t380r1014b396],
7	January	NNP	DATE	January	prep_on	1	SENT_481	[p27l1022t373r1125b403],
8	5	CD	DATE	5	num	7	SENT_481	[p27l1135t373r1158b400],
9	,	,	DATE	,	_	0	SENT_481	[p27l1135t373r1158b400],
10	2014	CD	DATE	2014	num	7	SENT_481	[p27l1168t373r1241b396],
11	.	.	O	.	_	0	SENT_481	[p27l1168t373r1241b396],

1	For	IN	O	for	_	0	SENT_482	[p27l1251t373r1298b396],
2	personal	JJ	O	personal	amod	3	SENT_482	[p27l1306t373r1418b403],
3	use	NN	O	use	pobj	1	SENT_482	[p27l1427t380r1471b396],
4	only	RB	O	only	advmod	3	SENT_482	[p27l1480t373r1545b403],
5	.	.	O	.	_	0	SENT_482	[p27l1480t373r1545b403],

1	No	DT	O	no	det	3	SENT_483	[p27l1556t373r1595b396],
2	other	JJ	O	other	amod	3	SENT_483	[p27l1605t373r1673b396],
3	uses	NNS	O	use	_	0	SENT_483	[p27l1682t380r1738b396],
4	without	IN	O	without	_	0	SENT_483	[p27l1748t373r1849b396],
5	permission	NN	O	permission	prep_without	3	SENT_483	[p27l1857t373r2010b403],
6	.	.	O	.	_	0	SENT_483	[p27l1857t373r2010b403],

1	Copyright	NN	O	copyright	_	0	SENT_484	[p27l728t414r862b445],
2	©	CD	NUMBER	©	num	6	SENT_484	[p27l871t414r895b438],
3	2011	CD	DATE	2011	num	6	SENT_484	[p27l905t414r967b438],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_484	[p27l979t414r1170b438],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_484	[p27l1180t414r1288b438],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_484	[p27l1299t414r1404b445],
7	.	.	O	.	_	0	SENT_484	[p27l1299t414r1404b445],

1	All	DT	O	all	det	2	SENT_485	[p27l1415t414r1456b438],
2	rights	NNS	O	rights	nsubj	3	SENT_485	[p27l1465t414r1540b445],
3	reserved	VBN	O	reserve	_	0	SENT_485	[p27l1550t414r1668b438],
4	.	.	O	.	_	0	SENT_485	[p27l1550t414r1668b438],

